# Diphenhydramine Hydrochloride 디펜히드라민염산염  

![](images/d2aec0f70c4769658ce922ee69823345e103891e76023bdcc243153b049abdaa.jpg)  

$\mathrm{C_{17}H_{21}N O{\cdot}H C l}:291.82$  

2-BenzhydryloxyN,N -dimethyl-ethanamine hydrochloride [ 147-24-0 ]  

Diphenhydramine Hydrochloride, when dried, contains NLT $98.0\%$ and NMT $101.0\%$ of diphenhydramine hydrochloride $(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}{\cdot}\mathrm{HCl})$ .  

**Description** Diphenhydramine Hydrochloride occurs as white crystals or a crystalline powder. It is odorless, has a bitter taste, and paralyzes the tongue.  

It is very soluble in methanol or acetic acid(100), freely soluble in water or ethanol(95), sparingly soluble acetic anhydride and practically insoluble in ether. It is gradually affected by light.  

Identification (1) Determine the absorption spectra of solutions of Diphenhydramine Hydrochloride and Diphenhydramine hydrochloride RS in methanol (1 in 2000) as directed under the Ultraviolet-visible Spectroscopy; both exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Diphenhydramine Hydrochloride and Diphenhydramine Hydrochloride RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Diphenhydramine Hydrochloride (1 in 50) responds to the Qualitative Analysis for chloride.  

Melting point Between 166 and $170\ ^{\circ}\mathrm{C}$ $\mathbf{pH}$ Dissolve $1{\mathrm{~g~}}$ of Diphenhydramine Hydrochloride in $10~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 4.0 and 5.0.  

Purity (1) Clarity and color of solution —Dissolve $1.0\;\mathrm{g}$ of Diphenhydramine Hydrochloride in $10\,\mathrm{\mL}$ of water; the solution is clear and colorless.  

(2) Heavy metals —Proceed with $1.0\ \mathrm{~g~}$ of Diphenhydramine Hydrochloride according to Method 4 and perform the test. Prepare the control solution with 2.0 mL of lead standard solution (NMT 20 ppm).  

(3) Related substances —Dissolve $0.20\,\mathrm{~g~}$ of Diphenhydramine Hydrochloride in $10~\mathrm{mL}$ of methanol and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add methanol to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with the upper layer of a mixture of hexane, ethyl acetate, methanol and ammonia water(28) $(10:4:2:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Spray evenly iodine TS on the plate; the spots other than the principal spot and the spot at the starting point from the test solution are not more intense than the spots from the standard solution.  

# Loss on drying NMT $0.5\%$ $\langle2\;\mathrm{g},\,105\;^{\circ}\mathrm{C},$ , 3 hours).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\ensuremath~{~1~g~}~}$  

Assay Weigh accurately about $0.4\mathrm{~g~}$ of Diphenhydramine Hydrochloride, previously dried, dissolve by adding $50~\mathrm{mL}$ of a mixture of acetic anhydride and acetic acid $(7:3)$ , and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=29.182\;\mathrm{mg}$ of $\mathrm{C}_{17}\mathrm{H}_{21}\mathrm{NO}.$ ·HCl  

Packaging and storage Preserve in light-resistant, tight containers.  

# Diphenhydramine Hydrochloride Capsules 디펜히드라민염산염 캡슐  

Diphenhydramine Hydrochloride Capsules contain NLT $90.0\%$ and NMT $110.0\%$ the labeled amount of diphenhydramine hydrochloride ($\mathrm{(C_{17}H_{21}N O{\cdot}H C l}$ :291.82).  

Method of preparation Prepare as directed under Capsules, with Diphenhydramine Hydrochloride.  

Identification (1) Weigh an amount equivalent to $50~\mathrm{mg}$ of Diphenhydramine Hydrochloride according to the labeled amount and perform the test as directed under the Identification under Diphenhydramine Hydrochloride.  

(2) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Dissolution Perform the test with 1 capsule of Diphenhydramine Hydrochloride Capsules at 100 revolutions per minute according to Method 1, using $500~\mathrm{mL}$ of water as the dissolution medium. Take the dissolved solution 30 minutes after starting the test, and filter. Discard the first $10~\mathrm{mL}$ of the filtrate and use the subsequent filtrate as the test solution. Separately, weigh an appropriate amount of Diphenhydramine Hydrochloride RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 3 hours, and dissolve in water to obtain a solution with the same concentration as the test solution. Use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Assay under Diphenhydramine Hydrochloride Injection. Meets the requirements if the dissolution rate of Diphenhydramine Hydrochloride Capsules in 30 minutes is NLT $80\%$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of the contents of NLT 20 capsules of Diphenhydramine Hydrochloride Capsules. Weigh accurately an amount equivalent to $50~\mathrm{mg}$ of Diphenhydramine Hydrochloride $(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}{\cdot}\mathrm{HCl})$ ), dissolve in water, add water to make exactly $100\;\mathrm{mL}$ , and filter. Perform the test as directed under the Assay under Diphenhydramine Hydrochloride Injection.  

Amount $(\mathrm{mg})$ of diphenhydramine hydrochloride $(\mathbf{C}_{17}\mathbf{H}_{21}\mathbf{NO}{\cdot}\mathbf{H}\mathbf{C}\mathrm{l})$ $=$ Amount $\mathrm{(mg)}$ of diphenhydramine hydrochloride RS $\times\,\frac{\mathrm{\bar{A}_{T}}}{\mathrm{A}_{S}}$  

Packaging and storage Preserve in tight containers.  

# Diphenhydramine Hydrochloride Injection 디펜히드라민염산염주사액  

Diphenhydramine Hydrochloride Injection is an aqueous solution for injection. Diphenhydramine Hydrochloride Injection contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of diphenhydramine hydrochloride ($\mathrm{{C}_{17}H_{21}N O}$ ·HCl: 291.82).  

Method of preparation Prepare Diphenhydramine Hydrochloride Injection as directed under Injections, with Diphenhydramine Hydrochloride.  

Description Diphenhydramine Hydrochloride Injection occurs as a clear, colorless liquid.  

Identification (1) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

(2) Weigh an amount of Diphenhydramine Hydrochloride Injection, equivalent to $50~\mathrm{mg}$ of diphenhydramine hydrochloride, according to the labeled amount, and add $0.03\mathrm{~mol/L}$ sulfuric acid to make $25~\mathrm{mL}$ . Filter this solution, if necessary, and use it as the test solution. Separately, dissolve $50~\mathrm{mg}$ of diphenhydramine hydrochloride RS in $0.01\;\mathrm{mol/L}$ hydrochloric acid to make $25~\mathrm{mL}$ ,and use this solution as the standard solution. Pipet $2~\mathrm{mL}$ each of the test solution and the standard solution, add 2 mL of $1~\mathrm{\mol/L}$ sodium hydroxide and $4\,\textrm{m L}$ of carbon disulfide, and shake well to mix for 2 minutes. If necessary, centrifuge, filter, and determine as directed under the solution method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

pH Between 4.0 and 6.5. Sterility Meets the requirements. Bacterial endotoxins Less than 3.4 EU per mg of Diphenhydramine Hydrochloride.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Accurately take an amount, equivalent to $50~\mathrm{mg}$ of Diphenhydramine Hydrochloride $(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}{\cdot}\mathrm{HCl})$ ,according to the labeled amount, add water to make exactly $100~\mathrm{mL}$ and use this solution as the test solution. Separately, weigh accurately $50~\mathrm{mg}$ of Diphenhydramine Hydrochloride RS, previously dried at $105~^{\circ}\mathrm{C}$ , add water to make $100\,\mathrm{\mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of Diphenhydramine, respectively.  

Amount (mg) of Diphenhydramine Hydrochloride $(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}{\cdot}\mathrm{HCl})$  

$=$ $\times\,\frac{\mathrm{\dot{A}_{T}}}{\mathrm{A_{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with nitrile silica gel for liquid chromatography (5 to $10~{\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: Adjust the $\mathrm{pH}$ to 6.5 with a mixture of water, acetonitrile and triethylamine $(50\,:\,50\,:\,0.5)$ with acetic acid(100). Adjustments can be made if necessary.  

Flow rate: 1 mL/min   
System suitability   
System performance: Dissolve $5~\mathrm{mg}$ of benzophe  

none in $5~\mathrm{mL}$ of acetonitrile, and add water to make 500 mL. To $1.0~\mathrm{mL}$ of this solution, add $5~\mathrm{mg}$ of Diphenhydramine Hydrochloride RS, and add water to make 10 mL. Proceed with $10\;\mathrm{mL}$ of this solution according to the above conditions; benzophenone and Diphenhydramine are eluted in this order with the resolution being NLT 2.0. System repeatability: Repeat the test 6 times according to the above conditions with $10~\upmu\mathrm{L}$ each of the standard solution; the relative standard deviation of the peak area is NMT $2.0\%$  

Packaging and storage Preserve in light-resistant, hermetic containers.  

# Dipotassium Glycyrrhizinate 글리시리진산이칼륨  

![](images/2dd4638b1db567a3198c1784d663d55cb23a0738964171a4b3a1d5056fdf9751.jpg)  
$\mathrm{C}_{42}\mathrm{H}_{60}\mathrm{K}_{2}\mathrm{O}_{16}:899.13$  

(3β,20β)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl-2- O$-\upbeta$ -D-glucopyranuronosyl-α- D-glucopyranosiduronic acid potassium salt (1:2), [68797-35-3]  

Dipotassium Glycyrrhizinate $(\mathbf{C}_{42}\mathbf{H}_{60}\mathbf{K}_{2}\mathbf{O}_{16})$ contains NLT $95.0\%$ and NMT $101.0\%$ of dipotassium glycyrrhizinate, calculated on the anhydrous basis.  

Description Dipotassium Glycyrrhizinate occurs as a white to light yellow powder with no odor and has a sweet taste.  

It is freely soluble in dilute ethanol and slightly soluble in ethanol, and practically insoluble in chloroform or ether. Identification (1) The residue obtained after the ignition of Dipotassium Glycyrrhizinate responds to the Qualitative Analysis for potassium salt.  

(2) Add $10~\mathrm{mL}$ of $1~\mathrm{mol/L}$ hydrochloric acid TS10 mL to $0.5~\mathrm{g}$ of Dipotassium Glycyrrhizinate and boil for 10 minutes. After cooling, filter the precipitate, wash it with water, and dry it at $105~^{\circ}\mathrm{C}$ for 1 hour. Add $0.5~\mathrm{mL}$ of 2,6-di-tert-butyl-p-cresol TS and $1~\mathrm{mL}$ of sodium hydroxide solution (1 in 5) to $1~\mathrm{mL}$ of the dried in ethanol solution (1 in 1000). Then, heat the mixture on a steam bath for 90 minutes; a reddish purple to purple precipitate forms suspension.  

(3) Weigh $10\,\mathrm{\mg}$ of Dipotassium Glycyrrhizinate, dissolve in $10~\mathrm{mL}$ of methanol, and use this solution as the test solution. Separately, weigh about $10~\mathrm{mg}$ of dipotassium glycyrrhizinate RS, dissolve in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and standard solution on a plate of silica gel with a fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of methanol, toluene and acetic acid(100) $(7:2:1)$ to about $15~\mathrm{cm}$ , and air-dry the plate. Expose it to ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the color and $\mathbf{R}_{\mathrm{f}}$ value of the spots obtained from the test solution and the standard solution are the same.  

pH Between 5.0 and 6.0 ( $1\%$ aqueous solution). Purity (1) Clarity and color of solution― Dissolve $1.0~\mathrm{g}$ of Dipotassium Glycyrrhizinate in $20\,\mathrm{\mL}$ of water; the solution is colorless to light yellow in color and clear.  

(2) Chloride― Add $6\;\mathrm{mL}$ of dilute nitric acid and 10 mL of water to $0.5\;\mathrm{g}$ of Dipotassium Glycyrrhizinate, boil the mixture for 10 minutes, then filter it. Wash the residue with a small amount of water twice, and combine the washings with the filtrate. If the filtrate is colored, add 1 mL of hydrogen peroxide and heat on a steam bath for 10 minutes. After cooling, filter the precipitate and wash the residue twice with a small amount of water. Combine the washings with the filtrate, and add water to make $50~\mathrm{mL}$ .Use this as the test solution and perform the test according to the Chloride. Prepare the control solution by adding $6~\mathrm{mL}$ of dilute nitric acid and water to $0.20~\mathrm{mL}$ of $0.01\,\mathrm{\mol/L}$ hydrochloric acid solution to make $50\,\mathrm{\mL}$ (NMT $0.014\%$ ).  

(3) Sulfate― To $0.5\mathrm{~g~}$ of Dipotassium Glycyrrhizinate, add $5~\mathrm{mL}$ of dilute nitric acid and $10~\mathrm{mL}$ of water, dissolve for 10 minutes, and filter it. Wash the residue with a small amount of water twice, combine the washings with the filtrate, and neutralize it with ammonia TS. If the filtrate is colored, add $1~\mathrm{mL}$ of hydrogen peroxide and heat on a steam bath for 10 minutes. After cooling, if necessary, filter it and wash the residue twice with a small amount of water. Collect the washings and the filtrate and add water to make $50~\mathrm{mL}$ . Use this solution as the test solution, perform the test according to the Sulfate. Prepare the control solution with $0.30\;\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid and $1\,\mathrm{\mL}$ of dilute hydrochloric acid and add water to make $50\;\mathrm{mL}$ (NMT $0.029\%$ ).  

(4) Heavy metals― Dissolve the residue obtained from Residue on Ignition test in $2\mod$ of dilute Acetic Acid and add water, and filter it if necessary, to make a volume of $50~\mathrm{mL}$ . Use this as the test solution and perform the test according to the Heavy Metals. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution (NMT $10\,\mathrm{ppm}$ ).  

(5) Arsenic― Proceed with $0.5\,\mathrm{~g~}$ of Dipotassium Glycyrrhizinate, and perform the test according to Method 3 (NMT 4 ppm).  

Water NMT $8.0\%$ ($\mathrm{[0.1~\,g}$ , volumetric titration, direct titration).  

Residue on ignition Between $18.0\%$ and $21.0\%$ $\left(2.0\ \mathrm{g}.\right.$ calculated on the anhydrous basis).  

Assay Weigh accurately about $0.1\,\mathrm{~g~}$ of Dipotassium Glycyrrhizinate and add water to make $500\,\mathrm{\mL}$ . Take $10.0~\mathrm{mL}$ of Dipotassium Glycyrrhizinate and add $50~\mathrm{mL}$ of water. Use this solution as the test solution. After separately drying ncotinamide RS in a desiccator (in vacuum, silica gel) for 4 hours, weigh accurately about $20~\mathrm{mg}$ of the nicotinamide RS and add water to make $200\,\mathrm{\mL}$ .Take $10.0\;\mathrm{mL}$ of this solution, add water to make $50\;\mathrm{mL}$ ,and use this solution as the standard solution. Perform the test according to the Ultraviolet-visible Spectroscopy, measure the absorbance $A_{\mathrm{T}}$ of the test solution at the absorption maximum wavelength around $257\,\textrm{n m}$ and the absorbance $A_{S}$ of the standard solution at the absorption maximum wavelength around $261~\mathrm{nm}$ , respectively.  

$$
\begin{array}{r}{(\mathrm{C}_{42}\mathrm{H}_{60}\mathrm{K}_{2}\mathrm{O}_{16})\qquad\qquad\qquad\qquad\qquad}\\ {=\frac{2A_{\mathrm{T}}}{A_{\mathrm{S}}\times1.053}\qquad\qquad\qquad}\\ {\times\left(\frac{A m o u n t\;o f\;n i c o t i n a m i d e\;R S\;t a k e n\;(m g)}{\mathrm{Amount\;of\;sample\;taken\;(mg)\;\,-\;\,water\;(mg)}}\right)}\\ {\times\;2.5\times100\qquad\qquad\qquad\qquad\qquad\qquad}\end{array}
$$  

Packaging and storage Preserve in tight containers.   
Dipyridamole 디피리다몰  

![](images/3fcc244bf109635d64e5fd0ebf242d49ef9e448019c35bf1102ccaa6846902c7.jpg)  
$\mathrm{C_{24}H_{40}N_{8}O_{4}}$ : 504.63  

2-[[2-[ bis (2-Hydroxyethyl)amino]-4,8-di(piperidin-1- yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol [ 58-32-2 ]  

Dipyridamole, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of dipyridamole $\left({\bf C}_{24}{\bf H}_{40}{\bf N}_{8}{\bf O}_{4}\right)$ .  

Description Dipyridamole occurs as yellow crystals or a crystalline powder. It is odorless and has a slightly bitter taste.  

It is freely soluble in chloroform, sparingly soluble in methanol or ethanol(99.5) and practically insoluble in water or ether.  

Identification (1) Dissolve $5~\mathrm{mg}$ of Dipyridamole in 2 mL of sulfuric acid, add 2 drops of nitric acid, and mix by shaking; the resulting solution exhibits a dark purple color.  

(2) Determine the absorption spectra of solutions of Dipyridamole and Dipyridamole RS in a mixture of methanol and hydrochloric acid $(99:1)$ (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Dipyridamole and Dipyridamole RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 165 and $169\,^{\circ}\mathrm{C}$ Purity (1) Clarity and color of solution —Dissolve $0.5~\mathrm{g}$ of Dipyridamole in $10~\mathrm{mL}$ of chloroform; the solution is clear and yellow.  

(2) Chloride —Dissolve $0.5~\mathrm{g}$ of Dipyridamole in 5 mL of ethanol(95) and $2~\mathrm{mL}$ of $2~\mathrm{mol/L}$ nitric acid, and add $1~\mathrm{mL}$ of silver nitrate TS; neither turbidity nor precipitate develops.  

(3) Heavy metals —Proceed with $2.0\,\mathrm{~g~}$ of Dipyridamole according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution (NMT $10\,\mathrm{ppm})$ ).  

(4) Arsenic —Proceed with $1.0\,\mathrm{~g~}$ of Dipyridamole according to Method 3 and perform the test (NMT 2 ppm).  

(5) Related substances —Dissolve $50~\mathrm{mg}$ of Dipyridamole in $50~\mathrm{mL}$ of mobile phase and use this solution as the test solution. Pipet $0.5~\mathrm{mL}$ of this solution, add the mobile phase to it make exactly $100\,\mathrm{\mL}$ , and use this solution as the standard solution. Perform the test with 20 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area of each solution as directed in the automatic integration method; the total area of the peak other than that of Dipyridamole from the test solution is not greater than the peak area of Dipyridamole from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and $15~\mathrm{cm}$ to $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve $0.2\ \ \mathrm{~g~}$ of potassium dihydrogen phosphate in $200\,\mathrm{\mL}$ of water and add $800\;\mathrm{mL}$ of methanol.  

Flow rate: Adjust the flow rate so that the retention time of dipyridamole is about 4 minutes. System suitability  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of dipyridamole obtained from $20~\upmu\mathrm{L}$ of the standard solution is between $2\;\mathrm{mm}$ and $6\;\mathrm{mm}$ .  

System performance: Weigh $7~\mathrm{mg}$ of Dipyridamole and $3~\mathrm{mg}$ of terphenyl, and dissolve in $50~\mathrm{mL}$ of methanol. Proceed with $20~\upmu\mathrm{L}$ of this solution according to the above conditions; dipyridamole and terphenyl are eluted in this order with the resolution being NLT 5.  

Time span of measurement: About 5 times the retention time of dipyridamole.  

Loss on drying NMT $0.2\%$ (1 g, $105\;^{\circ}\!C$ , 3 hours). Residue on ignition NMT $0.1\%$ (1 g). Assay Weigh accurately about $0.6\ \mathrm{g}$ of Dipyridamole, previously dried, dissolve in $70\,\textrm{m L}$ of methanol, and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=50.46~\mathrm{mg}$ of $\mathrm{C_{24}H_{40}N_{8}O_{4}}$  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Dirithromycin 디리트로마이신  

![](images/ba704afa4cae9af7ab357bf892c7b55e0d8109e52e2b2b36bb4f6cb3a4563f91.jpg)  

(1 S,2 R,4 R,5 R,6 S,7 S,8 R,11 R,12 R,15 R,17 S)-5- [(2 S,3 R,4 S,6 R)-4-(Dimethylamino)-3-hydroxy-6- methyloxan-2-yl]oxy-11-ethyl-4,12-dihydroxy-7- [(2 R,4 R,5 S,6 S)-5-hydroxy-4-methoxy-4,6-dimethyloxan2-yl]oxy-15-(2-methoxyethoxymethyl)-2,4,6,8,12,17- hexamethyl-10,14-dioxa-16- azabicyclo[11.3.1]heptadecan-9-one [ 62013-04-1 ]Dirithromycin contains NLT $96.0\%$ and NMT $102.0\%$ per mg of dirithromycin and epidirithromyciin $(\mathbf{C}_{42}\mathbf{H}_{78}\mathbf{N}_{2}\mathbf{O}_{14})$ , calculated on the anhydrous basis.  

Description Dirithromycin occurs as a white or pale gray crystalline powder.  

It is freely soluble in chloroform, soluble in methanol, slightly soluble in propanol or acetonitrile, and very slightly soluble in water or cyclohexane.  

Identification (1) Determine the infrared spectra of Dirithromycin and dirithromycin RS, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Crystallinity Meets the requirements. Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Dirithromycin according to Method 2 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}]$ ).  

(2) Related substances— Weigh accurately $0.1\ \mathrm{g}$ of Dirithromycin, dissolve in a mixture of acetonitrile and methanol $(70:30)$ to make exactly $10~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately a suitable amount of dirithromycin RS, dissolve in a mixture of acetonitrile and methanol $(70:30)$ to make a solution containing $0.2~\mathrm{mg}$ per mL, and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions. Determine each peak area in each solution by the automatic integration method and calculate the content $(\%)$ of each related substance according to the following equation; the content of 9-(S)- erythromycilamine is NMT $1.5\%$ , the content of any other related substance is NMT $1.0\%$ , and the total content of related substances is NMT $4.0\%$ . However, dirithromycin 16S-epimer is not regarded as a related substance for calculation.  

Content $(\%)$ of 9-(S)-erythromycilamine or other related  

$$
=\frac{\mathrm{c}}{\mathrm{w}}\times\frac{A_{\mathrm{i}}}{A_{s}}\times1000
$$  

C: Concentration $(\mathrm{mg/mL})$ of dirithromycin in the standard solution.   
W: Amount (mg) of Dirithromycin taken.   
$A_{\mathrm{i}}$ : Peak area of each related substance obtained from the test solution.   
$A_{S}$ : Peak area of dirithromycin (16R-epimer) obtained from the standard solution. Operating conditions   
For the detector, column and mobile phase, proceed as directed under the Assay.   
Time span of measurement: About 3 times the retention time of dirithromycin (16R-epimer).  

(3) Dirithromycin 16s-epimer— Determine the content $(\%)$ of dirithromycin 16S-epimer in Dirithromycin using the chromatogram obtained from the related substances test, according to the following equation (NMT $1.5\%)$ ).  

$$
=\cfrac{\mathrm{C}}{\mathrm{W}}\times\cfrac{\mathrm{A_{E}}}{\mathrm{A_{S}}}\times1000
$$  

$A_{\mathrm{E}}$ : Peak area of dirithromycin 16S-epimer in the test solution.  

$C$ : Concentration $(\mathrm{mg}\ /\mathrm{mL})$ of dirithromycin in the standard solution.  

W: Amount (mg) of Dirithromycin taken. $A_{S}$ : Peak area of dirithromycin (16R-epimer) obtained from the standard solution.  

Water NMT $1.0\%$ $\mathrm{~\textmu~}^{1.0}\mathrm{~g~}$ , volumetric titration, direct titration).  

Assay Weigh accurately about $20~\mathrm{mg}$ each of Dirithromycin and dirithromycin RS, dissolve each in a mixture of acetonitrile and methanol $(70:30)$ to make exactly 10 $\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with 10 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of dirithromycin (16R-epimer).  

(16R-epimer) and dirithromycin 16S-epimer is NLT 2.0, the resolution between the peaks of dirithromycin (16Repimer) and 9-(S)-erythromycilamine is NLT 5.0, and the symmetry factor of the dirithromycin (16R-epimer) peak is NMT 2.  

System repeatability: Repeat the test 5 times with $10~\upmu\mathrm{L}$ of the system suitability solution under the above operating conditions; the relative standard deviation of the peak areas of dirithromycin (16R-epimer) is NMT $1.0\%$ .  

System suitability solution —Weigh accurately a suitable amount of dirithromycin RS and dissolve in the mobile phase to make a solution containing $2.5~\mathrm{mg}$ per mL. Keep this solution at room temperature for 24 hours. The solution is an equilibrium mixture of dirithromycin (16R-epimer), dirithromycin 16S-epimer and 9-(S)- erythromycilamine, and may be used for 1 month at room temperature.  

Packaging and storage Preserve in well-closed containers.  

$$
\mathrm{~\boldmath~\Gamma~}=\;1000\times\frac{\mathrm{C}}{\mathrm{W}}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}+\mathrm{P_{E}}
$$  

CS: Concentration $(\mathrm{mg/mL})$ ) of dirithromycin in the standard solution.  

W: Amount $(\mathrm{mg})$ of Dirithromycin taken. $P_{\mathrm{{E}}}$ : Content $(\%)$ of dirithromycin 16S-epimer calculated in (3) under Purity above.  

Operating conditions  

Detector: An ultraviolet absorption spectrophotometer (wavelength: $205\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of acetonitrile, phosphate buffer solution $(\mathrm{pH}\,7.5)$ and ethanol $(44:37:19)$ .  

Flow rate: $2\;\mathrm{mL/min}$ System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the system suitability solution under the above operating conditions; the relative retention times of 9-(S)- erythromycilamine, dirithromycin (16R-epimer) and dirithromycin 16S-epimer are 0.7, 1.0 and 1.12, respectively. The resolution between the peaks of dirithromycin DiethylcarbamothioylsulfanylN,N -diethylcarbamo dithioate [ 97-77-8 ]  

Disulfiram, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of disulfiramm $(\mathbf{C}_{10}\mathbf{H}_{20}\mathbf{N}_{2}\mathbf{S}_{4})$ .  

Description Disulfiram occurs as white to yellow crystals or a crystalline powder.  

It is freely soluble in acetone or toluene, slightly soluble in methanol or ethanol(95) and practically insoluble in water.  

Identification (1) Determine the absorption spectra of Disulfiram and disulfiram RS in ethanol(95) (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Disulfiram and disulfiram RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

# Melting point Between 70 and $73\ ^{\circ}\mathrm{C}$  

Purity (1) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Disulfiram according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 10 ppm).  

(2) Arsenic —Proceed with $1.0\ \mathrm{g}$ of Disulfiram according to Method 4 and perform the test (NMT 2 ppm). (3) Diethyldithiocarbamic acid —Dissolve $0.10~\mathrm{g}$ of Disulfiram in $10\,\mathrm{\mL}$ of toluene, add $10\,\mathrm{\mL}$ of diluted sodium carbonate TS (1 in 20), and shake to mix. Take the water layer separately, wash with $10~\mathrm{mL}$ of toluene, and add 5 drops of copper sulfate (1 in 250) and $2~\mathrm{mL}$ of toluene. Shake to mix and allow to stand; the toluene layer does not exhibit a pale yellow color.  

(4) Related substances —Dissolve $50~\mathrm{mg}$ of Disulfiram in $40~\mathrm{mL}$ of ethanol, add water to make $50~\mathrm{mL}$ , and use this solution as the test solution. Pipet $1\ \mathrm{mL}$ of the test solution, add the mobile phase to make exactly 200 mL, and use this solution as the standard solution. Pipet $10~\upmu\mathrm{L}$ each of the test solution and the standard solution and perform the test as directed under the Liquid Chromatography according to the following conditions. Determine the peak area of each solution according to the automatic integration method; the total area of the peaks other than disulfiram obtained from the test solution is not larger than the peak area of disulfiram from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm}$ ).  

Column: A stainless steel column about $5\,\textrm{m m}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of methanol and water (7:3).   
Flow rate: Adjust the flow rate so that the retention time of disulfiram is about 8 minutes.  

Selection of column: Dissolve $50~\mathrm{mg}$ each of Disulfiram and benzophenone in $40~\mathrm{mL}$ of methanol, and add water to make $50~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution add the mobile phase to make $200~\mathrm{mL}$ . Proceed with $10~\upmu\mathrm{L}$ each of this solution according to the above operating conditions, and calculate the resolution. Use a column giving elution of benzophenone and disulfiram in this order with the resolution between these peaks being NLT 4.  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of disulfiram obtained from 10 $\upmu\mathrm{L}$ of the standard solution is 15 to $30\;\mathrm{mm}$ .  

Time span of measurement: About 3.5 times of the retention time of disulfiram.  

Loss on drying NMT $0.2\%$ ($\mathbf{\nabla}2~\mathbf{g}$ , silica gel, 24 hours).  

# Residue on ignition NMT $0.1\%$ $(2\;\mathrm{g})$  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Disulfiram, previously dried, in an iodine bottle, dissolve in $20\,\mathrm{\mL}$ of acetone, add $1.5~\mathrm{mL}$ of water and $1.0~\mathrm{g}$ of potassium iodide, and dissolve by shaking thoroughly. To this solution, add $3.0~\mathrm{mL}$ of hydrochloric acid, stopper the bottle tightly, shake to mix, and allow to stand in a dark place for 3 minutes. Add $70~\mathrm{mL}$ of water and titrate with 0.1 mol/L sodium thiosulfate VS (potentiometric titration under the Titrimetry). Perform a blank test and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ sodium thiosulfate VS $=14.83~\mathrm{mg}$ of $\mathrm{C}_{10}\mathrm{H}_{20}\mathrm{N}_{2}\mathrm{S}_{4}$  

Packaging and storage Preserve in tight containers.  

# Dobesilate Calcium Hydrate 도베실산칼슘수화물  

![](images/c504999e5a6ef46e9b535cf876f03b1f4372a73e873ff996aa2bdbd3a42a59c9.jpg)  

$\mathrm{C_{12}H_{10}O_{10}S_{2}C a{\cdot}H_{2}O{\cdot}}$ 436.43 Calcium di(2,5-dihydroxybenzenesulfonate) monohydrate, [ 20123-80-2 ]  

Dobesilate Calcium Hydrate contains NLT $99.0\%$ and NMT $101.0\%$ of dobesilate calcium $(\mathbf{C}_{12}\mathbf{H}_{10}\mathbf{O}_{10}\mathbf{S}_{2}\mathbf{C}\mathbf{a}$ :418.40), calculated on the anhydrous basis.  

Description Dobesilate Calcium Hydrate occurs as a white crystalline powder. It is odorless.  

It is freely soluble in water or ethanol and practically insoluble in ether and chloroform.  

Melting point— About $300\ {}^{\circ}\mathrm{C}$ (with decomposition). Identification (1) A solution of Dobesilate Calcium Hydrate responds to the Qualitative Analysis for calcium hydrate.  

(2) Determine the absorption spectrum of the solution (2.5 in 1000000) of Dobesilate Calcium Hydrate as directed under the Ultraviolet-visible Spectroscopy; it exhibits maxima between $218\,\mathrm{\nm}$ and $222\ \mathrm{nm}$ and between $298~\mathrm{nm}$ and $302\;\mathrm{nm}$ .  

pH Between 4.3 and 5.1 ( $12\%$ solution). Purity (1) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Dobesilate Calcium Hydrate according to the Method 1, and perform the test. Prepare the control solution with $3.0\;\mathrm{mL}$ of lead standard solution (NMT $15\,\mathrm{ppm}$ ).  

(2) Arsenic —Proceed with $0.4~\mathrm{g}$ of Dobesilate Calcium Hydrate according to the Method 1 and perform the test (NMT 5 ppm).  

(3) Sulfate —Proceed with $0.5~\mathrm{g}$ of Dobesilate Calcium Hydrate and perform the test. Prepare the control solution with $0.1~\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid (NMT $0.01\%$ ).  

(4) Iron —Weigh accurately $10.0\,\mathrm{~g~}$ of Dobesilate Calcium Hydrate and add $100\;\mathrm{mL}$ of water not containing carbon dioxide. Take $10\ \mathrm{mL}$ of this solution and add 2 mL of $200\,\mathrm{g/L}$ citric acid and $0.1\;\mathrm{mL}$ of thioglycolic acid. Alkalify the solution with $10.6\,\mathrm{\mol/L}$ ammonia water, add $20~\mathrm{mL}$ of water and shake, and use this solution as the test solution. Separately, take $1~\mathrm{mL}$ of iron standard solution and prepare the control solution in the same way as the test solution. After allowing it to stand for 5 minutes, compare the colors of the test solution and the control solution against a pink background; the color of the test solution is not more intense than that of the control solution (NMT 10 ppm).  

(5) Hydroquinone —Weigh $1.0~\mathrm{g}$ of Dobesilate Calcium Hydrate, dissolve in $10~\mathrm{mL}$ of water, and use this solution as the test solution. Separately, weigh $10~\mathrm{mg}$ of hydroquinone RS, dissolve in water to make $100\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel (with a fluorescence indicator) for thin-layer chromatography, develop the plate with a mixture of nbutanol, acetic acid and water $(72:10:18)$ , and air-dry the plate. Expose the plate to ultraviolet irradiation (254 nm) or spray a mixture of $1\%$ ferric chloride, $1\%$ potassium ferricyanide and nitric acid $(50:50:5)$ on the plate; the spots other than the principal spot from the test solution are not more intense than the blue principal spot from the standard solution $\Delta\mathbf{M}\mathbf{T}\,0.1\%)$ .  

Water NMT $6.0\%$ $\left(0.2\,\mathrm{~g~}\right)$ , volumetric titration, direct titration).  

Assay Weigh accurately about $0.9~\mathrm{g}$ of Dobesilate Calcium Hydrate, previously dried, dissolve in $80~\mathrm{mL}$ of water, add $2~\mathrm{mL}$ of $8\;\mathrm{mol/L}$ potassium hydroxide TS and 0.1 $\mathrm{g}$ of N,N indicator, and titrate with $0.05~\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS. The endpoint of titration is when the reddish purple color of solution turns into the blue color. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.05\;\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS $=20.920\;\mathrm{mg}$ of $\mathrm{C_{12}H_{10}O_{10}S_{2}C a}$  

Packaging and storage Preserve in tight containers.  

# Dobesilate Calcium Tablets 도베실산칼슘정  

Dobesilate Calcium Tablets contains NLT $95.0\%$ and NMT $105.0\%$ equivalent to the labeled amount of dobesilate calcium hydrate $(\mathrm{C_{12}H_{10}O_{10}S_{2}C a{\cdot}H_{2}O}$ :436.43).  

Method of preparation Prepare as directed under Tablets, with Dobesilate Calcium Hydrate.  

Identification (1) Take equivalent to about $40~\mathrm{{mg}}$ of Dobesilate Calcium Hydrate according to the labeled amount of Dobesilate Calcium Tablets, add water to make $100~\mathrm{mL}$ , and filter. Take $10~\mathrm{mL}$ of the filtrate, and add water to make $100\,\mathrm{\mL}$ . Determine the absorption spectra of this solution as directed under the Ultravioletvisible Spectroscopy; it exhibits maxima around $220\pm2$ nm and $300\pm2$ nm wavenumbers.  

(2) Weigh a portion of powdered Dobesilate Calcium Tablets, equivalent to $0.1\,\mathrm{~g~}$ of Dobesilate Calcium according to labeled amount, add $10~\mathrm{mL}$ of water, filter, and use this filtrate as the test solution. Separately, weigh about $0.1~\mathrm{g}$ of dobesilate calcium hydrate RS, dissolve in $10~\mathrm{mL}$ of water, and use this solution as the standard solution. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate of silica gel with fluorescent indicator for thin-layer-chromatography. Develop the plate with the upper layer of a mixture of n-butanol, water and acetic acid $(36:9:5)$ to a distance of about $17~\mathrm{cm}$ and air-dry the plate. Examine under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ). The $R_{\mathrm{f}}$ values of the spots from the test solution and the standard solutions are the same.  

Purity Hydroquinone —Weigh the amount of Dobesilate Calcium Tablets, previously powdered, equivalent to 1.0 $\mathrm{g}$ of Dobesilate Calcium Hydrate, add $10\,\mathrm{\mL}$ of water, shake to mix, centrifugate, and use the clear liquid at the top layer as the test solution. Separately, take $10~\mathrm{mg}$ of hydroquinone RS, dissolve in water to make $100\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Thin Layer Chromatography according to the conditions of the Identification 2) and observe the solutions under ultraviolet light; spots other than the principal spot from the test solution is not more intense than the purple spots from the standard solution $(\mathrm{NMT}\,0.1\%)$ .  

Dissolution Perform the test with 1 tablet of Dobesilate Calcium Tablets at 50 revolutions per minute according to the Method 2 under the Dissolution Test, using 900 mL of water as the dissolution medium. Take the dissolved solution 30 minutes after starting the test, and filter. Pipet $5~\mathrm{mL}$ of this solution, add water to make exactly $20~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $70~\mathrm{mg}$ of dobesilate calcium hydrate RS and dissolve in water to make $100~\mathrm{mL}$ .Pipet $10~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of Dobesilate Calcium Hydrate from each solution, $A_{\mathrm{T}}$ and $A_{S}$ , respectively.  

It meets the requirements when the dissolution rate of Dobesilate Calcium Tablets in 30 minutes should be NLT $85\%$ .  

$$
=W_{\mathrm{S}}\times\left(A_{\mathrm{T}}/A_{\mathrm{S}}\right)\times\left(1/C\right)\times360
$$  

$W\mathrm{s}$ : Amount $\mathrm{(mg)}$ of dobesilate calcium hydrate RS. $C$ : Labeled amount (mg) of dobesilate calcium hydrate $\mathrm{\bf\left(C_{12}H_{10}O_{10}S_{2}C a{\cdot}H_{2}O\right)}$ per tablet.  

Operating conditions  

Detector: An ultraviolet-visible spectrophotometer (wavelength: $301\;\mathrm{nm}$ ).  

Column: A stainless steel column, about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of $0.1\%$ phosphoric acid and methanol $(9:1)$ .  

Flow rate: 1.0 mL/minute System suitability  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the standard solution under the above operating conditions, the relative standard deviation of the peak areas of Dobesilate Calcium Hydrate is NMT $2.0\%$ .Uniformity of dosage units Meets the requirements. Assay Weigh accurately and powder NLT 20 Dobesilate Calcium Tablets. Weigh accurately equivalent to about 100 mg of dobesilate calcium hydrate $(\mathrm{C_{12}H_{10}O_{10}S_{2}C a{\cdot}H_{2}O)}$ , add $100\;\mathrm{mL}$ of water. Pipet $10\;\mathrm{mL}$ of the test solution, add the mobile phase to make exactly $100~\mathrm{mL}$ and use this solution as the test solution. Separately, weigh accurately about $100~\mathrm{mg}$ of dobesilate calcium hydrate RS, add water to make exactly $100\,\mathrm{\mL}$ ,take $10~\mathrm{mL}$ of this solution, add water to make $100~\mathrm{mL}$ ,and use it as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and determine, $A_{\mathrm{T}}$ and $A_{S}$ ,of the peak areas of Dobesilate Calcium.  

Amount $\mathrm{(mg)}$ of dobesilate calcium hydrate $(\mathrm{C_{12}H_{10}O_{10}S_{2}C a{\cdot}H_{2}O)}$ $=$ Amount $(\mathrm{mg})$ ) of dobesilate calcium hydrate RS $\times\left(A_{\mathrm{T}}/A_{\mathrm{S}}\right)$  

Operating conditions  

Detector: An ultraviolet-visible spectrophotometer (wavelength: $301\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of $0.1\%$ phosphoric acid and methanol $(9:1)$ .  

Flow rate: 1.0 mL/minute System suitability  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak areas is NMT 2.0.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Dobutamine Hydrochloride 도부타민염산염  

![](images/a91e1bbbce0535b2d042f7b5faff143542c36ba9ecdaaf04b03a5b2390fef6a6.jpg)  

C18 H23 NO 3 ·HCl : 337.84 ylamino]ethyl]benzene-1,2-diol hydrochloride [ 49745- 95-1 ]  

Dobutamine Hydrochloride, when dried, contains NLT $98.0\%$ and NMT $101.0\%$ of dobutaime hydrochloride ( $\mathrm{\bfC}_{18}\mathrm{H}_{23}\mathrm{NO}_{3}\cdot\mathrm{HCl}_{2}$ ).  

Description Dobutamine Hydrochloride occurs as a white to very pale orange crystalline powder or grain.  

It is freely soluble in methanol, sparingly soluble in water or ethanol(95), and practically insoluble in ether.  

A solution of Dobutamine Hydrochloride (1 in 100) shows no optical rotation.  

Identification (1) Determine the infrared spectra of Dobutamine Hydrochloride and dobutamine hydrochloride RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) A solution of Dobutamine Hydrochloride (1 in 50) responds to the Qualitative Analysis (2) for chloride. Melting point Between 188 and $191\ {}^{\circ}\mathrm{C}$ $\mathbf{pH}$ Dissolve $1{\mathrm{~g~}}$ of Dopamine Hydrochloride in $100~\mathrm{mL}$ of water; the pH of this solution is between 4.0 and 5.5. Purity (1) Clarity and color of solution —Dissolve $0.5~\mathrm{g}$ of Dopamine Hydrochloride in $30~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Heavy metals —Dissolve $1.0\,\mathrm{~g~}$ of Dopamine Hydrochloride in $40~\mathrm{~mL}$ of water by warming, cool down, and add $2~\mathrm{mL}$ of dilute acetic acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(3) Related substances —Dissolve $0.10\mathrm{~g~}$ of Dopamine Hydrochloride in $10~\mathrm{mL}$ of methanol and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add methanol to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel for thinlayer chromatography. Develop the plate with a mixture of chloroform, methanol and formic acid $(78:22:5)$ to a distance of about $12~\mathrm{cm}$ , and air-dry the plate. Allow the plate to stand for 5 minutes in iodine vapor; spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.3\%$ (1 g, $105\ ^{\circ}\mathrm{C}$ , 3 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.1\ \mathrm{g}$ of Dobutamine Hydrochloride and dobutamine hydrochloride RS, previously dried, dissolve in exactly $10~\mathrm{mL}$ of the internal standard solution, add diluted methanol (1 in 2) to make 50 mL, and use these solutions as the test solution and the standard solution, respectively. Perform the test with 5 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $Q_{T}$ and $Q_{S}$ , of Dobutamine Hydrochloride to the internal standard, respectively.  

Internal standard solution —A solution of salicylamide in diluted methanol (1 in 2) (1 in 125).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.0\ \mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silical gel for liquid chromatography ($?\,\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of tartaric acid buffer solution, $\mathrm{pH}\,3.0$ and methanol $(7:3)$ .  

Flow rate: Adjust the flow rate so that the retention time of dobutamine is about 7 minutes.  

# System suitability  

System performance: Proceed with $5\,\upmu\mathrm{L}$ of the standard solution under the above conditions; dobutamine and the internal standard are eluted in this order with the resolution being NLT 5.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution as directed under the above conditions, the relative standard deviation of peak area ratios of dobutamine to the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers. 5-Chloro-1-(1-(3-(2-oxo-2,3-dihydro$1H\cdot$ -benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)- $1H\cdot$ -benzo[d]imidazol$2(3H)$ -one [ 57808-66-9 ]Domperidone, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of domperidone $\left({\bf C}_{22}\mathrm{H}_{24}\mathrm{ClN}_{5}{\bf O}_{2}\right)$ ).  

![](images/36e90cbc949c7155d45a52219eb7b6bed3de0ab0d07afe059381534055ea8693.jpg)  
$\mathrm{C_{22}H_{24}C l N_{5}O_{2}}$ : 425.91  

Description Domperidone occurs as a white to pale yellow crystalline powder.  

It is soluble in $N,N.$ -dimethylformamide, slightly soluble in methanol and ethanol(95), and practically insoluble in water.  

Identification Determine the infrared spectra of Domperidone and domperidone RS, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 218 and $248~^{\circ}\mathrm{C}$ Purity (1) Clarity and color of solution —Dissolve $0.2\;\mathrm{g}$ of Domperidone in $20\,\mathrm{\mL}$ of $N,N.$ -dimethylformamide; the solution is colorless and clear.  

(2) Heavy metals —Proceed with about $2.0\,\mathrm{~g~}$ of Domperidone according to Method 2, and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT 10 ppm).  

(3) Related substances —Prepare the solutions for the test immediately before use. Dissolve $0.1\ \mathrm{~g~}$ of Domperidone in $10~\mathrm{mL}$ of $N,N\!.$ -dimethylformamide, and use this solution as the test solution. Pipet $1\ \mathrm{mL}$ of the test solution, and add $N,N.$ -dimethylformamide to make exactly $100\ \mathrm{mL}$ . Pipet $5\ \mathrm{mL}$ of this solution, add $N,N_{\mathrm{-}}$ dimethylformamide to make exactly $20~\mathrm{mL}$ , and use this solution as the standard solution (1). Perform the test with $10~\upmu\mathrm{L}$ each of $N{,}N$ -dimethylformamide (as a blank test solution), the test solution and the standard solution (1) as directed under the Liquid Chromatography according to the following conditions. Determine each peak area from each solution by the automatic integration method and calculate the amount of related substances in the test solution; none of the domperidone related substance I {5- chloro-1(piperidin-4-yl)-1,3-dihydro $.2H\!\!\!/.$ -benzimidazol-2- one} having a relative retention time of about 0.4, the domperidone related substance II {4-(5-chloro-2-oxo2,3- dihydro$1H\cdot$ -benzimidazol-1-yl)-1-formylpiperidine} having a relative retention time of about 0.65, the domperidone related substance III { cis -4-(5-chloro-2-oxo-2,3- dihydro$1H\cdot$ -benzimidazol-1-yl)-1-[3-(2-oxo2,3-dihydro$1H\cdot$ -benzimidazol-1-yl)propyl]piperidine1-oxide} having a relative retention time of about 0.7, the domperidone related substance IV {5-chloro-3-[3-(2-oxo-2,3-dihydro$1H\cdot$ -benzimidazol-1-yl)propyl]-1-[1-[3-(2-oxo-2,3- dihydro$1H\cdot$ -benzimidazol-1-yl)propyl]piperidin-4-yl]- 1,3-dihydro-2-benzimidazol-2-one} having a relative retention time of about 1.15, the domperidone related substance V {1-[3-[4-(5-chloro-2-oxo-2,3-dihydro- $1H\cdot$ -benzimidazol-1-yl)piperidin-1-yl]propyl]-3-[3-(2-oxo2,3-dihydro-1Hbenzimidazol-1-yl)propyl]-1,3-dihydro$2H\cdot$ -benzimidazol-2-one} having a relative retention time of about 1.2 and the domperidone related substance VI {1,3-bis[3-[4-(5-chloro2-oxo-2,3-diihydro- $1H\cdot$ -benzimidazol-1-yl)piperidin-1-yl]propyl]-1,3-dihydro$2H\cdot$ -benzimidazol-2-one} having a relative retention time of about 1.3, with respect to domperidone, is greater than the peak area of domperidone from the standard solution (1) $(0.25\%)$ . Each peak area of other related substances is not greater than 0.4 times the peak area of domperidone from the standard solution (1) $(0.1\%)$ . The sum of the peak areas of the related substances is not greater than 2 times the peak area of domperidone from the standard solution (1) $(0.5\%)$ . Disregard any peak in the chromatogram obtained with the blank test solution and any peak with an area less than 0.2 times the area of the peak of Domperidone from the standard solution (1).  

Operating conditions  

Detector: An ultraviolet absorption spectrophotometer (wavelength: $280\;\mathrm{nm}$ ).  

A stainless steel column, $4.6~\mathrm{mm}$ in internal diameter and about $10~\mathrm{\cm}$ in length, packed with basedeactivated octadecylsilanized silica gel for liquid chromatography $3\;{\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: Apply a mixture of ammonium acetate (5 in 1000) and methanol $(70:30)$ to the column at a flow rate of $1.5\;\mathrm{mL}$ per minute, then increase the ratio of methanol sequentially over $10\ \mathrm{min}$ , followed by elution with methanol for 2 minutes.  

Flow rate: $1.5\;\mathrm{mL/min}$ .  Apply methanol to the column for at least $30\;\mathrm{min}$ to reach an equilibrium, and then equilibrate it again with the initial mobile phase composition (a mixture of ammonium acetate (5 in 1000) and methanol $(70:30)$ for at least 5 minutes.  

Selection of column: Dissolve $10\,\mathrm{\mg}$ of domperidone RS and $15~\mathrm{mg}$ of droperidol RS in $100~\mathrm{mL}$ of $N,N\!\cdot$ dimethylformamide, and use this solution as the standard solution (2). Proceed with $10~\upmu\mathrm{L}$ of the standard solution (2) under the above operating conditions. At this time, use a column from which the retention times for domperidone and droperidol is 6.5 minutes and 7 minutes, respectively, with the resolution between these peaks being NLT 2.0. If necessary, adjust the concentration of methanol in the mobile phase or control it through the gradient elution.  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of domperidone obtained from $10~\upmu\mathrm{L}$ of the standard solution (1) is NLT $50.0\%$ of the full scale.  

Loss on drying NMT $0.5\%$ ($1\ \mathrm{g},\,100\textrm{-}105\ ^{\mathrm{o}}\mathrm{C}$ , constant mass).  

# Ignition residue NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.3\,\mathrm{~g~}$ of Domperidone, previously dried, dissolve in a mixture of 2-butanone and acetic acid(100) $(7:1)$ to make $50~\mathrm{mL}$ , and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (indictor: $0.2\,\mathrm{~mL}$ of 1- naphtholbenzein TS). However, the endpoint of the titration is when the color changes from orange to green.  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Domperidone Oral Suspension 돔페리돈현탁액  

Domperidone Oral Suspension contains NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of domperidone $(\mathbf{C}_{22}\mathrm{H}_{24}\mathbf{C}\mathrm{lN}_{5}\mathbf{O}_{2}:425.91$ ).  

Method of preparation Prepare as directed under Suspensions, with domperidone.  

Identification Take $10~\mathrm{mL}$ of Domperidone Oral Suspension, put in a $125{\-}\mathrm{mL}$ separatory funnel, add $10\;\mathrm{mL}$ of water and $2.5\,\mathrm{\mL}$ of ammonia TS, and extract 3 times with $20~\mathrm{mL}$ of ethyl acetate each time. Filter the extracts and evaporate to dryness. Dissolve the dried material in 5 mL of methanol, and use this solution as the test solution. Separately, dissolve $20~\mathrm{mg}$ of domperidone RS in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thinlayer chromatographic plate made of silica gel with fluorescence indicator for thin-layer chromatography, develop the plate with a mixture of ethyl acetate, methanol and acetate buffer solution $(\mathrm{pH}\,4.7)$ $(100:15:5)$ as the developing solvent to a distance of about $17\;\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ) or spray Dragendorff's TS onto the plate; the $R_{\mathrm{f}}$ values and color of the spots obtained from the test solution and the standard solution are the same.  

# pH Between 5.2 and 7.2.  

Assay Take exactly an amount of Domperidone Oral Suspension, equivalent to about $10~\mathrm{mg}$ of domperidone $\left({\bf C}_{22}\mathrm{H}_{24}\mathrm{CIN}_{5}\mathrm{O}_{2}\right)$ , put in a $100{\-}\mathrm{mL}$ volumetric flask, add 1 mL of $0.1\,\mathrm{\mol/L}$ hydrochloric acid TS and $50\,\mathrm{\mL}$ of methanol, and sonicate for 20 minutes. Then, add methanol to make exactly $100\;\mathrm{mL}$ . Centrifuge this solution, and use the supernatant as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ of domperidone RS, add $1~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid TS and $50~\mathrm{mL}$ of methanol, and sonicate for 20 minutes. Add methanol to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography and determine the peak areas, $A_{\mathrm{T}}$ and $A_{\mathrm{s}}$ of domperidone in each solution.  

Amount (mg) of domperidone $\left({\bf C}_{22}\mathrm{H}_{24}\mathrm{ClN}_{5}\mathrm{O}_{2}\right)$ $=$ Amount (mg) of domperidone $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A_{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of $0.5\%$ ammonium acetate solution and methanol $(4:6)$ .  
Flow rate: 1.0 mL/min  

Packaging and storage Preserve in light-resistant, tight containers.  

# Domperidone Tablets 돔페리돈정  

Domperidone Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of Domperidone $\mathrm{\DeltaC_{22}H_{24}C l N_{5}O_{2}:425.91}$ ).  

Method of preparation Prepare as directed under Tablets, with Domperidone.  

Identification Weigh a portion of powdered Domperidone Tablets, equivalent to $20~\mathrm{mg}$ of Domperidone, dissolve in $10~\mathrm{mL}$ of a mixture of ethyl acetate - methanol $(1:1)$ , and filter. Use the filtrate as the test solution. Separately, weigh about $20~\mathrm{mg}$ of domperidone RS, dissolve in $10~\mathrm{mL}$ of a mixture of ethyl acetate-methanol $(1:1)$ ,and use the filtrate as the standard solution. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of methanolacetone -acetate $(\mathrm{pH}\,3.9)$ $(50:40:1)$ as the developing solvent to a distance of about $15\ \mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\ \mathrm{nm}$ ); the colors and $\mathbf{R}_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

Dissolution Perform the test with 1 tablet of Domperidone Tablets at 50 revolutions per minute according to Method 2 under the Dissolution, using $900\;\mathrm{mL}$ of the first solution as the dissolution medium. Take the dissolved solution after 30 minutes from the start of the test, and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $\mathrm{~V~mL~}$ of the subsequent filtrate, add the dissolution medium so that Each mL of the solution contains $11~\upmu\mathrm{g}$ of Domperidone according to the labeled amount. Make it exactly $\mathrm{V}^{\prime}$ mL and use this solution as the test solution. Separately, weigh accurately about $11\,\mathrm{\mg}$ of domperidone RS and dissolve in $50\%$ methanol to make $100~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add the dissolution medium to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of domperidone from each solution. Meets the requirements if the dissolution rate of Domperidone Tablets in 30 minutes is NLT $75\%$ .  

Dissolution rate $(\%)$ of the labeled amount of domperi  

$$
=W_{\mathrm{S}}\times\frac{\nabla\,\u^{\prime}}{\v V}\,\times\,\frac{\mathrm{A_{T}}}{\mathrm{A_{S}}}\,\times\,\frac{1}{\mathrm{c}}\,\times\,90\
$$  

Ws: Amount (mg) of domperidone RS. $C$ : The labeled amount (mg) of domperidone $(\mathbf{C}_{22}\mathbf{H}_{24}\mathbf{C}1\mathbf{N}_{5}\mathbf{O}_{2})$ ) in 1 tablet.  

Operating conditions   
Detector: An ultraviolet-visible spectrometer (wavelength: $285\;\mathrm{nm}$ ).   
Column: A stainless-steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).   
Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of $0.02\,\mathrm{\mol/L}$ potassium dihydrogen phosphate-methanol $(1:1)$ ${\mathrm{(pH}}\,3.5\)$ ). Flow rate: 1.0 mL/minute  

Uniformity of dosage units Meets the requirements. Assay Weigh accurately the mass of NLT 20 tables of Domperidone Tablets and powder. Weigh accurately an amount equivalent to about $25~\mathrm{~mg~}$ of Domperidone $\mathrm{{[C_{22}H_{24}}}$ ClN $s\mathrm{O}_{2}^{\phantom{\dagger}}$ ), dissolve in $50\%$ methanol, and make exactly $250\;\mathrm{mL}$ . Pipet $10\;\mathrm{mL}$ of the solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately $10~\mathrm{mg}$ of domperidone RS and dissolve in $50\%$ methanol to make exactly $100~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with 20 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, AT and AS, for the test solution and the standard solution, respectively.  

Amount (mg) of domperidone $\left({\bf C}_{22}\mathrm{H}_{24}\mathrm{ClN}_{5}{\bf O}_{2}\right)$ $=$ Amount (mg) of domperidone $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A}_{S}}\times2.5$  

Operating conditions  

Detector: An ultraviolet-visible spectrometer (wavelength: $285\;\mathrm{nm}$ ).  

Column: A stainless-steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of $0.02\,\mathrm{\mol/L}$ potassium dihydrogen phosphate-methanol $(1:1)$ $(\mathrm{pH}\,3.5)$ .Flow rate: 1.0 mL/minute  

System suitability  

System repeatability: Repeat the test 6 times with $20\,\textrm{\textmu L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak areas of Domperidone is NMT $1.5\%$ .  

Packaging and storage Preserve in tight containers.  

# Domperidone Maleate 돔페리돈말레산염  

![](images/06b67bd255bb29c1a76a26b58c3e0cbfdfc5028e999be322f9315ad7ad64c1ce.jpg)  

$\mathrm{C_{22}H_{24}C l N_{5}O_{2}\cdot C_{4}H_{4}O_{4}:541.98}$ $(Z)$ -But-2-enedioic acid; 5-chloro-1-(1-(3-(2-oxo-2,3- dihydro$1H\cdot$ -benzo[d]imidazol-1-yl) propyl)piperidin-4- yl)- $1H\cdot$ -benzo[d]imidazol-2 $(3H)$ -one [ 83898-65-1 ]  

Domperidone Maleate, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of domperidone maleate  

$(\mathrm{C}_{22}\mathrm{H}_{24}\mathrm{ClN}_{5}\mathrm{O}_{2}\cdot\mathrm{C}_{4}\mathrm{H}_{4}\mathrm{O}_{4}).$  

Description Domperidone Maleate occurs as a white powder.  

It is sparingly soluble in $N,N.$ -dimethylformamide, slightly soluble in methanol, and very slightly soluble in water or ethanol(95).  

It shows polymorphism.  

Identification (1) Triturate $0.1~\mathrm{g}$ of Domperidone Maleate with a mixture of $1~\mathrm{mL}$ of $10~\mathrm{mol/L}$ sodium hydroxide solution and $3\ \mathrm{mL}$ of water, followed by extraction three times each with $5~\mathrm{mL}$ of ether. Add $0.1~\mathrm{mL}$ of the aqueous layer to $3\ \mathrm{mL}$ of resorcinol solution in sulfuric acid (1 in 300) and heat on a steam bath for $15~\mathrm{min}$ ; no color appears. To the remainder of the aqueous layer, add $2~\mathrm{mL}$ of bromine TS, heat on a steam bath for $15\ \mathrm{min}$ ,and then heat further to boiling. After cooling, add 0.1 mL of this solution to $3\ \mathrm{mL}$ of resorcinol solution in sulfuric acid (1 in 300) and heat on a steam bath for $15\;\mathrm{min}$ ;a reddish purple color appears.  

(2) Determine the infrared spectra of Domperidone Maleate and domperidone maleate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers. If there is any difference between the spectra, dissolve Domperidone Maleate and domperidone maleate RS each in as little volume of 2-propanol as possible, evaporate to dryness on a steam bath, and perform the test with the residues in the same way above.  

(3) Dissolve $20~\mathrm{mg}$ of Domperidone Maleate in 10 mL of methanol, and use this solution as the test solution. Separately, dissolve $20~\mathrm{mg}$ of domperidone maleate RS in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution (1). Also, dissolve $20~\mathrm{mg}$ of domperidone maleate RS and $20~\mathrm{mg}$ of droperidole RS in $10\ \mathrm{mL}$ of methanol, and use this solution as the standard solution (2). Perform the test with these solutions as directed under the Thin-layer chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution, standard solution (1) and standard solution (2) on a thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate using a mixture of methanol, acetonitrile and ammonium acetate TS $(40:40:20)$ as a developing solvent to a distance of about $15~\mathrm{cm}$ , and air-dry the plate. Expose the plate with iodine vapor until spots appear and examine in day-light; the spot in the chromatogram obtained with the test solution corresponds in the size and the $R_{\mathrm{f}}$ value to that with the standard solution (1), and the two spots in the chromatogram obtained with the standard solution (2) are clearly separated with each other.  

Purity (1) Clarity and color of solution —Dissolve $0.2\;\mathrm{g}$ of Domperidone Maleate in $20\quad\mathrm{~mL~}$ of N,N -dimethylformamide; the solution is clear and not darker than a solution made by mixing $5~\mathrm{mL}$ of the mixed solution of $1~\mathrm{w}/\mathrm{v}\%$ hydrochloric acid, iron(III) chloride hexahydrate colorimetric stock solution and cobalt(II) chloride hexahydrate colorimetric stock solution $(70:24:6)$ and $95~\mathrm{mL}$ of $1~\mathrm{w}/\mathrm{v}\%$ hydrochloric acid.  

(2) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Domperidone Maleate according to Method 4, and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT 20 ppm).  

(3) Related substances —Prepare the solutions for the test immediately before use. Dissolve $0.1\ \mathrm{~g~}$ of Domperidone Maleate in $10\ensuremath{\mathrm{~\textrm~{~\,~}~}}\ensuremath{\mathrm{mL}}$ of N,N -dimethylformamide, and use this solution as the test solution. Pipet $1\ \mathrm{\mL}$ of the test solution, and add N,N -dimethylformamide to make exactly $100~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add $N,N\!\cdot$ -dimethylformamide to make exactly $20~\mathrm{mL}$ , and use this solution as the standard solution (1). Perform the test with $10~\upmu\mathrm{L}$ each of N,N -dimethylformamide (as a blank test solution), the test solution and the standard solution (1) as directed under the Liquid Chromatography according to the following conditions. Determine each peak area from each solution by the automatic integration method; none of the peak areas, other than the peak area of domperidone maleate, obtained from the test solution is larger than the peak area of domperidone maleate obtained from the standard solution (1) $(0.25\%)$ , and the sum of the areas of all peaks other than the peak of domperidone maleate from the test solution is not larger than 2 times the peak area of domperidone maleate from the standard solution (1) $(0.5\%)$ . Disregard any peak in the chromatogram obtained with the blank test solution and any peak with an area less than 0.2 times the area of the peak of domperidone maleate from the standard solution (1).  

Operating conditions  

Detector: An ultraviolet absorption spectrophotometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $10~\mathrm{cm}$ in length, packed with basedeactivated octadecylsilanized silica gel for liquid chromatography $3\;{\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: Apply a mixture of ammonium acetate (5 in 1000) and methanol $(70:30)$ to the column at a flow rate of $1.5\;\mathrm{mL}$ per minute, then increase the ratio of methanol sequentially to $100\%$ over $10\ \mathrm{min}$ , followed by elution with methanol for 2 minutes.  

Flow rate: $1.5~\mathrm{mL/min}$ . Apply methanol to the column for at least $30\;\mathrm{min}$ to reach an equilibrium, and then equilibrate it again with the initial mobile phase composition (a mixture of ammonium acetate (5 in 1000) and methanol $(70:30)$ for at least 5 minutes.  

# System suitability  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of domperidone maleate obtained from $10~\upmu\mathrm{L}$ of the standard solution (1) is NLT $50.0\%$ of that obtained from the water bath.  

System performance: Dissolve $10~\mathrm{mg}$ of domperidone maleate RS and $15~\mathrm{mg}$ of droperidol RS in $100~\mathrm{mL}$ of $N,N.$ -dimethylformamide, and use this solution as the standard solution (2). Proceed with $10~\upmu\mathrm{L}$ of this solution, as directed under the above operating conditions; domperidone maleate and droperidol are eluted in this order with the resolution between their peaks being NLT 2.  

Loss on drying NMT $0.5\%$ ($\mathrm{~\,~1~g,~}105\,^{\circ}\mathrm{C}$ , constant mass). Ignition residue NMT $0.1\%$ ($\mathrm{~\ensuremath~{~1~g~}~}$ Assay Weigh accurately about $0.4\mathrm{~g~}$ of Domperidone Maleate, previously dried, dissolve in $50\,\mathrm{\mL}$ of acetic acid(100), and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (indicator: $0.2\ \mathrm{mL}$ of 1-naphtholbenzein TS). However, the endpoint of the titration is when the color changes from orange to green.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=54.20\;\mathrm{mg}$ of $\mathrm{C_{26}H_{28}C l N_{5}O_{6}}$  

![](images/a81e2e4882d7bb352dcee071910efa13e6e7781d616d5cea98686390399c4079.jpg)  
Packaging and storage Preserve in light-resistant, wellclosed containers.  

$\mathrm{C_{8}H_{11}N O_{2}\mathrm{{:HCl}:189.64}}$ 4-(2-Aminoethyl)benzene-1,2-diol hydrochloride [ 62-31- 7 ]Dobutamine Hydrochloride, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of dobutaime hydrochloride ( $\mathrm{\bf\{C_{8}H_{11}N O_{2}\cdot H C l}}_{,}$ ).  

Description Dobutamine Hydrochloride occurs as white crystals or a crystalline powder.  

It is freely soluble in water or formic acid and sparingly soluble in ethanol(95).  

Melting point —About $248~^{\circ}\mathrm{C}$ (with decomposition). Identification (1) Determine the absorption spectra of solutions of Dopamine Hydrochloride and dopamine hydrochloride RS in $0.1\ \mathrm{mol/L}$ hydrochloric acid TS (1 in 25000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Dopamine Hydrochloride and dopamine hydrochloride RS, previously dried, as directed in the potassium chloride disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Dopamine Hydrochloride (1 in 50) responds to the Qualitative Analysis (1) for $\mathbf{pH}$ Dissolve $1\textrm{g}$ of Dopamine Hydrochloride in $50~\mathrm{mL}$ of water; the pH of this solution is between 4.0 and 5.5. Purity (1) Clarity and color of solution —Dissolve $1.0\;\mathrm{g}$ of Dopamine Hydrochloride in $10~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Sulfate —Prepare the test solution with $0.8~\mathrm{g}$ of Dopamine Hydrochloride and perform the test. Prepare the control solution with $0.35~\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid (NMT $0.021\%$ ).  

(3) Heavy metal —Proceed with $1.0~\mathrm{g}$ of Dopamine Hydrochloride according to the Method 1 and perform the test. Prepare the control solution with $2.0~\mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(4) Arsenic —Proceed with $1.0~\mathrm{g}$ of Dopamine Hydrochloride according to the Method 1 and perform the test (NMT 2 ppm).  

(5) Related substances —Dissolve $0.10~\mathrm{g}$ of Dopamine Hydrochloride in $10~\mathrm{mL}$ of water and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add water to make exactly $250~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of $^{\,I}$ -butanol, water and acetic acid(100) ( ${\mathrm{~16~}};$ $8:1)$ ) to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Spray evenly a solution of ninhydrin in acetone (1 in 50) on the plate and heat at $90~^{\circ}\mathrm{C}$ for 10 minutes; spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.5\%$ (1 g, $105\ ^{\circ}\mathrm{C}$ , 3 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Dopamine Hydrochloride, previously dried, dissolve in $5\,\textrm{m L}$ of formic acid, add exactly $15~\mathrm{mL}$ of $0.1\;\mathrm{mol/L}$ perchloric acid, and heat on a steam bath for 15 minutes. After cooling, add $50~\mathrm{mL}$ of acetic acid(100) and titrate the exceeding amount of perchloric acid with $0.1\ \mathrm{mol/L}$ sodium acetate VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $1\ \mathrm{mol/L}$ perchloric acid VS $=18.964\;\mathrm{mg}$ of $\mathrm{C}_{8}\mathrm{H}_{11}\mathrm{NO}_{2}$ ·HCl  

Packaging and storage Preserve in light-resistant, tight containers.  

# Doxapram Hydrochloride Hydrate 독사프람염산염수화물  

![](images/03786b4ec07a58acfb965ebb4cb59029aa40bcfe1fc7af18ae15b48e7b7728c1.jpg)  
Doxapram Hydrochloride  

$\mathrm{C}_{24}\mathrm{H}_{30}\mathrm{N}_{2}\mathrm{O}_{2}$ ·HCl· $\mathrm{H}_{2}\mathrm{O}:432.98\$ (RS )-1-Ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride [ 7081-53-0 ]  

Doxapram Hydrochloride Hydrate contains NLT $98.0\%$ and NMT $101.0\%$ of doxapram hydrochloride $(\mathrm{C24H30N2O2{\cdot}H C l}\ :\ 414.97)$ , calculated on an anhydrous basis.  

Description Doxapram Hydrochloride Hydrate occurs as white crystals or a crystalline powder.  

It is freely soluble in methanol or acetic acid(100), sparingly soluble in water, ethanol(95), or acetic anhydride, and practically insoluble in ether.  

Identification (1) Determine the absorption spectra of solutions of Doxapram Hydrochloride Hydrate and doxapram hydrochloride hydrate RS (1 in 2500) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectrum of Doxapram Hydrochloride Hydrate and doxapram hydrochloride hydrate RS as directed in the potassium bromide disk method under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) A solution of Doxapram Hydrochloride Hydrate (1 in 50) responds to the Qualitative Analysis for chloride.  

# Melting point Between 218 and $222\,^{\circ}\mathbf{C}$  

pH Dissolve about $1.0\,\mathrm{~g~}$ of Doxapram Hydrochloride Hydrate in $50~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 3.5 and 5.0.  

Purity (1) Clarity and color of solution —Dissolve $1.0~\mathrm{g}$ of Doxapram Hydrochloride Hydrate in $50~\mathrm{mL}$ of water; the solution is clear and colorless  

(2) Sulfate —Proceed with about $1.0~\mathrm{g}$ of Doxapram Hydrochloride Hydrate and perform the test. Prepare the control solution with $0.50\,\mathrm{\mL}$ of $0.005\,\mathrm{\mol/L}$ sulfuric acid (NMT $0.024\%$ ).  

(3) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Doxapram Hydrochloride Hydrate according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT $10\,\mathrm{ppm}]$ ).  

(4) Arsenic —Proceed with $1.0~\mathrm{g}$ of Doxapram Hydrochloride Hydrate according to Method 3 and perform the test (NMT 2 ppm).  

(5) Related substances —Dissolve $0.5\ \ \mathrm{~g~}$ of Doxapram Hydrochloride Hydrate in $10~\mathrm{mL}$ of methanol and use this solution as the test solution. Pipet $3\ \mathrm{mL}$ of this solution and add methanol to make exactly $100~\mathrm{mL}$ .Pipet $5\;\mathrm{mL}$ of this solution, add methanol to make exactly $50\,\mathrm{\mL}$ , and use it as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $6~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel for the thin layer chromatography. Next, develop the plate with a mixture of chloroform, formic acid, ethyl formate and methanol $(8:3:3:2)$ to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Allow the plate to stand in iodine vapor; the spots other than the principal spot from the test solution are not more intense than that from the standard solution.  

Water Between $3.5\%$ and $4.5\%$ ($\mathrm{\Delta}[0.5~\mathrm{g}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.3\%$ (1 g).  

Assay Weigh accurately about $0.8~\mathrm{g}$ of Doxapram Hydrochloride Hydrate, dissolve in $50~\mathrm{mL}$ of a mixture of acetic anhydride and acetic acid(100) $(7:3)$ , and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=41.50\mathrm{mg}$ of $\mathrm{C}_{24}\mathrm{H}_{30}\mathrm{N}_{2}\mathrm{O}_{2}$ ·HCl  

Packaging and storage Preserve in tight containers. (RS )-[4-(4-Amino-6,7-dimethoxyquinazolin-2- yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzo-dioxin-3- yl)methanone; methanesulfonic acid [ 77883-43-3 ]Doxazosin Mesilate contains NLT $98.0\%$ and NMT $102.0\%$ of doxazosin mesilate $\left({\bf C}_{23}\mathrm{H}_{25}\mathrm{N}_{5}\mathrm{O}_{5}\mathrm{\cdotCH}_{4}\mathrm{O}_{3}\mathrm{S}\right)$ ,calculated on the dried basis.  

![](images/9bec7c5561d814335810bc8ddbe475d09d00d725b32fb4c9a6dd90c499484d49.jpg)  
$\mathrm{C_{23}H_{25}N_{5}O_{5}{\cdot}C H_{4}O_{3}S:547.58}$  

Method of preparation If there is a possibility that alkyl (such as methyl, ethyl, and isopropyl) methanesulfonate esters are included as impurities during the manufacturing process of Doxazosin Mesilate, precautions must be taken in controlling the starting materials, manufacturing process, and intermediates in order to minimize the residue amounts of these impurities considering the results of risk assessment. If necessary, the validity of the manufacturing process can be demonstrated using test data that prove the absence of quality risk in the final drug substance.  

Description Doxazosin Mesilate occurs as a white to pale yellow crystalline powder.  

It is freely soluble in dimethylsulfoxide, slightly soluble in water or methanol, and very slightly soluble in ethanol(99.5).  

A solution (1 in 20) of Doxazosin Mesilate in dimethylsulfoxide exhibits no optical rotation.  

Melting point —About $272~^{\circ}\mathrm{C}$ (with decomposition). Identification (1) Determine the absorption spectra of solutions of Doxazosin Mesilate and doxazosin mesilate RS in $0.01\,\mathrm{\mol/L}$ hydrochloric acid-methanol TS (1 in 200000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Doxazosin Mesilate and doxazosin mesilate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy ; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Doxazosin Mesilate responds to the Qualitative Analysis (2) for phosphate.  

Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Doxazosin Mesilate and perform the test according to Method 2. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(2) Related substances —Dissolve $20~\mathrm{mg}$ of Doxazosin Mesilate in $5\ \mathrm{mL}$ of a mixture of methanol and acetic acid(100) $(1:1)$ , and use this solution as the test solution. Pipet $10~\mathrm{mL}$ of this solution, add a mixture of methanol and acetic acid(100) $(1:1)$ to make exactly 100 mL, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography (with a fluorescence indicator). Next, develop the plate with a mixture of 4-methyl-2-pentanone, water and acetic acid(100) $(2:1:1)$ as the developing solvent, and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm})$ ); the spot with an $R_{\mathrm{f}}$ value of about 0.15 obtained from the test solution is not intense than the one obtained from the standard solution. Also, no spots other than the principal spot and a spot with an $R_{\mathrm{f}}$ value of about 0.15 are observed in the test solution.  

Loss on drying NMT $1.0\%$ (1 g, 105 ℃, 4 h.). Residue on ignition NMT $0.2\%$ ($\mathrm{~\textit~{~1~}~g~})$  

Assay Weigh accurately about $25~\mathrm{mg}$ each of Doxazosin Mesilate and doxazosin mesilate RS, previously dried, dissolve separately in methanol to make exactly $50~\mathrm{mL}$ .Pipet $3\ \mathrm{mL}$ of these solutions, add the mobile phase to make them exactly $100\;\mathrm{mL}$ , and use them as the test solution and the standard solution, respectively. Proceed with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution, and perform the test as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of doxazosin in the test solution and the standard solution.  

Amount (mg) of doxazosin mesilate $(\mathrm{C_{23}H_{25}N_{5}O_{5}{\cdot}C H_{4}O_{3}S)}$ $=$ Amount (mg) of doxazosin mesilate $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A_{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $246\;\mathrm{nm}$ ).  

Column: A stainless steel column with about 3.9 mm in internal diameter and $15\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (4 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of $0.05~\mathrm{mol/L}$ potassium dihydrogen phosphate TS $(\mathrm{pH}\ 3.0)$ , methanol and acetonitrile $(12:8:3)$ .  

Flow rate: Adjust the flow rate so that the retention time of doxazosin is about 5 minutes.  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plates of the doxazosin peak is NLT 2,000 plates with the symmetry factor being NMT 2.0.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area of doxazosin is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers.  

# Doxazosin Mesilate Tablets 독사조신메실산염정  

Doxazosin Mesilate Tablets contain NMT $95.0\%$ and NLT $105.0\%$ of the labeled amount of doxazosin $(\mathrm{C_{23}H_{25}N_{5}O_{5}:451.48})$ ).  

Method of preparation Prepare Doxazosin Mesilate Tablets as directed under Tablets, with Doxazosin Mesilate.  

Identification Weigh an amount of Doxazosin Mesilate Tablets, previously powdered, equivalent to about $5~\mathrm{mg}$ of doxazosin according to the labeled amount, put into $100\,\mathrm{\mL}$ of $0.01\,\mathrm{\mol/L}$ hydrochloric acid-methanol TS, shake to mix, and centrifuge. Pipet $4~\mathrm{mL}$ of the clear supernatant, add $0.01\;\mathrm{mol/L}$ hydrochloric acid-methanol TS to make $50\,\mathrm{mL}$ , and determine the absorption spectrum as directed under the Ultraviolet-visible Spectroscopy; it exhibits an absorption maximum at wavelengths between $244\;\mathrm{nm}$ and $248~\mathrm{nm}$ .  

Dissolution Take 1 tablet of Doxazosin Mesilate Tablets and perform the test at 75 revolutions per minute according to Method 2 under the Dissolution, using $900~\mathrm{mL}$ of $0.05\;\mathrm{mol/L}$ acetic acid-sodium acetate buffer solution, pH 4.0 as the dissolution medium. Take NLT $20~\mathrm{mL}$ of the medium 15 minutes after starting the test, filter through a membrane filter with a pore size not exceeding $0.45~{\upmu\mathrm{m}}$ .Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $V\,\mathrm{mL}$ of the subsequent filtrate, and add the dissolution medium to make exactly $V^{\prime}\;m L$ so that the solution contains about $0.56~\upmu\mathrm{g}$ of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ per mL according to the labeled amount. Pipet $5\;\mathrm{mL}$ of this solution, add $5\;\mathrm{mL}$ of methanol, and use it as the test solution. Separately, weigh accurately about $21~\mathrm{mg}$ of doxazosin mesilate RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 4 hours, and dissolve in methanol to make exactly $50\,\mathrm{mL}$ . Pipet $2\;\mathrm{mL}$ of this solution and add methanol to make exactly $50~\mathrm{mL}$ . Pipet 5 mL of this solution, add $5~\mathrm{mL}$ of the dissolution medium, and use it as the standard solution. Proceed with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution, respectively, and perform the test as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $\mathrm{A_{T}}$ and A S, of doxazosin in the test solution and the standard solution. NLT $75\%$ of the labeled amount of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ is dissolved in 15 minutes.  

The dissolution rate $(\%)$ of the labeled amount of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$  

$$
\times\;\frac{{\mathrm{A_{T}}}}{{\mathrm{A_{S}}}}\times\frac{{\mathrm{V}}^{\;\prime}}{\mathrm{V}}\times\frac{1}{C}\times\frac{72}{25}\times0.825
$$  

$C$ :Labeled amount (mg) of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ . in 1 tablet  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $246\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of methanol and buffer $(55:45)$ .  
  
Buffer solution —Dissolve $3.4~\mathrm{g}$ of potassium dihydrogen phosphate in $500~\mathrm{mL}$ of water and adjust $\mathrm{pH}$ to 3.0 with diluted phosphoric acid (1 in 10).  

Flow rate: Adjust the flow rate so that the retention time of doxazosin is about 5 minutes.  

System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plates of the doxazosin peak is NLT 1000 plates with the symmetry factor being NMT 2.0.  

System repeatability: Repeat the test 6 times with $20\,\textrm{\textmu L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area of doxazosin is NMT $2.0\%$ .  

Uniformity of dosage units It meets the requirements when the procedure for content uniformity is performed according to the following procedure. Take 1 tablet of Doxazosin Mesilate Tablets, add $1~\mathrm{mL}$ of water, shake to mix, and then add $0.01\;\mathrm{mol/L}$ hydrochloride-methanol TS to make exactly $100~\mathrm{~mL~}$ , and shake to mix for 30 minutes. Centrifuge this solution, pipet $\mathrm{~V~mL~}$ of clear supernatant, and add $0.01\mod[2]$ hydrochloridemethanol TS to make exactly $\mathrm{V^{\prime}~m L}$ so that the solution contains about $5~\upmu\mathrm{g}$ of doxazosin mesilate per mL, and use it as test solution. Separately, weigh accurately about $30~\mathrm{\mg}$ of doxazosin mesilate RS, previously dried at $105~^{\circ}\mathrm{C}$ for 4 hours, and dissolve it in $0.01\ \mathrm{mol/L}$ hydrochloric acid-methanol TS to make exactly $100~\mathrm{mL}$ . Pipet $2~\mathrm{mL}$ of this solution, add $0.01\ \mathrm{mol/L}$ hydrochloric acidmethanol TS to make exactly $100~\mathrm{mL}$ , and use it as the standard solution. Perform the test as directed under the Assay described below.  

Amount (mg) of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ $=$ Amount (mg) of doxazosin mesilate RS $\times\mathit{\Pi}_{\overline{{\mathrm{A}_{5}}}}^{\mathrm{A_{\overline{{\mathrm{T}}}}}}\times\frac{\mathrm{V}^{\mathit{\prime}}}{\mathrm{V}}\times\frac{1}{50}\times0.825$  

Assay Weigh accurately the mass of NLT 20 Doxazosin Mesilate Tablets, and power. Weigh accurately an amount, equivalent to about $5~\mathrm{~mg}$ of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ and dissolve in $5~\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ hydrochloric acid-methanol TS to make $100~\mathrm{mL}$ , and shake to mix for 30 minutes. Centrifuge this solution, pipet $4~\mathrm{mL}$ of the clear supernatant, add $0.01\ \mathrm{\mol/L}$ hydrochloric acid-methanol TS to make exactly $50~\mathrm{mL}$ , and use it as the test solution. Separately, weigh accurately about 24 mg of doxazosin mesilate RS, previously dried at $105~^{\circ}\mathrm{C}$ for 4 hours, and dissolve in $0.01\;\mathrm{mol/L}$ hydrochloric acidmethanol TS to make exactly $100~\mathrm{mL}$ . Pipet $2~\mathrm{mL}$ of this solution, add $0.01\ \mathrm{mol/L}$ hydrochloric acid-methanol TS to make exactly $100~\mathrm{mL}$ , and use it as the standard solution. Using the test solution and the standard solution with $0.01\;\mathrm{mol/L}$ hydrochloric acid-methanol TS as a control solution, perform the test as directed under the Ultraviolet-visible Spectroscopy, and determine the absorbances, $\mathrm{A_{T}}$ and $\mathrm{As}$ , at $246\;\mathrm{nm}$ .  

Amount (mg) of doxazosin $(\mathbf{C}_{23}\mathbf{H}_{25}\mathbf{N}_{5}\mathbf{O}_{5})$ $=$ Amount (mg) of doxazosin mesilate RS $\times\,\frac{{\mathrm{A_{T}}}}{{\mathrm{A_{S}}}}\times\frac{1}{4}\times0.825$  

Packaging and storage Preserve in tight containers.  

# Doxorubicin Hydrochloride 독소루비신염산염  

![](images/3298eff3af7b10888c8a108a71b3fe703e535ea447a4be739215eb149fb0921d.jpg)  
$\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}$ ·HCl : 579.98  

(7 S,9 S)-7-[(2 R,4 S,5 S,6 S)-4-Amino-5-hydroxy-6- methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxy  

acetyl)-4-methoxy-8,10-dihydro$.7H$ -tetracene-5,12-dione hydrochloride [ 25316-40-9 ]  
Doxorubicin Hydrochloride is the hydrochloride of a derivative of daunorubicin.  

Doxorubicin hydrochloride, when dried, contains NLT $980~\upmu\mathrm{g}$ and NMT $1080~\upmu\mathrm{g}$ (potency) of doxorubicin hydrochloride (C27H29NO11·HCl), calculated on the anhydrous basis.  

Description Doxorubicin Hydrochloride occurs as an orange crystalline powder.  

It is sparingly soluble in water, slightly soluble in methanol, very slightly soluble in ethanol(99.5), and practically insoluble in acetonitrile.  

Identification (1) Determine the absorption spectra of solutions of Doxorubicin Hydrochloride and doxorubicin hydrochloride RS in methanol (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Doxorubicin Hydrochloride and doxorubicin hydrochloride RS as directed in the potassium chloride disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous of Doxorubicin Hydrochloride (1 in 200) responds to the Qualitative Analysis (1) for chloride.  

# Crystallinity Meets the requirements.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+240^{\circ}$ and $+290^{\circ}$ (20 mg calculated on the anhydrous basis, methanol, $20~\mathrm{mL}$ ,$100\;\mathrm{mm})$ ).  

$\mathbf{pH}$ Dissolve $50~\mathrm{mg}$ of Doxorubicin Hydrochloride in 10 mL of water; the $\mathrm{pH}$ of this solution is between 4.0 and 5.5.  

Absorbance $E_{\mathrm{1cm}}^{1\%}$ ($495\ \mathrm{nm}$ ): Between 200 and 230 (10 mg calculated on the anhydrous basis, methanol, 500 mL).  

Purity (1) Clarity and color of solution —Dissolve 50 mg of Doxorubicin Hydrochloride in $10\;\mathrm{mL}$ of water; the solution is clear and red.  

(2) Related substances —Dissolve $25~\mathrm{mg}$ of Doxorubicin Hydrochloride in $100\;\mathrm{mL}$ of the mobile phase and use this solution as the test solution. Pipet $2~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ ,and use it as the standard solution. Pipet $20~\upmu\mathrm{L}$ each of the test solution and the standard solution, perform the test as directed under the Liquid Chromatography under the following operating conditions, measure the peak areas of each peak of the solutions using the automatic integration method, and determine the peak areas of each solution; each peak area of the peaks other than that of doxorubicin in the test solution is not greater than onefourth of the peak area of doxorubicin in the standard solution. Additionally, the sum of peak areas other than that of doxorubicin in the test solution is not greater than the peak area of doxorubicin in the standard solution.  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).   
Column: A stainless steel column $4.6\;\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for the liquid chromatography $\ensuremath{\left\langle5\ \upmu\mathrm{m}\right.\right.}$ in particle diameter).   
Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  
Mobile phase: A mixture of a solution of phosphoric acid diluted in $3~\mathrm{g}$ of sodium lauryl sulfate and acetonitrile $(1:1)$ .  
Flow rate: Adjust the flow rate so that the retention time of doxorubicin is about 8 minutes.   
System suitability   
Test for required detectability: Pipet $1~\mathrm{mL}$ of the standard solution and add the mobile phase to make exactly $20~\mathrm{mL}$ . Confirm that the peak area of doxorubicin obtained from $20~\upmu\mathrm{L}$ of this solution is in the range of $3.5\%$ to $6.5\%$ of the peak area of doxorubicin in the  

standard solution.  

System performance: Dissolve $5~\mathrm{mg}$ of Doxorubicin Hydrochloride in $20\,\mathrm{\mL}$ of water, add $1.5\,\mathrm{\mL}$ of phosphoric acid, and allow it to stand at room temperature for 30 minutes. Adjust the $\mathrm{pH}$ of this solution to 2.5 with $2~\mathrm{mol/L}$ sodium hydroxide TS. Proceed with $20~\upmu\mathrm{L}$ of this solution under the above operating conditions; doxorubicinone, in which the relative retention time is about 0.6 with respect to doxorubicin, and doxorubicin are eluted in this order with the resolution between these peaks being NLT 5.  

System repeatability: Repeat the test 6 times with $20\,\mathrm{\,\,\upmuL}$ of the standard solution according to the above operating conditions; the relative standard deviation of the peak area for doxorubicin is NMT $2.0\%$ .  

Time span of measurement: About 3 times the retention time of doxorubicin.  

Water NMT $3.0\%$ ($\mathrm{~\textmu~}[0.3\,\mathrm{~g~}$ , volumetric titration, direct titration).  

Sterility It meets the requirements when used in a sterile preparation.  

Bacterial endotoxins Less than $2.50\ \mathrm{EU/mg}$ of doxorubicin hydrochloride when used in a sterile preparation. Histamine It meets the requirements when used in a sterile preparation. Proceed with an appropriate amount of Doxorubicin Hydrochloride to prepare a solution containing $2.0~\mathrm{mg}$ (potency) per mL .Use the solution as the test solution. Use $0.5\;\mathrm{mL}$ of the solution for the test.  

Assay Take exactly an amount of Doxorubicin Hydrochloride, equivalent to about $2.0~\mathrm{mg}$ (potency) according to the labeled potency, dilute it with the mobile phase to make the concentration $0.1~\mathrm{mg}$ (potency) per mL, and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ (potency) of doxorubicin hydrochloride RS, dilute it with the mobile phase to make the concentration $0.1~\mathrm{mg}$ (potency) per mL, and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions and determine the peak areas, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of doxorubicin hydrochloride in the test solution and in the standard solution.  

Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride $=$ Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride RS $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A}_{S}}$ Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with trimethylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter). Mobile phase: Dissolve $1~\mathrm{g}$ of sodium lauryl sulfate in a mixture of water, acetonitrile, ethanol(95) and phosphoric acid $(540:290:170:2)$ , and adjust $\mathrm{pH}$ to $3.6\pm$ 0.1 with $2\;\mathrm{mol/L}$ sodium hydroxide TS.  

Flow rate: About $1.5\;\mathrm{mL}/$ minute. System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the resolution test solution under the above operating conditions; the relative retention time of doxorubicinone with respect to doxorubicin is about 0.6 with the resolution between these peaks being NLT 5.5, and the relative retention time of doxorubicinone to doxorubicin is about 0.6, and the resolution is NLT 5.5. The number of theoretical plates and the symmetric factor for the peak of doxorubicin are NLT 2250 and between 0.7 and 1.2, respectively.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of the standard solutions under the above operating conditions; the relative standard deviation of the peak area of doxorubicin is NMT $1.0\%$ .  

Resolution test solution —Dissolve about $10~\mathrm{~mg}$ (potency) of Doxorubicin Hydrochloride in $5~\mathrm{mL}$ of water, add $5\;\mathrm{mL}$ of phosphoric acid, and allow it to stand for about 30 minutes. Adjust $\mathrm{pH}$ to $2.6\,\pm\,0.1$ with $2~\mathrm{mol/L}$ sodium hydroxide TS (about $37~\mathrm{mL}$ ), add $15~\mathrm{mL}$ of acetonitrile and $10~\mathrm{mL}$ of methanol, mix, filter, and use this solution as the resolution test solution. Store some of this solution in a freezer, and unfreeze and mix before use. Packaging and storage Preserve in tight containers.  

# Doxorubicin Hydrochloride Injection 독소루비신염산염주사액  

Doxorubicin Hydrochloride Injection contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of doxorubicin hydrochloride $(\mathbf{C}_{27}\mathbf{H}_{29}\mathbf{NO}_{11}{\cdot}\mathbf{H}\mathbf{C}1:579.98)$ .  

Method of preparation Prepare as directed under Injections, with Doxorubicin Hydrochloride.  

Description Doxorubicin Hydrochloride Injection occurs as an orange liquid.  

Identification The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

pH Between 2.5 and 3.5. Sterility Meets the requirements. Bacterial endotoxins Less than 2.2 EU per mg (potency) of doxorubicin hydrochloride.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Pipet the amount of Doxorubicin Hydrochloride Injection, equivalent to about $2.0~\mathrm{mg}$ (potency) according to the labeled potency, dilute with the mobile phase to make a solution containing $0.1~\mathrm{mg}$ (potency) per mL, and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ (potency) of doxorubicin hydrochloride RS, dilute with the mobile phase to make a solution containing $0.1\,\mathrm{~mg~}$ (potency) per mL, and use this solution as the standard solution. Perform the test with 20 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas, A Tand A S, of doxorubicin in the test solution and the standard solution.  

Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride  

# $(\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}{\cdot}\mathrm{HCl})$  

$=$ Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A}_{S}}$  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with trimethylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Dissolve $1\ \mathrm{g}$ of sodium lauryl sulfate in a mixture of water, acetonitrile, ethanol(95) and phosphoric acid $(540:290:170:2)$ and adjust $\mathrm{pH}$ to $3.6\pm$ 0.1 with $2\;\mathrm{mol/L}$ sodium hydroxide TS.  

Flow rate: About 1.5 mL/minute.  

# System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the resolution test solution under the above operating conditions; the relative retention time of doxorubicinone with respect to doxorubicin is about 0.6 with the resolution between these peaks being NLT 5.5. The number of theoretical plates of doxorubicin is 2250 and the symmetry factor is between 0.7 and 1.2.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of the standard solutions; the relative standard deviation of the peak area of doxorubicin is NMT $1.0\%$ .Resolution test solution —Dissolve about $10~\mathrm{~mg}$ (potency) of Doxorubicin Hydrochloride in $5~\mathrm{mL}$ of water, add $5\;\mathrm{mL}$ of phosphoric acid, and allow it to stand for about 30 minutes. Adjust $\mathrm{pH}$ to $2.6\,\pm\,0.1$ with $2~\mathrm{mol/L}$ sodium hydroxide TS (about $37\ \mathrm{mL}$ ), add $15~\mathrm{mL}$ of acetonitrile and $10~\mathrm{mL}$ of methanol, filter, and use this solution as the resolution test solution. Store some of this solution in a freezer and unfreeze before use.  

# Doxorubicin Hydrochloride for Injection 주사용독소루비신염산염  

Doxorubicin Hydrochloride for Injection is a preparation for injection, which is dissolved before use. Doxorubicin Hydrochloride for Injection contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of doxorubicin hydrochloride $(\mathbf{C}_{27}\mathbf{H}_{29}\mathbf{NO}_{11}{\cdot}\mathbf{HCl}:579.98)$ .  

Method of preparation Prepare as directed under Injections, with Doxorubicin Hydrochloride for Injection.  

Description Doxorubicin Hydrochloride for Injection occurs as an orange powder or a mass.  

Identification (1) Dissolve an amount of Doxorubicin Hydrochloride for Injection, equivalent to $10~\mathrm{mg}$ (potency) of doxorubicin hydrochloride according to the labeled amount, in methanol to make $100~\mathrm{mL}$ . To $5~\mathrm{mL}$ of this solution, add methanol to make $50\;\mathrm{mL}$ , and determine the absorption spectrum of the solution as directed under the Ultraviolet-visible Spectroscopy; it exhibits absorption maxima at wavelengths of between 231 and $235~\mathrm{nm}$ , between 250 and $254\ \mathrm{nm}$ , between 477 and $481\,\textrm{n m}$ , between 493 and $497\;\mathrm{nm}$ , and between 528 and $538\;\mathrm{nm}$ .  

(2) Both the test solution and the standard solution exhibit the same retention times in the chromatograms obtained by the test under the Assay.  

$\mathbf{pH}$ Dissolve $50~\mathrm{mg}$ of Doxorubicin Hydrochloride for Injection in $10\,\mathrm{\mL}$ of water; the $\mathrm{pH}$ of this solution is between 5.0 and 6.0.  

Purity Clarity and color of solution —Take exactly an amount of Doxorubicin Hydrochloride for Injection, equivalent to about $50~\mathrm{mg}$ of doxorubicin hydrochloride according to the labeled amount, and dissolve in $10~\mathrm{mL}$ of water; the solution is clear and red.  

Water NMT $4.0\%$ $\mathbf{\nabla}[0.2\textbf{g}$ , volumetric titration, direct titration).  

Sterility Meets the requirements. Bacterial endotoxins Less than 2.50 EU per mg (potency) of Doxorubicin Hydrochloride for Injection.  

Uniformity of dosage units Meets the requirements. Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Assay Weigh accurately the mass of the contents of NLT 10 vials of Doxorubicin Hydrochloride for Injection. Weigh accurately the amount equivalent to $10~\mathrm{mg}$ (potency) of Doxorubicin Hydrochloride, add exactly $5~\mathrm{mL}$ of the internal standard solution, dissolve in the mobile phase to make $100~\mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately an amount of doxorubicin hydrochloride RS, equivalent to $10~\mathrm{mg}$ (potency), add exactly $5\ \mathrm{mL}$ of the internal standard solution, dissolve in the mobile phase to make $100~\mathrm{mL}$ , and use this solution as the standard solution.  

Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography, and determine the peak area ratios of doxorubicin, $\mathrm{Q_{T}}$ and $\mathrm{Q}_{\mathrm{S}}$ ,to the internal standard solution in each solution.  

Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride  

# $(\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}{\cdot}\mathrm{HCl})$  

$=$ Potency $\mathrm{(\upmug)}$ of doxorubicin hydrochloride RS $\mathrm{RS}\times\frac{\mathrm{Q_{T}}}{\mathrm{Q_{S}}}$  

Internal standard solution —A solution of parahydroxybenzoic acid in the mobile phase (1 in 10000).  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve the diluted phosphoric acid (7 in 5000) in $3\mathrm{~g~}$ of sodium lauryl sulfate. To this solution, add $1000\;\mathrm{mL}$ of acetonitrile.   
Flow rate: Adjust the flow rate so that the retention time of doxorubicin is about 8 minutes.  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; doxorubicin and the internal standard solution are eluted in this order with the resolution being NLT 5, and the symmetry factor for the doxorubicin peak is between 0.8 and 1.2.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ of the standard solutions under the above operating conditions; the relative standard deviation of the ratio of the peak area of doxorubicin to that of the internal standard solution is NMT $1.0\%$ .  

Packaging and storage Preserve in hermetic containers.  

# Doxycycline Hydrate 독시사이클린수화물  

![](images/b40055796d733930b854901e88193e5651469e9b8229e1f15b40fa0125d905cf.jpg)  

$\mathrm{C_{22}H_{24}N_{2}O_{8}{\cdot}H_{2}O:462.45}$  

$(4S,4\mathrm{a}R,5S,5\mathrm{a}R,6R,12\mathrm{a}S)-\nonumber$ 4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrate [ 17086-28-1 ]  

Doxycycline Hydrate contains NLT $880~\upmu\mathrm{g}$ and NMT $980\ \ \mathrm{{\mug}}\ \$ (potency) per mg of doxycycline $(\mathrm{C}_{22}\mathrm{H}_{24}\mathrm{N}_{2}\mathrm{O}_{8}:444.44)$ ), calculated on the anhydrous basis. Description Doxycycline Hydrate occurs as a yellow crystalline powder.  

It is sparingly soluble in ethanol(95), very slightly soluble in water and practically insoluble in chloroform or ether. It dissolves in dilute acid or alkaline solutions.  

Identification Determine the infrared spectra of Doxycycline Hydrate and doxycycline RS, as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Crystallinity Meets the requirements. $\mathbf{pH}$ The pH of a suspension obtained by suspending $0.1\;\mathrm{g}$ of Doxycycline Hydrate in $10\;\mathrm{mL}$ of water is between 5.0 and 6.5.  

Purity (1) Heavy metals— Weigh $0.5~\mathrm{g}$ of Doxycycline Hydrate, mix with $4~\mathrm{mL}$ of a solution of magnesium sulfate heptahydrate in dilute sulfuric acid (1 in 4), heat until a liquid is obtained, and then evaporate to dryness on a steam bath. Ignite the residue at below $800\ ^{\circ}\mathrm{C}$ to incinerate. Allow to cool and moisten the residue with a small amount of dilute sulfuric acid.  Evaporate to dryness, incinerate for NMT 2 hours, and allow to cool. Extract the residue twice each with $5\;\mathrm{mL}$ of $2\;\mathrm{mol/L}$ hydrochloric acid TS, add $0.1\,\mathrm{~mL~}$ of phenolphthalein TS, and add ammonia water(28) until the solution turns pale red. Allow to cool, add acetic acid(100) until the color disappears, and add another $0.5~\mathrm{mL}$ . Filter and wash, if necessary. Add water to make $20~\mathrm{mL}$ and use this solution as the test solution. Separately, proceed in the same manner as the preparation of the test solution using $2.5\,\mathrm{\mL}$ of lead standard solution instead of Doxycycline Hydrate. To $10~\mathrm{mL}$ of this solution, add $2~\mathrm{mL}$ of the test solution and use this solution as the control solution. Separately, add $2~\mathrm{mL}$ of the test solution to $10~\mathrm{mL}$ of water and use this solution as the blank test solution. To $12~\mathrm{mL}$ each of the test solution, the standard solution and the blank test solution, add $2~\mathrm{mL}$ of acetate buffer $(\mathsf{p H}\,3.5)$ , mix, add $1.2~\mathrm{mL}$ of thioacetamide TS, mix immediately, and allow to stand for 2 minutes. The brown color of the test solution is not more intense than that of the control solution. System suitability: The control solution shows a faint brown color compared to the blank test solution. Add $2.5~\mathrm{mL}$ of lead standard solution to the test solution. To $10~\mathrm{mL}$ of this solution, add $2~\mathrm{mL}$ of the test solution, and use this solution as the system suitability solution. The system suitability solution is more intense than or has the same intensity as the control solution.  

(2) Related substances— Weigh accurately about $55~\mathrm{mg}$ of Doxycycline Hydrate, dissolve in $12~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid, add $0.01\ \mathrm{mol/L}$ hydrochloric acid to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Weigh accurately an appropriate amount of methacycline hydrochloride RS, dissolve in $0.01\;\mathrm{mol/L}$ hydrochloric acid to make a solution containing $1.2~\mathrm{mg}$ per mL, and use this solution as the methacycline standard stock solution. Separately, weigh accurately about $12\,\mathrm{~mg}$ of doxycycline RS, dissolve in $0.01\;\mathrm{mol/L}$ hydrochloric acid to make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution (1). Pipet $2.0\ \mathrm{mL}$ of standard solution (1) and $2.0~\mathrm{mL}$ of the methacycline standard stock solution, add $0.01\ \mathrm{mol/L}$ hydrochloric acid to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution (2). Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and standard solution (2) as directed under the Liquid Chromatography according to the following operating conditions, and then determine the peak areas of methacycline $A_{\mathrm{M}}$ and $A_{\mathrm{U}}$ , obtained from standard solution (2) and the test solution, respectively. Likewise, determine the peak area of doxycycline $A_{S}$ , obtained from standard solution (2) and the peak areas of each related substance other than methacycline $A_{\mathrm{i}}$ from the test solution. The content of methacycline is NMT $2.0\%$ , the content of related substances eluted before methacycline is NMT $0.5\%$ , the content of 6-epidoxycycline is NMT $2.0\%$ , and the content of related substances eluted after the doxycycline peak is NMT $0.5\%$ .  

$$
\begin{array}{r}{\mathrm{Content}\left(\%\right)\mathrm{of~methacy}}\\ {=\frac{C_{\mathrm{M}}}{\mathrm{W}}\times\frac{A_{\mathrm{U}}}{A_{\mathrm{M}}}\times5000}\end{array}
$$  

Content $(\%)$ of each related substance other than meth  

$$
=\frac{C_{s}}{\mathsf{W}}\times\frac{A_{\mathrm{i}}}{A_{s}}\times5000
$$  

$C_{\mathbf{M}}$ : Concentration $(\mathrm{{mg/mL})}$ of methacycline hydrochloride in standard solution (2)  

W: Weight (mg) of Doxycycline Hydrate taken $C_{S}$ : Concentration $\mathrm{(mg/mL)}$ of doxycycline in standard solution (2)  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $270\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25\;\mathrm{cm}$ in length, packed with spherical styrene-divinylbenzene copolymer for liquid chromatography ( $5\,\upmu\mathrm{m}$ to $10\,\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $60\ {}^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2.72\mathrm{~g~}$ of potassium dihydrogen phosphate, $0.74~\mathrm{g}$ of sodium hydroxide, $0.50~\mathrm{g}$ of tetrabutyl ammonium hydrogen sulfate and $0.40\,\mathrm{~g~}$ of disodium dihydrogen ethylenediaminetetraacetate in 850 mL of water. To this solution, add $60~\mathrm{g}$ of $t$ -butyl alcohol, add water to make exactly $1000~\mathrm{mL}$ , and adjust the $\mathrm{pH}$ to $7.0\textrm{-}9.0\$ with $1\ \mathrm{mol/L}$ sodium hydroxide solution.  

Flow rate: $1\ \mathrm{mL/min}$  

# System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the system suitability solution under the above operating conditions; the relative retention times of 4- epidoxycycline, methacycline, 6-epidoxycycline and doxycycline are 0.4, 0.6, 0.7 and 1.0, respectively, and the resolution between the peaks of 4-epidoxycycline and doxycycline is NLT 3.0 with the symmetry factor of the peaks being NMT 2.0.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of standard solution (1) under the above operating conditions; the relative standard deviation of the peak area of doxycycline is NMT $2.0\%$ .  

Time span of measurement: About 1.7 times the retention time of doxycycline.  

System suitability solution —Dissolve doxycycline RS in $0.01\ \mathrm{mol/L}$ hydrochloric acid to make a solution containing $6~\mathrm{mg}$ per mL. Pipet $5\,\textrm{m L}$ of this solution, warm on a steam bath for 60 minutes, and evaporate to dryness on a hot plate while taking care not to burn the residue. Dissolve the residue in $0.01\ \mathrm{mol/L}$ hydrochloric acid to make exactly $25~\mathrm{mL}$ and use this solution as the system suitability solution. This solution contains 4- epidoxycycline, 6-epidoxycycline and doxycycline. Keep this solution in a refrigerator and use it within 14 days. Water Between $3.6\%$ and $4.6\%$ ($\mathrm{.}2\mathrm{~g~}$ , volumetric titration, direct titration).  

Assay Weigh accurately an appropriate amount of Doxycycline Hydrate, equivalent to about $55~\mathrm{mg}$ (potency), dissolve in $12~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid by shaking, add $0.01\;\mathrm{mol/L}$ hydrochloric acid to make exactly $50\,\mathrm{\mL}$ , and filter through a filter with pore size of NMT $0.5\ \upmu\mathrm{m}$ . Use the filtrate as the test solution. Separately, weigh accurately about $11~\mathrm{~mg}$ (potency) of doxycycline RS, add $6\ \mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid, sonicate for 5 minutes to dissolve, and make exactly $10\,\mathrm{\mL}$ . Use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ of doxycycline in each solution.  

Operating conditions   
Proceed as directed under the Assay under Doxycycline Hyclate Hydrate.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Doxycycline Capsules 독시사이클린캡슐  

Doxycycline Capsules contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of doxycycline $\mathrm{(C_{22}H_{24}N_{2}O_{8}:444.44)}$ ).  

Method of preparation Prepare as directed under Capsules, with Doxycycline Hydrate.  

Identification (1) Weigh about $0.1\ \mathrm{g}$ (potency) each of Doxycycline Capsules and doxycycline RS, add $100~\mathrm{mL}$ of methanol, shake well to mix, filter, and use the clear supernatant as the test solution and the standard solution, respectively. Perform the test with these solutions as directed under the Thin Layer Chromatography. Heat a plate coated with octylsilanized silica gel for liquid chromatography, $0.25\ \mathrm{mm}$ in thickness, at $130~^{\circ}\mathrm{C}$ for 20 minutes and allow to cool. Spot the test solution and the standard solution on the plate while the plate is still warm, develop the plate with a mixture of $0.5\ \mathrm{mol/L}$ oxalic acid (previously adjusted to $\mathrm{pH}\,2.0$ with ammonium hydroxide), methanol and acetonitrile $(80:20:20)$ as a developing solvent. After air-drying the plate, expose it to ammonia vapor for 5 minutes and examine it under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spot obtained from the test solution shows the same $R_{\mathrm{f}}$ value as that obtained from the standard solution.  

(2) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

# Loss on drying NMT $5.0\%$ (0.1 g, $60\ ^{\circ}\mathrm{C}$ , 2 hours).  

Dissolution Perform the test with 1 tablet of Doxycycline Capsules at 75 revolutions per minute according to Method 2 under the Dissolution using $900\,\mathrm{\mL}$ of 0.01 mol/L hydrochloric acid TS as the dissolution medium. Take the dissolved solution after 60 minutes from the start of the test and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $V\mathrm{~mL}$ of the subsequent filtrate, add the dissolution medium to make exactly $V^{\tt m L}$ , and use this solution as the test solution. Separately, weigh accurately an appropriate amount of doxycycline RS, dissolve it in the dissolution medium to make it the same concentration as the test solution, and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and A S, of the test solution and the standard solution, respectively, at the absorbance maximum wavelength of about $268\,\mathrm{\nm}$ as directed under the Ultraviolet-visible Spectroscopy, using the dissolution medium as the control solution. Doxycycline Capsules meet the requirement when the dissolution rate at 60 minutes is NLT $85\%$ (Q).  

Dissolution rate $(\%)$ with respect to the labeled amount of doxycycline $(\mathbf{C}_{22}\mathbf{H}_{24}\mathbf{N}_{2}\mathbf{O}_{8})$ )  

$$
=C_{S}\times{\frac{V^{\prime}}{V}}\times{\frac{1}{\complement}}\times90000
$$  

$C s$ : Concentration [mg (potency)/mL] of the standard solution  

$C$ : Labeled amount [mg (potency)] of doxycycline $\left({\bf C}_{22}{\bf H}_{24}{\bf N}_{2}{\bf O}_{8}\right)$ in 1 capsule  

Uniformity of dosage units Meets the requirements. Assay Perform the test as directed under the Assay under Doxycycline Hyclate Hydrate. In this case, weigh accurately the contents of NLT 20 Doxycycline Capsules. Weigh accurately an appropriate amount of the combined contents, equivalent to about $100~\mathrm{mg}$ (potency), according to the labeled potency of Doxycycline Capsules, add $20\,\mathrm{\mL}$ of $0.1\,\mathrm{\mol/L}$ hydrochloric acid, sonicate for 5 minutes, shake for 15 minutes to dissolve, and add 0.01 $\mathrm{mol/L}$ hydrochloric acid to make exactly $100~\mathrm{mL}$ . Filter this solution through a membrane filter with a pore size of NMT $0.5\ \upmu\mathrm{m}$ and use the filtrate as the test solution. Separately, weigh accurately about $10~\mathrm{{mg}}$ (potency) of doxycycline RS, add $6\ \mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid, sonicate for 5 minutes to dissolve, make exactly 10 mL, and use this solution as the standard solution.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Doxycycline Hyclate Hydrate 독시사이클린하이클레이트수화물  

![](images/169d70657f4cbb55a7fdd3fe78381dff9aced421ea8596317eed025371b2c877.jpg)  

Doxycycline Hyclate  

(C 22 H24 N2 O8 ·HCl) 2 ·C 2 H6 O·H 2 O : 1025.89 (4 S,4a R,5 S,5a R,6 R,12a S)-4-(Dimethylamino)- 3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; ethanol; hydrate; dihydrochloride [ 24390-14-5 Doxycycline Hyclate Hydrate is the hydrochloride of a derivative of oxytetracycline.  

Doxycycline Hyclate Hydrate contains NLT $800~\upmu\mathrm{g}$ and NMT $920~\mathrm{\,\upmug}$ (potency) per mg of doxycycline $(\mathrm{C_{22}H_{24}N_{2}O_{8}:444.43})$ ), calculated on the anhydrous basis and corrected by the amount of ethanol.  

Description Doxycycline Hyclate Hydrate occurs as yellow to dark yellow crystals or a crystalline powder. It is freely soluble in water and in methanol, and slightly soluble in ethanol(99.5).  

Identification (1) Determine the infrared spectra of Doxycycline Hyclate Hydrate and doxycycline hyclate hydrate RS, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) An aqueous solution of Doxycycline Hyclate Hydrate (1 in 20) responds to the Qualitative Analysis for chlorides.  

Crystallinity Meets the requirements. Specific optical rotation $[\alpha]_{D}^{20}$ : Between $-105^{\circ}$ and - $120^{\circ}$ ($\mathbf{0.25~g}$ calculated on the anhydrous basis and corrected by the amount of alcohol, $0.01\;\mathrm{mol/L}$ hydrochloric acid-methanol TS, $25~\mathrm{mL}$ ,$100\ \mathrm{mm}$ ). Determine within 5 minutes after the test solution is prepared.  

$\mathbf{pH}$ Dissolve $1.0\;\mathrm{g}$ of Doxycycline Hyclate Hydrate in 10 mL of water; the $\mathrm{pH}$ of this solution is between 2.0 and 3.0.  

Absorbance (249 nm): Between 285 and 315 (10 $\mathrm{mg},0.01\;\mathrm{mol/L}$ hydrochloric acid-methanol, $500\;\mathrm{mL}$ ).  

Purity (1) Ethanol —Weigh accurately about $1.0\mathrm{~g~}$ of Doxycycline Hyclate Hydrate, dissolve in exactly $5~\mathrm{mL}$ of the internal standard solution, add water to make exactly $25\,\mathrm{\mL}$ , and use this solution as the test solution. Separately, pipet $2\,\textrm{m L}$ of ethanol(99.5), add water to make exactly $100\ \mathrm{mL}.$ ., and use this solution as the standard stock solution. Pipet $0.25\ \mathrm{mL}$ of this standard stock solution, add exactly $5~\mathrm{mL}$ of the internal standard solution, add water to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $1~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Gas Chromatography according to the following conditions, and determine the ratio of the peak area of ethanol to that of the internal standard, $\mathrm{Q_{T}}$ and $\mathrm{Q}_{\mathrm{S}}$ .The amount of ethanol is between $4.3\%$ and $6.0\%$ .  

Content $(\%)$ of ethanol per $\mathrm{g}$ of Doxycycline Hyclate Hydrate  

$$
=1\mid W_{T}\times Q_{T}/\,Q_{s}\times0.5\times0.79
$$  

$\mathrm{W_{T}}$ : Weight (g) of Doxycycline Hyclate Hydrate  

# 0.79: Density $(\mathrm{{g}/\mathrm{{mL}})}$ ) of ethanol at $20~^{\circ}\!C$  

Internal standard solution —1-propanol solution (1 in 1000).  

Operating conditions Detector: A flame-ionization detector Column: A fused silica capillary column, $0.53\,\mathrm{\mm}$ in internal diameter and $30\textrm{m}$ in length, of which the inner surface is coated with $6\%$ cyanopropylphenyl$.94\%$ polydimethylsiloxane for gas chromatography to a thickness of $3.0\;\upmu\mathrm{m}$ .  

Column temperature: Maintain at $50\ \ ^{\circ}\mathrm{C}$ for 5 minutes, then raise to $200~^{\circ}\mathrm{C}$ by $50~^{\circ}\mathrm{C}$ per minute, and keep at $200\ {}^{\circ}\mathrm{C}$ for 5 minutes.  

Sample injection port temperature: $210\;^{\circ}\mathrm{C}$   
Detector temperature: $280\,^{\circ}\mathrm{C}$   
Split ratio: $1:5$   
Carrier gas: Nitrogen   
Flow rate: $5\;\mathrm{mL/min}$   
System suitability  

System performance: Proceed with $1~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; ethanol and the internal standard are eluted in this order. System reproducibility: Repeat the test 5 times with $1~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area of ethanol with respect to that of the internal standard is NMT $2.0\%$ .  

(2) Heavy metal —Proceed with $1.0\mathrm{~g~}$ of Doxycycline Hyclate Hydrate according to Method 2 and perform the test. Prepare the control solution with $5.0\;\mathrm{mL}$ of lead standard solution (NMT 50 ppm).  

(3) Related substances —Weigh accurately about $120~\mathrm{mg}$ (potency) each of Doxycycline Hyclate Hydrate and doxycycline RS, dissolve them each in $0.01\,\mathrm{\mol/L}$ hydrochloric acid TS to make exactly $100~\mathrm{mL}$ , and use these solutions as the test solution and standard solution (1). Separately, weigh an appropriate amount of methacycline hydrochloride RS and dissolve in $0.01\,\mathrm{\mol/L}$ hydrochloric acid TS to make a solution containing 1.2 mg per mL. Pipet $2.0~\mathrm{mL}$ of this solution and $2.0~\mathrm{mL}$ of standard solution (1), dissolve in $0.01\;\mathrm{mol/L}$ hydrochloric acid TS to make $100~\mathrm{mL}$ of a solution containing 0.024 mg of doxycycline and methacycline hydrochloride per mL, and use this solution as standard solution (2). Perform the test with exactly $20~\upmu\mathrm{L}$ each of the test solution and standard solution (2) as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak area of methacycline obtained from standard solution (2), $A_{\mathrm{M}}$ , and that from the test solution, $A_{\mathrm{U}}$ . Likewise, determine the peak area of doxycycline obtained from standard solution (2), $A_{S}$ , and the peak areas of each related substance other than methacycline obtained from the test solution, $A_{\mathrm{i}}$ ; the content of methacycline is NMT $2.0\%$ , the content of each related substance eluted before the methacycline peak is NMT $0.5\%$ , the content of 6-epidoxycycline is NMT $2.0\%$ , and the content of each related substance eluted after the doxycycline peak is NMT $0.5\%$ .  

$$
\begin{array}{c}{{\mathrm{Content}\left(\%\right)\mathrm{of~methacyclin\epsilon}}}\\ {{=\displaystyle\frac{C_{\mathrm{M}}}{\mathrm{W}}\times\frac{A_{\mathrm{U}}}{A_{\mathrm{M}}}\times10000}}\end{array}
$$  

Content $(\%)$ of each related substance other than  

$$
=\frac{C_{s}}{W}\times\frac{\bar{A}_{\mathrm{i}}}{A_{s}}\times10000
$$  

$C_{\mathrm{M}}$ : Concentration $(\mathrm{mg/mL})$ ) of methacycline hydrochloride in standard solution (2)  

W: Weight [mg (potency)] of Doxycycline Hyclate Hydrate taken  

$C_{S}$ : Concentration [mg (potency)/mL] of doxycycline in standard solution (2)  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $270\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with spherical styrene-divinylbenzene copolymer for liquid chromatography ( $\ensuremath{\left\{5\,\upmu\mathrm{m}\right.}}$ to $10\,\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $60\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2.72\mathrm{~g~}$ of potassium dihydrogen phosphate, $0.74~\mathrm{g}$ of sodium hydroxide, $0.50~\mathrm{g}$ of tetrabutylammonium hydrogen sulfate and $0.40\,\mathrm{~g~}$ of disodium dihydrogen ethylenediaminetetraacetate in 850 mL of water. To this solution, add $60~\mathrm{g}$ of $t$ -butyl alcohol, add water to make $1000\,\mathrm{\mL}$ , and adjust the $\mathrm{pH}$ to 8.0 with $1\,\mathrm{\mol/L}$ sodium hydroxide. If necessary, increase the resolution between the peaks of related substances and doxycycline and the retention time of doxycycline by reducing the proportion of $t$ -butyl alcohol.  

Flow rate: About $1.0\,\mathrm{mL/min}$ System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the system suitability solution under the above operating conditions; the relative retention times of 4- epidoxycycline, 6-epidoxycycline and doxycycline are about 0.4, 0.7 and 1.0, respectively, and the resolution between the peaks of 4-epidoxycycline and doxycycline is NLT 3.0 with the symmetry factor of doxycycline being NMT 2.0.  

System repeatability: Repeat the test 6 times with a solution prepared by dissolving $12~\mathrm{mg}$ of doxycycline RS in $10\;\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ hydrochloric acid; the relative standard deviation is NMT $2.0\%$ .  

Time span of measurement: About 1.7 times the retention time of doxycycline.  

System suitability solution —Weigh an appropriate amount of doxycycline RS and dissolve in $0.01\,\mathrm{\mol/L}$ hydrochloric acid to make a solution containing $6~\mathrm{mg}$ of doxycycline per mL. Take $5\ \mathrm{mL}$ of this solution, heat over a steam bath for 60 minutes, and evaporate to dryness on a hot plate while taking care not to burn the residue. Dissolve the residue in $0.01\;\mathrm{mol/L}$ hydrochloric acid to make exactly $25~\mathrm{mL}$ , filter through a membrane filter with a pore size of NMT $0.5~{\upmu\mathrm{m}}$ , and use this solution as the system suitability solution. Keep this solution in a refrigerator and use it within 14 days.  

Water Between $1.4\%$ and $2.8\%$ ($\mathrm{~\textmu~}^{0.3}\mathrm{~g~}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.3\%$ ($\mathrm{~\textit~{~1~g~}~}$  

Assay Weigh accurately about $0.120\,\mathrm{~g~}$ (potency) of Doxycycline Hyclate Hydrate, dissolve in $0.01\,\mathrm{\mol/L}$ hydrochloric acid to make exactly $100~\mathrm{mL}$ , filter through a membrane filter with a pore size of NMT $0.5\ \upmu\mathrm{m}.$ , and use the filtrate as the test solution. Separately, weigh accurately about $12~\mathrm{mg}$ (potency) of doxycycline RS, add 6 mL of $0.01\;\mathrm{\mol/L}$ hydrochloric acid, sonicate for 5 minutes to dissolve, make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution. Perform the test with 20 mL each of the test solution and the standard solution as directed under the Liquid Chromatography, and determine the peak areas $A_{\mathrm{T}}$ and $A_{S}$ of doxycycline in each solution.  

Potency $\mathrm{(\upmug)}$ of doxycycline $(\mathrm{C}_{22}\mathrm{H}_{24}\mathrm{N}_{2}\mathrm{O}_{8})$ $=$ Potency $\mathrm{(\upmug)}$ of doxycycline $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times10$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $270\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25\;\mathrm{cm}$ in length, packed with spherical styrene-divinylbenzene copolymer for liquid chromatography $(5\,\upmu\mathrm{m}\cdot10\,\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $60\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2.72\mathrm{~g~}$ of potassium dihydrogen phosphate, $0.74\mathrm{~g~}$ of sodium hydroxide, $0.50~\mathrm{g}$ of tetrabutylammonium hydrogen sulfate and $0.40\,\mathrm{~g~}$ of disodium dihydrogen ethylenediaminetetraacetate in 850 mL of water. To this solution, add $60\ \mathrm{g}$ of $t$ -butyl alcohol, add water to make $1000~\mathrm{{mL}}$ , and adjust the $\mathrm{pH}$ to $8.0\pm$ 0.1 with $1~\mathrm{\mol/L}$ sodium hydroxide. If necessary, increase the resolution between the peaks of related substances and doxycycline and the retention time of doxycycline by reducing the proportion of $t$ -butyl alcohol.  

Flow rate: $1.0\,\mathrm{mL/min}$ System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the system suitability solution under the above operating conditions; the relative retention times of 4- epidoxycycline, 6-epidoxycycline and doxycycline are about 0.4, 0.7 and 1.0, respectively, and the resolution between the peaks of 4-epidoxycycline and doxycycline is NLT 3.0 with the symmetry factor of the doxycycline peak being NMT 2.0.  

System repeatability: Repeat the test 5 times with $20~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area of doxycycline is NMT $2.0\%$ .  

System suitability solution —Weigh an appropriate amount of doxycycline RS and dissolve in $0.01\,\mathrm{\mol/L}$ hydrochloric acid to make a solution containing $6~\mathrm{mg}$ of doxycycline per mL. Take $5\,\textrm{m L}$ of this solution, heat over a steam bath for 60 minutes, and evaporate to dryness on a hot plate while taking care not to burn the residue. Dissolve the residue in $0.01\;\mathrm{mol/L}$ hydrochloric acid to make exactly $25~\mathrm{mL}$ , filter through a membrane filter with a pore size of NMT $0.5\ \upmu\mathrm{m}.$ , and use this solution as the system suitability solution. Keep this solution in a refrigerator and use it within 14 days.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Doxycycline Hyclate Capsules 독시사이클린하이클레이트캡슐  

Doxycycline Hyclate Capsules contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of doxycycline $\mathrm{(C_{22}H_{24}N_{2}O_{8}:444.44)}$ ).  

Method of preparation Prepare as directed under Capsules, with Doxycycline Hyclate Hydrate.  

Identification (1) Take the contents of 1 capsule of Doxycycline Hyclate Capsules and add 3 drops of sulfuric acid to the powdered contents; a yellow color is observed.  

(2) Weigh about $10~\mathrm{~mg}$ (potency) of powdered Doxycycline Hyclate Capsules, dissolve in $20~\mathrm{mL}$ of water, and add silver nitrate TS; the solution becomes turbid in white.  

(3) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Water NMT $5.0\%$ ($\mathrm{~\,~}^{0.2}\mathrm{~g~}$ , volumetric titration, direct titration).  

Dissolution Perform the test with 1 capsule of Doxycycline Hyclate Capsules at 75 revolutions per minute according to Method 2 under the Dissolution, using $900\;\mathrm{mL}$ of water as the dissolution medium, with the distance between the bottom edge of the stirring blade and the inside bottom of the flask being maintained at $4.5\pm0.5$ cm during the test. Take the dissolved solution after 30 minutes from the start of the test and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $V\,{\mathrm{mL}}$ of the subsequent filtrate, add the dissolution medium to make exactly $V^{\prime}$ mL, and use this solution as the test solution. Separately, weigh accurately an appropriate amount of doxycycline RS, dissolve it in the dissolution medium to make it the same concentration as the test solution, and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and A S, of the test solution and the standard solution, respectively, at the absorbance maximum wavelength of about $276\ensuremath{\,\mathrm{\nm}}$ as directed under the Ultraviolet-visible Spectroscopy, using the dissolution medium as the control solution. Doxycycline Hyclate Capsules meet the requirement when the dissolution rate at 30 minutes is NLT $80\%$ (Q).  

Dissolution rate $(\%)$ with respect to the labeled amount of doxycycline $(\mathbf{C}_{22}\mathbf{H}_{24}\mathbf{N}_{2}\mathbf{O}_{8})$  

$$
={\mathsf{C}}_{\mathsf{S}}\times\frac{{\mathsf{A}}_{\mathrm{T}}}{{\mathsf{A}}_{\mathrm{S}}}\times\frac{\mathsf{V}^{\mathrm{~\prime~}}}{\mathsf{V}}\times\frac{1}{\mathsf{C}}\times90000
$$  

$C s$ : Concentration [mg (potency)/mL] of the standard solution  

$C$ : Labeled amount [mg (potency)] of doxycycline $\left({\bf C}_{22}{\bf H}_{24}{\bf N}_{2}{\bf O}_{8}\right)$ in 1 capsule  

Uniformity of dosage units Meets the requirements. Assay Perform the test as directed under the Assay under Doxycycline Hyclate Hydrate. In this case, weigh accurately the contents of NLT 20 Doxycycline Hyclate Capsules. Weigh accurately an appropriate amount of the combined contents of Doxycycline Hyclate Capsules, equivalent to about $100\,\mathrm{\mg}$ (potency) according to the labeled potency of this drug, add $75~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid, sonicate for 5 minutes, shake for 15 minutes to dissolve, and add $0.01\,\mathrm{\mol/L}$ hydrochloric acid to make exactly $100~\mathrm{mL}$ . Filter this solution through a membrane filter with a pore size of NMT $0.5\ \upmu\mathrm{m}$ and use the filtrate as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ (potency) of doxycycline RS, add 6 mL of $0.01\;\mathrm{\mol/L}$ hydrochloric acid, sonicate for 5 minutes to dissolve, make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Doxycycline Hyclate Tablets 독시사이클린하이클레이트정  

Doxycycline Hyclate Tablets contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of doxycycline $\mathrm{(C_{22}H_{24}N_{2}O_{8}:444.44)}$ ).  

Method of preparation Prepare as directed under Tablets, with Doxycycline Hyclate Hydrate.  

Identification The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Water NMT $5.0\%$ ($\mathbf{\nabla}[0.2\,\textbf{g}$ , volumetric titration, direct titration).  

Dissolution Perform the test with 1 tablet of Doxycycline Hyclate Tablets at 75 revolutions per minute according to Method 2 under the Dissolution, using $900\;\mathrm{mL}$ of water as the dissolution medium, with the distance between the bottom edge of the stirring blade and the inside bottom of the flask being maintained at $4.5\pm0.5$ cm during the test. Take the dissolved solution after 90 minutes from the start of the test and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $V\,{\mathrm{mL}}$ of the subsequent filtrate, add the dissolution medium to make exactly $V^{\prime}$ mL, and use this solution as the test solution. Separately, weigh accurately an appropriate amount of doxycycline RS, dissolve it in the dissolution medium to make it the same concentration as the test solution, and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and A S, of the test solution and the standard solution, respectively, at the absorbance maximum wavelength of about $276\ensuremath{\,\mathrm{\nm}}$ as directed under the Ultraviolet-visible Spectroscopy, using the dissolution medium as the control solution. Doxycycline Hyclate Tablets meet the requirement when the dissolution rate at 90 minutes is NLT $85\%$ (Q).  

Dissolution rate $(\%)$ with respect to the labeled amount of doxycycline $(\mathbf{C}_{22}\mathbf{H}_{24}\mathbf{N}_{2}\mathbf{O}_{8})$  

$$
=C_{\mathrm{S}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\times{\frac{\mathrm{V}^{\mathrm{~\prime~}}}{\mathrm{V}}}\times{\frac{1}{\mathrm{C}}}\times90000
$$  

$C s$ : Concentration [mg (potency)/mL] of the standard solution   
$C$ : Labeled amount [mg (potency)] of doxycycline $(\mathbf{C}_{22}\mathbf{H}_{24}\mathbf{N}_{2}\mathbf{O}_{8})$ in 1 tablet  

# Uniformity of dosage units Meets the requirements.  

Assay Perform the test as directed under the Assay under Doxycycline Hyclate Hydrate. Take NLT 20 Doxycycline Hyclate Tablets and powder them. Then, weigh accurately an appropriate amount of the powder, equivalent to about $100~\mathrm{mg}$ (potency), according to the labeled potency of Doxycycline Hyclate Tablets, add $75~\mathrm{mL}$ of $0.01\,\mathrm{\mol/L}$ hydrochloric acid, sonicate for 5 minutes, shake for 15 minutes to dissolve, and add $0.01\,\mathrm{\mol/L}$ hydrochloric acid to make exactly $100\,\mathrm{\mL}$ . Filter this solution through a membrane filter with a pore size of NMT $0.5~{\upmu\mathrm{m}}$ and use the filtrate as the test solution. Separately, weigh accurately about $10~\mathrm{~mg}$ (potency) of doxycycline RS, add $6\ \mathrm{mL}$ of $0.01\,\mathrm{\mol/L}$ hydrochloric acid, sonicate for 5 minutes to dissolve, make exactly 10 mL, and use this solution as the standard solution.  

Packaging and storage Preserve in light-resistant, tight containers.  

![](images/4823207907229774bdd94950bf5e96d6cb67faa16a1d84159b874ae2ad1065fb.jpg)  
Dydrogesterone 디드로게스테론  

${\bf C}_{21}{\bf H}_{28}{\bf O}_{2}$ : 312.45  

(8S,9R,10S,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one [ 152-62-5 ]Dydrogesterone, when dried, contains NLT $98.0\%$ and NMT $102.0\%$ of dydrogesterone $(\mathbf{C}_{21}\mathbf{H}_{28}\mathbf{O}_{2})$ .  

Description Dydrogesterone occurs as white or pale yellow crystals or a crystalline powder and is odorless. It is freely soluble in chloroform, soluble in acetonitrile, sparingly soluble in methanol or in ethanol(95), slightly soluble in ether and practically insoluble in water.  

Identification (1) To $5~\mathrm{mg}$ of Dydrogesterone, add $5\;\mathrm{mL}$ of 4-methoxybenzaldehyde-acetic acid TS and 2 to 3 drops of sulfuric acid, and heat on a steam bath for 2 minutes; an orange color appears.  

(2) Determine the absorption spectra of solutions of Dydrogesterone and dydrogesterone RS in methanol (1 in 200000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Dydrogesterone and dydrogesterone RS, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-47^{\circ}$ and $-50^{\circ}$ (after drying $0.1~\mathrm{g}$ , chloroform, $10\,\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 167 and $171\,^{\circ}\!C$ Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Dydrogesterone according to Method 2, and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(2) Related substances —Dissolve $10~\mathrm{mg}$ of Dydrogesterone in $200\,\mathrm{\mL}$ of the mobile phase, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area of these solutions by the automatic integration method; the sum of the peak areas, other than the peak of dydrogesterone, obtained from the test solution, is not larger than the peak area of dydrogesterone obtained from the standard solution.  

Operating conditions   
Detector: An ultraviolet absorption spectrophotometer (wavelength: $280\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 $\upmu\mathrm{m}$ in particle diameter).   
Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of water, ethanol(95) and acetonitrile $(53:26:21)$ .  
Flow rate: Adjust the flow rate so that the retention time of dydrogesterone is about 12 minutes.  

# System suitability  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of dydrogesterone obtained from $10\,\upmu\mathrm{L}$ of the standard solution is between $5\;\mathrm{mm}$ and $10\;\mathrm{mm}$ .  

Selection of column: Dissolve $1~\mathrm{~mg}$ each of Dydrogesterone and progesterone in $20~\mathrm{mL}$ of the mobile phase. Proceed with $10\,\textrm{\textmu L}$ of this solution under the above operating conditions. At this time, use a column from which dydrogesterone and progesterone are eluted in this order with the resolution between these peaks being NLT 8. In this case, use the wavelength of $265~\mathrm{nm}$ for measurement.  

Time span of measurement: About twice the retention time of dydrogesterone after the solvent peak.  

Loss on drying NMT $0.5\%$ ($\mathrm{.5~g}$ , in vacuum, $\mathrm{P}_{2}\mathrm{O}_{5}$ , 24 hours).  

# Ignition residue NMT $0.1\%$ ($\mathrm{~\textit~{~1~}~}\mathrm{g})$  

Assay Weigh accurately about $50~\mathrm{mg}$ of Dydrogesterone, previously dried, and dissolve in methanol to make exactly $100\,\mathrm{\mL}$ . Pipet $1\,\textrm{m L}$ of this solution and add methanol to make exactly $100\,\mathrm{\mL}$ . Determine the absorbance $A$ of this solution at the absorbance maximum wavelength around $286~\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy.  

$$
=\frac{\dot{A}}{845}\times100000
$$  

Packaging and storage Preserve in tight containers.  

# Dydrogesterone Tablets 디드로게스테론정  

Dydrogesterone Tablets contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of dydrogesterone $\mathrm{(C_{21}H_{28}O_{2}:312.45)}$ ).  

Method of preparation Prepare Dydrogesterone Tablets as directed under Tablets, with Dydrogesterone.  

Identification (1) Take a portion of powdered Dydrogesterone Tablets, equivalent to $50~\mathrm{{mg}}$ of dydrogesterone, add $50~\mathrm{mL}$ of methanol, shake well to mix, and filter. Evaporate $5~\mathrm{mL}$ of the filtrate to dryness on a steam bath. Perform the test as directed under the Identification (1) of Dydrogesterone with the residue.  

(2) Take $1\ \mathrm{mL}$ of the filtrate and add methanol to make $200~\mathrm{mL}$ . Determine the absorption spectrum of this solution as directed under the Ultraviolet-visible  spectrophotometry; it exhibits a maximum at the wavelengths between $284\;\mathrm{nm}$ and $288~\mathrm{nm}$ .  

Dissolution Perform the test with 1 tablet of Dydrogesterone Tablets. Perform the test with 1 tablet of Dydrogesterone Tablets at 50 revolutions per minute according to Method 2 under the Dissolution, using $900~\mathrm{mL}$ of water as the test solution. Take NLT $20~\mathrm{mL}$ of the dissolved solution 30 minutes after starting the test, filter, and discard $10~\mathrm{mL}$ of the first filtrate. Pipet $V\,\mathrm{mL}$ of the subsequent filtrate and add water to make $V^{\prime}\,m L$ so that each mL contains about $50~\upmu\mathrm{g}$ of dydrogesterone according to the labeled amount. Use this solution as the test solution. Separately, dry dydrogesterone RS in a desiccator (in vacuum, phosphorus pentoxide) for 24 hours, weigh accurately $50~\mathrm{mg}$ of dydrogesterone RS, dissolve in methanol to make exactly $100~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Measure the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution at the wavelength of $296~\mathrm{nm}$ as directed under the Ultravioletvisible Spectroscopy. Meets the requirements if the dissolution rate of Dydrogesterone Tablets in 30 minutes is NLT $80\%$ .  

Dissolution rate $(\%)$ of the labeled amount of dydroges  

$$
=W_{S}\times\frac{A_{\mathrm{T}}}{\mathrm{A}_{\mathrm{S}}}\times\frac{1}{\mathrm{C}}\times9
$$  

$W_{S}$ : Amount (mg) of dydrogesterone RS $C$ : Labeled amount (mg) of dydrogesterone $(\mathbf{C}_{21}\mathbf{H}_{28}\mathbf{O}_{2})$ in 1 tablet  

Uniformity of dosage units It meets the requirements when tested according to the following procedure. Powder 1 tablet of Dydrogesterone Tablets and add methanol to make exactly $100\;\mathrm{mL}$ . Shake well to mix until the tablet is fully disintegrated and filter through a membrane filter with a pore diameter of NMT $0.45~\upmu\mathrm{m}$ . Discard 20 mL of the first filtrate, pipet $V\,\mathrm{mL}$ of the subsequent filtrate, and add methanol to make exactly $\mathrm{V^{\prime}~m L}$ so that each mL contains about $5~\upmu\mathrm{g}$ of dydrogesterone. Use this solution as the test solution. Perform the test as directed under the Assay below.  

Amount (mg) of dydrogesterone $(\mathbf{C}_{21}\mathbf{H}_{28}\mathbf{O}_{2})$ $=$ Amount (mg) of dydrogesterone $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A}_{S}}\times\frac{\mathrm{V}\,_{\prime}}{\mathrm{V}}\times\frac{1}{20}$ Assay Weigh accurately the mass of NLT 20 Dydrogesterone Tablets and powder. Weigh accurately a portion of the powder, equivalent to about $10~\mathrm{mg}$ of dydrogesterone $(\mathbf{C}_{21}\mathbf{H}_{28}\mathbf{O}_{2})$ , add $50~\mathrm{mL}$ of methanol, shake well to mix, and add methanol to make exactly $100\,\mathrm{\mL}$ . Filter this solution, discard the first $20\;\mathrm{mL}$ of the filtrate, take $5~\mathrm{mL}$ of the subsequent filtrate, and add methanol to make exactly $100\;\mathrm{mL}$ . Use this solution as the test solution. Separately, dry dydrogesterone RS in a desiccator (in vacuum, phosphorus pentoxide) for 24 hours, weigh accurately 10 mg of dydrogesterone RS, and proceed in the same manner as in the preparation of the test solution. Use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution, respectively, at $286\,\mathrm{\nm}$ as directed under the Ultraviolet-visible Spectroscopy.  

Amount (mg) of dydrogesterone $\left(\mathbf{C}_{21}\mathbf{H}_{28}\mathbf{O}_{2}\right)$ $=$ Amount (mg) of dydrogesterone $\mathrm{RS}\times\frac{\mathrm{A_{T}}}{\mathrm{A_{S}}}$ Ebastine $\mathrm{C}_{32}\mathrm{H}_{39}\mathrm{NO}_{2}$ : 469.66 4-(4-Benzhydryloxypiperidin-1-yl)-1-(4- tert -butylphenyl)butan-1-one [ 90729-43-4 ]  

![](images/0e0f89f242fa4ce1772e0e7113d851a4fde8746cd867227262d46b1bf8a06901.jpg)  
Packaging and storage Preserve in tight containers.  

Ebastine contains NLT $99.0\%$ and NMT $101.0\%$ of ebastine $(\mathbf{C}_{32}\mathbf{H}_{39}\;\mathbf{NO}_{2})$ , calculated on the anhydrous basis. Description Ebastine occurs as white crystals or a crystalline powder.  

It is very soluble in dichloromethane, slightly soluble in methanol, and practically insoluble in water. Melting point —About $86\,^{\circ}\mathbf{C}.$ .  

Identification Determine the infrared spectra of Ebastine and ebastine RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Purity (1) Sulfate —Weigh $2.5~\mathrm{g}$ of Ebastine and add 25 mL of dilute nitric acid and shake. Reflux with a reflux condenser for 10 minutes, cool and filter. Rinse the filter paper and the residue with a suitable amount of water, combine with the filtrate all together, dilute with water to make $50~\mathrm{mL}$ , and use this solution as the test solution. Prepare the control solution with $0.53~\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid and $25~\mathrm{mL}$ of dilute nitric acid to make 50 mL (NMT $0.01\%$ ).  

(2) Related substances —Keep the test solution and the standard solution of this test protected from light. Dissolve about $0.125~\mathrm{g}$ of Ebastine in the mobile phase to make $50.0~\mathrm{mL}$ , and use this solution as the test solution. Dissolve $5.0\,\mathrm{~mg~}$ of ebastine related substance III [4- (Diphenylmethoxy)piperidine] RS and $5.0~\mathrm{mg}$ of ebastine related substance IV {1-[4-(1,1-Dimethylethyl) phenyl]- 4-(4-hydroxypiperidine-1-yl)butan-1-one] RS in the mobile phase to make exactly $20~\mathrm{mL}$ , pipet $1.0~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ and use this solution as the standard solution (1). Pipet $1.0~\mathrm{mL}$ of the test solution, and add the mobile phase to make exactly $100~\mathrm{mL}$ . Pipet $1.0\ \mathrm{mL}$ of this solution, add the mobile phase to make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution (2). Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution (2) as directed under the Liquid Chromatography according to the following conditions. Determine each peak area by the automatic integration method; any peak area of related substances I, II, III, IV, V, VI, and VII in the automatic integration method obtained with the test solution is NMT the area of the major peak with the standard solution (2) $(0.1\%)$ , the peak area of the other related substances are NMT that of the major peak from the standard solution (2) $(0.1\%)$ . The total area of all related substances is not greater than 4 times the area of the major peak area from the standard solution (2) $(0.4\%)$ . Exclude any peak being NMT 0.5 times the area of the major peak with the standard solution (2).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25\mathrm{cm}$ in length, packed with nitrile silica gel for liquid chromatography $5\;{\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: A mixture of phosphate buffer and acetonitrile $(65:35)$ . Adjust the percentage of acetonitrile so that the retention time of ebastine is about 110 minutes.  

# Flow rate: 1 mL/min  

System suitability System performance: Proceed with $10~\upmu\mathrm{L}$ of the test solution under the above operating conditions; the relative retention time of related substances I, II, III, IV, V, VI, and VII with reference to ebastine are 0.04, 0.05, $0.20,\ 0.22,\ 0.42,\ 0.57$ and 1.14, respectively. Proceed with $10~\upmu\mathrm{L}$ of the standard solution (1) under the above operating conditions; the resolution between the peaks of related substance IV and related substance III is NLT 2.0. Time span of measurement: About 1.4 times the retention time of ebastine.  

Phosphate buffer —Adjust $\mathrm{pH}$ of $0.06~\mathrm{w/v}\%$ phosphoric acid with $4\,\mathrm{w}/\mathrm{v}\%$ sodium hydroxide to $\mathrm{pH}\,5.0$ .  

Water NMT $0.5\%$ ($\mathrm{~\ensuremath~{~0.5~\mathrm{~g~}~}~}$ , volumetric titration, direct titration).  

# Residue on ignition $0.1\%\:(1.0\:\mathrm{g})$ .  

Assay Weigh accurately about $0.35\mathrm{~g~}$ of Ebastine, dissolve it in $50~\mathrm{mL}$ of acetic acid(100) and titrate with 0.1 mol/L perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=46.97~\mathrm{mg}$ of $\mathrm{C}_{32}\mathrm{H}_{39}\mathrm{NO}_{2}$  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

![](images/d951de63c22a43a62788436b1c7020ea2b028c3d29ce15512c83c677eaa6e34e.jpg)  

$\mathrm{C}_{19}\mathrm{H}_{22}\mathrm{N}_{2}\mathrm{O}$ : 294.39 (-)-Eburnamonin-14(15 H)-one, [ 474-00-0 ](-)Eburnamonine, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of (-)eburnamonine $\mathrm{(C_{19}H_{22}N_{2}O}$ :294.39).  

Description (-)Eburnamonine occurs as a white crystalline powder. It is practically insoluble or insoluble in water, soluble in ethanol, and very soluble in chloroform, but slightly soluble in ether. It dissolves in inorganic acid. Melting point — Between 172 and $174\,^{\circ}\!C$ .  

Identification (1) To a solution of (-)Eburnamonine in ether, add dehydrated ethanol solution containing phosphoric acid to form a white precipitate of eburnamonine phosphate. Filter this precipitate and recrystallize this with ethanol and measure the melting point; the melting point is between 255 and $258\;^{\circ}\mathrm{C}$ .  

(2) Pass a hydrogen chloride gas through the solution of (-)Eburnamonine in ether to form a white precipi(3) Weigh about $25~\mathrm{mg}$ each of (-)Eburnamonine and (-)eburnamonine RS, dissolve each in $5~\mathrm{\mL}$ of ethyl acetate, and use these solutions as the test solution and the standard solution, respectively. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ of each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography (previously sprayed with $0.1\,\mathrm{\mol/L}$ sodium hydroxide solution and dried for 20 minutes at $105\ ^{\circ}\mathrm{C}_{\prime}$ ). Next, develop the plate with a mixture of acetone and methanol $(1:1)$ as the developing solvent to a distance of about $15\ \mathrm{cm}$ , and air-dry the plate. Examine under ultraviolet light (main wavelength: $254\:\mathrm{\nm})$ or spray sulfuric acid and heat it, the colors (blue) and $R_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

(4) Determine the absorption maxima at wavelengths of 299 to $301~\mathrm{nm}$ , 292 to $294\;\mathrm{nm}$ ,$263~\mathrm{nm}$ , 239 to $241~\mathrm{~nm~}$ , and 202 to $206~\mathrm{\nm}$ under a solution of (- )Eburnamonine in $0.01\,\mathrm{\mol/L}$ hydrochloric acid (1 in 100000).  

Optical rotation $[a]_{D}^{20}$ : Between $-88^{\circ}$ and $-104^{\circ}$ (after drying, $1\;\mathrm{g}$ , chloroform, $100\;\mathrm{mL}$ ).  

Purity Heavy metals —Weigh about $1.0\ \mathrm{~g~}$ of (- )Eburnamonine and perform the test according to Method 2. Prepare the control solution with $1.0\;\mathrm{mL}$ of lead standard solution (NMT 10 ppm).  

Loss on drying NMT $0.5\%$ $(1.0\,\mathrm{~g},\,100\,\,^{\circ}\mathrm{C}$ , constant mass).  

Residue on ignition NMT $0.1\%$ (1.0 g). Assay Weigh accurately about $0.1~\mathrm{g}$ of $(-)$ Eburnamonine, previously dried, and put it in a $100{\-}\mathrm{mL}$ volumetric flask. Dissolve in $0.1\ \mathrm{mol/L}$ hydrochloric acid-ethanol solution to make $100~\mathrm{mL}$ . Take $1.0\ \mathrm{mL}$ of this solution and dilute it with $0.1\,\mathrm{\mol/L}$ hydrochloric acid-ethanol solution to make $100\;\mathrm{mL}$ . Perform the test according to the Ultraviolet-visible Spectroscopy and measure the absorbance $A$ at the wavelength of ${240}\,\mathrm{nm}$ .  

$$
={\frac{A}{725}}\times100000
$$  

Packaging and storage Preserve in tight containers.  

# Econazole Nitrate and Triamcinolone Acetonide Ointment 에코나졸질산염·트리암시놀론아세토니드연고  

Econazole Nitrate and Triamcinolone Acetonide Ointment contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amounts of econazole nitrate $(\mathrm{C_{18}H_{15}C_{13}N_{2}O}\cdot\mathrm{HNO_{3}}\,:\,444.70)$ and triamcinolone acetonide $\mathrm{(C_{24}H_{31}F O_{6}:434.49)}$ ).  

Method of preparation Prepare as directed under Ointments, with Econazole Nitrate and Triamcinolone Acetonide.  

Identification Weigh an amount of Econazole Nitrate and Triamcinolone Acetonide Ointment, equivalent to 10 mg of econazole nitrate ( $\mathrm{~\textit~{~1~}~m g~}$ of triamcinolone acetonide), dissolve in $10\;\mathrm{mL}$ of methanol, and use this solution as the test solution. Separately, use a $0.1\%$ methanol solution of econazole nitrate and a $0.01\%$ methanol solution of triamcinolone acetonide as the standard solutions. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $1~\upmu\mathrm{L}$ each of the test solution and the standard solution onto a thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of toluene, ethanol, ethyl acetate and $85\%$ formic acid $(50:20:20:5)$ ) as the developing solvent, and air-dry the plate. Examine the plate under ultraviolet light (principal wavelength: $254~\mathrm{nm}$ ) or spray evenly with platinic acid iodide-potassium iodide TS; the colors and $R_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

Assay (1) Econazole nitrate —Weigh accurately an amount of Econazole Nitrate and Triamcinolone Acetonide Ointment equivalent to about $40~\mathrm{mg}$ of econazole nitrate $(\mathrm{C_{18}H_{15}C_{13}N_{20}{\cdot}H N O_{3})}$ according to the labeled amount, add a mixture of methanol and water $(40:60)$ to make $100~\mathrm{mL}$ , filter, and use the filtrate as the test solution. Separately, weigh accurately about $40~\mathrm{mg}$ of econazole nitrate RS, add a mixture of methanol and water $(40:60)$ to make $100~\mathrm{mL}$ , and use this solution as the econazole nitrate standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of econazole nitrate, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , for each solution.  

Amount (mg) of econazole nitrate $(\mathrm{C_{18}H_{15}C_{13}N_{20}{\cdot}H N O_{3})}$ $=$ Amount (mg) of econazole nitrate $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $10~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $3~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  
Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.   
Mobile phase A: Dissolve $0.77\,\mathrm{~g~}$ of ammonium acetate in water to make $1000~\mathrm{{mL}}$ . Add $200~\mathrm{mL}$ of methanol to $800\;\mathrm{mL}$ of this solution.  

Mobile phase B: A mixture of acetonitrile and methanol $(60:40)$ .  

![](images/491ae876a24370199fb4162a538cc08feabb9a9aa573751a40154f654d7e086e.jpg)  

Flow rate: $1.5\;\mathrm{mL/min}$ System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor is NMT 1.5.  

System repeatability: Repeat the test 5 times with $10\,\upmu\mathrm{L}$ each of the standard solution according to the above operating conditions; the relative standard deviation of the peak areas of Piroxicam is NMT $0.73\%$ .  

(2) Triamcinolone acetonide —Weigh accurately an amount of Econazole Nitrate and Triamcinolone Acetonide Ointment equivalent to about $5~\mathrm{mg}$ of triamcinolone acetonide $\left({\bf C}_{24}\mathrm{H}_{31}\mathrm{FO}_{6}\right)$ according to the labeled amount, add methanol to make $100\;\mathrm{mL}$ , filter, and use the filtrate as the test solution. Separately, weigh accurately about $50~\mathrm{~mg}$ of triamcinolone acetonide RS and add methanol to make $100\;\mathrm{mL}$ . Take $10.0\;\mathrm{mL}$ of this solution, add methanol to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas of triamcinolone acetonide, $A_{\mathrm{T}}$ and $A_{S}$ , for each solution.  

Amount (mg) of triamcinolone acetonide $\left({\bf C}_{24}{\bf H}_{31}{\bf F}{\bf O}_{6}\right)$ $=$ Amount (mg) of triamcinolone acetonide $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{1}{10}$  

decylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).   
Mobile phase: A mixture of water, acetonitrile and acetic acid(100) $(59:40:1)$ .  
Flow rate: $1.0\,\mathrm{mL/min}$  

Packaging and storage Preserve in tight containers.  

# Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream 에코나졸질산염·트리암시놀론아세토니드·겐타마이신황산염크림  

Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amounts of econazole nitrate $\mathrm{(C_{18}H_{15}C l_{3}N_{2}O}$ $\cdot\mathrm{HNO}_{3}:444.70\rangle$ ) and triamcinolone acetonide $({\bf C}_{24}{\mathrm{H}}_{31}{\mathrm{FO}}_{6}:434.50)$ ), and NMT $90.0\%$ and NLT $120.0\%$ of the labeled amount of gentamicin sulfate.  

Method of preparation Prepare as directed under Creams, with Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate.  

Identification (1) Econazole nitrate and triamcinolone acetonide —Weigh an amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream equivalent to $10~\mathrm{mg}$ of econazole nitrate, dissolve in 10 mL of methanol, and use this solution as the test solution. Separately, use a $0.1\%$ methanol solution of econazole nitrate RS and a $0.01\%$ methanol solution of triamcinolone acetonide RS as the standard solutions. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solutions onto a thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of toluene, ethanol, ethyl acetate and $85\%$ formic acid $(55:20:20:5)$ ) as the developing solvent, and air-dry the plate. Spray evenly hexachloroplatinic (IV) acid-potassium iodide TS on the plate and examine under ultraviolet light; the $R_{f}$ values and the colors of the spots obtained from the test solution and the standard solution are the same.  

(2) Gentamicin sulfate —(1) Dissolve $5~\mathrm{g}$ of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream in $10~\mathrm{mL}$ of water, then add $2~\mathrm{mL}$ of $\mathfrak{a}$ -naphtholethanol solution (1 in 500). Gently superimpose the solution onto $1~\mathrm{mL}$ of sulfuric acid; a purplish blue color develops at the boundary layer.  

(3) Weigh an amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream equivalent to $0.1\ \mathrm{g}$ of gentamicin sulfate, add $0.1\ \mathrm{mol/L}$ of phosphate buffer solution $\ensuremath{\left(\mathrm{pH}\ 8.0\right)}$ to make $100~\mathrm{{mL}}$ ,and use this solution as the test solution. Separately, weigh $10~\mathrm{{mg}}$ of gentamicin sulfate RS, add $0.1\,\mathrm{\mol/L}$ phosphate buffer solution $\ensuremath{\left(\mathrm{pH}\ 8.0\right)}$ to make $10~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $50~\upmu\mathrm{L}$ each of the test solution and the standard solution onto a thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Develop with a mixture of chloroform, methanol and strong ammonia water $(2:1:1)$ as the developing solvent, and air-dry the plate. Place the plate in an appropriate container containing between $2{\mathrm{~g~}}$ and $4\textrm{g}$ of iodine crystals, close the lid, and let stand for 3 to 5 minutes; the spots obtained from the test solution and the standard solution have the same $R_{f}$ value and color.  

Assay (1) Econazole nitrate —Weigh accurately an amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream equivalent to about $40~\mathrm{mg}$ of econazole nitrate $(\mathrm{C_{18}H_{15}C_{13}N_{20}{\cdot}H N O_{3})}$ according to the labeled amount, add a mixture of methanol and water $(40:60)$ to make $100\;\mathrm{mL}$ , filter, and use the filtrate as the test solution. Separately, weigh accurately about $40\;\mathrm{mg}$ of econazole nitrate RS, add a mixture of methanol and water $(40:60)$ to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of econazole nitrate from each solution, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , respectively.  

Amount (mg) of econazole nitrate $(\mathrm{C_{18}H_{15}C_{13}N_{20}{\cdot}H N O_{3})}$ $=$ Amount (mg) of econazole nitrate $\begin{array}{r}{\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\end{array}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $10~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $3~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.  

Mobile phase A: Dissolve $0.77\,\mathrm{~g~}$ of ammonium acetate in water to make $1000~\mathrm{{mL}}$ . Add $200~\mathrm{mL}$ of methanol to $800\;\mathrm{mL}$ of this solution.  

Mobile phase B: A mixture of acetonitrile and methanol $(60:40)$ .  

![](images/4c34ecbbc92dd1c49a78e1f7cb988396d54cd9c10614e6ecb329fc959ce85195.jpg)  

Flow rate: $1.5\;\mathrm{mL/min}$ System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor is NMT 1.5.  

System repeatability: Repeat the test 5 times with $10\,\upmu\mathrm{L}$ each of the standard solution according to the above operating conditions; the relative standard deviation of the peak areas of Piroxicam is NMT $0.73\%$ .  

(2) Triamcinolone acetonide —Weigh accurately an amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream equivalent to about $5~\mathrm{mg}$ of triamcinolone acetonide $\left({\bf C}_{24}{\bf H}_{31}{\bf F}{\bf O}_{6}\right)$ , add methanol to make $100~\mathrm{mL}$ , filter, and use the filtrate as the test solution. Separately, weigh accurately about $50~\mathrm{{mg}}$ of triamcinolone acetonide RS and add methanol to make 100 mL. Take $10.0\;\mathrm{mL}$ of this solution, add methanol to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of triamcinolone acetonide, $A_{\mathrm{T}}$ and $A_{S}$ , in each solution.  

Amount (mg) of triamcinolone acetonide $\left({\bf C}_{24}\mathrm{H}_{31}\mathrm{FO}_{6}\right)$ $=$ Amount $\mathrm{(mg)}$ of triamcinolone acetonide $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{1}{10}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.0\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of water, acetonitrile and acetic acid(100) $(59:40:1)$ .  

Flow rate: $1.0\,\mathrm{mL/min}$  

(3) Gentamicin sulfate —(1) (A) Cylinder plate method $\textcircled{1}$ Medium (a) Medium for seed and base layer Peptone $6.0\;\mathrm{g}$ Glucose $1.0\;\mathrm{g}$ Yeast extract $3.0~\mathrm{g}$ Sodium chloride $10.0~\mathrm{g}$ Meat extract 1.5 g Agar $13.0\sim20.0\mathrm{\,g}$ Weigh the above ingredients, add purified water to make $1000\;\mathrm{mL}$ , and adjust the $\mathrm{pH}$ after sterilization of the solution so that it will be 7.8 to 8.0.  

(b) Agar medium for transferring test organism: Use the medium in $(\mathrm{A})\mathrm{\rightarrow}\mathcal{\emptyset}$ (b) (ⅱ) $\circledcirc$ under the Microbial Assays for Antibiotics.  

$\circled{2}$ Test organism: Use Staphylococcus epidermidi sATCC 12228 as the test organism. $\circled{3}$ Standard solution: Weigh an appropriate amount of gentamicin RS, dry for 3 hours at $110\ ^{\circ}\mathrm{C}$ under vacuum (NMT $0.67\ \mathrm{kPa})$ ), then weigh accurately an amount equivalent to $5~\mathrm{mg}$ (potency) and dissolve in $0.1\ \mathrm{mol/L}$ phosphate buffer solution $(\mathrm{pH}\ 8.0)$ to prepare a standard stock solution containing $1~\mathrm{mg}$ (potency) per mL. Pipet an appropriate amount of this standard stock solution, dilute with the above buffer solution to contain $4.0~\upmu\mathrm{g}$ and $1.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the standard solutions.  

$\circledast$ Test solution: Weigh accurately an amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream equivalent to about $25~\mathrm{mg}$ (potency), dissolve in $0.1\ \mathrm{mol/L}$ phosphate buffer solution $\mathrm{(pH}$ 8.0) to prepare a solution containing $1~\mathrm{mg}$ (potency) per mL; pipet an appropriate amount of this solution and dilute with the above buffer solution to contain $4.0~\upmu\mathrm{g}$ and $1.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the test solutions.  

(B) Standard curve method $\textcircled{1}$ Medium: Prepare according to (A) $\textcircled{1}$ under the Microbial assays for antiobiotics.  

$\circled{2}$ Test organism: Follow (A) $\circled{2}$ under Microbial assays for antiobiotics.  

$\circled{3}$ Standard solution: Pipet an appropriate amount of the standard stock solution of (A) $\circled{3}$ under Microbial Assays for Antibiotics, dilute to contain $0.064~\upmu\mathrm{g}$ (potency), $0.080~\upmu\mathrm{g}$ (potency), $0.100~\upmu\mathrm{g}$ (potency), $0.125~\upmu\mathrm{g}$ (potency) and $0.156~\upmu\mathrm{g}$ (potency) per mL with $0.1\ \mathrm{mol/L}$ phosphate buffer solution $\ensuremath{\left(\mathrm{pH\8.0}\right)}$ , and use these solutions as the standard solutions. Prepare a solution containing $0.100~\upmu\mathrm{g}$ (potency) per mL and use this as the standard intermediate diluent.  

$\circledast$ Test solution: Pipet an appropriate amount of the solution from (A) $\circled{4}$ under Microbial Assays for Antibiotics, and dilute to contain $0.10~\upmu\mathrm{g}$ (potency) per mL with $0.01\ \mathrm{mol/L}$ phosphate buffer solution $\left(\mathrm{pH}\ 8.0\right)$ , and use this solution as the test solution.  

(2) Content of gentamicin C1, etc. (liquid chromatography) Weigh an appropriate amount of Econazole Nitrate, Triamcinolone Acetonide and Gentamicin Sulfate Cream and gentamicin RS and dissolve in water to prepare solutions containing $0.65~\mathrm{mg}$ per mL; take $10.0\ \mathrm{mL}$ of the solution, add $5~\mathrm{mL}$ of isopropanol and $4~\mathrm{mL}$ of $o$ -phthaldehyde, shake to mix, add isopropanol to make 25 mL, warm for 15 minutes on a steam bath at $60\ ^{\circ}\mathrm{C}$ , cool, and use as the test solution and the standard solution, respectively. Using the test solution and the standard solution, perform the test as directed under the Liquid Chromatography under the following conditions, and measure the peak areas of gentamicin $A_{\mathrm{T}}$ ,and $A_{S}$ for each solution (Gentamicin $C_{1};\,25$ to $50\%$ , Gentamicin $\mathrm{{C}_{1a}}$ : 10 to $35\%$ , Gentamicin ${\mathbf{C}}_{2}$ and $\mathrm{C}_{2\mathrm{a}}$ : 25 to $55\%$ ).  

Respective content $(\%)$ of Gentamicin $C_{1}$ , Gentamicin $\mathrm{C_{1a}}$ , Gentamicin $\mathrm{C}_{2\mathrm{a}}$ and Gentamicin ${\mathbf{C}}_{2}$  

$$
=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times100
$$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $330\,\mathrm{nm})$ ).  

Column: A stainless steel column about $5\,\textrm{m m}$ in internal diameter and about $10~\mathrm{cm}$ in length, packed with octadecylsilanized porous silica gel for liquid chromatography (5 to $10\,\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Add $250~\mathrm{mL}$ of water and $50~\mathrm{mL}$ of acetic acid(100) to $700\,\mathrm{\mL}$ of methanol, shake to mix, and dissolve $5~\mathrm{mg}$ of sodium 1-heptanesulfonate in this solution.  

Flow rate: About $1.5\;\mathrm{mL/min}$ System suitability  

System performance: K as determined from the Gentamicin ${\bf C}_{1}$ peak is 2 to 7, the number of theoretical plates determined from the Gentamicin ${\bf C}_{2}$ peak is NLT 1200, and the resolution R between the two peaks is NLT 1.25. Test according to the above conditions; Gentamicin ${\mathrm{C}}_{1}$ , Gentamicin $\mathrm{{C_{1a}}}$ , Gentamicin $\mathrm{{C}}_{2\mathrm{{a}}}$ and Gentamicin ${\bf C}_{2}$ are eluted in this order.  

System repeatability: The relative standard deviation for repeatability is NMT 2.0.  

Packaging and storage Preserve in tight containers.  

# Edrophonium Chloride 에드로포늄염화물  

![](images/9e7326b37a8152bb3c7143dd0bec7a709cb3c76f112a08009f8fbb1d81cc82b6.jpg)  

Edrophonium Chloride $\mathrm{C_{10}H_{16}C l N O:201.69}$ $N\!\cdot$ -Ethyl-3-hydroxyN,N -dimethylbenzenaminium chloride [ 116-38-1 ]  

Edrophonium Chloride, when dried, contains NLT $98.0\%$ and NMT $101.0\%$ of edrophonium chloride (${\mathrm{C}}_{10}{\mathrm{H}}_{16}$ ClN).  

Description Edrophonium Chloride occurs as white crystals or a crystalline powder and is odorless.   
It is very soluble in water, freely soluble in ethanol(99.5) or acetic acid(100), and practically insoluble in acetic anhydride or ether.   
It is hygroscopic.   
It is gradually colored by light.  

Identification (1) To $5\ \mathrm{mL}$ of an aqueous solution of Edrophonium Chloride (1 in 100), add one drop of iron(III) chloride TS; the solution exhibits a pale purple color.  

(2) Determine the absorption spectra of the solutions of Edrophonium Chloride and edrophonium chloride RS in $0.1\ \mathrm{mol/L}$ hydrochloric acid (1 in 20000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) An aqueous solution of Edrophonium Chloride (1 in 50) responds to the Qualitative Analysis for chloride.  

Melting point Between 166 and $171\ {}^{\circ}\mathrm{C}$ (with decomposition).  

$\mathbf{pH}$ Dissolve $1.0\;\mathrm{g}$ of Edrophonium Chloride in $10\;\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 3.5 and 5.0.  

Purity (1) Clarity and color of solution —Dissolve $1.0\;\mathrm{g}$ of Edrophonium Chloride in $10\;\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Heavy metals— Proceed with $1.0~\mathrm{g}$ of Edrophonium Chloride according to Method 1 and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT 20 ppm).  

(3) Arsenic— Proceed with $1.0\,\mathrm{~g~}$ of Edrophonium Chloride according to Method 1 and perform the test $(\mathrm{NMT}\ 2\ \mathrm{ppm})$ ).  

(4) Related substances —Dissolve about $0.50\mathrm{~g~}$ of Edrophonium Chloride in $10~\mathrm{mL}$ of ethanol(95) and use this solution as the test solution. Pipet $1\ \mathrm{mL}$ of the test solution, and add ethanol(95) to make exactly $100~\mathrm{mL}$ Pipet $3\ \mathrm{mL}$ of this solution, add ethanol(95) to make exactly $10~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thinlayer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of methanol, chloroform and ammonia water(28) $(16:4:1)$ to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Observe the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.2\%$ ($\mathrm{~\textit~{~1~g~}~}$ , in vacuum, phosphorus pentoxide, 3 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.2\mathrm{~g~}$ of Edrophonium Chloride, previously dried, dissolve in $100~\mathrm{mL}$ of a mixture of acetic anhydride and acetic acid(100) $(7:3)$ , and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in light-resistant, tight containers.  

![](images/bae5828b6539a7f54f2803017b348b62cd2a26892a3cb19b74f74e99710ad0c2.jpg)  
His Lys Leu Gln Thr Tyr Pro Arg Thr Asp Val Gly Ala Gly Thr Pro NH 2  

Elcatonin $\mathrm{C_{148}H_{244}N_{42}O_{47}}$ : 3363.77 N-{[(3 S,6 S,9 S,12 S)-3-Amino-6-(2-amino-2-   
oxoethyl)-15-[(1 R)-1-hydroxyethyl]-12-   
(hydroxymethyl)-9-isobutyl-4,7,10,13,16,24-   
hexaoxo-1-oxa-5,8,11,14,17-pentaazacyclotetra  
cosan-18-yl]carbonyl}-L-valyl-L-le ucylglycyl-L-lysylL-leucyl-L-seryl-L-glutaminyl-L-α-   
glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L  
glutaminyl-L-threonyl-L-tyrosyl-L-prolyl-L-arginyl-Lthreonyl-L-α-aspartyl-L-valylglycyl-L-alanylglycyl-Lthreonyl-L-prolinamide [ 60731-46-6 ]  
Elcatonin contains NLT 5000 and not more 7000 of elcatonin units per mg of peptide, calculated on the anhydrous basis. Description Elcatonin occurs as a white powder.   
It is very soluble in water, freely soluble in ethanol(95), and practically insoluble in acetonitrile.   
It is hygroscopic.   
The $\mathrm{pH}$ of aqueous solution of Elcatonin (1 in 500) is between 4.5 and 7.0.  

Identification Determine the absorption spectra of the solutions of $5~\mathrm{mg}$ each of Elcatonin and elcatonin RS in 5 mL of water, respectively, as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

Constituent amino acids Put about $1~\mathrm{mg}$ of Elcatonin into a test tube for hydrolysis, dissolve in phenolic acid TS, replace the air inside with nitrogen, seal the tube in vacuum, and heat at $110{\pm}2\ ^{\circ}\mathrm{C}$ for 24 hours. After cooling, open the tube, evaporate the hydrolysate to dryness in vacuum, dissolve the residue in about $1\,\mathrm{\mL}$ of 0.02 mol/L hydrochloric acid TS, and use this solution as the test solution. Separately weigh exactly $1.33\,\mathrm{~mg~}$ of Laspartic acid, $1.19\,\mathrm{~mg~}$ of L-threonine, $1.05\,\mathrm{~mg~}$ of Lserine, $1.47~\mathrm{mg}$ of L-glutamic acid, $1.15~\mathrm{mg}$ of L-proline, $0.75~\mathrm{mg}$ of glycine, $0.89~\mathrm{mg}$ of $\mathrm{L}$ -alanine, $1.17~\mathrm{mg}$ of Lvaline, $1.89~\mathrm{mg}$ of L-2-aminosuberic acid, $1.31~\mathrm{mg}$ of Lleucine, $1.81~\mathrm{mg}$ of L-tyrosine, $1.83~\mathrm{mg}$ of L-lysine hydrochloride, $2.10~\mathrm{mg}$ of L-histidine hydrochloride monohydrate and $2.11\,\mathrm{~mg~}$ of L-arginine hydrochloride, dissolve them in $0.02\ \mathrm{mol/L}$ hydrochloric acid TS to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions; 14 peaks of amino acids obtained from the test solution appear. Molar ratios of respective constituent amino acids to alanine are as follows: between 1.7 and 2.2 for aspartic acid, between 3.5 and 4.2 for threonine, between 2.4 to 3.0 for serine, between 2.7 and 3.2 for glutamic acid, between 1.7 and 2.2 for proline, between 2.7 and 3.2 for glycine, between 1.6 and 2.2 for valine, between 0.8 and 1.2 for 2-aminosuberic acid, between 4.5 and 5.2 for leucine, between 0.7 and 1.2 for tyrosine, between 1.7 and 2.2 for lysine, between 0.8 and 1.2 for histidine, and between 0.7 and 1.2 for arginine.  

Operating conditions  

Detector: Visible spectrophotometer (wavelengths: $440\;\mathrm{nm}$ and $570\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $8~\mathrm{{cm}}$ in length, packed with strongly acidic ion exchange resin for liquid chromatography composed of a sulfonated styrene-divinylbenzene copolymer ( $\ensuremath{3\,\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: Varied between 50 and $65\ ^{\circ}\mathrm{C}$ .Chemical reaction vessel temperature: A constant temperature of about $130\,^{\circ}\mathrm{C}$ .Color developing time: About 1 minute. Mobile phase: Buffer solutions A, B, C and D, with sodium ion concentrations of $0.10\ \mathrm{mol/L}$ ,$0.135\,\mathrm{\mol/L}$ $1.26~\mathrm{mol/L}$ and $0.20\ \mathrm{mol/L}$ , respectively; provided that the ion concentration is varied stepwise from $0.10\;\mathrm{mol/L}$ to $1.26\;\mathrm{mol/L}$ with the buffer solutions A, B, C and D.  

![](images/ec81b5faeca8d36bfdf2d3aa0f361a1f0631c4e9fbb5f25789b26d89b3e675be.jpg)  

Reaction reagent: Mix $407\ \mathrm{g}$ of lithium acetate dihydrate, $245\,\mathrm{\mL}$ of acetic acid(100) and $801\,\mathrm{\mL}$ of 1- methoxy-2-propanol, add water to make $2000~\mathrm{mL}$ , stir for about 20 minutes to mix while passing nitrogen, and use this solution as the solution A. Separately, add $77\,\mathrm{\textrm{g}}$ of ninhydrin and $0.134\:\mathrm{g}$ of sodium borohydride to $1957~\mathrm{mL}$ of 1-methoxy-2-propanol, stir for 20 minutes to mix while passing nitrogen, and use this solution as the solution B. Mix the solution A and solution B before use.  

Flow rate of mobile phase: Adjust so that the retention time of arginine is about 75 minutes.  

Flow rate of reaction reagent: About $0.2\;\mathrm{mL/min}$ .Selection of column: Proceed with $10\,\mathrm{\upmuL}$ of the standard solution according to the above conditions; use a column from which aspartic acid, threonine, serine, glutamic acid, proline, glycine, alanine, valine, 2- aminosuberic acid, leucine, tyrosine, lysine, histidine and arginine are eluted in this order with complete separation of each peak.  

Purity (1) Acetic acid —Weigh accurately about $3~\mathrm{mg}$ to $6~\mathrm{mg}$ of Elcatonin quickly under conditions of $25{\pm}2\ ^{\circ}\mathrm{C}$ and $50{\pm}5\%$ relative humidity, add exactly $1\ \mathrm{mL}$ of the internal standard solution to mix, and use this solution as the test solution. Separately, weigh accurately about $0.5\;\mathrm{g}$ of acetic acid(100), and add the internal standard solution to make exactly $100\;\mathrm{mL}$ . Pipet $5\;\mathrm{mL}$ of the resulting solution, add the internal standard solution to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of acetic acid to that of the internal standard; the amount of acetic acid is NMT $7.0\%$ .  

$$
=\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times\frac{W_{S T}}{W_{\mathrm{SA}}}\times50
$$  

Internal standard solution —An aqueous solution of citric acid monohydrate (1 in 4000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.0\ \mathrm{mm}$ in internal diameter and $6\;\mathrm{{cm}}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $25~^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve $13.2\,\mathrm{~g~}$ of monobasic ammonium phosphate in $900~\mathrm{mL}$ of water, adjust the $\mathrm{pH}$ to 2.5 with phosphoric acid, and add water to make 1000 Flow rate: Adjust the flow rate so that the retention time of acetic acid is about 4 minutes.  

System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; acetic acid and citric acid are eluted in this order with the resolution being NLT 2.0.  

(2) Related substances —Dissolve $1.0\ \mathrm{~mg~}$ of Elcatonin in $1~\mathrm{mL}$ of a mixture of trichloroacetic acid and acetonitrile $(2:1)$ , and use this solution as the test solution. Pipet $0.3\;\mathrm{mL}$ of the resulting solution, add a mixture of trichloroacetic acid and acetonitrile $(2:1)$ to make 10 mL, and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine each peak area as directed in the automatic integration method; the sum of the peak areas other than elcatonin in the test solution is not greater than the peak area of elcatonin in the standard solution, and each peak area other than elcatonin in the test solution is not greater than one-third of the peak area of elcatonin in the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of trifluoroacetic acid TS and acetonitrile (change the ratio from $85:15$ to $55:45$ in 30 minutes).  

Flow rate: Adjust the flow rate so that the retention time of elcatonin is about 25 minutes.  

# System suitability  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of elcatonin obtained from $10~\upmu\mathrm{L}$ of the standard solution is between $50\;\mathrm{mm}$ and 200 System performance: Dissolve $2~\mathrm{mg}$ of Elcatonin in $200~\upmu\mathrm{L}$ of trypsin TS for test of elcatonin. Warm this solution at $37\ ^{\circ}\mathrm{C}$ for 1 hour, and add one drop of acetic acid(100), and heat at $95~^{\circ}\mathrm{C}$ for 1 minute. To $10~\upmu\mathrm{L}$ of this solution, add $50~\upmu\mathrm{L}$ of the test solution, and mix it. Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above operating conditions; the resolution between the peak of elcatonin and the peak which is eluted immediately before the peak of elcatonin is NLT 2.0, and the retention time of elcatonin is about 25 minutes.  

Time span of measurement: A range in which the gradient elution appearing on the chromatogram is regularly changing after the solvent peak.  

Water Weigh accurately about 1 to $3~\mathrm{mg}$ of Elcatonin quickly and perform the test as directed under the coulometric titration under the Water; it is NMT $8.0\%$ . It should be weighed under conditions of $25{\pm}2~\,^{\circ}\mathrm{C}$ and $50{\pm}5\%$ relative humidity.  

Nitrogen content Weigh accurately 15 to $20\,\mathrm{~mg~}$ of Elcatonin quickly under the conditions of $25{\pm}2~^{\circ}\mathrm{C}$ and $50{\pm}5\%$ relative humidity, and perform the test as directed under the Nitrogen Determination; the amount of nitrogen (N: 14.01) is NLT $16.1\%$ and NMT $18.7\%$ , calculated on the anhydrous and residual acetic acid-free basis. Assay (i) Animals: Select healthy male Sprague-Dawley rats each weighing between $90~\mathrm{g}$ and $110~\mathrm{g}$ . Keep the rats for NLT 3 days before use, providing an appropriate uniform diet and water.  

(ii) Solution for elcatonin: Dissolve $2.72{\mathrm{~g~}}$ of sodium acetate trihydrate in water to make $200\;\mathrm{mL}$ , add $0.2\;\mathrm{g}$ of bovine serum albumin, and adjust the $\mathrm{pH}$ to 6.0 with acetic acid(100). Prepare before use.  

(iii) Standard solution: Dissolve elcatonin RS in the solution for elcatonin to make two standard solutions: the high-dose standard solution, $S_{\mathrm{H}}$ , containing exactly 0.075 unit in each mL, and the low-dose standard solution, $S_{\mathrm{{L}}}$ ,containing exactly 0.0375 unit in each mL.  

(iv) Test solution: Weigh accurately 0.5 to $2.0~\mathrm{mg}$ of Elcatonin quickly under conditions of $25{\pm}2\;\mathrm{~}^{\circ}\mathrm{C}$ and $50{\pm}5\%$ relative humidity, and dissolve in the solution for elcatonin to make two test solutions: the high-dose test solution, $T_{\mathrm{H}}$ , containing the units per mL equivalent to $S_{\mathrm{H}}$ and the low-dose test solution, $T_{\mathrm{{L}}}$ , containing the units per mL equivalent to $S_{\mathrm{{L}}}$ .  

(v) Deproteinizing solution for elcatonin: Dissolve $160\;\mathrm{g}$ of trichloroacetic acid and $30.6~\mathrm{g}$ of strontium chloride in water to make $3600\,\mathrm{mL}$ .  

(vi) Procedure: Divide the animals into 4 equal groups of NLT 10 animals each. Withhold all food for 18 to 24 hours before the injections, and also withhold water during the assay until the final blood sample is taken. Handle the animals with care in order to avoid undue excitement.  

Inject exactly $0.2\ \mathrm{mL}$ each of the standard solution and the test solution into the tail vein of each animal as indicated in the following regimen:  

First Group $\mathrm{S_{H}}$ Third Group THSecond Group $\S_{\mathrm{{L}}}$ Fourth Group  T LAt 1 hour after the injection, take a sufficient blood sample to perform the test from the carotid vein of each animal under ether anesthesia, centrifuge the blood samples to separate serum, and determine the serum calcium according to the following (G).  

(vii) Serum calcium determination: Pipet $0.3\ \mathrm{mL}$ of the serum, add the deproteinizing solution for elcatonin to make exactly $3\,\textrm{m L}$ , mix well, centrifuge, and use the clear supernatant as the test solution for calcium determination. Separately, pipet $1~\mathrm{mL}$ of calcium standard solution for the Atomic Absorption Spectroscopy, and add a solution of sodium chloride (17 in 2000) to make exactly $50~\mathrm{mL}$ . Use this solution as the standard solution for calcium determination. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and standard solution as directed under the Atomic Absorption Spectroscopy according to the following conditions. Determine the absorbance, $A_{0}$ ,of a solution obtained in the same manner used for preparation of the standard solution, but with $1\ \mathrm{mL}$ of water. Amount (mg) of calcium (Ca) in $100\;\mathrm{mL}$ of the serum  

$$
\mathit{\Omega}=\,0.01\frac{A_{\mathrm{T}}-A_{0}}{A_{\mathrm{S}}-A_{0}}\times10\times100
$$  

$\Sigma\,y^{2}$ : The sum of squares of ${\bf y}_{1},\;{\bf y}_{2},\;{\bf y}_{3}$ and ${\mathrm{y}}4$ in each group  

$$
\begin{array}{c}{{Y=Y_{1}^{2}+Y_{2}^{2}+Y_{3}^{2}+Y_{4}^{2}}}\\ {{\ }}\\ {{n=4(f\cdot1)}}\\ {{L=2\sqrt{(C-1)(C M^{2}+0.09062)}}}\\ {{\ }}\\ {{C=\displaystyle\frac{Y_{b}^{2}}{Y_{b}^{2}-4f s^{2}t^{2}}}}\end{array}
$$  

Gas: Air–acetylene   
Lamp: Calcium hollow cathode lamp   
Wavelength: $422.7\;\mathrm{nm}$  

(viii) Calculation: Amounts of calcium in $100\;\mathrm{mL}$ of the serum obtained with $\mathrm{S_{H}}$ ,$\mathrm{S_{L}}$ ,${\mathrm{T}}_{\mathrm{H}}$ and $\mathrm{T_{L}}$ in (G) are denoted by ${\bf y}_{1},\,{\bf y}_{2},\,{\bf y}_{3}$ and ${\mathrm{y}}_{4}$ , respectively. Sum up y 1 ,${\tt y}_{2}$ , y 3 and ${\mathrm{y}}_{4}$ of each group to obtain ${\sf Y}_{1}$ ,$\mathbf{Y}_{2}$ ,$\Upsilon_{3}$ and $\mathrm{Y}_{4}$ , respectively.  

Units per mg of peptide, calculated on the anhydrous and residual acetic acid-free basis.  

$=$ Anti log $M\times$ (units per mL of high-dose standard solu  

$$
\operatorname{tion})\times{\frac{b}{a}}
$$  

$$
\begin{array}{l}{M=0.3010\times\frac{Y_{a}}{Y_{b}}}\\ {Y_{\mathrm{a}}=-Y_{1}-Y_{2}+Y_{3}+Y_{4}}\\ {Y_{\mathrm{b}}=Y_{1}-Y_{2}+Y_{3}-Y_{4}}\end{array}
$$  

$a$ : Amount (mg) of sample taken 100−[𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 $(\%)$ 𝑜𝑜𝑜𝑜 𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤𝑤+𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 $(\%)$ 𝑜𝑜𝑜𝑜 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎] ×100  

$b$ : Total volume (mL) of the high-dose test solution prepared by dissolving the sample with solution for elcatonin  

$\boldsymbol{\mathrm{F}}^{\flat}$ calculated by the following equation is smaller than F shown in the table against n with which $\mathrm{s}^{2}$ is calculated. When calculate L $\left(\mathbf{P}\;=\;0.95\right)$ ) according to the following equation, $\mathrm{L}$ is NMT 0.20. If $\boldsymbol{\mathrm{F}}^{\prime}$ exceeds F, or if $\mathrm{L}$ exceeds 0.20, repeat the test, increasing the number of animals or arranging the assay conditions so that $\boldsymbol{\mathrm{F}}^{\prime}$ is NMT F and $\mathrm{L}$ is NMT 0.20.  

$$
F^{\prime}\,={\frac{(-Y_{1}+Y_{2}+Y_{3}-Y_{4})^{2}}{4f s^{2}}}
$$  

$f!$ : Number of the animals of each group  

$$
s2\ ={\frac{\sum y^{2}-{\frac{Y}{f}}}{n}}
$$  

$t^{2}$ : Value shown in the following table against $n$ used to calculate $s^{2}$   

![](images/8cd27a40a0d89669e7ce4e7f63da00dba2a6b591054f874d60f74231a990552a.jpg)  

Packaging and storage Preserve in tight containers and store at below $8\,^{\circ}\mathrm{C}$ .  

# Elcatonin Injection 엘카토닌주사액  

Elcatonin Injection is an aqueous injection and contains NLT $80.0\%$ and NMT $125.0\%$ of the labeled amount of elcatonin units.  

Method of preparation Prepare as directed under Injections, with Elcatonin.  

Description Elcatonin Injection occurs as a clear, colorless liquid.  

Identification (1) Take $12\ \mathrm{mL}$ of Elcatonin Injection, evaporate to dryness on a steam bath, dissolve in $3\ \mathrm{mL}$ of water, and use this solution as the test solution. Add $1~\mathrm{mL}$ of alkaline copper TS to the test solution, shake to mix, and allow to stand for 10 minutes.  To this solution, add $0.2~\mathrm{mL}$ of diluted Folin TS (1 in 2) and heat on a steam bath for 3 minutes; the solution exhibits a pale blue color. (2) Perform the test with Elcatonin Injection as directed under Assay; the test group exhibits NLT $20\%$ serum calcium reduction compared to the control group. The test animals are divided into 2 groups with 5 animals, respectively: the test group and control group. For the test group, Prepare the test solution by pipetting $0.5\,\mathrm{\mL}$ of Elcatonin Injection and diluting in solution for elcatonin to obtain a solution having known a concentration of 0.1 elcatonin unit per mL. Use a solution for elcatonin vehicle as a control solution. Inject $0.2\ \mathrm{mL}$ of each of these solutions into the tail vein.  

pH Between 5.0 and 6.5. Sterility Meets the requirements. Pyrogen Meets the requirements. The amount tested is $2.0\;\mathrm{mL}$ per kg of the body weight of a test animal.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay (1) Animals— Select healthy male SpragueDawley rats each weighing 90 to $110~\mathrm{g}$ . Keep the rats for NLT 3 days before use, providing an appropriate uniform diet and water.  

(2) Solution for elcatonin— Dissolve $2.72{\mathrm{~g~}}$ of sodium acetate trihydrate in water to make $200\;\mathrm{mL}$ , add 0.2 g of bovine serum albumin, and adjust the $\mathrm{pH}$ to 6.0 with acetic acid(100). Prepare before use.  

(3) Standard solution— Dissolve elcatonin RS in the solution for elcatonin to prepare solutions containing exactly 0.075 units and 0.0375 units per mL, respectively. Use these solutions as the high-concentration standard solution $S_{\mathrm{H}}$ and the low-concentration standard solution $S_{\mathrm{{L}}}$ , respectively.  

(4) Test solution —Pipet $0.5~\mathrm{mL}$ of Elcatonin Injection, add the solution for elcatonin to obtain solutions having known concentration of units equivalent to the high-concentration standard solution $\mathrm{S_{H}}$ and the lowconcentration standard solution $\S_{\mathrm{{L}}}$ , and use these solutions as the high-concentration test solution $\mathrm{T_{H}}$ and the low-concentration test solution $\mathrm{T_{L}}$ , respectively.  

(5) Procedure— Divide the test animals into 4 groups of NLT 10 animals each (the same number of animals). Withhold all food for 18 to 24 hours before the injections, and also withhold water during the assay until the final blood sample is taken. Handle the animals with care in order to avoid undue excitement.  

Inject exactly $0.2\ \mathrm{mL}$ each of the standard solutions and the test solutions into the tail vein of each animal as indicated in the following regimen:  

![](images/a2b7401615821d4698d2efae266d04bc44809cb5e3b1ff45629f0e21be04e1c9.jpg)  

At 1 hour after the injection, take a sufficient blood sample to perform the test from the carotid artery and vein of each animal under ether anesthesia, centrifuge the blood samples to separate serum, and determine the serum calcium according to the following (G).  

(6) Serum calcium assay— Pipet $0.5~\mathrm{mL}$ of serum, add the deproteinizing solution for elcatonin to make exactly $5~\mathrm{mL}$ , shake to mix well, centrifuge, and use the clear supernatant as the test solution for calcium assay. Separately, pipet $1.0\;\mathrm{mL}$ of calcium standard solution for atomic absorption spectrophotometry, and add sodium chloride solution (0.85 in 100) to make $10~\mathrm{mL}$ . Pipet $5.0~\mathrm{mL}$ of this solution, add deproteinizing solution for elcatonin to make exactly $50\;\mathrm{mL}$ , and use this solution as the standard solution for calcium assay. Separately, take $1.0\;\mathrm{mL}$ of water, proceed in the same manner as in preparation of standard solution for calcium assay, and use this solution as the blank test solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution, standard solution and the blank test solution as directed under the Atomic Absorption Spectroscopy according to the following conditions.  

Gas: Air–acetylen   
Lamp: Calcium hollow cathode lamp   
Wavelength: $422.7\;\mathrm{nm}$  

$$
\begin{array}{r}{=0.01\times\frac{A_{\mathrm{T}}-A_{0}}{A_{\mathrm{S}}-A_{0}}\times10\times100}\end{array}
$$  

Deproteinizing solution for elcatonin —Dissolve $160~\mathrm{~g~}$ of trichloroacetic acid and $30.6\ \mathrm{~g~}$ of strontium chloride in water to make $3600~\mathrm{mL}$ .  

(7) Calculation— The amounts of calcium in 100 mL of serum obtained from $\mathrm{S_{H}}$ ,$\S_{\mathrm{{L}}}$ ,$\mathrm{T_{H}}$ and $\mathrm{T_{L}}$ in the serum calcium Assay shall be ${\bf y}_{1},\,{\bf y}_{2},\,{\bf y}_{3}$ and ${\mathrm{y}}_{4}$ , respectively. For each group, add ${\bf y}_{1},\,{\bf y}_{2},\,{\bf y}_{3}$ and ${\mathrm{y}}_{4}$ to make ${\sf Y}_{1}$ ,$\mathbf{Y}_{2}$ ,$\Upsilon_{3}$ and $\mathrm{Y}_{4}$ , respectively.  

Number of elcatonin units per mL of Elcatonin Injection $=$ antilog $M\times$ [Number of elcatonin units in $1\;\mathrm{mL}$ of  the high − concentration standard solution] × $\times\,{\frac{b}{a}}$  

$$
\begin{array}{c}{\mathbf{M}=0.3010\times\frac{\mathbf{Y}_{\mathbf{a}}}{\mathbf{Y}_{\mathbf{b}}}}\\ {\mathbf{Y}_{\mathbf{a}}=\mathbf{\Omega}-\mathbf{\Omega}\mathbf{Y}_{1}\ -\ \mathbf{Y}_{2}+\mathbf{Y}_{3}+\mathbf{Y}_{4}}\\ {\mathbf{Y}_{\mathbf{b}}=\mathbf{Y}_{1}\ -\ \mathbf{Y}_{2}+\mathbf{Y}_{3}\ -\ \mathbf{Y}_{4}}\end{array}
$$  

a: Amount (mL) of sample taken b: Total amount (mL) when elcatonin vehicle is added to the sample to prepare the high-concentration test solution  

$\mathrm{F^{\prime}}$ calculated according to the following equation is less than the $\boldsymbol{\mathrm F}$ in the table for n when $S^{2}$ is calculated. Also, when L $(\mathbf{P}=0.95)$ is calculated according to the following equation, $\mathrm{L}$ is NMT 0.2. If $\boldsymbol{\mathrm{F}}^{\prime}$ exceeds F, or if $\mathrm{L}$ exceeds 0.2, repeat the test, increasing the number of animals or arranging the assay conditions so that $\boldsymbol{\mathrm{F}}^{\prime}$ is NMT F and $\mathrm{L}$ is NMT 0.20.  

$$
\mathrm{F^{\prime}=\frac{(-Y_{1}+Y_{2}+Y_{3}-Y_{4})^{2}}{4f S^{2}}}
$$  

$\operatorname{f}=$ Number of test animals in each group  

$$
S^{2}=\frac{\sum\Upsilon^{2}-\Upsilon/\mathrm{f}}{\mathrm{n}}
$$  

$\Sigma\mathbf{y}^{2}=$ The sum of the squares of ${\mathrm{y}}_{1},{\mathrm{y}}_{2},{\mathrm{y}}_{3}$ and ${\mathrm{y}}_{4}$ of each  

$$
\mathrm{Y}={\mathrm{Y}_{1}}^{2}+{\mathrm{Y}_{2}}^{2}+{\mathrm{Y}_{3}}^{2}+{\mathrm{Y}_{4}}^{2}
$$  

$$
\mathtt{n}=4(f\ -\ 1)
$$  

$$
\begin{array}{c}{{\mathrm{L}=2\sqrt{(C-1)(C M^{2}+0.09062)}}}\\ {{{}}}\\ {{C={\frac{\mathrm{Y}_{\mathrm{b}}^{2}}{\mathrm{Y}_{\mathrm{b}}^{2}-4\mathrm{fs}^{2}\mathrm{t}^{2}}}}}\end{array}
$$  

$\mathrm{t}^{2}$ : The table corresponding to $\mathbf{n}$ in the following table when $\mathrm{s}^{2}$ is calculated.   

![](images/513912c741cd2744f067541a632d25e2be13b857ffd3aac442035222f37d175e.jpg)  

Packaging and storage Preserve in hermetic containers.  

# Enalapril Maleate 에날라프릴말레산염  

![](images/a2784eb14cf5e3ecd8198a8427b6a6bc5ef2718fc136f2de92931c39a49cce1a.jpg)  

$\mathrm{C_{20}H_{28}N_{2}O_{5}{\cdot}C_{4}H_{4}O_{4}:492.52}$ (2S)-1-[(2S)-2-{[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-  

carboxylic acid $(Z)$ -but-2-enedioate [ 76095-16-4 ]Enalapril Maleate contains NLT $98.0\%$ and NMT $102.0\%$ of enalapril maleate $\mathrm{(C_{20}H_{28}N_{2}O_{5}{\cdot}C_{4}H_{4}O_{4})}$ , calculated on the dried basis.  

Description Enalapril Maleate occurs as white crystals or a crystalline powder. It is freely soluble in methanol, sparingly soluble in water or ethanol(99.5), and slightly soluble in acetonitrile.  

Melting point —About $145\ ^{\circ}\mathrm{C}$ (with decomposition). Identification (1) To $20~\mathrm{mg}$ of Enalapril Maleate, add 1 mol/L hydrochloric acid TS, shake, add $5\ \mathrm{mL}$ of ether, and shake for 5 minutes. Take $3\ \mathrm{mL}$ of the upper layer, distill the ether on a steam bath, and add $5\;\mathrm{mL}$ of water to the residue while shaking. Add 1 drop of potassium permanganate TS; the red color of the solution disappears immediately.  

(2) Determine the infrared spectra of Enalapril Maleate and enalapril maleate RS as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) The retention times of the major peaks obtained from the test solution and the standard solution in the Assay are the same.  

Optical rotation $[\alpha]_{\mathrm{D}}^{25}$ : Between $-41.0^{\circ}$ and $-43.5^{\circ}$ (0.1 g after drying, methanol, $10\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity (1) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Enalapril Maleate according to Method 2 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT $10\,\mathrm{ppm})$ ).  

(2) Related substances —Weigh accurately about 30 mg of Enalapril Maleate, dissolve in a mixture of phosphate buffer solution, $\mathrm{pH}\,2.5$ , and acetonitrile $(95:5)$ to make exactly $100\,\mathrm{\mL}$ , and use this solution as the test solution. Separately, weigh accurately about $30~\mathrm{{mg}}$ of enalapril maleate RS, dissolve in a mixture of phosphate buffer solution, $\mathrm{pH}\,2.5$ and acetonitrile $(95:5)$ to make exactly $100~\mathrm{mL}$ . Pipet accurately $1\ \mathrm{mL}$ of this solution, add a mixture of phosphate buffer solution, $\mathrm{pH}\ 2.5$ and acetonitrile $(95:5)$ to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution Perform the test with 50 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of each solution by the automatic integration method, and calculate the content of each related substance; a peak among two peaks other than the major peak is NMT $1.0\%$ , another peak is NMT $0.3\%$ , and the total content of the related substances is NMT $2.0\%$ .  

Content $(\%)$ of each related substance $=\ 100\times\left({\frac{C_{\mathrm{S}}}{C_{\mathrm{i}}}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\right)$  

$C_{\mathrm{{S}}}$ : Concentration $(\mathrm{mg/mL})$ of the standard solution $C_{\mathrm{i}}$ : Concentration $(\mathrm{mg/mL})$ ) of Enalapril Maleate in the test solution $A_{\mathrm{T}}$ : Peak area of each related substance in the test solution  

$A_{S}$ : Peak area of each related substance in the standard solution  

Operating conditions  

For the detector, column, column temperature, mobile phase and flow rate, proceed as directed in the operating conditions under the Assay.  

Loss on drying NMT $1.0\%$ (NMT 0.67 kPa, $60~^{\circ}\mathrm{C}_{!}$ , 2 hours).  

# Residue on ignition NMT $0.2\%$ ($\,[\,{\bf\rho}_{1}\,{\bf g})$  

Assay Weigh accurately about $30~\mathrm{mg}$ of Enalapril Maleate, dissolve in a mixture of phosphate buffer solution, $\mathrm{pH}\,2.5$ , and acetonitrile $(95:5)$ to make exactly $100~\mathrm{mL}$ ,and use this solution as the test solution. Separately, dissolve about $30~\mathrm{mg}$ , accurately weighed, of enalapril maleate RS in a mixture of phosphate buffer solution, $\mathrm{pH}$ 2.5, and acetonitrile $(95:5)$ to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the major peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , from each solution.  

Amount (mg) of enalapril maleate $\mathrm{(C_{20}H_{28}N_{2}O_{5}{\cdot}C_{4}H_{4}O_{4})}$ $\equiv.$ Amount (mg) of enalapril maleate $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.1~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with styrene-divinylbenzene copolymer for liquid chromatography ( $5\;\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: $70\ ^{\circ}\mathbf{C}$ Flow rate: $1.5\;\mathrm{mL/min}$  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase $\mathbf{B}$ in stages or gradient elution  

as follows.  

Mobile phase A: A mixture of phosphate buffer solution, $\mathrm{pH}\,6.8$ and acetonitrile $(19:1)$ .  

Mobile phase B: A mixture of acetonitrile and phosphate buffer solution, pH 6.8 $(33:17)$ .  

![](images/f91b602efdd460ef21d61a4aed55faa7fc4c468343bc5df4553512dcd03a0e87.jpg)  

System suitability  

System performance: Mix $1\mod$ of enalapril diketopiperazine solution and $50\;\mathrm{mL}$ of the standard solution. Proceed with $50~\upmu\mathrm{L}$ of this solution according to the above operating conditions; enalapril and enalapril diketopiperazine are eluted in this order with the resolution being NLT 3.5.  

System repeatability: Repeat the test 6 times with $50~\upmu\mathrm{L}$ each of the standard solution according to the operating conditions under the Assay; the relative standard deviation of the peak areas is NMT $1.0\%$ .  

$p H\,6.8$ phosphate buffer solution —Dissolve $2.8~\mathrm{g}$ of sodium dihydrogen phosphate dihydrate in about $900~\mathrm{mL}$ of water. Adjust with $9\;\mathrm{mol/L}$ of sodium hydroxide TS to a $\mathrm{pH}$ of 6.8, dilute with water to make $1000\;\mathrm{mL}$ .  

$p H\,2.5$ phosphate buffer solution —Dissolve $2.8~\mathrm{g}$ of sodium dihydrogen phosphate dihydrate in about $900~\mathrm{mL}$ of water. Adjust with phosphoric acid to a $\mathrm{pH}$ of 2.5, dilute with water to make $1000\,\mathrm{mL}$ .  

Enalapril diketopiperazine solution —Place about $20~\mathrm{mg}$ of enalapril maleate RS in a $100{\-}\mathrm{mL}$ beaker to form a mound on the bottom of the beaker, and place the beaker on a hotplate stirrer. Heat up to a temperature not to cause pyrolysis for about 5 to 10 minutes until the solid is melted. Immediately allow to cool, add $50\,\mathrm{\ml}$ of acetonitrile, and sonicate for a few minutes. The solution typically contains, in each mL, between $0.2~\mathrm{mg}$ and 0.4 mg of enalapril diketopiperazine.  

Packaging and storage Preserve in well-closed containers.  

# Enalapril Maleate Tablets 에날라프릴말레산염정  

Enalapril Maleate Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of enalapril maleate $\mathrm{(C_{20}H_{28}N_{2}O_{5}{\cdot}C_{4}H_{4}O_{4}}$ : 492.52).  

Method of preparation Prepare as directed under Tablets, with Enalapril Maleate.  

Identification (1) Weigh an amount of previously powdered Enalapril Maleate Tablets equivalent to $50~\mathrm{mg}$ of Enalapril Maleate according to the labeled amount, add $20~\mathrm{mL}$ of methanol, and shake well. Centrifuge this solution, take the clear supernatant, and use this solution as the test solution. Separately, dissolve $25~\mathrm{mg}$ of enalapril maleate RS in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $20~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of water, acetone, 1-butanol and acetic acid(100) $\lfloor1:1:$ $1:1)$ ) as the developing solvent to a distance of about 10 cm, and air-dry the plate. Examine under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the $R_{\mathrm{f}}$ values of the 2 spots obtained from the test solution and 2 spots obtained from the standard solution are the same.  

(2) The retention times of the major peaks obtained from the test solution and the standard solution in the Assay are the same.  

Purity Related substances —Use the test solution and the standard solution prepared as directed under the Assay, the $\mathrm{pH}\,2.2$ phosphate buffer solution, and the enalapril diketopiperazine solution prepared as directed under the Assay of Enalapril Maleate. Take $1.0\,\mathrm{~mL~}$ of the standard solution, add phosphate buffer solution, $\mathrm{pH}\,2.2$ ,to make exactly $100~\mathrm{mL}$ , and use this solution as the related substance standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution, the standard solution, the related substance standard solution and the buffer solution as directed under the Liquid Chromatography according to the conditions of the Assay, determine the peak area of each solution by the automatic integration method, and calculate the content of related substances. Determine the peak areas of all peaks with peak areas NLT $0.1\%$ of the enalapril peak area except for peaks appearing in the buffer solution in the chromatogram of the test solution.  

$$
=\frac{492.53}{348.39}\times\frac{C V}{N}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{100}{L}
$$  

492.53: Molecular weight of enalapril maleate  

348.39: Molecular weight of anhydrous enalaprilate   
C: Concentration $(\upmu\mathrm{g/mL)}$ of enalaprilate in the   
standard solution   
$V$ : Volume (mL) of the test solution   
N: Number of tablets taken for the test   
$L$ : Labeled amount $\mathrm{(mg)}$ of enalapril maleate for   
tablets   
$A_{\mathrm{T}}$ : Peak area of enalaprilate in the test solution  

$$
={\frac{492.53}{358.44}}\times{\frac{C^{\prime}V}{N}}\times{\frac{\phantom{4}A_{\mathrm{T}}}{1.25A_{\mathrm{S}}}}\times{\frac{100}{L}}
$$  

492.53: Molecular weight of enalapril maleate  

358.44: Molecular weight of enalapril diketopiperazine   
$C^{\prime}$ : Concentration $(\mathrm{mg/mL})$ ) of enalapril maleate RS in related substance standard solution  

V: Volume (mL) of the test solution N: Number of tablets taken for the test 1.25: Peak area of enalapril diketopiperazine to enalapril  

$L$ : Labeled amount (mg) of enalapril maleate for tablets  

$$
={\frac{C^{\prime}V}{N}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\times{\frac{100}{L}}
$$  

The total amount of related substances, including enalaprilate and enalapril diketopiperazine, is NMT $5.0\%$ .  

Enalaprilate standard solution —Weigh accurately an appropriate amount of enalaprilate RS, and dissolve in water to make a solution containing $0.4~\mathrm{mg}$ per mL.  

Standard solution —Weigh accurately about $20~\mathrm{mg}$ of enalapril maleate RS, add $0.5\ \mathrm{mL}$ of enalaprilate RS, add $50~\mathrm{mL}$ of buffer solution, dissolve by mixing well, and add phosphate buffer solution, $\mathrm{pH}\,2.2$ , to make exactly $100\;\mathrm{mL}$ .  

Related substance standard solution —Pipet $1~\mathrm{mL}$ of the standard solution accurately, and add phosphate buffer solution, $\mathrm{pH}\,2.2$ , to make exactly $100\;\mathrm{mL}$ .Dissolution Perform the test with 1 tablet of Enalapril Maleate Tablet at 50 revolutions per minute according to Method 2 under the Dissolution, using $900~\mathrm{mL}$ of phosphate buffer solution, $\mathrm{pH}\,6.8$ , as the dissolution medium. After 30 minutes from starting the dissolution test, take $20\;\mathrm{~mL}$ of the dissolved solution, and filter through a membrane filter with a pore size NMT $0.8\ \upmu\mathrm{m}$ . Discard the first $10~\mathrm{mL}$ of the filtrate, and use the subsequent filtrate as the test solution. Separately, weigh accurately 10 mg of enalapril maleate RS, dissolve in phosphate buffer solution, $\mathrm{pH}\ 6.8$ , to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test according to the operating conditions under the Assay of Enalapril Maleate.  

It meets the requirements if the dissolution rate of Enalapril Maleate Tablets for 30 minutes is NLT $80\%$ .  

Uniformity of dosage units It meets the requirements of the Content Uniformity Test when the test is performed according to the following method. Take 1 tablet of Enalapril Maleate Tablet, add $50~\mathrm{mL}$ of phosphate buffer solution, $\mathrm{pH}\,2.2$ , sonicate for 15 minutes if necessary, shake for 30 minutes, add phosphate buffer solution, $\mathrm{pH}\,2.2$ , to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Take a certain amount of this solution, and dilute exactly with the buffer solution to the concentration of $0.1~\mathrm{mg}$ per mL. Separately, weigh accurately $10~\mathrm{mg}$ of enalapril maleate RS, dissolve in phosphate buffer solution, $\mathrm{pH}\,2.2$ , to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test as directed under the Assay of Enalapril Maleate.  

Amount (mg) of enalapril maleate $\left({\bf C}_{20}\mathrm{H}_{28}\mathrm{N}_{2}\mathrm{O}_{5}{\cdot}{\bf C}_{4}\mathrm{H}_{4}\mathrm{O}_{4}\right)$  

$$
\dot{\mathbf{\eta}}=T\times\frac{C}{D}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}
$$  

$T:$ Labeled amount $\mathrm{(mg)}$ of enalapril maleate in 1 tablet $C$ : Concentration $(\mathrm{mg/mL})$ of the standard solution $D$ : Concentration $\mathrm{(mg/mL)}$ of enalapril maleate in the test solution $A_{\mathrm{T}}$ : Peak area of enalapril maleate in the test solution $A_{S}$ : Peak area of enalapril maleate in the standard solution $p H~2.2$ phosphate buffer solution —Dissolve $1.38\mathrm{~g~}$ of sodium dihydrogen phosphate dihydrate in about 800 mL of water, add phosphoric acid to adjust the $\mathrm{pH}$ to 2.2, and add water to make $1000\,\mathrm{mL}$ .  

Assay Weigh accurately the mass of NLT 20 tablets of Enalapril Maleate Tablets, and powder. Weigh accurately a portion of this powder, equivalent to about $20~\mathrm{mg}$ of enalapril maleate $\left({\bf C}_{20}\mathrm{H}_{28}\mathrm{N}_{2}\mathrm{O}_{5}{\cdot}\mathrm{C}_{4}\mathrm{H}_{4}\mathrm{O}_{4}\right)$ ), add $50\,\mathrm{\mL}$ of phosphate buffer solution, $\mathrm{pH}\,2.2$ , from the Uniformity of dosage units, sonicate for 15 minutes, and shake for 30 minutes. Then, add phosphate buffer solution, $\mathrm{pH}\,2.2$ , to make $100~\mathrm{mL}$ , sonicate for 15 minutes, filter through a membrane filter, and use this solution as the test solution. Separately, weigh accurately about $20~\mathrm{mg}$ of enalapril maleate RS, add $0.5\;\mathrm{mL}$ of enalaprilate RS, dissolve in 50 mL of phosphate buffer solution, $\mathrm{pH}\,2.2$ , and sonicate if necessary. Then, add phosphate buffer solution, $\mathrm{pH}\ 2.2$ ,to make exactly $100\,\mathrm{\mL}$ , and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of each solution.  

Amount (mg) of enalapril maleate $\left({\bf C}_{20}{\mathrm{H}}_{28}{\mathrm{N}}_{2}{\mathrm{O}}_{5}{\cdot}{\mathrm{C}}_{4}{\mathrm{H}}_{4}{\mathrm{O}}_{4}\right)$ $=$ Amount (mg) of enalapril maleate $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $215\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25\ \mathrm{cm}$ in length, packed with hydroxy propylsilyl silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: $50\;^{\circ}\mathrm{C}$  

Mobile phase: A mixture of phosphate buffer solution, $\mathrm{pH}\,2.2$ , and acetonitrile $(75:25)$ .  

Flow rate: $2\ \mathrm{mL/min}$ System suitability  

System performance: Take $0.5\,\mathrm{\mL}$ of enalapril diketopiperazine solution, and add the standard solution to make $25~\mathrm{mL}$ . Proceed with $50~\upmu\mathrm{L}$ of this solution according to the above conditions; maleic acid, enalaprilate, enalapril and enalapril diketopiperazine are eluted in this order with the resolutions between maleic acid and enalaprilate, enalaprilate and enalapril, and enalapril and enalapril diketopiperazine being NLT 2.0, respectively.  

System repeatability: Repeat the test 6 times with $50\,\textrm{\textmu L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak areas of enalapril is NMT $2.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

![](images/955f969494cf68df4f5634ebc345cb70ba10d5cfb8135b1a4059eacae8a0578b.jpg)  
Enflurane $\mathrm{C}_{3}\mathrm{H}_{2}\mathrm{ClF}_{5}\mathrm{O}:184.49$ 2-Chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane [13838-16-9 ]  

Description Enflurane occurs as a clear, colorless fluid.   
It is slightly soluble in water.   
It is miscible with ethanol(95) or ether.   
It is a volatile, and not inflammable.   
It shows no optical rotation.   
Boiling point —Between 54 and $57^{\circ}\mathbf{C}$ .  

Identification (1) Take $50~\upmu\mathrm{L}$ of Enflurane, and prepare the test solution as directed under the Oxygen Flask Combustion using $40~\mathrm{mL}$ of water as the absorbent. The test solution responds to the Qualitative Analysis for chloride and fluoride.  

(2) Determine the infrared spectra of Enflurane and enflurane RS as directed under the liquid film method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Refractive index $n_{D}^{20}$ : Between 1.302 and 1.304. Purity (1) Acidity or alkalinity —To $60\,\mathrm{\mL}$ of Enflurane, add $60\,\mathrm{\mL}$ of freshly boiled and cooled water, shake for 3 minutes to mix, take the water layer, and use this solution as the test solution. To $20\,\mathrm{\mL}$ of the test solution, add 1 drop of bromocresol purple TS and 0.10 mL of $0.01\,\mathrm{\mol/L}$ sodium hydroxide solution; a violet color develops. To $20~\mathrm{mL}$ of the test solution, add 1 drop of bromocresol purple TS and $60~\upmu\mathrm{L}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid; a yellow color is produced.  

(2) Chloride —Weigh $20~\mathrm{g}$ of Enflurane, add $20~\mathrm{mL}$ of water, shake well to mix, and separate the water layer. Take $10~\mathrm{mL}$ of the water layer, and add $6~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{{mL}}$ . Perform the test using this solution as the test solution. Prepare the control solution with $0.30~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid (NMT $0.001\%$ ).  

(3) Related substances —Perform the test with $5\;\upmu\mathrm{L}$ of Enflurane as directed under the Gas Chromatography according to the following conditions. Introduce the sample, immediately determine each peak area other than the peak of air as directed in the automatic integration method, and calculate the amount of each peak by the percentage peak area method; the amount of the substances other than enflurane is NMT $0.10\%$ .  

Operating conditions Detector: A thermal conductivity detector Column: A stainless steel about $3\ \mathrm{mm}$ in inside diameter and about $3\,\textrm{m}$ in length, packed with diatomaceous earth for gas chromatography, 180 to $250~{\upmu\mathrm{m}}$ in particle diameter, coated with diethylene glycol succinate ester for gas chromatography at the ratio of $20\%$ .  

Column temperature: A constant temperature of about $80\,^{\circ}\mathrm{C}$ .  

Carrier gas: Helium  

Flow rate: Adjust the flow rate so that the retention time of enflurane is about 3 minutes.  

# System suitability  

Test for required detectability: Take $1~\mathrm{mL}$ of Enflurane, and add 2-propanol to make $100~\mathrm{mL}$ . Take $2~\mathrm{mL}$ of this solution, add 2-propanol to make $10~\mathrm{mL}$ , and use this solution as the system suitability solution. Take 1.0 mL of this solution and add 2-propanol to make exactly $10~\mathrm{mL}$ . Confirm that the peak area of enflurane obtained from $5\,\upmu\mathrm{L}$ of this solution is equivalent to 7 to $13\%$ of the peak area of enflurane from the system suitability solution.  

System performance: Mix $5\;\mathrm{mL}$ of Enflurane with $5~\mathrm{mL}$ of 2-propanol. Proceed with $5~\upmu\mathrm{L}$ of this solution according to the above operating conditions, enflurane and 2-propanol are eluted in this order with the resolution being NLT 2.0.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ of the system suitability solution according to the above operating conditions; the relative standard deviation of the ratios of the peak area of enflurane is NMT Time span of measurement: About 3 times the retention time of enflurane.  

(4) Evaporation residue —Pipet $65\,\mathrm{\mL}$ of Enflurane, evaporate to dryness on a steam bath, and dry the residue at $105~^{\circ}\mathrm{C}$ for 1 hour; the mass of the residue is NMT $1.0\;\mathrm{mg}$ .  

Water NMT $0.1\%$ ($\mathrm{~10~g~}$ , volumetric titration, direct titration).  

Packaging and storage Preserve in tight containers and store at below $30\,^{\circ}\mathbf{C}$ .  

![](images/a9ba63a7b46aba82105b4255d4f03aece7c9bdf5e195fde3d6754596a9dd862e.jpg)  

Enoxacin $\mathrm{C_{15}H_{17}F N_{4}O_{3}{\cdot}1\%H_{2}O}:347.34$ 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro1,8-naphthyridine-3-carboxylic acid sesquihydrate [84294-96-2 ]  

Enoxacin Hydrate, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of enoxacin $(\mathrm{C}_{15}\mathrm{H}_{17}\mathrm{FN}_{4}\mathrm{O}_{3}:320.32)$ .Description Enoxacin Hydrate occurs as white to pale yellowish brown crystals or a crystalline powder. It is freely soluble in acetic acid(100), slightly soluble in methanol, very slightly soluble in chloroform, and practically insoluble as water, ethanol(95) or ether. It dissolves in dilute sodium hydroxide TS. It is gradually colored by light.  

Identification (1) Put $20~\mathrm{mg}$ of Enoxacin Hydrate and $30~\mathrm{mg}$ of sodium metal in a test tube, and heat gently with caution until glowing red. After cooling, add $0.5\;\mathrm{mL}$ of methanol and $5~\mathrm{mL}$ of water, and heat to boiling. Add $2~\mathrm{mL}$ of dilute acetic acid and filter; the filtrate responds to the Qualitative Analysis (2) for fluoride.  

(2) Dissolve $50~\mathrm{mg}$ each of Enoxacin Hydrate and enoxacin hydrate RS in dilute sodium hydroxide TS to make $100\;\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ each of these solutions and add water to make $100~\mathrm{mL}$ . With these solutions, determine the absorption spectra as directed under the Ultravioletvisible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Enoxacin Hydrate and enoxacin hydrate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of ab  

# Melting point Between 225 and $229\ ^{\circ}\mathrm{C}$ (after drying).  

Purity (1) Sulfate —Dissolve $1.0~\mathrm{g}$ of Enoxacin Hydrate in $50~\mathrm{mL}$ of dilute sodium hydroxide TS, add $10~\mathrm{mL}$ of dilute hydrochloric acid, shake to mix, and centrifuge. Filter the clear supernatant, take $30\;\mathrm{mL}$ of the filtrate, and add water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution by adding $0.50~\mathrm{mL}$ of $0.005~\mathrm{mol/L}$ sulfuric acid, $25~\mathrm{mL}$ of dilute sodium hydroxide TS, $5\;\mathrm{mL}$ of dilute hydrochloric acid and water to make $50\;\mathrm{mL}$ (NMT $0.048\%$ ).  

(2) Heavy metals— Proceed with $1.0~\mathrm{g}$ of Enoxacin Hydrate according to Method 2 and perform the test. Prepare the control solution with $2.0\,\textrm{m L}$ of lead standard solution (NMT 20 ppm).  

(3) Arsenic —Proceed with $1.0\mathrm{~g~}$ of Enoxacin Hydrate according to Method 3 and perform the test (NMT 2 ppm).  

(4) Related substances —Dissolve $50~\mathrm{mg}$ of Enoxacin Hydrate in $25~\mathrm{mL}$ of a mixture of methanol and chloroform $(7:3)$ , and use this solution as the test solution. Pipet $1\ \mathrm{mL}$ of this solution, add a mixture of methanol and chloroform $(7:3)$ to make $200\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5\,\textrm{\scriptsize\sharp L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of 1-butanol, water and acetic acid(100) $(3:1:1)$ as the developing solvent to a distance of about $10\;\mathrm{cm}$ , and airdry the plate. Observe the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying Between $7.0\%$ and $9.0\%$ ($\mathrm{~\,~1~g,~105~^{o}C.}$ , 3 hours).  

Residue on ignition NMT $0.1\%$ ($1\;\mathrm{g}$ , platinum crucible). Assay Weigh accurately about $0.3\mathrm{~g~}$ of Enoxacin Hydrate, previously dried, dissolve in $30~\mathrm{mL}$ of acetic acid(100), and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=32.03~\mathrm{mg}$ of $\mathrm{C}_{15}\mathrm{H}_{17}\mathrm{FN}_{4}\mathrm{O}_{3}$  

Packaging and storage Preserve in light-resistant, tight containers.  

# Eperisone Hydrochloride 에페리손염산염  

![](images/a7317a8e80e5283a62ee0d39f7e853255bf4ad4c232dea9ed3b9ea2afe677585.jpg)  

1-(4-Ethylphenyl)-2-methyl-3-(piperidin-1-yl)   
propan-1-one hydrochloride [ 56839-43-1 ]  
Eperisone Hydrochloride contains NLT $98.5\%$ and NMT $101.0\%$ of eperisone hydrochloride $(\mathrm{C_{17}H_{25}N O{\cdot}H C l})$ .Description Eperisone Hydrochloride occurs as a white crystalline powder.   
It is freely soluble in water, methanol or acetic acid(100), and soluble in ethanol(99.5).  

Melting point— About $167\,^{\circ}\mathrm{C}$ (with decomposition) A solution of Eperisone Hydrochloride in methanol (1 in 100) shows no optical rotation.  

Identification (1) Determine the absorption spectra of solutions of Eperisone Hydrochloride and eperisone hydrochloride RS in methanol (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Eperisone Hydrochloride and eperisone hydrochloride RS as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Eperisone Hydrochloride (1 in 50) responds to the Qualitative Analysis for chloride.  

Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Eperisone Hydrochloride as directed under Method 1 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(2) Piperidine hydrochloride —Weigh $1.0\ \mathrm{~g~}$ of Eperisone Hydrochloride and dissolve in $20~\mathrm{mL}$ of water, add $2.0~\mathrm{mL}$ of diluted hydrochloric acid (1 in 2), $2.0~\mathrm{mL}$ of copper(II) sulfate pentahydrate solution (1 in 20) and $1.5\ \mathrm{mL}$ of ammonia water(28), and use this solution as the test solution. Separately, to $2.0~\mathrm{mL}$ of piperidine hydrochloride solution (1 in 1000), add $18~\mathrm{mL}$ of water, 2.0 mL of diluted hydrochloric acid (1 in 2), $2.0~\mathrm{mL}$ of copper(II) sulfate pentahydrate solution (1 in 20) and $1.5\;\mathrm{mL}$ of ammonia water(28), and use this solution as the standard solution. To each of the test solution and the standard solution, add $10~\mathrm{mL}$ of a mixture of isopropyl ether and carbon disulfide $(3:1)$ , mix well for 30 seconds, allow them to stand for 2 minutes, and compare the color of two supernatants; the color obtained from the test solution is not more intense than that obtained from the standard solution.  

(3) Related substances —Weigh $0.1\ \mathrm{g}$ of Eperisone Hydrochloride, dissolve it in $100\;\mathrm{mL}$ of the mobile phase, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add the mobile phase to make exactly 100 mL, and use this solution as the standard solution. Perform the test with exactly $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine each peak area as directed in the automatic integration method; the total area of the peaks other than eperisone obtained from the test solution is not greater than 1/5 times the peak area of eperisone from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $30\,^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of methanol, $0.0375\;\mathrm{mol/L}$ sodium 1-decanesulfonate solution and perchloric acid $(600:400:1)$ ).  

Flow rate: Adjust so that the retention time of eperisone is about 17 minutes.  

# System suitability  

Test for required detectability: Pipet $1~\mathrm{mL}$ of the standard solution and add the mobile phase to make exactly $10~\mathrm{mL}$ . Confirm that the peak area of eperisone obtained from $10~\upmu\mathrm{L}$ of this solution is equivalent to 7 to $13\%$ of that from the standard solution.  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above operating conditions; the number of theoretical plates and symmetry factor of the peak of eperisone are NLT 4000 and NMT 2.0, respectively.  

System repeatability: Repeat the test 6 times with $10\,\upmu\mathrm{L}$ each of the standard solution according to the above operating conditions; the relative standard deviation of the peak area of eperisone is NMT $3.0\%$ .  

Time span of measurement: About 2 times the retention time of eperisone.  

Sodium $^{\,l}$ -decanesulfonate solution, 0.0375 mol/L —Dissolve $3.665\ \mathrm{g}$ of sodium 1-decanesulfonate in $400\;\mathrm{mL}$ of water.  

Water NMT $0.2\%$ $\mathrm{[0.1~g}$ , coulometric titration).  

# Residue on ignition NMT $0.2\%$ ($\,[\,{\bf\rho}_{1}\,{\bf g})$  

Assay Weigh accurately about $0.6\ \mathrm{g}$ of Eperisone Hydrochloride, dissolve in $20~\mathrm{mL}$ of acetic acid(100), add $80\,\mathrm{\mL}$ of acetic anhydride, and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=29.59\ \mathrm{mg}$ of C 17 H25 NO∙HCl  

Packaging and storage Preserve in well-closed containers.  

![](images/1c5b71f37f44f7c8f5d45ffbc69a24c593b046ebc00c95a7aa0edec040a4e1e3.jpg)  
$\mathrm{C_{10}H_{15}N O}.$ HCl: 201.69  

(1 R,2 S)-2-(Methylamino)-1-phenylpropan-1-ol hydrochloride [ 50-98-6 ]  

Ephedrine Hydrochloride, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of ephedrine hydrochloride $\mathrm{(C_{10}H_{15}N O{\cdot}H C l)}$ ).  

Description Ephedrine Hydrochloride occurs as white crystals or a crystalline powder.  

It is freely soluble in water, soluble in ethanol(95), slightly soluble in acetic acid(100), and practically insoluble in acetic anhydride or acetonitrile.  

Identification (1) Determine the absorption spectra of aqueous solutions of Ephedrine Hydrochloride and ephedrine hydrochloride RS (1 in 2000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelength. (2) Determine the infrared spectra of Ephedrine Hydrochloride and ephedrine hydrochloride RS as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Ephedrine Hydrochloride (1 in 15) responds to the Qualitative Analysis for chloride.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-33.0^{\circ}$ and $-36.0^{\circ}$ (after drying, $1\;\mathrm{g}$ , water, $20\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 218 and $222\ ^{\circ}\mathrm{C}$ $\mathbf{pH}$ Dissolve $1.0\;\mathrm{g}$ of Ephedrine Hydrochloride in $20~\mathrm{mL}$ of water; the pH of this solution is between 4.5 and 6.5. Purity (1) Clarity and color of solution —Dissolve $0.5~\mathrm{g}$ of Ephedrine Hydrochloride in $10~\mathrm{mL}$ of water; the solution is colorless and clear.  

(2) Acidity and Alkalinity —Weigh accurately $1.0~\mathrm{g}$ of  Ephedrine Hydrochloride, dissolve in $20\;\mathrm{mL}$ of water, and add 1 drop of methyl red TS. Add $0.01\;\mathrm{mol/L}$ of sulfuric acid until the solution turns red if the solution exhibits a yellow color; the amount used of sulfuric acid is NMT $0.10\,\mathrm{~mL~}$ . Add $0.02\,\mathrm{\mol/L}$ of sodium hydroxide solution until the solution turns yellow if the solution exhibits a pink color; the amount used of the sodium hydroxide solution is NMT $0.20\,\mathrm{mL}$ .  

(3) Sulfate —Dissolve $50~\mathrm{mg}$ of Ephedrine Hydrochloride in $40~\mathrm{mL}$ of water, add $1\ \mathrm{mL}$ of dilute hydrochloric acid and $1~\mathrm{mL}$ of barium chloride TS and allow to stand for 10 minutes; the solution remains unchanged.  

(4) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Ephedrine Hydrochloride as directed under Method 2 and perform the test. Prepare the control solution with $1.0\ \mathrm{mL}$ of lead standard solution $\left\langle10\,\mathrm{ppm}\right\rangle$ .  

(5) Related substances —Dissolve $50~\mathrm{mg}$ of Ephedrine Hydrochloride in $50\;\mathrm{mL}$ of mobile phase and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add the mobile phase to it make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine the peak area obtained from each solution as directed in the automatic integration method; the sum of peak areas other than the major peak area from the test solution is not greater than the major peak area from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm})$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).   
Column temperature: A constant temperature of about $45\,^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of sodium lauryl sulfate solution (1 in 128), acetonitrile and phosphoric acid $(640:360:1)$ ).   
Flow rate: Adjust so that the retention time of  

ephedrine is about 14 minutes.  

# System suitability  

Test for required detectability: Pipet $1~\mathrm{mL}$ of the standard solution and add the mobile phase to make 20 mL. Confirm that the peak area of ephedrine obtained from $10~\upmu\mathrm{L}$ of this solution is equivalent to $4\%$ to $6\%$ of that of ephedrine from the standard solution.  

System performance: Dissolve $1~\mathrm{mg}$ of ephedrine hydrochloride RS and $4~\mathrm{mg}$ of atropine sulfate in $100\;\mathrm{mL}$ of diluted methanol (1 in 2). Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above operating conditions; ephedrine and atropine are eluted in this order with the resolution being NLT 1.5.  

System repeatability: Repeat the test 6 times according to the above operating conditions with $10\,\upmu\mathrm{L}$ each of the standard solution; the relative standard deviation of the peak areas of ephedrine is NMT $2.0\%$ .Time span of measurement: About 3 times the retention time of ephedrine after the solvent peak.  

Loss on drying NMT $0.5\%$ $\mathrm{~\,~1~g,~}105\ ^{\circ}\mathrm{C}$ , 3 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ Assay Weigh accurately about $0.4~\mathrm{g}$ of Ephedrine Hydrochloride, previously dried, dissolve in $50\,\mathrm{\mL}$ of a mixture of acetic anhydride and acetic acid(100) $(7:3)$ by warming. After cooling, titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=20.169\;\mathrm{mg}$ of $\mathrm{C_{10}H_{15}N O}.$ ·HCl  

Packaging and storage Preserve in well-closed containers.  

# Ephedrine Hydrochloride Injection 에페드린염산염주사액  

Ephedrine Hydrochloride Injection is an aqueous injection and contains NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of ephedrine hydrochloride $(\mathrm{C_{10}H_{15}N O}\cdot\mathrm{HCl}:201.69)$ .  

Method of preparation Prepare as directed under Injections, with Ephedrine Hydrochloride.  

Description Ephedrine Hydrochloride Injection occurs as a clear, colorless liquid.   
$p H$ —Between 4.5 and 6.5.  

Identification Take an amount of Ephedrine Hydrochloride Injection equivalent to $509~\mathrm{mg}$ of ephedrine hydrochloride according to the labeled amount, and add water to make $100\;\mathrm{mL}$ . Determine the absorption spectra of this solution as directed under Ultraviolet-visible Spectroscopy; it exhibits maxima between $249~\mathrm{nm}$ and $253~\mathrm{nm}$ , between $255~\mathrm{nm}$ and $259\;\mathrm{nm}$ , and between $261~\mathrm{nm}$ and 265 nm.  

Sterility Meets the requirements. Bacterial endotoxins Less than 7.5 EU per mg of ephedrine hydrochloride.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Pipet an amount of Ephedrine Hydrochloride Injection equivalent to about $40~\mathrm{{mg}}$ of ephedrine hydrochloride $\mathrm{\left(C_{10}H_{15}N O{\cdot}H C l\right)}$ , add exactly $10~\mathrm{mL}$ of the internal standard solution, then add water to make $200~\mathrm{mL}$ ,and use this solution as the test solution. Separately, weigh accurately about $40~\mathrm{mg}$ of ephedrine hydrochloride RS, previously dried at $105~^{\circ}\mathrm{C}$ for 3 hours, dissolve in exactly $10~\mathrm{mL}$ of the internal standard solution, then add water to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak area ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of ephedrine to the peak area of the internal standard, respectively.  

Internal standard solution —Etilefrine hydrochloride solution (1 in 500).  

# Operating conditions  

For the detector, column, column temperature, mobile phase and flow rate, proceed as directed under the operating conditions under the Purity (5) of Ephedrine Hydrochloride.  

# System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the internal standard and ephedrine are eluted in this order with the resolution being NLT 1.5.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratios of ephedrine to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, hermetic containers.  

# $10\%$ Ephedrine Hydrochloride Powder 에페드린염산염10배산  

Ephedrine Hydrochloride $10\%$ Ephedrine Hydrochloride  

$10\%$ Ephedrine Hydrochloride Powder contains NLT $9.3\%$ and NMT $10.7\%$ of ephedrine hydrochloride $(\mathrm{C_{10}H_{15}N O}\cdot\mathrm{HCl}:201.69)$ .  

# Method of preparation  

Ephedrine hydrochloride  

$100\;\mathrm{g}$  

Prepare as directed under Powders, with the above. Identification Take $0.5\,\mathrm{~g~}$ of $10\%$ Ephedrine Hydrochloride Powder, add $100\,\mathrm{\mL}$ of water, shake for 20 minutes and filter. Determine the absorption spectrum of the filtrate as directed under Ultraviolet-visible Spectrophotometry: it exhibits maxima between $249~\mathrm{nm}$ and 253 nm, between $255~\mathrm{nm}$ and $259\ \mathrm{nm}$ and between $261\ \mathrm{nm}$ and $265\ensuremath{\,\mathrm{\nm}}$ . Determine the absorption spectrum of the filtrate as directed under the Ultraviolet-visible Spectroscopy; it exhibits maxima between $249\ \mathrm{nm}$ and $253\,\mathrm{\nm}$ ,between $255~\mathrm{nm}$ and $259\ \mathrm{nm}$ , and between $261\ \mathrm{nm}$ and $265~\mathrm{nm}$ .  

# Particle size distribution estimation by analytical sieving Meets the requirements.  

Uniformity of dosage units (distribution) Meets the requirements.  

Assay Weigh accurately about $0.4~\mathrm{g}$ of $10\%$ Ephedrine Hydrochloride Powder, add $150~\mathrm{mL}$ of water and extract with the aid of ultrasonicator for 10 minutes with occasional shaking. Shake more for 10 minutes, add exactly $10\;\mathrm{mL}$ of the internal standard solution and water to make $200\,\mathrm{\mL}$ , centrifuge and use the supernatant as the test solution. Separately, weigh accurately about $40\,\mathrm{~mg~}$ of Ephedrine Hydrochloride RS, previously dried at $105~^{\circ}\mathrm{C}$ for 3 hours, put exactly to $10\,\mathrm{\mL}$ of internal standard solution to dissolve, add water to make $200~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test and the standard solution as directed under Liquid Chromatography according to the following condition and calculate the ratios, QT and QS, of the peak area of ephedrine to that of the internal standard of each solution.  

Amount (mg) of ephedrine hydrochloride $(\mathrm{C_{10}H_{15}N O{\cdot}H C l})$ $=$ Amount (mg) of ephedrine hydrochloride $\mathrm{RS}{\times}\,\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —Etilefrine hydrochloride solution (1 in 500).  

# Operating conditions  

Follow the operating conditions under the Purity (4) of Ephedrine Hydrochloride for the detector, column, column temperature, mobile phase and flow rate.  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the internal standard and ephedrine are eluted in this order with the resolution being NLT 1.5.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratio of ephedrine to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

# Ephedrine Hydrochloride Tablets 에페드린염산염정  

Ephedrine Hydrochloride Tablets contain NLT $93.0\%$ and NMT $107.0\%$ of the labeled amount of ephedrine hydrochloride $\mathrm{{(C_{10}H_{15}N O{\cdot}H C l{:}201.69)}}$ .  

Method of preparation Prepare as directed under Tablets, with Ephedrine Hydrochloride.  

Identification Weigh an amount of Ephedrine Hydrochloride Tablets, previously powdered, equivalent to 50 mg of ephedrine hydrochloride according to the labeled amount, add $100~\mathrm{mL}$ of water, shake for 20 minutes to mix, and then filter. Determine the absorption spectrum of the filtrate as directed under the Ultraviolet-visible Spectroscopy; it exhibits maxima between $249\,\mathrm{\Omeganm}$ and $253\ \mathrm{nm}$ , between $255~\mathrm{nm}$ and $259\ \mathrm{nm}$ , and between 261 nm and $265~\mathrm{nm}$ .  

Dissolution Perform the test with 1 tablet of Ephedrine Hydrochloride Tablets at 50 revolutions per minute according to Method 2 under the Dissolution, using $900\;\mathrm{mL}$ of water as the dissolution medium. Take $20~\mathrm{mL}$ or more of the dissolved solution 30 minutes after starting the test, and filter through a membrane filter with a pore size of NMT $0.45~{\upmu\mathrm{m}}$ . Discard the first $10\;\mathrm{mL}$ of the filtrate, and use the subsequent filtrate as the test solution. Separately, weigh accurately about $28~\mathrm{mg}$ of ephedrine hydrochloride RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 3 hours, and dissolve in water to make exactly $100\;\mathrm{mL}$ . Pipet $5\;\mathrm{mL}$ of this solution, add water to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of ephedrine, respectively. The acceptable dissolution criterion is NLT $80\%$ of Ephedrine Hydrochloride Tablets dissolved in 30 minutes.  

Dissolution rate $(\%)$ of the labeled amount of ephedrine $(\mathrm{C_{10}H_{15}N O{\cdot}H C l})$  

$=$ Amount (mg) of the ephedrine RS taken $\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{1}{C}\times90$  

$C$ :Labeled amount (mg) of ephedrine $(\mathrm{C_{10}H_{15}N O{\cdot}H C l})$ ) in 1 tablet.  

Operating conditions  

Ephedrine Hydrochloride: Perform the test according to the operating conditions under the Purity (5) Related substances.  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plates and the symmetry factor of the peak of ephedrine are NLT 10000 and NMT 2.0, respectively.  

System repeatability: Repeat the test 6 times with $10\,\upmu\mathrm{L}$ each of the standard solutions according to the above operating conditions; the relative standard deviation of the peak areas of ephedrine is NMT $2.0\%$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of NLT 20 tablets of Ephedrine Hydrochloride Tablets, and powder. Weigh accurately an amount, equivalent to about $40~\mathrm{~mg}$ of ephedrine hydrochloride $(\mathsf{C}_{10}\mathrm{H}_{15}\mathrm{NO}{\cdot}\mathrm{HCl})$ , add $150\,\mathrm{\mL}$ of water, sonicate for 10 minutes while occasionally shaking to mix, and shake for 10 minutes to mix. Then, add exactly $10~\mathrm{mL}$ of the internal standard solution, and then add water to make $200\;\mathrm{mL}$ . Centrifuge this solution, and use the clear supernatant as the test solution. Separately, weigh accurately about $40~\mathrm{mg}$ of ephedrine hydrochloride RS, previously dried at $105~^{\circ}\mathrm{C}$ for 3 hours, dissolve exactly $10\,\mathrm{\mL}$ of the internal standard solution, then add water to make $200~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak area ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of ephedrine to the peak area of the internal standard, respectively.  

$=$ Amount (mg) of ephedrine hydrochloride $\mathrm{RS}{\times}\,\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —Etilefrine hydrochloride solution (1 in 500).  

# Operating conditions  

For the detector, column, column temperature, mobile phase and flow rate, proceed as directed under the operating conditions in the Purity (4) under Ephedrine Hydrochloride.  

# System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the internal standard and ephedrine are eluted in this order with the resolution being NLT 1.5.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratios of ephedrine to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

![](images/9ae511d5282ae1a9ab40c396ba8c699d0dcb8546e63e1051ccb6ceeaae59d6a2.jpg)  

Adrenaline   
Epirenamine $\mathrm{C}9\mathrm{H}_{13}\mathrm{NO}_{3}$ : 183.20 4-[(1 R)-1-Hydroxy-2-(methylamino)ethyl]benzene-1,2- diol [ 51-43-4 ]  
Epinephrine, when dried, contains NLT $98.0\%$ and NMT $101.0\%$ of epinephrine $\left({\bf C}_{9}{\bf H}_{13}{\bf N O}_{3}\right)$ .Description Epinephrine occurs as a white to grayish white crystalline powder and is odorless.   
It is freely soluble in acetic acid(100), very slightly soluble in water, and practically insoluble in methanol, ethanol(95) or ether.   
It dissolves in dilute hydrochloric acid.   
It is gradually changed to brown by air or light.  

Identification (1) Dissolve $10~\mathrm{mg}$ of Epinephrine in 10 mL of diluted ethanol (1 in 500) and use this solution as the test solution. To $1~\mathrm{mL}$ of the test solution, add $4~\mathrm{mL}$ of water and 1 drop of iron(III) chloride TS; the resulting solution exhibits dark green and then slowly turns red.  

(2) Take $1~\mathrm{mL}$ each of the test solution in (1) in test tubes A and B, respectively, add $10\,\mathrm{\mL}$ of potassium hydrogen phthalate buffer solution $(\mathrm{pH}\ 3.5)$ to the test tube A and add $10~\mathrm{mL}$ of phosphate buffer solution (pH 6.5) to the test tube B, add $1~\mathrm{mL}$ of iodine TS to the test tubes A and B, respectively, allow them to stand for 5 minutes, then add $2~\mathrm{mL}$ of sodium thiosulfate TS to each test tube; the test tube A exhibits red and the test tube B develops deep red color.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-50.0^{\circ}$ and $-53.5^{\circ}$ $\mathrm{~\textit~{~1~g~}~}$ ,after drying, 1 mol/L hydrochloric acid TS, $25~\mathrm{mL}$ , 100 mm).  

Purity (1) Clarity and color of solution —Dissolve $0.1~\mathrm{g}$ of Epinephrine in $10~\mathrm{mL}$ of dilute hydrochloric acid; the solution is clear and the color is not more intense than that of the Color Matching Fluid A.  

(2) Adrenalone —Dissolve $50~\mathrm{mg}$ of Epinephrine in $0.05\;\mathrm{mol/L}$ hydrochloric acid TS to make exactly $25~\mathrm{mL}$ ,and perform the test as directed under the Ultravioletvisible Spectroscopy; the absorbance at a wavelength of $310\;\mathrm{nm}$ is NMT 0.40.  

(3) Norepinephrine —Weigh $10.0~\mathrm{mg}$ of Epinephrine, dissolve in $2.0\ \mathrm{mL}$ of a solution of L-tartaric acid in methanol (1 in 200). Pipet $1~\mathrm{mL}$ of this solution, and add $3.0\;\mathrm{mL}$ of pyridine. Add $1.0\;\mathrm{mL}$ of freshly prepared sodium naphthoquinone sulfonate TS, allow to stand for 30 minutes in the dark, and add $5.0~\mathrm{mL}$ of pyridine containing $50~\mathrm{mg}$ of L-ascorbic acid to the resulting solution; the color of the solution is not more intense than that of the control solution.  

Control solution —Dissolve $2.0~\mathrm{mg}$ of norepinephrine tartrate RS and $90~\mathrm{mg}$ of epinephrine tartrate RS in methanol to make exactly $10\,\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, and proceed in the same manner.  

Loss on drying NMT $1.0\%$ ($\,2~\mathrm{g}$ , in vacuum, silica gel, 18 hours).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~}~}\mathrm{g})$  

Assay Weigh accurately about $0.3\,\mathrm{~g~}$ of Epinephrine, previously dried, dissolve in $50~\mathrm{mL}$ of acetic acid(100), and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (indicator: 2 drops of methylrosaniline chloride TS). Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in light-resistant, tight containers. Store at a cold place under nitrogen atmosphere.  

# Epinephrine Injection 에피네프린주사액  

Adrenaline Hydrochloride Injection   
Epirenamine Hydrochloride Injection   
Epinephrine Hydrochloride Injection   
Epinephrine Injection is an aqueous solution for injection and contains NLT $0.085~\mathrm{w/v}\%$ and NMT 0.115 $\mathrm{w}/\mathrm{v}\%$ of epinephrine (C9H13NO3: 183.20).  

Preparation Prepare as directed under Injections, with Epinephrine by dissolving in diluted hydrochloric acid (9 in 10000).  

Description Epinephrine Injection occurs as a clear, colorless liquid.   
It is gradually changed to pale red and then brown by air or light.   
$p H$ —Between 2.3 and 5.0.  

Identification (1) Add $4~\mathrm{mL}$ of water and 1 drop of iron(III) chloride TS to $1\,\mathrm{\mL}$ of Epinephrine Injection; the solution turns dark green and slowly changes to red. (2) Take $1~\mathrm{mL}$ each of Epinephrine Injection in test tubes A and B and perform the test as directed under the Identification (2) under Epinephrine.  

Sterility Meets the requirements. Bacterial endotoxins Less than 357.0 EU per mg of epinephrine.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Pipet $30~\mathrm{mL}$ of Epinephrine Injection, transfer to a separatory funnel, add $25~\mathrm{mL}$ of carbon tetrachloride, and shake vigorously to mix for 1 minute. Allow to stand, and discard the carbon tetrachloride layer. Repeat this procedure 3 times. Wash the stopper and inlet of the separatory funnel with a small amount of water, and introduce $0.2~\mathrm{mL}$ of starch TS. While shaking, add iodine TS dropwise until the solution exhibits a persistent blue color, then immediately add sodium thiosulfate TS dropwise until the blue color disappears. Add $2.1\ \mathrm{g}$ of sodium bicarbonate to the liquid, preventing it from coming in contact with the inlet of the separatory funnel, and shake until most of the sodium bicarbonate dissolves. To this solution, immediately add $1.0\,\mathrm{\mL}$ of acetic anhydride. Immediately stopper the separatory funnel loosely and allow to stand until the evolution of gas ceases. Shake vigorously, allow to stand for 5 minutes, extract six times with $25~\mathrm{mL}$ volumes of chloroform. Filter each chloroform extract using cotton wool. Combine all chloroform extracts, evaporate on a steam bath to $3\;\mathrm{mL}$ with a current of air. Transfer this residue by means of small portions of chloroform to a tared beaker and heat again to evaporate to dryness. Dry the residue at $105\;^{\circ}\mathrm{C}$ for 30 minutes, cool in a desiccator (silica gel), weigh accurately the weight, W (mg), of the dried residue, and dissolve in chloroform to make exactly $5\;\mathrm{mL}$ . Determine the optical rotation, α D,using a $100{\-}\mathrm{mm}$ cell as directed under the Optical Rotation.  

$$
=\,0.5923\times W\times\dot{\left(0.5+}\frac{0.5\times\upalpha_{\mathrm{D}}}{93}\right)
$$  

Packaging and storage Preserve in light-resistant, hermetic containers. Colored containers may be used for Epinephrine Injection.  

# Epirubicin Hydrochloride 에피루비신염산염  

![](images/3b76ddfc449d64b68a7f46a16ee051fda3f60d690d8fc070b6664fc364eb3cf3.jpg)  

$\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}$ ·HCl: 579.98 (8R,10S)-10-((2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-6,8,11-tri-hydroxy-8- (2-hydroxyacetyl)-1-methoxy-7,8,9,10- tetrahydrotetracene-5,12-dione hydrochloride [ 56390-09- 1 ]Epirubicin Hydrochloride is the hydrochloride of a derivative of daunorubicin. Epirubicin Hydrochloride contains NLT $970~\upmu\mathrm{g}$ and NMT $1020~\mathrm{\upmug}$ (potency) of epirubicin hydrochloride $(\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}\cdot\mathrm{HCl})$ per mg, calculated on the anhydrous and solvent-free basis.  

Description Epirubicin Hydrochloride occurs as a pale yellowish red to brownish red powder.   
It is soluble in water or methanol, slightly soluble in ethanol(95) and practically insoluble in acetonitrile.   
It is hygroscopic.  

Identification (1) Determine the absorption spectra of solutions of Epirubicin Hydrochloride and epirubicin hydrochloride RS in methanol (3 in 200000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Epirubicin Hydrochloride and epirubicin hydrochloride RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+310^{\circ}$ and $+340^{\circ}$ (10 mg calculated on the anhydrous and solvent-free basis, methanol, $20\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

$\mathbf{pH}$ Dissolve $10~\mathrm{mg}$ of Epirubicin Hydrochloride in $2\;\mathrm{mL}$ of water; the pH of this solution is between 4.0 and 5.5. Absorbance $E_{1c m}^{1\%}$ ($495\ \mathrm{nm})$ ): 200 to 230 ( $15~\mathrm{mg}$ calculated on the anhydrous and solvent-free basis, methanol, $1000\;\mathrm{mL}$ ).  

Purity (1) Clarity and color of solution —Dissolve 50 mg of Epirubicin Hydrochloride in $5\ \mathrm{mL}$ of water; the solution is clear and dark red.  

(2) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Epirubicin Hydrochloride as directed under Method 2 and perform the test. Prepare the control solution with $2.0~\mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(3) Related substances —Weigh accurately an amount equivalent to $50~\mathrm{mg}$ (potency) of Epirubicin Hydrochloride, dissolve in the internal standard solution to make exactly $50~\mathrm{mL}$ . Use this solution as the test solution. Take $10~\upmu\mathrm{L}$ of the test solution and perform the test as directed under the Liquid Chromatography according to the following conditions. Determine each peak area as directed in the automatic integration method and calculate the total peak area of substances other than epirubicin and 2-naphthalenesulfonic acid by the percentage peak area method; it is NMT $5.0\%$ .  

Internal standard solution —A solution of sodium 2- naphthalenesulfonate in a mixture of water, acetonitrile, methanol and phosphoric acid $(540:290:170:1)$ ) (1 in 2000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with trimethylsilyl silica gel for liquid chromatography ( $\left(6~\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2{\mathrm{~g~}}$ of sodium lauryl sulfate in a mixture of water, acetonitrile, methanol and phosphoric acid $(540:290:170:1)$ to make $1000\;\mathrm{mL}$ .  

Flow rate: Adjust so that the retention time of epirubicin is about 9.5 minutes.  

# System suitability  

Test for required detectability: Pipet $1~\mathrm{mL}$ of the test solution, add the mobile phase to make exactly 100 mL, and use this solution as the system suitability solution (1). Pipet $1.0\;\mathrm{mL}$ of this solution and add the mobile phase to make exactly $10\;\mathrm{mL}$ . Confirm that the peak area of epirubicin obtained from $10\,\mathrm{\upmuL}$ of this solution is equivalent to $7\%$ to $13\%$ of that obtained from $10~\upmu\mathrm{L}$ of the system suitability solution (1).  

System performance: Weigh $50~\mathrm{mg}$ (potency) of epirubicin hydrochloride RS and dissolve in the internal standard solution to make exactly $50~\mathrm{mL}$ . Use this solution as the system suitability solution (2). Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above conditions; the internal standard and epirubicin are eluted in this order with the resolution being NLT 20.  

System repeatability: Repeat the test 5 times with $10\;\mathrm{mL}$ each of the system suitability solutions (2) according to the above conditions; the relative standard deviation of the ratios of the peak area of epirubicin to that of the internal standard is NMT $1.0\%$ .  

Time span of measurement: About 3 times the retention time of epirubicin after the solvent peak.  

(4) Residual solvent —Weigh accurately about $0.3~\mathrm{g}$ of Epirubicin Hydrochloride, add exactly $0.6~\mathrm{mL}$ of the internal standard solution, dissolve in dimethylacetamide to make $6~\mathrm{mL}$ , and use it as the test solution. Separately, pipet $1~\mathrm{mL}$ of methanol, add dimethylacetamide to make exactly $25~\mathrm{mL}$ , and use this solution as the standard stock solution. Pipet $125~\upmu\mathrm{L}$ of acetone, $30~\upmu\mathrm{L}$ of ethanol(99.5), $32\ \upmu\mathrm{L}$ of 1-propanol, and $17\,\upmu\mathrm{L}$ of the standard stock solution each, add exactly $10~\mathrm{mL}$ of the internal standard solution, then add dimethylacetamide to make $100\ \mathrm{mL}$ .Use this solution as the standard solution. Perform the test with $1~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratios, $Q_{\mathrm{Ta}}$ and $Q_{\mathrm{Sa}}$ ,$Q_{\mathrm{Tb}}$ and $Q_{\mathrm{Sb}}$ ,$Q_{\mathrm{Tc}}$ and $Q_{\mathrm{Sc}}$ , and $Q_{\mathrm{Td}}$ and $Q_{\mathrm{Sd}}.$ , of peak areas of acetone, ethanol, 1-propanol and methanol to that of the internal standard, respectively. Calculate the amounts of acetone, ethanol, 1-propanol and methanol with the following equation: NMT $1.5\%$ ,NMT $0.5\%$ , NMT $0.5\%$ and NMT $0.1\%$ , respectively.  

$$
\begin{array}{r}{\mathrm{Content}\left(\mathcal{U}\right)\mathrm{of~acetone}=\frac{1}{W_{\mathrm{T}}}\times\frac{Q_{\mathrm{Ta}}}{Q_{\mathrm{Sa}}}\times593}\end{array}
$$  

$$
\begin{array}{r}{\mathrm{Content}\left(\%\right)\mathrm{of~ethanol}=\frac{1}{W_{\mathrm{T}}}\times\frac{Q_{\mathrm{Tb}}}{Q_{\mathrm{Sb}}}\times142}\end{array}
$$  

$$
\begin{array}{r l}{\centering}&{{}\mathrm{Content}\left(\%\right)\mathrm{of~1-propanol}=\frac{1}{W_{\mathrm{T}}}\times\frac{Q_{\mathrm{Tc}}}{Q_{\mathrm{Sc}}}\times154}\end{array}
$$  

Internal standard solution —A solution of toluene in dimethylacetamide (1 in 100).  

# Operating conditions  

Detector: A flame ionization detector Column: A glass column about $0.25\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{m}$ in length, packed with $5\%$ phenylmethyl silicone polymer for gas chromatography coated at $0.25\;\upmu\mathrm{m}$ thick.  

Column temperature: Maintain the temperature at $30~^{\circ}\mathrm{C}$ for the first 5 minutes, then raise the temperature at the rate of $2~^{\circ}\mathrm{C}$ per minute up to $40~^{\circ}\mathrm{C}$ , and raise at the rate of $25~^{\circ}\mathrm{C}$ per minute up to $200~^{\circ}\mathrm{C}$ if necessary. Keep at $200\;^{\circ}\!C$ for 5 minutes.  

Sample injection port temperature: A constant temperature of about $200~^{\circ}\mathrm{C}$ .  

Detector temperature: A constant temperature of about $200~^{\circ}\mathrm{C}$ .  

Carrier gas: Helium Flow rate: About $1.0\;\mathrm{mL}$ per minute. Split ratio: $1:100$ System suitability  

System performance: Proceed with $1~\upmu\mathrm{L}$ of the standard solution according to the above operation conditions; acetone, methanol, ethanol, 1-propanol and the internal standard are eluted in this order. The resolution between the peaks of acetone and the internal standard is NLT 30.  

System repeatability: Repeat the test 6 times with $1~\upmu\mathrm{L}$ each of the standard solutions according to the above conditions; the relative standard deviation of the peak areas of acetone, methanol, ethanol and 1-propanol is NMT $4.0\%$ each.  

Water NMT $8.0\%$ $\left(0.1\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Residue on ignition NMT $0.5\%$ (0.1 g). Sterility It meets the requirements when used in sterile preparations.  

Bacterial endotoxins It is less than 1.1 EU per mg (potency) of epirubicin when used in the manufacturing of sterile preparations.  

Histamine It meets the requirements when used in manufacturing of sterile preparations. Weigh an appropriate amount of Epirubicin Hydrochloride to prepare an aqueous solution containing $2.0~\mathrm{mg}$ (potency) per mL and use the solution as the test solution. The amount of the test solution is $0.5\;\mathrm{mL}$ .  

Assay Weigh accurately about $50~\mathrm{mg}$ each of Epirubicin Hydrochloride and epirubicin hydrochloride RS, dissolve in the mobile phase to make exactly $50~\mathrm{mL}$ each, and use these solutions as the test solution and the standard solution, respectively. Perform the test with $10\,\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratios, $Q_{\mathrm{T}}$ and $Q_{\mathrm{S}}$ , of the peak area of epirubicin hydrochloride to that of the internal standard.  

Potency $\mathrm{(\upmug)}$ of epirubicin hydrochloride $(\mathbf{C}_{27}\mathbf{H}_{29}\mathbf{NO}_{11}{\cdot}\mathbf{H}\mathbf{C}\mathrm{l})$ $=$ Potency $\left(\upmu\mathrm{g}\right)$ of epirubicin hydrochloride RS $\mathrm{RS}{\times}\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —A solution of sodium 2- naphthalenesulfonate in a mixture of water, acetonitrile, methanol and phosphoric acid $(540:290:170:1)$ (1 in 2000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with trimethylsilyl silica gel for liquid chromatography ( $(6~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2{\mathrm{~g~}}$ of sodium lauryl sulfate in a mixture of water, acetonitrile, methanol and phosphoric acid $(540:290:170:1)$ to make $1000\;\mathrm{mL}$ .  

Flow rate: Adjust so that the retention time of epirubicin hydrochloride is about 9.5 minutes.  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above operating conditions; the internal standard and epirubicin are eluted in this order with the resolution being NLT 20.  

System repeatability: Repeat the test 5 times with $10\,\upmu\mathrm{L}$ each of the standard solutions according to the above operating conditions; the relative standard deviation of the ratios of the peak area of epirubicin to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers (0 to $5\ ^{\circ}\mathrm{C})$ .  

# Epirubicin Hydrochloride Injection 에피루비신염산염주사액  

Epirubicin Hydrochloride Injection contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of epirubicin hydrochloride $(\mathbf{C}_{27}\mathbf{H}_{29}\mathbf{NO}_{11}{\cdot}\mathbf{H}\mathbf{C}1:579.98)$ .  

Method of preparation Prepare as directed under Injections, with Epirubicin Hydrochloride.  

Identification The retention time ratios of the major peaks from the test solution and standard solution obtained under the Assay to the peaks of the internal standard are the same.  

pH Between 2.5 and 3.5. Sterility Meets the requirements. Bacterial endotoxins Less than 1.1 EU per mg (potency) of epirubicin hydrochloride. Weigh an appropriate amount of Epirubicin Hydrochloride Injection, dissolve in water for endotoxin assay to obtain a solution having known concentration of $0.125~\mathrm{mg}$ (potency) per mL, and use this solution as the test solution.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Weigh accurately about $10~\mathrm{mg}$ of Epirubicin Hydrochloride Injection according to the labeled potency, dissolve in $4.0~\mathrm{mL}$ of internal standard solution, add the mobile phase to make $10\;\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{{mg}}$ (potency) of epirubicin hydrochloride RS, dissolve in exactly $4.0~\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $10~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography, and calculate the ratios, QT and QS, of the peak area of epirubicin hydrochloride to that of the internal standard.  

Internal standard solution —Weigh $1{\mathrm{~g~}}$ of sodium 2- naphthalenesulfonate and dissolve in a mixture of water and acetonitrile $(69:31)$ to make $500\;\mathrm{mL}$ .  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ($10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of water and acetonitrile $(69:31)$ , adjusted the $\mathrm{pH}$ to 2.0 with phosphoric acid.  

Flow rate: Adjust the flow rate so that the retention time of epirubicin hydrochloride is about 10 minutes. System suitability  

System performance: Proceed with $5\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the internal standard and epirubicin hydrochloride are eluted in this order with the resolution being NLT 8.0.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratio of epirubicin to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in hermetic containers.  

# Epirubicin Hydrochloride for Injection 주사용에피루비신염산염  

Epirubicin Hydrochloride for Injection is an injection to be dissolved before use and contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of epirubicin hydrochloride $(\mathbf{C}_{27}\mathbf{H}_{29}\mathbf{NO}_{11}{\cdot}\mathbf{H}\mathbf{C}1:579.98)$ .  

Method of preparation Prepare as directed under Injections, with Epirubicin Hydrochloride.  

Description Epirubicin Hydrochloride for Injection occurs as a red powder or a mass.  

Identification The retention time ratios of the major peaks from the test solution and the standard solution obtained under the Assay to the peak of the internal standard are the same.  

$\mathbf{pH}$ Dissolve Epirubicin Hydrochloride for Injection in water to make $2~\mathrm{mg}$ (potency) per mL; the pH of the solution is between 4.5 and 6.0.  

Sterility Meets the requirements. Bacterial endotoxins Less than 1.1 EU per mg (potency) of epirubicin hydrochloride for injection. Weigh an appropriate amount of Epirubicin Hydrochloride for Injection to obtain a solution having known concentration of $0.125~\mathrm{mg}$ (potency) per mL using water for endotoxin assay, and use this solution as the test solution.  

Histamine Meets the requirements. Weigh an appropriate amount of Epirubicin Hydrochloride for Injection to obtain an aqueous solution having known concentration of $2.0~\mathrm{mg}$ per mL, and use this solution as the test solution. The amount of test solution is $0.5\;\mathrm{mL}$ .  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Uniformity of dosage units Meets the requirements. Water NMT $4.0\%$ ($\mathrm{~\ensuremath~{~0.2~\,g~}~}$ , volumetric titration, direct titration).  

Assay Weigh accurately about $10~\mathrm{mg}$ (potency) of Epirubicin Hydrochloride for Injection according to the labeled potency, dissolve in the internal standard solution to make exactly $10~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ (potency) of epirubicin hydrochloride RS, dissolve in the internal standard solution to make exactly $10\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography, and determine the ratios, QT and QS, of the peak area of epirubicin hydrochloride to that of the internal standard in each solution.  

Potency $\mathrm{(\upmug)}$ of epirubicin hydrochloride $(\mathrm{C}_{27}\mathrm{H}_{29}\mathrm{NO}_{11}{\cdot}\mathrm{HCl})$  

Internal standard solution —Weigh $1\;\mathrm{g}$ of sodium 2- naphthalenesulfonate and dissolved in a mixture of water and acetonitrile $(69:31)$ to make $500\;\mathrm{mL}$ .  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (10 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of water and acetonitrile $(69:31)$ , adjusted the pH to 2.0 with phosphoric acid.  

Flow rate: Adjust the flow rate so that the retention time of epirubicin hydrochloride is about 10 minutes.  

System suitability  

System performance: Proceed with $5\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the internal standard and epirubicin hydrochloride are eluted in this order with the resolution being NLT 8.0.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratio of epirubicin to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in hermetic containers.  

![](images/9f0bcdbf26c1a5f27c8bc02c9a26e6aa23f84caa82e18f190ee9a96ae89f7c46.jpg)  

Vitamin $\ensuremath{\mathrm{D}}_{2}$   
Calciferol $C_{28}\mathrm{H}_{44}\mathrm{O}:396.65$ $(5Z,7E,22E)$ -(3 S)-9,10-Seco-5,7,10(19),22-   
ergostatetraen-3-ol [ 50-14-6 ]  
Ergocalciferol contains NLT $97.0\%$ and NMT $103.0\%$ of ergocalciferol $(\mathbf{C}_{28}\mathbf{H}_{44}\,\mathrm{O})$ .  

Description Ergocalciferol occurs as white crystals. It is odorless or has a slightly characteristic odor. It is freely soluble in ethanol(95), chloroform or ether, sparingly soluble in isooctane, and practically insoluble in water.  

It is affected by air or light.  

Melting point —Between 115 and $118\ ^{\circ}\mathrm{C}$ [Put Ergocalciferol into a capillary tube, and dry in a desiccator (in vacuum, NMT $2.67\,\mathrm{\kPa})$ for 3 hours, immediately seal the capillary tube and put the tube into a bath fluid, previously heated at a temperature $10~^{\circ}\mathrm{C}$ lower than the expected melting point, and measure the melting point with heating at a rate of $3^{\circ}\mathbf{C}$ per minute.]  

Identification (1) Dissolve $0.5~\mathrm{mg}$ of Ergocalciferol in 5 mL of chloroform, add $0.3\,\mathrm{\mL}$ of acetic anhydride and $0.1\ \mathrm{mL}$ of sulfuric acid, and shake to mix; the resulting solution exhibits a red color, and rapidly changes through violet and blue to green.  

(2) Determine the infrared spectra of Ergocalciferol and ergocalciferol RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+102^{\circ}$ and $+107^{\circ}$ (0.3 g, ethanol(95), $20~\mathrm{mL}$ ,$100\;\mathrm{mm})$ ). Dissolve Ergocalciferol within 30 minutes after the container has been opened, and determine the rotation within 30 minutes after the solution has been prepared.  

Absorbance $E_{1c m}^{1\%}$ ($265~\mathrm{nm})$ : Between 445 and 485 (10 mg, ethanol(95), $1000\;\mathrm{mL}$ ).  

Purity (1) Ergosterol —Dissolve $10~\mathrm{mg}$ of Ergocalciferol in $20~\mathrm{mL}$ of diluted ethanol (9 in 10), add a solution of $20~\mathrm{mg}$ of digitonin dissolved in $2.0~\mathrm{mL}$ of ethanol (9 in 10), and allow to stand for 18 hours; no precipitate is formed.  

(2) Reducing substances —To $10~\mathrm{mL}$ of a solution of Ergocalciferol in ethanol(99.5) (1 in 100), add $0.5~\mathrm{mL}$ of a solution of blue tetrazolium in methanol (1 in 200) and $0.5\,\mathrm{\mL}$ of a solution of tetramethylammonium hydroxide in ethanol(99.5) (1 in 10), and allow to stand for 5 minutes. After exactly 5 minutes, add $1~\mathrm{mL}$ of acetic acid(100), and use this solution as the test solution. Proceed with $10~\mathrm{{mg}}$ of ethanol(95.5) in the same manner, and use the resulting solution as the blank test solution. Dissolve an appropriate amount of hydroquinone in anhydrous alcohol to make a solution containing $0.2~\upmu\mathrm{g}$ per mL, proceed with this solution in the same manner, and use the resulting solution as the standard solution. Determine the absorption spectra of the test solution and the standard solution, using the blank test solution as the control solution, as directed under the Ultraviolet-visible Spectroscopy at the absorbance maximum wavelength around $525~\mathrm{nm}$ ; the absorbance of the test solution is not greater than that of the standard solution.  

Assay Weigh accurately about $30~\mathrm{mg}$ each of Ergocalciferol and ergocalciferol RS and dissolve them in isoctane, respectively, to make exactly $50~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ each of these solutions, add exactly $3\,\mathrm{\ml}$ of the internal standard solution to each, add the mobile phase to make $50\;\mathrm{mL}$ , and use these solutions as the test solution and the standard solution. Perform the test with $10~\upmu\mathrm{L}$ to $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratios $Q_{\mathrm{T}}$ and $Q_{S}$ ,of peak area of ergocalciferol to that of the internal standard from each solution. Perform the procedure quickly avoiding contact with air or other oxidizing agents as much as possible and using light-resistant containers.  

Internal standard solution —A solution of dimethyl phthalate in isooctane (1 in 100).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and $10\ \mathrm{cm}$ to $30~\mathrm{cm}$ in length, packed with silica gel for liquid chromatography $5~{\upmu\mathrm{m}}$ to $10~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $20~^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of hexane and $n$ -amyl alcohol $(997:3)$ .  

Flow rate: Adjust the flow rate so that the retention time of ergocalciferol is about 25 minutes.  

# System suitability  

System performance: Dissolve $15~\mathrm{mg}$ of ergocalciferol RS in $25~\mathrm{mL}$ of isooctane, transfer the resulting solution into a flask, heat in an oil bath under a reflux condenser for 2 hours, and then cool immediately to room temperature. Transfer the cooled solution to a quartz test tube and irradiate with a short-wavelength lamp (main wavelength: $254~\mathrm{nm}$ ) and a long-wavelength lamp (main wavelength: $365~\mathrm{nm}$ ) for 3 hours. To $10~\mathrm{mL}$ of this solution, add the mobile phase to make $50~\mathrm{mL}$ . Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above operating conditions; the relative retention times of previtamin $\ensuremath{\mathrm{D}}_{2}$ ,transvitamin $\ensuremath{\mathrm{D}}_{2}$ and tachysterol 2 to that of ergocalciferol are about 0.5, about 0.6 and about 1.1, respectively, and the resolution between previtamin $\ensuremath{\mathrm{D}}_{2}$ and transvitamin $\ensuremath{\mathrm{D}}_{2}$ is NLT 0.7, and the resolution between ergocalciferol and tachysterol 2 is NLT 1.0.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the standard solution according to the above operating conditions; the relative standard deviation of the ratios of the peak area of ergocalciferol to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in light -resistant, hermetic containers under nitrogen atmosphere in a cold place.  

# Ergotamine Tartrate 에르고타민타르타르산염  

![](images/d458d44276be80a6762672f2b4ab534768d5b022797474287d53a86e07d3445a.jpg)  
$(\mathrm{C_{33}H_{35}N_{5}O_{5}})_{2}\,\mathrm{C_{4}H_{6}O_{6}}:1313.41$ $(5^{\prime}S)$ -5'-Benzyl-12'-hydroxy-2'-methylergotaman-3',6',18- trione hemitartrate [ 379-79-3 ]  

Ergotamine Tartrate contains NLT $98.0\%$ and NMT $101.0\%$ of ergotamine tartrate $\mathrm{\small{[(C_{33}H_{35}N_{5}O_{5})_{2}{\cdot}C_{4}H_{6}O_{6}]}}$ ,calculated on the dried basis.  

Description Ergotamine Tartrate occurs as a colorless crystal, or a white to pale yellowish white or grayish white crystalline powder.  

It is slightly soluble in water or ethanol(95). Melting point —About $180\,^{\circ}\mathrm{C}$ (with decomposition). Identification (1) Dissolve $1~\mathrm{mg}$ of Ergotamine Tartrate in a mixture of acetic acid(100) and ethyl acetate $(1:1)$ ,pipet $0.5~\mathrm{mL}$ of this solution, shake to mix in cold water, add $0.5\ \mathrm{mL}$ of sulfuric acid, and allow to stand; the resulting solution exhibits a violet color. Add $0.1\,\mathrm{~mL~}$ of diluted iron(III) chloride TS (1 in 12) to the solution; the color of the solution turns blue to bluish purple.  

(2) Dissolve $1~\mathrm{mg}$ of Ergotamine Tartrate in $5~\mathrm{mL}$ of L-tartaric acid (1 in 100). To $1~\mathrm{mL}$ of this solution, add 2 mL of 4-dimethylaminobenzaldehydeiron(III) chloride TS, and shake to mix; the resulting solution exhibits a blue color.  

Optical rotation Ergotamine base $[\alpha]_{\mathrm{D}}^{20}$ : Between - $155^{\circ}$ and $-165^{\circ}$ . Dissolve $0.35\mathrm{~g~}$ of Ergotamine Tartrate in $25~\mathrm{mL}$ of L-tartaric acid (1 in 100), add $0.5~\mathrm{g}$ of sodium bicarbonate, shake gently and sufficiently to mix, and extract with four $10~\mathrm{mL}$ portions of ethanol-free chloroform. Filter each chloroform extract through a small filter paper, moistened with ethanol-free chloroform, into a 50- mL volumetric flask, allow to stand on a steam bath at $20~^{\circ}\mathrm{C}$ for 10 minutes, and add $20~^{\circ}\mathrm{C}$ ethanol-free chloroform to make $50~\mathrm{mL}$ . Determine the optical rotation of this solution in a $100\ \mathrm{mm}$ cell. Pipet $25~\mathrm{mL}$ of this solution, and evaporate to dryness in vacuum at below $45\ ^{\circ}\mathrm{C}$ .Dissolve the residue in $25~\mathrm{mL}$ of acetic acid(100), and titrate with $0.05\,\mathrm{\mol/L}$ perchloric acid VS (indicator: 1 drop of methylosaniline chloride TS). Perform a blank test in the same manner and make any necessary correction. Calculate the specific optical rotation of ergotamine base from the consumed volume of $0.05\;\mathrm{mol/L}$ perchloric acid and the optical rotation.  

Each mL of $0.05\;\mathrm{mol/L}$ perchloric acid VS $=29.084~\mathrm{mg}$ of $\mathrm{C}_{33}\mathrm{H}_{35}\mathrm{N}_{5}\mathrm{O}_{5}$  

Purity Related substances —Perform this test using light-resistant containers. Weight $40~\mathrm{mg}$ of Ergotamine Tartrate, add exactly $10\,\mathrm{\mL}$ of a solution of L-tartaric acid in diluted methanol (1 in 2) (1 in 1000), dissolve by shaking well to mist, and use the resulting solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add a solution of L-tartaric acid in diluted ethanol (1 in 2) (1 in 1000) to make exactly $50\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of chloroform and methanol $(9:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Spray evenly 4-dimethylaminobenzaldehyde TS on the plate; the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $5.0\%$ $\mathrm{[0.1~g.}$ , in vacuum, $60~^{\circ}\mathrm{C}$ , 4 hours).  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Ergotamine Tartrate, dissolve in $15~\mathrm{mL}$ of a mixture of acetic acid(100) and acetic anhydride $(50:3)$ , and titrate with $0.05\;\mathrm{mol/L}$ perchloric acid VS (indicator: 1 drop of methylrosaniline chloride TS). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.05\;\mathrm{mol/L}$ perchloric acid VS $=32.836\;\mathrm{mg}$ of $(\mathrm{C_{33}H_{35}N_{5}O_{5}})_{2}{\cdot}\mathrm{C_{4}H_{6}O_{6}}$ Packaging and storage Preserve in light-resistant, tight containers. Fill the container almost full or replace the air in the empty part with nitrogen and store at below $5\mathrm{{}^{\circ}C}$ .  

# Ergotamine Tartrate Tablets 에르고타민타르타르산염정  

Ergotamine Tartrate Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of ergotamine tartrate $\mathrm{\small{[(C_{33}H_{35}N_{5}O_{5})_{2}{\cdot}C_{4}H_{6}O_{6}}}$ : 1313.41].  

Method of preparation Prepare as directed under Tablets, with Ergotamine Tartrate.  

Identification Weigh an amount of Ergotamine Tartrate Tablets, previously powdered, equivalent to $5~\mathrm{mg}$ of ergotamine tartrate according to the labeled amount, add 10 mL of hexane, shake for a few minutes to mix, and allow to stand. Then, discard the hexane extracts, add $10\;\mathrm{mL}$ of ammonia water(28)-saturated chloroform to the residue, shake for a few minutes to mix, filter, and evaporate the filtrate to dryness on a steam bath. Dissolve the residue with $8\ \mathrm{~mL}$ of a mixture of acetic acid(100) and ethyl acetate $(1:1)$ , take $1~\mathrm{mL}$ of this solution, and slowly add $1\ \mathrm{mL}$ of sulfuric acid dropwise while shaking to mix in iced water; the resulting solution exhibits a violet color. To this solution, add $0.1\mod$ of diluted iron(III) chloride TS (1 in 2); the solution turns blue to bluish purple.  

Disintegration It meets the requirements when it is a sublingual tablet. However, the time of the test is 5 minutes.  

Dissolution This test is applicable when it is not a sublingual tablet. Perform the test with 1 tablet of Ergotamine Tartrate Tablets at 75 revolutions per minute according to Method 2 under the Dissolution, using 1000 mL of L-tartaric acid solution (1 in 100) as the dissolution medium. Take the dissolved solution 30 minutes after starting the dissolution test, filter, and use the filtrate as the test solution. Separately, weigh accurately an appropriate amount of ergotamine tartrate RS, add the dissolution medium to make the constant concentration, and use this solution as the standard solution. Perform the test with the test solution and the standard solution as directed under the Fluorescence Spectroscopy using the dissolution medium as a control solution, and determine the absorbances at an excitation wavelength of $327\ \mathrm{nm}$ and a fluorescence wavelength of $427\;\mathrm{nm}$ .  

It meets the requirements when the dissolution rate of Ergotamine Tartrate Tablets for 30 minutes is NLT $75\%$ .  

Uniformity of dosage units It meets the requirements when the procedure for content uniformity is performed as directed under the Assay.  

Assay Weigh accurately the mass of NLT 20 Ergotamine Tartrate Tablets, and powder. Weigh an amount equivalent to about $10~\mathrm{mg}$ of ergotamine tartrate $[(\mathbf{C}_{33}\mathrm{H}_{35}\mathrm{N}_{5}\mathrm{O}_{5})_{2}$ ·$\mathrm{C_{4}H_{6}O_{6}\mathrm{~J~}}$ , add $50.0~\mathrm{mL}$ of the internal standard solution and $300~\mathrm{mL}$ of a mixture of acetonitrile and water $(55:$ 45), sonicate for 10 minutes, and shake to mix. Then, add a mixture of acetonitrile and water $(55:45)$ to make exactly $500~\mathrm{mL}$ , mix, and filter. Discard the first filtrate, and use the subsequent filtrate as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ ergotamine tartrate RS, previously dried at $60\ ^{\circ}\mathrm{C}$ in vacuum for 4 hours, and dissolve in a mixture of acetonitrile and water (55 in 45) to make exactly $50~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add $5.0\;\mathrm{mL}$ of the internal standard solution, add a mixture of acetonitrile and water $(55:45)$ to make exactly $50~\mathrm{mL}$ ,and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of ergotamine to the peak area of the internal standard, respectively.  

# $=$ Amount (mg) of ergotamine tartrate $\mathrm{RS}\!\times\!\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$  

Internal standard solution —Dissolve about $40~\mathrm{mg}$ of ergometrine maleate in a mixture of acetonitrile and water to make $250\;\mathrm{mL}$ .  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $3.9\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile and 0.01 mol/L potassium dihydrogen phosphate solution $\textbf{(55:}$ 45).  

Flow rate: 1 mL/min System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor of ergotamine is NMT 2.0 with the resolution between the standard solution and the internal standard being NLT 3.0.  

System repeatability: Repeat the test 6 times with $20\,\textrm{\textmu L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area ratio is NMT $2.0\%$ .  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

Identification (1) Determine the infrared spectra of Ertapenem Sodium and ertapenem sodium RS as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) Dissolve $0.1\ \mathrm{g}$ (potency) of Ertapenem Sodium in $10~\mathrm{mL}$ of water; the resulting solution responds to the Qualitative Analysis (1) for sodium salt.  

Optical rotation $[\alpha]_{405n m}^{25}$ : Between $+216^{\circ}$ and $+238^{\circ}$ ($\mathrm{~\,~}^{1.0~g}$ , calculated on the anhydrous and solvent-free basis, water, $100\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity (1) Related substance s—Just before starting this test, weigh accurately about $20~\mathrm{~mg~}$ (potency) of Ertapenem Sodium, dissolve in water to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Perform the test with $10~\upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratios of the peak area of each related substance to total area of the peaks excluding solvent peak from the test solution (ringopened compound: NMT $1.4\%$ ,xazinone: NMT $0.2\%$ ,ProMABA: NMT $0.6\%$ , total dimer: NMT $1.3\%$ , other individual related substances: NMT $0.1\%$ , total related substances: NMT $3.1\%$ ).  

Contents $(\%)$ of individual related substances  

# Ertapenem Sodium 에르타페넴나트륨  

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑜𝑜 𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 Ertapenem Sodium $\mathrm{C}_{22}\mathrm{H}_{24}\mathrm{N}_{3}\mathrm{NaO}_{7}\mathrm{S}$ : 497.50 Sodium 3-({[(2 S,4 S)-4-({(4 R,5 S,6 S)-2-carboxy-6-[(1 R)- 1-hydroxyethyl]-4-methyl-7-oxo-1- azabicyclo[3.2.0]hept-2-en-3-yl}sulfanyl)pyrrolidin-2- yl]carbonyl}amino)benzoate, [ 153773-82-1 ]  

![](images/ebd3430f84741768249347586b3b29743f18a04aa57820af346bd9bf8fc24a8f.jpg)  

Ertapenem Sodium contains NLT $917~\upmu\mathrm{g}$ and NMT $970~\upmu\mathrm{g}$ (potency) of ertapenem $\mathrm{\left(C_{22}H_{25}N_{3}O_{7}S\,:\,475.52\right)}$ per mg, calculated on the anhydrous and solvent-free basis.  

Description Ertapenem Sodium occurs as a white to grayish white powder.  

It is freely soluble in water, and practically insoluble in ethanol.   
It is hygroscopic.  

𝑆𝑆𝑆𝑆𝑆𝑆 𝑜𝑜𝑜𝑜 𝑎𝑎𝑎𝑎𝑎𝑎 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑜𝑜ℎ𝑒𝑒𝑒𝑒 𝑡𝑡ℎ𝑎𝑎𝑎𝑎 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 ൤൨ 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖𝑖𝑖 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠  

Total content $(\%)$ of related substances $=$ Sum of contents $(\%)$ of all related substances  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $230\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with phenylated silica gel for liquid chromatography ( $5~{\upmu\mathrm{m}}$ in particle diameter).  

# Mobile phase  

Mobile phase A: 15 mmol/L sodium phosphate TS $(\mathrm{pH}\,8.0)$ .  

Mobile phase B: Acetonitrile Mobile phase gradient elution conditions   

![](images/a977c82db713a6770b77a9a57bfafbee95e89ba579705f119aa8f45f95ed501f.jpg)  
Flow rate: 1.0 mL/min  

The relative retention time of each related substance peak to the ertapenem peak is as follows.   

![](images/bb44e04b07b0a871fc07da6809afb15f95fd78cfc5931e37bc90cb2c31b9e478.jpg)  

(2) Residual solvent —Weigh accurately about 50 mg (potency) of Ertapenem Sodium, dissolve in water to make exactly $10~\mathrm{mL}$ , and use this solution as the test solution. Pipet $1~\mathrm{mL}$ each of methyl acetate, methanol, 2- propanol and 1-propanol, add water to make exactly 100 mL, and use this solution as the standard stock solution. Dilute this standard stock solution with water to prepare $0.01\ \mathrm{vol}\%$ and $0.0001\,\;\mathrm{vol}\%$ standard solutions, and use water as a blank test solution. Pipet accurately $1~\mathrm{mL}$ each of the test solution, the standard solution and the blank test solution, transfer them to headspace vials, close with appropriate elastomeric closures, perform the test as directed under the Gas Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of the residual solvent from the test solution and the standard solution (methyl acetate: NMT $1.3\%$ , methanol: NMT $0.3\%$ , 2-propanol: NMT $0.5\%$ , 1-propanol: NMT $0.1\%$ ).  

$$
=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}
$$  

×𝑑𝑑× 𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉 (%) 𝑜𝑜𝑜𝑜 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑖𝑖𝑖𝑖 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑔𝑔) 𝑜𝑜𝑜𝑜 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 $\times$ Dilution factor of the test solution  

d: Density $(\mathrm{g/mL})$ of residual solvent (methyl acetate: 0.93, methanol and 2-propanol: 0.79, 1-propanol: 0.80)  

Operating conditions  

Detector: A hydrogen flame ionization detector Column: A stainless steel column about $0.32\;\mathrm{mm}$ in internal diameter and about $30\textrm{m}$ in length, packed with porous dimethylpolysiloxane for gas chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: Maintain at $35\ \ ^{\circ}\mathrm{C}$ for 8 minutes, and then raise to $125\ ^{\circ}\mathrm{C}$ at a rate of $50~^{\circ}\mathrm{C}$ per minute.  

Temperature of injection port: About $180\,^{\circ}\!C$ .  
Temperature of detector: About $250\;^{\circ}\mathrm{C}$ .  
Carrier gas: Helium   
Conditions of headspace   
Temperature of injection port: $85\,^{\circ}\!C$   
Injection time of test solution: 0.1 minute   
Temperature of needle: $125\;^{\circ}\mathrm{C}$   
Temperature of conveying port: $135\;^{\circ}\mathrm{C}$   
Circulation time of gas chromatograph: 20 minutes Constant temperature retention time: 15 minutes Pressurization time: 2.0 minutes  

Sterility It meets the requirements when used in sterile preparations. However, it is excluded in cases where there is a terminal sterilization process in the manufacturing process of sterile preparations.  

Water Between $15.5\%$ and $19.0\%$ $\left(0.1\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Assay Weigh accurately bout $30~\mathrm{~mg~}$ (potency) of Ertapenem Sodium and ertapenem sodium RS at places with the relative humidity of $50\%$ to $60\%$ and NMT $10\%$ ,respectively, dissolve in $10\,\mathrm{\mmol/L}$ 3-( $N$ -morpholine) propanesulfonic acid buffer solution, $\mathrm{pH}\ 7.0$ , and use these solutions as the test solution and the standard solution, respectively. Store the test solution and the standard solution at $4\,^{\circ}\mathrm{C}$ and use within 18 hours. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas $A_{\mathrm{T}}$ and $A_{S}$ , of ertapenem from each solution. Potency $(\upmu\mathrm{g})$ of ertapenem $(\mathbf{C}_{22}\mathbf{H}_{25}\mathbf{N}_{3}\mathbf{O}_{7}\mathbf{S})$ )$=$ Potency $(\upmu\mathrm{g})$ of ertapenem sodium $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $307\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $10~\mathrm{cm}$ in length, packed with octylsilanized silica gel for liquid chromatography $\ensuremath{\left\{5\;\upmu\mathrm{m}\right.}}$ in particle diameter).  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.  

Mobile phase A: $0.1\%$ phosphoric acid Mobile phase B: Acetonitrile. Mobile phase gradient elution conditions Flow rate: Adjust the flow rate so that the retention time of ertapenem is about 2.5 to 5.0 minutes.  

![](images/60e4f2ea6e726d5693b6cd13f2515a93326d9d5d8cd636bd09ee31f738c09c1d.jpg)  

Packaging and storage Preserve in tight containers.  

# Ertapenem Sodium for Injection 주사용에르타페넴나트륨  

Ertapenem Sodium for Injection is an injection, which is dissolved before use, and contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of ertapenem $(\mathbf{C}_{22}\mathbf{H}_{25}\mathbf{N}_{3}\mathbf{O}_{7}\mathbf{S}$ : 475.52).  

Preparation Prepare as directed under Injections, with Ertapenem Sodium.  

Description Ertapenem Sodium for Injection occurs as a white to grayish white powder.  

Identification The retention times of the major peaks obtained from the test solution and standard solution in the Assay are the same.  

$\mathbf{pH}$ Dissolve $1.0~\mathrm{g}$ (potency) of Ertapenem Sodium for Injection in $0.9\%$ sodium chloride injection to make 1 mL; the $\mathrm{pH}$ of this solution is 7.0 to 8.0.  

Purity Related substances —After performing the test as directed under the Assay, calculate as follows from the peak areas for each related substance (ring-opened NMT $10.0\%$ ; oxazinone NMT $1.2\%$ ; total dimers NMT $6.3\%$ ;NMT $0.2\%$ each for other related substances; total related substances NMT $17.5\%$ ).  

Content $(\%)$ of each related substance   
$=(A_{\mathrm{D}}/A_{\mathrm{S}})\times$ amount [mg (potency)] of ertapenem sodium   
$\mathrm{RS}\mid$ {labeled amount [mg (potency) / vial] of ertapenem $\mathrm{sodiuml}\times R R F\}\times100\$ × 100  

$\ensuremath{A_{\mathrm{D}}}$ : Peak area of related substance in test solution $A_{S}$ : Peak area of ertapenem in standard solution RRF : Relative response factor of individual related substance peaks  

![](images/621dd6c3dc55d2e657c74a77d7168aa5baca833f53fb4fba90491f5050b3f29e.jpg)  

Total dimers $(\%)=\mathrm{Sum}$ of amounts $(\%)$ of all dimers (Dimers I, II, III, Ⅴ, Ⅵ, Dimer $\mathrm{IV}+$ Dimer$\cdot\mathrm{H}_{2}\mathrm{O}_{\cdot}$ ). Sterility Meets the requirements. Bacterial endotoxins Ertapenem Sodium for Injection is NMT 0.35 EU per mg (potency) of ertapenem.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

# Uniformity of dosage units Meets the requirements.  

Water In a location of relative humidity NMT $25\%$ ,without removing the elastomeric closure and metal ring, weigh accurately the entire mass of 1 vial of Ertapenem Sodium for Injection, and inject $20.0~\mathrm{mL}$ of a mixture of methanol and dimethylformamide $(1:1)$ into the vial through a syringe. Shake to mix for 4 to 8 minutes until the sample is completely dissolved, and use a syringe to place the dissolved test solution in $2\,\,1.5\,\,\mathrm{mL}$ test tubes, immediately insert the stoppers, and centrifuge for 2 minutes at 14000 revolutions per minute. From the two test tubes, weigh the clean supernatant and place in vials for gas chromatography. Use these solutions as the test solutions. Evacuate the remaining solution from the vial of Ertapenem Sodium for Injection, wash with methanol and dry, measure the sum of the masses of the vial, elastomeric closure and metal ring, and subtract this sum from the total mass. Use the difference as the amount $(\mathrm{mg})$ of sample. Separately, place $100~\upmu\mathrm{L}$ of water each in $100{\-}\mathrm{mL}$ and $200{\mathrm{-mL}}$ volumetric flasks, previously dried for 2 hours at $100~^{\circ}\mathrm{C}$ and cooled to room temperature before use, and add a mixture of methanol and dimethylformamide $(1:1)$ to the gauge line. Immediately plug with an elastomeric closure and seal, and mix well. Use these solutions as the standard solution (1) $(1~\mathrm{mg/mL})$ and the standard solution (2) $(0.5\mathrm{~mg/mL})$ . Place a mixture of methanol and dimethylformamide $(1:1)$ in a volumetric flask previously dried for 2 hours at $100~^{\circ}\mathrm{C}$ and cooled to room temperature before use, immediately plug with an elastomeric closure and seal, and use this solution as the blank test solution. Perform the test with $1~\upmu\mathrm{L}$ each of the test solution and the standard solution (1) (1 $\mathrm{{mg/mL})}$ ) as directed under the Gas Chromatography according to the following conditions, and measure the water peak areas, $A_{\mathrm{T}}$ and $A_{S}$ of the test solution and the standard solution (NMT $2.3\%$ ). Use a mixture of methanol and dimethylformamide $(1:1)$ prepared by placing $500~\mathrm{mL}$ of methanol and $500~\mathrm{mL}$ of dimethylformamide in a $1000{\mathrm{-mL}}$ container, mixing well, substituting with nitrogen and sealing.  

Water $(\%)$ in Ertapenem Sodium for Injection $=\left(A_{\mathrm{T}}/\,A_{\mathrm{S}}\right)\times\left(0.1\,/\right.$ amount of sample $(\mathrm{mg}))\times1000$ $\times\,(20\,/\,100)\times100$  

0.1: Amount (mL) of water in the standard solution  

1000: Specific gravity of water $(\mathrm{{mg/mL})}$   
20: Dilution factor of the test solution   
100: Dilution factor of the standard solution  

Operating conditions Detector: Thermal conductivity detector Column: A gas pipe about $0.53\mathrm{~mm}$ in internal diameter and about $25\,\textrm{m}$ in length, packed with porous polystyrene-divinylbenzene copolymer for gas chromatography ( $20\;\upmu\mathrm{m}$ in particle diameter). Column temperature: Hold at $90~^{\circ}\mathrm{C}$ for 5 minutes, heat at a rate of $25~^{\circ}\mathrm{C}$ per minute to $250~^{\circ}\mathrm{C}$ , and hold at $250\ \,^{\circ}\mathrm{C}$ for 5 minutes. Re-equilibrate for 1 minute at $90\ ^{\circ}\mathrm{C}$ before the next injection.  

Injection port temperature: $200~^{\circ}\mathrm{C}$ Detector temperature: $250\;^{\circ}\mathrm{C}$ Carrier gas: Helium  

Flow rate: Adjust the flow rate so that the retention time of water is between 1 and 2 minutes.  

Assay Weigh accurately about $20~\mathrm{~mg~}$ (potency) of Ertapenem Sodium for Injection and ertapenem sodium RS, dissolve in the diluent to contain exactly $0.2~\mathrm{mg}$ (potency) per mL. Use these solutions as the test solution and the standard solution. Store the test solution and the standard solution at $5{\pm}3\ \,^{\circ}\mathrm{C},$ , and use within 24 hours. Pipet $10\,\upmu\mathrm{L}$ each of the test solution and the standard solution, perform the test as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of ertapenem for each solution.  

Amount [mg (potency)] of ertapenem $(\mathbf{C}_{22}\mathbf{H}_{25}\mathbf{N}_{3}\mathbf{O}_{7}\mathbf{S})$ $=$ Amount [mg (potency)] of ertapenem sodium RS $\times\left(A_{\mathrm{T}}\,/\,A_{\mathrm{S}}\right)$  

Diluent— Mixture of $15~\mathrm{mmol/L}$ 4-morpholine propane sulfonate $(\mathrm{pH}\,7.5)$ and acetonitrile $(9:1)$ .  

4-morpholine propane sulfonate $(p H\,7.5)$ —Dissolve $3.5~\mathrm{g}$ of 4-morpholine propane sulfate in $1000~\mathrm{mL}$ of water, and adjust $\mathrm{pH}$ to 7.5.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $230\;\mathrm{nm}$ ).  

Column: A stainless steel column $4.6\;\mathrm{mm}$ in internal diameter and $2.5~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography $(5\,\textrm{\textmu m}$ in  

particle diameter).  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.  

Mobile phase A: $0.1\%$ phosphoric acid $\mathrm{(pH\,8.0)}$ Mobile phase B: Mixture of acetonitrile and $0.1\%$ phosphoric acid $(\mathrm{pH}\,8.0)$ )$(1:3)$ .  

Mobile phase gradient elution conditions Flow rate: 1.0 mL/min  

![](images/21351dca2d7c3462d6aebb685fc8cf4390b685d045e6a85250f045e5f9381fd7.jpg)  

Relative retention time of each related substance   
Packaging and storage Preserve in hermetic containers.   

![](images/ed699fa89ff69b88cabf4a3a07f4414edadefc050c5a7b947683276c7e38a92d.jpg)  

# Erythromycin 에리트로마이신  

![](images/2e964c6fe5cd30183110df35eb04adcac7d416c110965e5dc57783d7983ea63a.jpg)  

Erythromycin $\mathrm{C}_{37}\mathrm{H}_{67}\mathrm{NO}_{13}$ : 733.93 (3 R,4 S,5 S,6 R,7 R,9 R,11 R,12 R,13 S,14 R)-6-[(2 S,3 R,4 S,6 R)- 4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy14-ethyl-7,12,13-trihydroxy-4-[(2 R,4 R,5 S,6 S)-5-hydroxy4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13- hexamethyl-oxacyclo-tetradecane-2,10-dione [ 114-07-8 ]Erythromycin is a macrolide substance having antifungal activity produced by the growth of Saccharopolyspora erythraea .  

Erythromycin contains NLT $930~\upmu\mathrm{g}$ and NMT 1020 μg (potency) of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{N}\mathbf{O}_{13})$ ) per mg, calculated on the anhydrous basis.  

Description Erythromycin occurs as a white to pale yellowish white powder.  

It is very soluble in $N,N\!\cdot$ -dimethylformamide, freely soluble in methanol or ethanol(95), and slightly soluble in water.  

Identification (1) Determine the infrared spectra of Erythromycin and erythromycin RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) Dissolve $10~\mathrm{mg}$ each of Erythromycin and erythromycin RS in $1~\mathrm{mL}$ of methanol, and use these solutions as the test solution and the standard solution, respectively. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thinlayer chromatographic plate made of silica gel for thinlayer chromatography. Next, develop the plate with a mixture of methanol and ammonia water(28) $(50:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Spray evenly 4-methoxybenzaldehydesulfuric acid TS on the plate, and heat at $100~^{\circ}\mathrm{C}$ for 15 minutes; the spots obtained from the test solution and the standard solution show a dark purple color and the $R_{\mathrm{f}}$ values are the same.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-71^{\circ}$ and $-78^{\circ}$ (1g, calculated on the anhydrous basis, ethanol(95), $50~\mathrm{mL}$ , 100 mm).  

pH Dissolve $0.1~\mathrm{g}$ of Erythromycin in $150~\mathrm{mL}$ of water;   
the $\mathrm{pH}$ of this solution is between 8.0 and 10.5.  

Purity (1) Thiocyanate —Weigh accurately about $0.1\ \mathrm{g}$ of Erythromycin, transfer into a $50{\-}\mathrm{mL}$ brown volumetric flask, dissolve by adding $20~\mathrm{mL}$ of methanol, add $1~\mathrm{mL}$ of iron(III) chloride TS and methanol to make to $50~\mathrm{mL}$ ,and use this solution as the test solution. Separately, weigh accurately potassium thiocyanate, previously dried at $105\ ^{\circ}\mathrm{C}$ for 1 hour and cooled, transfer into two $50{\-}\mathrm{mL}$ volumetric flasks, and add methanol to make $50\,\mathrm{\mL}$ .Take accurately $5.0\,\mathrm{\mL}$ each of these solutions, add methanol to make $50~\mathrm{mL}$ , then take exactly $5.0~\mathrm{mL}$ each of the resulting solutions, transfer into $50{\-}\mathrm{mL}$ brown volumetric flasks, add exactly $1.0\ \mathrm{mL}$ of iron(III) chloride TS to each solution, add methanol to make $50~\mathrm{mL}$ , and use these solutions as the standard solutions. Separately, transfer $1~\mathrm{mL}$ of the iron(III) chloride TS into a $50{\-}\mathrm{mL}$ brown volumetric flask, dissolve in methanol to make 50 mL, and use this solution as the standard test solution. Use the test solution, the standard solutions and the standard test solution within 30 minutes after the preparation. Perform the test with the test and standard solutions as directed in the potassium bromide disk method under the Ultraviolet-visible Spectroscopy using the blank test solution as the control solution, determine the absorbance at $492\;\mathrm{nm}$ , and calculate the amount of thiocyanate by the following formula; it is NMT $0.3\%$ .  

$$
={\frac{58.08}{97.18}}\times{\frac{A_{\mathrm{T}}}{W_{T}}}\times0.5\times\left[{\frac{W_{1}}{A_{1}}}+{\frac{W_{2}}{A_{2}}}\right]
$$  

$A_{\mathrm{{T}}}$ :Absorbance of the test solution $W_{\mathrm{T}}$ :Amount (mg) of sample taken $A_{1},A_{2}$ : Absorbance of each standard solution $W_{1}$ ,$W_{2}$ : Amount (mg) of potassium thiocyanate taken from each standard solution 58.08: Molecular weight of thiocyanate 97.18: Molecular weight of potassium thiocyanate System suitability :Determine the absorption spectrum of each standard solution, and calculate suitability factor (S) by the following formula; it is between 0.985 and 1.015.  

$$
S={\frac{A_{1}}{W_{1}}}\!+\!{\frac{W_{2}}{A_{2}}}
$$  

$A_{1},A_{2}$ : Absorbance of each standard solution $W_{1}$ ,$W_{2}$ : Amount (mg) of potassium thiocyanate taken from each standard solution  

(2) Heavy metals —Proceed with $1.0\ \mathrm{~g~}$ of Ceftazidime Hydrate according to Method 4 and perform the test. Prepare the control solution with $2.0~\mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(3) Arsenic —Proceed with $1.0\textbf{g}$ of Erythromycin according to Method 5 and perform the test with hydrochloric acid instead of dilute hydrochloric acid (1 in 2) $(\mathrm{NMT}\ 2\ \mathrm{ppm})$ ).  

(4) Related substances —Dissolve $40~\mathrm{mg}$ of Erythromycin in $2\;\mathrm{mL}$ of methanol, add a mixture of phosphate buffer solution, $\mathrm{pH}\nobreakspace7.0\$ and methanol $(15:1)$ to make exactly $10~\mathrm{mL}$ , and use this solution as the test solution. Separately, dissolve $16~\mathrm{mg}$ of erythromycin RS in $2~\mathrm{mL}$ of methanol, add a mixture of phosphate buffer solution, $\mathrm{pH}\,7.0$ and methanol $(15:1)$ to make exactly $10\;\mathrm{mL}$ , and use this solution as the standard stock solution. Dissolve $5~\mathrm{mg}$ each of erythromycin $\mathbf{B}$ and erythromycin C in 2 mL of methanol, add exactly $2~\mathrm{mL}$ of the standard stock solution, add a mixture of phosphate buffer solution, $\mathrm{pH}$ 7.0 and methanol $(15:1)$ to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. Take exactly each $100~\upmu\mathrm{L}$ of the test solution and the standard solution, perform the test as directed under the Liquid Chromatography according to the following conditions, and determine the peak area of each solution by the automatic integration method; the peak areas of erythromycin B and erythromycin C from the test solution are not greater than the peak areas of erythromycin B and erythromycin C in the standard solution. In addition, the peak areas other than erythromycin, erythromycin B and erythromycin C are not greater than the peak area of erythromycin from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $215\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 ${\upmu\mathrm{m}}\textrm{-}10~\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $70\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $3.5\mathrm{~g~}$ of dibasic potassium phosphate in water to make $100\,\mathrm{\mL}$ , adjust $\mathrm{pH}$ to 9.0 with diluted phosphoric acid (1 in 10). To $50~\mathrm{mL}$ of this solution, add $190~\mathrm{mL}$ of $t$ -butyl alcohol, $30~\mathrm{mL}$ of acetonitrile and water to make $1000\;\mathrm{mL}$ .  

Flow rate: Adjust the flow rate so that the retention time of erythromycin is about 20 minutes.  

# System suitability  

System performance: Dissolve $2~\mathrm{~mg}$ of Ndemethylerythromycin in $10~\mathrm{mL}$ of the standard solution. Proceed with $100\,\mathrm{\upmuL}$ of this solution according to the above conditions; N-demethylerythromycin, erythromycin C, erythromycin and erythromycin B are eluted in this order with the resolution between Ndemethylerythromycin and erythromycin C being NLT 0.8, and the resolution between N-demethylerythromycin and erythromycin being NLT 5.5.  

System repeatability: Repeat the test 3 times with $100~\upmu\mathrm{L}$ each of the standard solutions according to the above operating conditions; the relative standard deviation of the peak area of erythromycin is NMT $3.0\%$ .  

Time span of measurement: About 4 times the retention time of erythromycin after the solvent peak. Water NMT $10.0\%$ ($_{0.2\mathrm{~g~}}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.2\%$ ($\mathrm{~\ensuremath~{~1~}~}\mathrm{g})$  

Sterility It meets the requirements when used in the manufacturing of sterile preparations. However, it is exempt from the requirements when there is a terminal sterilization process in the manufacturing process of sterile preparations.  

Pyrogen It meets the requirements when used in the manufacturing of sterile preparations. Proceed with an appropriate amount of Erythromycin to prepare a solution containing $1.0~\mathrm{mg}$ per mL, use $50\ \mathrm{ml}$ of this solution as the test solution. However, inject the test solution to a rabbit by $1.0\;\mathrm{mL}$ per $\mathrm{kg}$ of the rabbit weight.  

Assay Weigh accurately about $50~\mathrm{mg}$ (potency) each of Erythromycin and erythromycin RS, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make exactly $50~\mathrm{mL}$ ,and use these solutions as the test solution and the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas, $\mathrm{Ar}$ and $\mathrm{A}_{\mathrm{S}}$ of erythromycin.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm})$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and about $15\ \mathrm{cm}$ to $30\ \mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;{\upmu\mathrm{m}}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of methanol and 0.067 $\mathrm{mol/L}$ potassium dihydrogen phosphate $(3:2)$ .  

System suitability  

System repeatability: Repeat the test 6 times with $20\,\upmu\mathrm{L}$ each of the standard solutions according to the above operating conditions; the relative standard deviation of the peak area of erythromycin is NMT $2.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

# Erythromycin Delayed-Release Capsules 에리트로마이신장용캡슐  

Erythromycin Delayed-Release Capsules contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $(\mathrm{C}_{37}\mathrm{H}_{67}\mathrm{NO}_{13}:733.93)$  

Method of preparation Prepare as directed under Capsules, with Erythromycin.  

Identification Perform the test as directed under the Identification of Erythromycin Delayed-Release Tablets. Water NMT $7.5\%$ $\left(0.1\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Dissolution Perform the test with 1 capsule of Erythromycin Delayed-Release Capsules at 50 revolutions per minute  for 60 minutes according to Method 1 under the Dissolution, using $900\,\mathrm{\mL}$ of $0.06\mathrm{\mol/L}$ hydrochloric acid as the dissolution medium. Immediately wash the remaining contents and the basket with water to remove hydrochloric acid, and perform the test for 60 minutes under the conditions described in the above test method, using $900~\mathrm{mL}$ of $0.2\;\mathrm{mol/L}$ phosphate buffer solution, pH 6.8, as the dissolution medium. Take $5\ \mathrm{mL}$ of the dissolved solution 60 minutes after starting the second dissolution test, and use the filtrate as the test solution.  

Uniformity of dosage units Meets the requirements. Assay Proceed as directed under the Assay under Erythromycin. Take NLT 20 capsules of Erythromycin Delayed-Release Capsules, weigh accurately the mass of the contents equivalent to about $50~\mathrm{mg}$ (potency) according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make exactly $50\;\mathrm{mL}$ , and use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Gel 에리트로마이신겔  

Erythromycin Gel contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $\mathrm{\bfC}_{37}\mathrm{H}_{67}\mathrm{NO}_{13}$ : 733.93).  

Method of preparation Prepare as directed under Gels, with Erythromycin.  

Identification Perform the test under the Identification (2) of Erythromycin Tropical Solution. However, weigh accurately an appropriate amount of Erythromycin Gel and erythromycin RS, and dissolve in methanol to make a solution containing $2.5~\mathrm{{mg}}$ (potency) per mL; use this solution as the test solution and standard solution, respectively.  

Assay Proceed as directed under the Assay of Erythromycin. However, weigh accurately an amount of Erythromycin Gel equivalent to about $50~\mathrm{mg}$ (potency) according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, and use the mobile phase to make exactly $50\;\mathrm{mL}$ ; use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Topical Solution 에리트로마이신외용액  

Erythromycin Topical Solution contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin ( $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ : 733.93), when quantified as a topical solution.  

Method of preparation Prepare as directed under the Liquids, with Erythromycin.  

Identification (1) Take $1\ \mathrm{mL}$ of Erythromycin Topical Solution, add acetone to make $10~\mathrm{mL}$ then add $2~\mathrm{mL}$ of hydrochloric acid; the solution exhibits amber to a reddish purple color.  

(2) Take $1\ \mathrm{mL}$ of Erythromycin Topical Solution, add $7~\mathrm{mL}$ of methanol, and use this solution as the test solution. Separately, dissolve $26~\mathrm{mg}$ (potency) of erythromycin RS in methanol to make $10\,\mathrm{\mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Develop the plate with a mixture of methanol and chloroform $(85:15)$ as the developing solvent, dry the plate at room temperature, spray evenly a mixture of ethanol(95), $p$ -methoxybenzaldehyde and sulfuric acid $(90:5:5)$ , and heat at $100~^{\circ}\mathrm{C}$ for 10 minutes; the $R_{\mathrm{f}}$ values are the same when comparing the spots of the test solution and the standard solution.  

Water (1) When using only ethanol as a solvent in the prescription: (1) NMT $8.0\%$ , when $20~\mathrm{mg}$ (potency) per mL, (2) NMT $5.0\%$ , when $15~\mathrm{mg}$ (potency) per mL.   
(2) When using ethanol and acetone as a solvent in the prescription: NMT $2.0\%$ .  
(3) When using neither ethanol as a solvent nor stabilizer in the prescription: no criteria to apply.   
However, use a mixture of pyridine and methanol for water determination $(1:1)$ , instead of methanol for water determination.  

Assay Perform the test as directed under the Assay of Erythromycin. Weigh accurately an amount of Erythromycin Gel equivalent to about $50~\mathrm{mg}$ (potency) according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, and add the mobile phase to make exactly $50~\mathrm{mL}$ . Use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Enteric-Coated Tablets 에리트로마이신장용정  

Erythromycin Enteric-Coated Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of erythromycin ( $\mathrm{\bf~\left(C_{37}H_{67}N O_{13}\right.}$ : 733.93). Erythromycin EntericCoated Tablets are delayed-release preparations.  

Method of preparation Prepare as directed under Tablets, with Erythromycin.  

Identification Perform the test as directed under the Identification (2) of Erythromycin. Weigh an amount of powdered Erythromycin Enteric-Coated Tablets, equivalent to $10~\mathrm{mg}$ (potency) of erythromycin according to the labeled amount, add $1\,\textrm{m L}$ of methanol, shake to mix, filter, and use this solution as the test solution.  

Loss on drying NMT $10.0\%$ $\mathrm{0.2\g,\,0.67\kPa}$ ,$60~^{\circ}\mathrm{C}$ , 3 hours).  

Disintegration Meets the requirements. Uniformity of dosage units Meets the requirements. Assay Perform the test as directed under the Assay of Erythromycin. Weigh accurately the mass of NLT 20 tablets of Erythromycin Enteric-Coated Tablets, powder, weigh accurately an amount of this powder, equivalent to about $50~\mathrm{mg}$ (potency) of eythromycin according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Estolate 에리트로마이신에스톨산염  

![](images/702276f1340ec7062fe04a6e7538a5a0fd60ed1c1fc913c5f03ef6fe26697a41.jpg)  

Erythromycin Estolate  

$\mathrm{C_{40}H_{71}N O_{14}{}\cdot C_{12}H_{25}O S O_{3}H:1056.39}$ [(2 S,3 R,4 S,6 R)-4-(Dimethylamino)-2- [[(3 R,4 S,5 S,6 R,7 R,9 R,11 R,12 R, 13 S,14 R)-14-ethyl  

7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4- methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13- hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6- methyloxan-3-yl] propanoate dodecyl hydrogen sulfate [3521-62-8 ]  

Erythromycin Estolate, when dried, contains NLT $600~\mathrm{~\mug~}$ (potency) of Erythromycin (C37H67NO13: 733.93) per mg, calculated on the anhydrous basis.  

Description Erythromycin Estolate occurs as a white crystalline powder or a powder. It is odorless and has a bitter taste.  

It is sparingly soluble in methanol or ethanol(95) and very slightly insoluble in water or benzene.  

Identification Determine the infrared spectra of Erythromycin Estolate and erythromycin estolate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both exhibit similar intensities of absorption at the same wavenumbers.  

pH Dissolve $1.0~\mathrm{g}$ of Erythromycin Estolate in $10\;\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 4.5 and 7.0.  

Purity Free erythromycin ―Dissolve $0.250\mathrm{g}$ of this drug, weighed accurately, in $5.0~\mathrm{mL}$ of the mobile phase and use this solution as the test solution. Separately, weigh accurately $75.0~\mathrm{mg}$ of erythromycin RS and dissolve in the mobile phase to make exactly $50~\mathrm{mL}$ . Take exactly $5.0~\mathrm{mL}$ of this solution, add acetonitrile to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions; the peak area obtained from the test solution is not larger than the major peak area obtained from the standard solution (NMT $6.0\%$ ).  

Buffer solution ―Dissolve $3.4~\mathrm{g}$ of potassium dihydrogen phosphate and $2.75~\mathrm{mL}$ of Triethylamine in water to make $1000\,\mathrm{mL}$ .  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $195\;\mathrm{nm}$ ).  

Column: A stainless steel column $4.6\;\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\ensuremath{\,\mathrm{\upmum}}\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $30\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Adjust the $\mathrm{pH}$ of a mixture of acetonitrile and buffer solution (35:65) to 3.0 by adding dilute phosphoric acid.  

Flow rate: $1\ \mathrm{mL/min}$ System suitability  

System performance: Proceed with $25~\upmu\mathrm{L}$ of the standard solution and the test solution according to the above conditions; the retention time of the first major peak in the test solution and erythromycin in the standard solution is about 5 minutes and about 10 minutes.  

Time span of measurement: About twice the retention time of the erythromycin peak for the standard solution, and about 4.5 times the first peak retention time of erythromycin propionate for the test solution.  

Water NMT $4.0\%$ $(0.2\ \mathrm{g},\,20\ \mathrm{mL}$ of methanol containing $10\%$ imidazole, volumetric titration, direct titration).  

Assay Proceed as directed under the Assay under Erythromycin. However, weigh accurately an appropriate amount of Erythromycin Estolate, dissolve in $25~\mathrm{mL}$ of methanol, add $0.1\ \mathrm{mol/L}$ phosphate buffer solution (pH 8.0) to contain $1.0~\mathrm{mg}$ (potency) per mL, and then warm this solution on a steam bath at $60~^{\circ}\mathrm{C}$ for 2 hours, or allow to stand at room temperature of 16 to 18 hours. Use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Estolate Capsules 에리트로마이신에스톨산염캡슐  

Erythromycin Estolate Capsules contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $(\mathbf{C}_{37}\mathrm{H}_{67}\mathrm{NO}_{13}:733.93)$ .  

Method of preparation Prepare as directed under Capsules, with Erythromycin Estolate.  

Identification Weigh the appropriate amount of each Erythromycin Estolate Capsules and erythromycin estolate RS, dissolve in a small amount of methanol, add water to make a solution containing $500~\upmu\mathrm{g}$ (potency) per $\mathrm{mL}$ , respectively, and use these solutions as the test solution and the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of methanol and 2- propanol $(85:15)$ as the developing solvent to a distance of about $10\;\mathrm{cm}$ , and air-dry the plate. Apply iodine vapor on the thin-layer chromatographic plate or evenly spray $10\%$ sulfuric acid solution; the $R_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

Loss on drying NMT $5.0\%$ $\mathrm{[0.1~g.}$ , in vacuum, $60~^{\circ}\mathrm{C}$ , 3 hours).  

romycin. Take NLT 20 capsules of Erythromycin Estolate Capsules, weigh accurately the mass of the contents, and weigh accurately an amount equivalent to about 50 mg (potency) according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, and dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ , to contain $1.0\;\mathrm{mg}$ (potency) per mL. Then warm this solution in a $60~^{\circ}\mathrm{C}$ water bath for 2 hours or allow it to stand at room temperature for 16 to 18 hours, and use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Ethylsuccinate 에리트로마이신에틸숙시네이트  

![](images/2903fdf7a13772cdc67f202694330f890df437edd81c935f7954183d34df4f94.jpg)  
$\mathrm{C_{43}H_{75}N O_{16}:862.05}$  

4- O-[(2 S,3 R,4 S,6 R)-4-(Dimethylamino)-2- [[(3 R,4 S,5 S,6 R,7 R,9 R,11 R,12 R,13 S,14 R)-14-ethyl7,12,13-trihydroxy-4-[(2 R,4 R,5 S,6 S)-5-hydroxy-4- methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13- hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6- methyloxan-3-yl] 1-O-ethyl-butanedioate [ 1264-62-6 ]Erythromycin Ethylsuccinate is a derivative of erythromycin.  

Erythromycin Ethylsuccinate contains NLT $780~\upmu\mathrm{g}$ and NMT $900~\upmu\mathrm{g}$ (potency) of erythromycin $(\mathrm{C}_{37}\mathrm{H}_{67}\mathrm{NO}_{13}:733.93)$ ) per mg, calculated on the anhydrous basis.  

Description Erythromycin Ethylsuccinate occurs as a white powder.  

It is freely soluble in methanol, soluble in ethanol(95) and practically insoluble in water.  

Identification (1) Dissolve $3~\mathrm{~mg}$ of Erythromycin Ethylsuccinate in $2~\mathrm{mL}$ of acetone and add $2~\mathrm{mL}$ of hydrochloric acid; the solution exhibits an orange color and immediately changes into red to dark purple.  

(2) Determine the infrared spectra of Erythromycin Ethylsuccinate and erythromycin ethylsuccinate RS, previously dried in a desiccator (in vacuum, silica gel) for 24 hours, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both exhibits similar intensities of absorption at the same wavenumbers. $\mathbf{pH}$ The pH of a solution obtained by suspending $0.1~\mathrm{g}$ of Erythromycin Ethylsuccinate in $10\,\mathrm{\mL}$ of water is between 6.0 and 8.5.  

Purity (1) Free erythromycin ―Weigh accurately 0.250 g of Erythromycin Ethylsuccinate, dissolve in the mobile phase to make exactly $50\;\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $75.0~\mathrm{mg}$ of the erythromycin RS and dissolve in the mobile phase to make exactly $50\;\mathrm{mL}$ . Pipet $5.0\;\mathrm{mL}$ of this solution, add acetonitrile to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions; the peak area obtained from the test solution is not larger than the area of the major peak obtained from the standard solution (NMT $6.0\%$ ).  

Operating conditions  

Proceed as directed under the operating conditions for free erythromycin under the Purity of Erythromycin Estolate.  

# System suitability  

System performance: Proceed with $25~\upmu\mathrm{L}$ each of the standard solution and the test solution under the above conditions; the peak retention times of erythromycin in the standard solution and erythromycin ethylsuccinate in the test solution are about $8\ \mathrm{min}$ and about 24 min, respectively.  

Time span of measurement: About 2 times the peak retention time of erythromycin for the standard solution, and about 2 times the peak retention time of erythromycin ethylsuccinate for the test solution.  

(2) Related substances ―Weigh accurately about $0.115~\mathrm{g}$ of Erythromycin Ethylsuccinate, put it into a 50- mL Erlenmeyer flask, dissolve in $25~\mathrm{mL}$ of methanol, and add $20\,\mathrm{\mL}$ of hydrolysis TS to mix. Allow to stand at room temperature for about 12 hours, add the hydrolysis TS to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of erythromycin, dissolve it in $12.5\,\mathrm{~mL~}$ of methanol, add hydrolysis TS to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution (1). Separately, weigh accurately about $5~\mathrm{mg}$ each of erythromycin B and erythromycin C, dissolve them in $25~\mathrm{mL}$ of methanol, add 2.5 mL of standard solution (1), and then add hydrolysis solution to make exactly $50~\mathrm{mL}$ . Use this solution as the standard solution (2). Perform the test with $200~\upmu\mathrm{L}$ each of the test solution and the standard solution (2) as directed under the Liquid Chromatography according to the following conditions and calculate the amount of individual related substances other than erythromycin A, erythromycin B, erythromycin C, erythromycin A enolether and erythromycin $N_{}$ -ethylsuccinate and the amount of erythromycin A enolether and erythromycin N-ethylsuccinate according to the following formula; each is NMT $3.0\%$ . However, the relative retention time of erythromycin $N\!\cdot$ -ethylsuccinate to the retention time of erythromycin A is about 1.3, and the peak areas of erythromycin A enolether and erythromycin $N_{}$ -ethylsuccinate are calculated by multiplying the area obtained by the automatic integration method by the sensitivity coefficients for erythromycin A of 0.09 and 0.14, respectively.  

$$
=\;50\times{\frac{C\times P}{W}}\times{\frac{A_{T}}{A_{S}}}
$$  

C: Concentration $(\mathrm{mg/mL})$ of erythromycin in the standard solution (2)  

P: Content $(\%)$ of erythromycin A in erythromycin RS  

# W: Amount (mg) of sample taken  

$A_{\mathrm{T}}$ : Peak areas of each related substance, other than erythromycin A, erythromycin B, erythromycin C, erythromycin A enol ether and erythromycin $N\!\cdot$ -ethylsuccinate obtained from the test solution, and erythromycin A enol ether and erythromycin $N_{}$ -ethylsuccinate  

AS: Peak area of erythromycin A obtained from the standard solution (2)  

Hydrolysis TS ―A solution prepared by dissolving 2 $\mathrm{g}$ of dibasic potassium phosphate in water to make 100 mL and adjust the pH to 8.0 with phosphoric acid.  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $215\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with spherical styrene-divinylbenzene copolymer for liquid chromatography ( $\ensuremath{\left\{5\,\upmu\mathrm{m}\right.}}$ to $10\,\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $70\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Add $400~\mathrm{mL}$ of water, $175~\mathrm{mL}$ of $t^{\star}$ -butyl alcohol and $30~\mathrm{mL}$ of acetonitrile to $50\;\mathrm{mL}$ of buffer solution, $\mathrm{pH}\,8.0$ , and add water to make $1000\;\mathrm{mL}$ .  

Flow rate: $2\ \mathrm{mL/min}$ System suitability  

System performance: Proceed with $200~\upmu\mathrm{L}$ of the system suitability solution (1) under the above conditions; $N\!\cdot$ -demethylerythromycin, erythromycin C, erythromycin A and erythromycin B are eluted in this order with the resolution of $N\!\cdot$ -demethylerythromycin and erythromycin C being $\mathrm{NLT}\ 0.8$ and the resolution of $N\cdot$ demethylerythromycin and erythromycin A being NLT 5.5. Additionally, proceed with $100\,\mathrm{\upmuL}$ of the system suitability solution (2) under the above conditions; the relative retention time of erythromycin A enol ether to the retention time of erythromycin A is about 4.3 to 4.7. System repeatability: Repeat the test 5 times with $200\,\textrm{\textmu L}$ each of standard solution (1) under the above operating conditions; the relative standard deviation of the peak area of erythromycin is NMT $1.0\%$ .  

System suitability solution $(I)$ ―Dissolve about 2 mg of $N\cdot$ -demethylerythromycin in $20~\mathrm{mL}$ of the standard  

solution (2).  

System suitability solution (2) ―Dissolve about 10 mg of erythromycin in $2~\mathrm{mL}$ of methanol, then add 10 mL of buffer solution, $\mathrm{pH}\,3.5$ , and allow to stand for 30 min. Keep refrigerated until use and discard after 8 hours after preparation.  

Buffer solution, $p H\ \&.O{\mathrm{-}}{\mathrm{A}}$ solution obtained by dissolving $2{\mathrm{~g~}}$ of dibasic potassium phosphate in water to make $100~\mathrm{mL}$ and adjusting the $\mathrm{pH}$ to 8.0 with phosphoric acid. Buffer solution, $p H\ 3.5{\mathrm{-}}{\mathrm{A}}$ solution obtained by adjusting $20~\mathrm{mL}$ of the buffer solution, $\mathrm{pH}\;8.0$ to ${\mathrm{pH}}\,3.5$ with phosphoric acid.  

Water NMT $5.0\%$ ($\mathrm{~\ensuremath~{~0.5~\mathrm{~g~}~}~}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $1.0\%$ (1 g).  

Sterility It meets the requirements when used in the manufacturing of a sterile preparation. However, it is excluded in cases where there is a terminal sterilization process in the manufacturing of a sterile preparation.  

Pyrogen It meets the requirements when used in a sterile preparation. However, weigh an appropriate amount of Erythromycin Ethylsuccinate to make an aqueous suspension containing $50~\mathrm{mg}$ per mL, use this solution as the test solution, and inject $0.1\ \mathrm{mL}$ of the test solution into the lower extremity muscle. However, the test solution injected to a rabbit shall be $1.0~\mathrm{mL}$ per $\mathrm{kg}$ of the rabbit weight.  

Assay Cylindrical plate method (1) Medium Agar medium for seed and base layer: Use the medium in (A) (2) (a) $\textcircled{2}\textcircled{6}$ under the Microbial Assays for Antibiotics. However, adjust the $\mathrm{pH}$ to 7.8 to 8.0.  

(2) Test organism: Use Staphylococcus aureus ATCC $6538\;\mathrm{P}$ as the test organism. (3) Weigh accurately about $50~\mathrm{~mg}$ (potency) of Erythromycin Ethylsuccinate, dissolve in $50\;\mathrm{mL}$ of methanol, and add $0.1\,\mathrm{\mol/L}$ phosphate buffer solution $\mathrm{(pH}$ 8.0) to make exactly $100\;\mathrm{mL}$ . Take exactly an appropriate amount of this solution, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution $(\mathrm{pH}\ 8.0)$ to contain 20.0 and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high concentration and low-concentration test solutions, respectively. Separately, weigh accurately about $50~\mathrm{mg}$ (potency) of the erythromycin RS, dissolve in $50~\mathrm{mL}$ of methanol, add again $0.1\ \mathrm{mol/L}$ phosphate buffer solution $\mathrm{(pH}$ 8.0) to make exactly $100~\mathrm{mL}$ , and use this solution as the standard stock solution. Store the standard stock solution at below $5~^{\circ}\mathrm{C}$ and use it within 7 days. Take exactly an appropriate amount of this standard stock solution, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution $\left(\mathrm{pH}\right.8.0\right)$ to contain 20.0 and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high-concentration standard solution and the low-concentration standard solution, respectively. With these solutions, perform the test according to (A) (8) under the Microbial Assays for Antibiotics.  

# Erythromycin and Tretinoin Topical Gel 에리트로마이신·트레티노인외용겔  

Erythromycin and Tretinoin Topical Gel contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ : 733.93); NLT $90.0\%$ and NMT $130.0\%$ of the labeled amount of tretinoin ($\mathrm{\bfC}_{20}\mathrm{H}_{28}\mathrm{O}_{2}$ : 300.44).  

Method of preparation Prepare as directed under Gels, with Erythromycin and Tretinoin.  

Identification (1) Erythromycin —(i) Dissolve Erythromycin and Tretinoin Topical Gel and erythromycin RS in methanol to make a solution containing $2.5~\mathrm{mg}$ (potency) per mL, and use this solution as the test solution and the standard solution, respectively. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography, develop the plate with a mixture of methanol and chloroform ( $\leftmoon\rightmoon\leftmoon$ 15) as the developing solvent, and take it out to dry at room temperature. Spray evenly a mixture of ethanol, $p_{-}$ -methoxybenzaldehyde and sulfuric acid $(90:5:5)$ , and warm at $100\ ^{\circ}\mathrm{C}$ for 10 minutes; when comparing the black-purple spots of the test solution and the standard solution, the $R_{\mathrm{f}}$ values of them are the same.  

(ii) Dissolve Erythromycin and Tretinoin Topical Gel in methanol to make a solution containing $2.5~\mathrm{mg}$ (potency) per mL. Take $1\ \mathrm{mL}$ of this solution, add acetone to make $10~\mathrm{mL}$ , and add $2~\mathrm{mL}$ of hydrochloric acid; the resulting solution turns from orange to reddish purple. (2) Tretinoin —The retention times of the major peaks obtained from the test solution and the standard solution under the Assay are the same.  

# Assay (1) Erythromycin  

(i) Microbial Assays for Antibiotics (i) Cylindrical plate method  

⑴ Medium: Agar medium for seed and base layer Microbial Assays for Antibiotics: Use the medium in (i) ⑵ (a) $\textcircled{2}\textcircled{6}$ . However, adjust the pH to 7.8 to 8.0. ⑵ Test organism: Use Staphylococcus aureus ATCC 6538P as the test organism.  

⑶ Common standard solution: Weigh accurately an amount equivalent to about $40~\mathrm{mg}$ (potency) of erythromycin RS, dissolve in $25~\mathrm{mL}$ of methanol, add $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\ 8.0$ , to make $100~\mathrm{mL}$ , and shake well to mix. Use this solution as the common standard stock solution. Store the common standard stock solution at below $5~^{\circ}\mathrm{C}$ and use within 7 days. Pipet an appropriate amount of the common standard stock solution, dilute with the above buffer solution to contain 20.0 and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use this solution as the common standard solution.  

⑷ Test solution: Weigh accurately an amount of Erythromycin and Tretinoin Topical Gel, equivalent to about $40~\mathrm{mg}$ (potency), dissolve in $25~\mathrm{mL}$ of methanol, and add $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathsf{p H}\ 8.0$ , to make $100~\mathrm{mL}$ . Take an appropriate amount of this solution, dissolve in the above buffer solution, and dilute it to contain 20.0 and $5.0~\upmu\mathrm{g}$ (potency) per mL. Use this solution as the test solution.  

(ii) Standard curve method  

⑴ Medium: Agar medium for seed and base layer Microbial Assays for Antibiotics  Use the medium in (i) ⑵ (a) $\textcircled{2}\textcircled{6}$ .  

⑵ Test organism: Use Micrococcus luteus ATCC   
9341 as the test organism.  

⑶ Common standard solution: Microbial Assays for Antibiotics  Pipet an appropriate amount of the common standard solution in (i) ⑶ , dilute it with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ , to contain 0.64, 0.80, 1.00, 1.25 and $1.56~\upmu\mathrm{g}$ (potency) per mL, and use this solution as the common standard solution. Use the solution containing $1.0~\upmu\mathrm{g}$ (potency) per mL as the common standard intermediate diluent.  

Pipet an appropriate amount of the solution in (i) ⑷ , dilute it with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\ 8.0$ to contain $1.0~\upmu\mathrm{g}$ (potency) per mL, and use this solution as the test solution.  

(iii) Weigh accurately about $40~\mathrm{mg}$ (potency) each of Erythromycin and Tretinoin Topical Gel and erythromycin RS, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make $50~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with $20\,\textrm{\textmu L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of erythromycin, $A_{\mathrm{T}}$ and $A_{S}$ , in each solution.  

Potency $(\upmu\mathrm{g}/\upmu\mathrm{g})$ of Erythromycin and Tretinoin Topical  

$$
=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times
$$  

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 $\left(m g\right)$ 𝑜𝑜𝑜𝑜 Erythromycin and Tretinoin Topical Gel taken × 1000  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm})$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and about $15\ \mathrm{cm}$ to $30\ \mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of methanol and 0.067 mol/L potassium dihydrogen phosphate solution $(3:2)$ .(2) Tretinoin —Weigh accurately about $250~\mathrm{mg}$ of tretinoin $(\mathbf{C}_{20}\mathbf{H}_{28}\mathbf{O}_{2})$ , dissolve in $50~\mathrm{mL}$ tetrahydrofuran, and filter if necessary. Take $5~\mathrm{mL}$ of this solution, add a mixture of tetrahydrofuran and phosphoric acid (1 in 100) $(3:2)$ to make $25~\mathrm{mL}$ , and use this solution as the test solution. Separately, proceed in the same manner as in the preparation of the test solution with about $250~\mathrm{mg}$ of tretinoin RS, and use this solution as the standard solution. Perform the test with $5~\mathrm{mL}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of tretinoin from each solution, $A_{\mathrm{T}}$ and $A_{S}$ , respectively.  

Detector: An ultraviolet absorption photometer (wavelength: $365\;\mathrm{nm}$ ).  

Column: A stainless steel column about $3.9\ \mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( ${}^{4}\ensuremath{\,\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: A mixture of phosphate buffer solution, $\mathrm{pH}\,3.0$ , and tetrahydrofuran $(58:42)$ .Flow rate: $1.0\,\mathrm{mL/min}$  

Packaging and storage Preserve in tight containers.  

# Erythromycin Lactobionate 에리트로마이신락토비온산염  

![](images/79b7c215a213a5669bd8711bfaaf9ea93b0a451c57b1a67e71446057d233ad3e.jpg)  

C37 H67 NO 1 ·C 12 H22 O12 : 1092.22 (3 R,4 S,5 S,6 R,7 R,9 R,11 R,12 R,13 S,14 R)-6-[(2 S,3 R,4 S,6 R)- 4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy  

14-ethyl-7,12,13-trihydroxy-4-[(2 R,4 R,5 S,6 S)-5-hydroxy4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13- hexamethyl-oxacyclo-tetradecane-2,10-   
dione(2 R,3 R,4 R,5 R)-2,3,5,6-tetrahydroxy-4-   
[(2 S,3 R,4 S,5 R,6 R)-3,4,5-trihydroxy-6-   
(hydroxymethyl)oxan-2-yl]oxyhexanoate [ 3847-29-8 ]Erythromycin Lactobionate is the lactobionate of erythromycin.   
Erythromycin Lactobionate contains NLT $590\ \upmu\mathrm{g}$ and NMT 700 μg (potency) of erythromycin $\left({37\mathrm{H}_{67}\mathrm{NO}_{13}}\right)$ per mg, calculated on the anhydrous basis. Description Erythromycin Lactobionate occurs as a white powder.   
It is freely soluble in water, methanol or ethanol(99.5) and slightly soluble in acetone.  

Identification (1) To the $3~\mathrm{mg}$ of Erythromycin Lactobionate, add $2~\mathrm{mL}$ of acetone and $2~\mathrm{mL}$ of hydrochloric acid; the resulting solution exhibits an orange color and immediately turns red to dark violet.  

(2) To $0.3\mathrm{~g~}$ of Erythromycin Lactobionate, add 15 mL of ammonia TS and $15~\mathrm{mL}$ of chloroform, shake to mix, and take the separated aqueous layer. Wash this solution with three $15\,\mathrm{\mL}$ portions of chloroform, and evaporate to dryness on a steam bath. Dissolve the residue in $10~\mathrm{mL}$ of a mixture of methanol and water $(3:2)$ ,and use this solution as the test solution. Separately, dissolve $0.10~\mathrm{g}$ of lactobionic acid in a mixture of methanol and water $(3:2)$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of water, 1-butanol and acetic acid(100) $(3:3:$ 1) as the developing solvent to a distance of about $10\;\mathrm{cm}$ ,and air-dry the plate. Spray evenly dilute sulfuric acid on the plate, and heat at $105\;^{\circ}\!C$ for 20 minutes; the principal spot obtained from the test solution exhibits a dark brown color and has the same $R_{\mathrm{f}}$ value as the spot obtained from the standard solution.  

$\mathbf{pH}$ Dissolve $0.5\mathrm{~g~}$ of Erythromycin Lactobionate in 10 mL of water; the $\mathrm{pH}$ of this solution is between 5.0 and 7.5.  

Purity Heavy metals —Proceed with $0.5\mathrm{~g~}$ of Erythromycin Lactobionate according to Method 2 and perform the test. Prepare the control solution with $2.5~\mathrm{mL}$ of lead standard solution (NMT 50 ppm).  

Water NMT $5.0\%$ $\left(0.5\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Residue on ignition NMT $2.0\%$ (1 g). However, moisten the charred residue with $2~\mathrm{mL}$ of nitric acid and 5 drops of sulfuric acid.  

Sterility It meets the requirements when used in the manufacturing of sterile preparations. However, it is exempt from the requirements there is a terminal sterilization process in the manufacturing process of sterile preparations.  

Bacterial endotoxins Less than 1.0 EU per mg (potency) of erythromycin when used in the manufacturing of sterile preparations.  

Assay Cylinder-plate method —(1) Medium: Agar media for seed and base layer  Use the medium in (A) (2) (a) $\textcircled{2}$ $\circledcirc$ under the Microbial Assays for Antibiotics. However, adjust the $\mathrm{pH}$ to 7.8 to 8.0.   
(2) Test organism: Use Staphylococcus aureus ATCC 6538P as the test organism.   
(3) Weigh accurately about $50~\mathrm{~mg}$ (potency) of Erythromycin Lactobionate, dissolve in $50~\mathrm{mL}$ of methanol, and add $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ to make exactly $100\,\mathrm{\mL}$ . Take exactly an appropriate amount of this solution, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ to make solutions containing 20.0 $\upmu\mathrm{g}$ (potency) and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high concentration test solution and low concentration test solution, respectively. Separately, dissolve approximately $50\,\mathrm{~mg}$ (potency) of erythromycin lactobionate RS in $50\,\mathrm{\mL}$ of methanol, add $0.1\,\mathrm{\mol/L}$ phosphate buffer solution, $\mathsf{p H}\ 8.0$ to make exactly 100 mL, and use this solution as the standard stock solution. Store the standard stock solution at below $5~^{\circ}\mathrm{C}$ and use it within 7 days. Take exactly an appropriate amount of the standard stock solution, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ to make solutions containing 20.0 $\upmu\mathrm{g}$ (potency) and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high concentration standard solution and the low concentration standard solution, respectively. With these solutions, perform the test according to (A)(8) under the Microbial Assays for Antibiotics.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment  

에리트로마이신락토비온산염·콜리스틴메탄설포네이트나트륨안연고  

Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment contains NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ :733.93) and colistin A $(\mathbf{C}_{53}\mathbf{H}_{100}\mathbf{N}_{16}\mathbf{O}_{13}$ : 1169.47).  

Method of preparation Prepare as directed under Ophthalmic Ointments, with Erythromycin Lactobionate and Colistin Sodium Methanesulfonate. Identification (1) Erythromycin lactobionate —Put about $1\,\mathrm{~g~}$ of Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment in a stoppered flask, and turn it into liquid by warming. Add 3 mL of warmed acetone, shake vigorously to mix, cool, and take the acetone layer. Add $2\ \mathrm{mL}$ of hydrochloric acid to the solution; the resulting solution turns from orange to red, and finally to reddish purple. Add $2~\mathrm{mL}$ of chloroform again and shake; the chloroform layer exhibits a purple color.  

(2) Colistin sodium methanesulfonate —Put about 1 $\mathrm{g}$ of Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment in a stoppered flask, and turn it into liquid by warming. Add $5~\mathrm{mL}$ of water, shake vigorously to mix, cool, and take the water layer. Add $10\%$ sodium hydroxide solution to this solution, and shake well. Add 5 drops of $1\%$ copper sulfate solution, and shake well to mix; the resulting solution exhibits a reddish purple color.  

Sterility Meets the requirements. Foreign metallic matter Meets the requirements. Water NMT $1.0\%$ $\mathrm{~\textit~{~1.0~g~}~}$ , volumetric titration, direct titration).  

Assay (1) Erythromycin lactobionate— Cylinder plate method (i) Medium: Agar media for seed and base layer Microbial Assays for Antibiotics  Use the medium in (i) (ii) Test organism: Use Bacillus subtilis ATCC 6633 as the test organism.  

(iii) Weigh accurately Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment, equivalent to about $25~\mathrm{mg}$ (potency) of erythromycin, according to the labeled potency, place it in a separatory funnel, add $50\,\textrm{m L}$ of ether, shake until the mixture becomes homogeneous, and then add $25~\mathrm{mL}$ of $0.1\,\mathrm{\mol/L}$ phosphate buffer solution $\ensuremath{\left(\mathrm{pH}\ 8.0\right)}$ . Extract three times, combine all extracts, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution, $\mathrm{pH}\,8.0$ , and use these solutions as the high concentration test solution and the low concentration test solution, respectively. Separately, weigh accurately about $25~\mathrm{mg}$ (potency) of erythromycin lactobionate RS, dissolve in $25\,\mathrm{\mL}$ of methanol, add 0.1 $\mathrm{mol/L}$ phosphate buffer solution $(\mathrm{pH}\,8.0)$ to make exactly $100~\mathrm{mL}$ , and shake well to mix. Use this solution as the standard stock solution. Store the standard stock solution at a temperature NMT $5~^{\circ}\mathrm{C}$ , and use it within 7 days. Pipet an appropriate amount of the standard stock solution, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution $(\mathrm{pH}\;8.0)$ to contain $2.0~\upmu\mathrm{g}$ and $0.5~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high concentration standard solution and the low concentration standard solution, respectively. With these solutions, perform the test according to (i) (8) under the Microbial Assays for Antibiotics. (2) Colistin sodium methanesulfonate— Cylinder plate method (i) Medium: Agar media for seed and base layer  Microbial Assays for Antibiotics  Use the medium in (ii) (2) (a) $\textcircled{1}\textcircled{a}$ .  

(ii) Test organism: Use Escherichia coli NIHJ as the test organism.  

(iii) Weigh accurately about 600000 units (potency) of Erythromycin Lactobionate and Colistin Sodium Methanesulfonate Ophthalmic Ointment according to the labeled potency of colistin to place in a separatory funnel, add $50~\mathrm{mL}$ of ether, and shake until the mixture becomes homogeneous. Extract 3 times with $10~\mathrm{mL}$ each of water, combine all extracts, and add $1\%$ phosphate buffer solution $(\mathrm{pH}\,6.0)$ to make exactly $60\;\mathrm{mL}$ . Pipet an appropriate amount of this solution, dilute with $1\%$ phosphate buffer solution $\ensuremath{\left(\mathrm{pH}\ 6.0\right)}$ , and use these solutions as the high concentration test solution and the low concentration test solution, respectivley. Separately, weigh accurately an appropriate amount of colistin sodium methanesulfonate RS and dissolve in water. Weigh accurately an appropriate amount of the erythromycin RS in this solution, add a small amount of methanol, and add water to make a solution containing 30000 units (potency) of colistin and 1 mg (potency) of erythromycin per mL. Pipet an appropriate amount of this solution, dilute with $1\%$ phosphate buffer solution $(\mathrm{pH}\,6.0)$ to contain 10000 and 2500 units (potency) per mL, and use these solutions as the high concentration standard solution and the low concentration standard solution, respectively. With these solutions, perform the test according (A) (8) under the Microbial Assays for Antibiotics.  

![](images/61a7a486780e76314c858a1dd2a78a2946cf83284e911db3b44b848d08c31869.jpg)  
Packaging and storage Preserve in tight containers.   
Erythromycin Stearate 에리트로마이신스테아르산염  
(3 R,4 S,5 S,6 R,7 R,9 R,11 R,12 R,13 S,14 R)-6-[(2 S,3 R,4 S,6 R)- 4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5- hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy  
$\mathrm{C}_{55}\mathrm{H}_{103}\mathrm{NO}_{15}$ : 1018.40  

3,5,7,9,11,13-hexamethyl-oxacyclo-tetradecane-2,10- dione octadecanoate [ 643-22-1 ]  

Erythromycin Stearate is the stearate of erythromyErythromycin Stearate contains NLT $600~\upmu\mathrm{g}$ and NMT $720\,\mathrm{\;\mug}$ (potency) of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13})$ per mg, calculated on the anhydrous basis.  

Description Erythromycin Stearate occurs as a white powder. It is freely soluble in ethanol(95) or acetone, soluble in methanol and practically insoluble in water.  

Identification (1) Dissolve $3~\mathrm{mg}$ of Erythromycin Stearate in $2~\mathrm{mL}$ of acetone, and add $2~\mathrm{mL}$ of hydrochloric acid; the resulting solution exhibits an orange color and immediately turns red to dark violet.  

(2) Determine the infrared spectra of Erythromycin Stearate and erythromycin stearate RS, previously dried in a desiccator (in vacuum, silica gel) for 24 hours, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

$\mathbf{pH}$ Dissolve $0.1~\mathrm{g}$ of Erythromycin Stearate in $10\;\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 6.0 and 11.0.  

Purity Related substances— Weigh accurately $0.165\mathrm{~g~}$ of Erythromycin Stearate, transfer into a $100{\-}\mathrm{mL}$ Erlenmeyer flask, dissolve in $15~\mathrm{mL}$ of methanol, and add 15 mL of buffer solution, $\mathrm{pH}~\textrm{8.0}$ . After mixing, filter through a $0.2\ \upmu\mathrm{m}$ filter, and use the filtrate as the test solution. Separately, weigh accurately $6~\mathrm{mg}$ each of erythromycin RS, erythromycin B, erythromycin C and Ndemethylerythromycin, and dissolve them in $15\,\mathrm{\mL}$ of methanol, and add $15~\mathrm{mL}$ of buffer solution, $\mathrm{pH}\;8.0$ , and use this solution as the standard solution. Perform the test with $100~\upmu\mathrm{L}$ each of the test and standard solutions as directed under the Liquid Chromatography according to the following conditions, and determine the amount of individual related substances other than erythromycin A, erythromycin B, erythromycin C, erythromycin A enol ether and pseudoerythromycin A enol ether, and the amount of erythromycin A enol ether and pseudoerythromycin A enol ether by the following formula; NMT $3.0\%$ However, the relative retention time of pseudoerythromycin A enol ether to erythromycin A is about 1.5, and the peak areas of ethyl erythromycin A enol ether and pseudoerythromycin A enol ether are calculated by multiplying the area obtained according to the automatic integration method by the correction factors for erythromycin A of 0.09 and 0.15, respectively.  

$$
=\;30\times{\frac{C\times P}{W}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}
$$  

C: Concentration $(\mathrm{mg/mL})$ of erythromycin in the standard solution  

# W: Weight (mg) of sample taken  

$A_{\mathrm{T}}$ : Peak areas of individual related substances other than erythromycin A, erythromycin B, erythromycin C, erythromycin A enol ether, pseudoerythromycin A enol ether, and erythromycin A enol ether and pseudoerythromycin A enol ether obtained from the test solution  

$A_{S}$ : Peak area of erythromycin A obtained from standard solution  

$p H\,\delta.O$ buffer solution —A solution prepared by dissolving $2{\mathrm{~g~}}$ of dibasic potassium phosphate in water to make $100~\mathrm{mL}$ and adjusting $\mathrm{pH}$ to 8.0 with phosphoric acid.  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $215\;\mathrm{nm})$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with spherical styrene  

divinylbenzene copolymer for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $70\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve $3.5\mathrm{~g~}$ of dibasic potassium phosphate in water to make $100~\mathrm{mL}$ , and adjust $\mathrm{pH}$ to 9.0 with dilute phosphoric acid (1 in 10). To $50~\mathrm{mL}$ of this solution, add $400\;\mathrm{mL}$ of water, $175\;\mathrm{mL}$ of $t$ -butyl alcohol, $30\;\mathrm{mL}$ of acetonitrile, and add water to make $1000\;\mathrm{mL}$ .  

Flow rate: $2\;\mathrm{mL/min}$ System suitability  

System performance: Proceed with $100~\upmu\mathrm{L}$ of the standard solution according to the above conditions; Ndemethylerythromycin, erythromycin C, erythromycin A and erythromycin B are eluted in this order with the resolution between N-demethylerythromycin and erythromycin C being NLT 0.8, and the resolution between Ndemethylerythromycin and erythromycin A being NLT 5.5. Separately, weigh accurately $5~\mathrm{mg}$ of erythromycin RS, dissolve in $1\ \mathrm{mL}$ of methanol, add $5~\mathrm{mL}$ of $\mathrm{pH}\;3.5$ buffer solution, and allow to stand for 30 minutes, and use this solution as the system suitability solution (1). Proceed with $100\,\upmu\mathrm{L}$ of this solution according to the above conditions; the relative retention time of erythromycin A enol ether to that of erythromycin A is between 4.3 and 4.7.  

$p H\,3.5$ buffer solution —A solution prepared by adjusting the pH of $20~\mathrm{mL}$ of $\mathrm{pH}\ 8.0$ buffer solution to $\mathrm{pH}$ 3.5 with phosphoric acid.  

System repeatability: Weigh accurately about 40 mg of erythromycin stearate RS, transfer into a $100{\-}\mathrm{mL}$ Erlenmeyer flask, dissolve in $5\ \mathrm{mL}$ of methanol, add 5 mL of $\mathrm{pH}\,8.0$ buffer solution, and use this solution as the system suitability solution (2). Repeat the test 5 times with $100~\upmu\mathrm{L}$ each of this solution according to the above conditions; the relative standard deviation of the peak area of Erythromycin is NMT $2.0\%$ .  

Water NMT $5.0\%$ $\left.\mathrm{0.5~\mathrm{~g~}}\right$ , volumetric titration, direct titration).  

# Residue on ignition NMT $2.0\%$ ($\,[\,{\bf\rho}_{1}\,{\bf g})$  

Assay Perform the test as directed under the Assay of Erythromycin. However, weigh accurately about $50~\mathrm{mg}$ (potency) of Erythromycin Stearate, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make exactly $50~\mathrm{mL}$ ,and use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Stearate Tablets 에리트로마이신스테아르산염정  

Erythromycin Stearate Tablets contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $\scriptstyle(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ : 733.93).  

Method of preparation Prepare as directed under Tablets, with Erythromycin Stearate.  

Identification Weigh an amount of powdered Erythromycin Stearate Tablets, equivalent to about $100~\mathrm{mg}$ (potency) of erythromycin stearate according to the labeled potency, add $50~\mathrm{{mL}}$ of chloroform, shake well to mix, filtrate, and use the filtrate as the test solution. Separately, dissolve $10~\mathrm{mg}$ of erythromycin RS in $5~\mathrm{mL}$ of chloroform, and use this solution as the standard solution. Perform the test with these solutions as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of 1- butanol, acetic acid and water $(3:1:1)$ , and air-dry the plate. Apply iodine vapor or spray $10\%$ sulfuric acid on the plate to examine the spots; the $R_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

Water NMT $5.0\%$ $_{\parallel.2{\mathrm{~g~}}}$ , volumetric titration, direct titration).  

Disintegration Meets the requirements. Uniformity of dosage units Meets the requirements. Assay Proceed as directed under the Assay under Erythromycin. However, weigh accurately the mass of NLT 20 tablets of Erythromycin Stearate Tablets, powder, weigh accurately an amount of this powder, equivalent to about $50~\mathrm{{mg}}$ (potency) of erythromycin stearate according to the labeled potency, dissolve in $25~\mathrm{mL}$ of methanol, add the mobile phase to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Stinoprate 에리트로마이신스티노프레이트  

![](images/5995c503bb08945c7010369d3ee4a68c64b862e01f550a48307b6cf25b29f974.jpg)  

Erythromycin Stinoprate  

$C_{40}\mathrm{H}_{71}\mathrm{NO}_{14}.\mathrm{C}_{5}\mathrm{H}_{9}\mathrm{NO}_{3}\mathrm{S}:953.18$ 2'-Propanoate erythromycin $N_{}$ -acetyl-L-cysteine (1:1), [84252-03-9 ]  

Erythromycin Stinoprate contains NLT $704~\mathrm{~\mug~}$ ( potency) of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ : 733.93) per mg, calculated on the anhydrous basis, and contains NLT $16.3\%$ and NMT $18.0\%$ of acetylcysteine and NLT $78.7\%$ and NMT $87.0\%$ of erythromycin propionate per mg, calculated on the anhydrous basis.  

Description Erythromycin Stinoprate occurs as a white, crystalline powder and has a characteristic odor. It is soluble in methanol, acetone or chloroform and slightly soluble in water.  

Identification (1) Dissolve $3~\mathrm{mg}$ (potency) of Erythromycin Stinoprate in $2~\mathrm{mL}$ of acetone, and add $2~\mathrm{mL}$ of hydrochloric acid; the resulting solution exhibits an orange color and immediately turns red to dark purple.  

(2) Determine the infrared spectra of Erythromycin Stinoprate and erythromycin stinoprate RS as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-51^{\circ}$ and $-58^{\circ}$ ($\mathrm{~\textit~{~\textcent~}~}^{\mathrm{~\textcent~}}1.0\mathrm{~\textg~}$ ,calculated on the anhydrous basis, ethanol anhydrous, 50 mL, after $30\;\mathrm{min}$ ,$100\;\mathrm{mm}$ ).  

$\mathbf{pH}$ Dissolve Erythromycin Stinoprate in water to make 1 mg (potency)/mL; the $\mathrm{pH}$ of the solution is between 4.0 and 5.0.  

Purity (1) Heavy metals —Perform the test with $1.0~\mathrm{g}$ of Erythromycin Stinoprate according to Method 2 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(2) Related substances —(i) $N,N.$ -diacetylcystine: Weigh accurately about $0.2{\mathrm{~g~}}$ (potency) of Erythromycin Stinoprate, dissolve in methanol to make $100\,\mathrm{\mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{{mg}}$ of $N,N\!\cdot$ -diacetylcystine RS, and add methanol to make exactly $100~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ and 6 mL of this solution, add methanol to make exactly 100 mL, and use these solutions as the detection limit solution and the standard solution. Within 30 minutes, perform the test with $20~\upmu\mathrm{L}$ each of the test and standard solutions as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas $A_{\mathrm{T}}$ and $A_{S}$ of $N,N\!.$ -diacetylcystine from each solution (NMT $0.3\%$ ).  

$$
=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times
$$  

𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑚𝑚𝑚𝑚) 𝑜𝑜𝑜𝑜 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠, 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑡𝑡ℎ𝑒𝑒 𝑎𝑎𝑎𝑎ℎ𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $205\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of water and acetonitrile $(99:5)$ , adjusted $\mathrm{pH}$ to 2.5 with phosphoric acid. Flow rate: $2.0\,\mathrm{mL/min}$  

(ii) Erythromycin propionate enol ether and other related substances: Weigh accurately about $0.5\,\mathrm{~g~}$ of Erythromycin Stinoprate, dissolve in ethanol to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ of erythromycin propionate enol ether RS, add methanol to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. Pipet $10~\mathrm{mL}$ of this solution, add methanol to make exactly $100\,\mathrm{\mL}$ , and use this solution as the detection limit solution. Perform the test with exactly $20\,\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, determine the peak areas $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of erythromycin propionate enol ether from each solution, and calculate total peak area after the erythromycin propionate peak other than the erythromycin propionate enol ether peak, $S_{\mathrm{T}}$ (NMT $0.5\%$ for each of erythromycin propionate enol ether and other related substances).  

$$
\times\,\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times25
$$  

# Content $(\%)$ of other related substances  

$$
\times\,\frac{S_{\mathrm{T}}}{A_{\mathrm{S}}}\times25
$$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $205\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\ \upmu\mathrm{m}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of water and acetonitrile $(65:35)$ , adjusted $\mathrm{pH}$ to 2.5 with phosphoric acid.  

Flow rate: $2.0\,\mathrm{mL/min}$  

(iii) Free erythromycin: Weigh $0.1~\mathrm{g}$ (potency) of Erythromycin Stinoprate, calculated on the anhydrous basis, dissolve in $10\;\mathrm{mL}$ of acetone, and use this solution as the test solution. Separately, weigh accurately $10.0~\mathrm{mg}$ (potency) of erythromycin RS, dissolve in $20~\mathrm{mL}$ of acetone, and use this solution as the standard solution. Perform the test with these solutions as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution to the thin-layer chromatographic plate made of silica gel for thin-layer chromatography (with fluorescence agent), and develop the plate with a mixture of chloroform, ethanol and $15\%$ ammonium acetate $(85:15:1)$ to a distance of about 10 cm. Spray evenly a mixture of methanol acetic anhydride sulfuric acid and anisaldehyde $(92:5:2:1)$ on the plate, and dry at $105\;^{\circ}\mathrm{C}$ for about 5 minutes. The spots of erythromycin obtained from the test solution are not more intense than the spots obtained from the standard solution $(\mathrm{NMT}\,5.0\%)$ .  

(iv) Acetylcysteine: Weigh accurately about $0.6~\mathrm{g}$ of Erythromycin Stinoprate, calculated on the anhydrous basis, and dissolve in methanol to make exactly $100~\mathrm{mL}$ .Pipet $10~\mathrm{mL}$ of this solution, add methanol to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of acetylcysteine RS, add methanol to make exactly $500~\mathrm{mL}$ , and use this solution as the standard solution. Within 30 minutes, perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas $\mathrm{A_{T}}$ and A S, of acetylcysteine from each solution.  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $205\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octa  

decylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).   
Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of water and acetonitrile $(95:5)$ , adjusted $\mathrm{pH}$ to 2.5 with phosphoric acid.   
Flow rate: $2.0\,\mathrm{mL/min}$  

(v) Erythromycin propionate: Weigh accurately $0.24~\mathrm{g}$ of Erythromycin Stinoprate, calculated on the anhydrous basis, dissolve in methanol to make exactly 50 mL, and use this solution as the test solution. Separately, weigh accurately about $0.2{\mathrm{~g~}}$ (potency) of erythromycin propionate RS, dissolve in methanol to make exactly 50 mL, and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak areas $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of erythromycin stinoprate from each solution.  

Potency $(\upmu\mathrm{g})$ of erythromycin stinoprate $=$ Potency $(\upmu\mathrm{g})$ of erythromycin stinoprate $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $214\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography $(5~{\upmu\mathrm{m}}$ in particle diameter).   
Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of acetonitrile and phosphate buffer solution, pH 7.0 (53 : 47).   
Flow rate: 2.0 mL/min  

Water NMT $2.5\%$ $\mathrm{[0.4~\,g}$ , volumetric titration, direct titration).  

Residue on ignition NMT $0.5\%$ $\mathrm{~\textit~{~1~}~g~})$  

Assay Cylinder-plate method —(1) Medium: Agar media for seed and base layer  Use the media in (A) (2) (a) $\textcircled{2}$ $\circledcirc$ under the Microbial Assays for Antibiotics. However, adjust the $\mathrm{pH}$ to 7.8 to 8.0.  

(2) Test organism: Use Staphylococcus aureus ATCC 6538P as the test organism.  

(3) Weigh accurately about $0.1\ \mathrm{g}$ (potency) each of Erythromycin and erythromycin RS, dissolve in methanol to make $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Take exactly an appropriate amount each of these solutions, dilute with $0.1\,\mathrm{\mol/L}$ phosphate buffer solution, $\mathrm{pH}~8.0$ , to make solutions containing $20.0~\upmu\mathrm{g}$ and $5.0~\upmu\mathrm{g}$ (potency) per mL, and use these solutions as the high concentration test solution and the low concentration test solution, respectively. Perform the test with these solutions according (A) (8) under the Microbial Assays for Antibiotics.  

Packaging and storage Preserve in tight containers.  

# Erythromycin Stinoprate Tablets 에리트로마이신스티노프레이트정  

Erythromycin Stinoprate Tablets contain NLT $90.0\%$ and NMT $120.0\%$ of the labeled amount of erythromycin $(\mathbf{C}_{37}\mathbf{H}_{67}\mathbf{NO}_{13}$ : 733.93). Also, Erythromycin Stinoprate Tablets contain NLT $16.3\%$ and NMT $18.0\%$ of acetylcysteine and NLT $78.7\%$ and NMT $87.0\%$ of erythromycin propionate, calculated on the anhydrous basis. Method of preparation Prepare as directed under Tablets, with Erythromycin Stinoprate.  

Identification Dissolve $0.1\,\mathrm{~g~}$ (potency) each of Erythromycin Stinoprate Tablets and erythromycin stinoprate RS in $10~\mathrm{mL}$ of acetone, and use these solutions as the test solution and the standard solution, respectively. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography, and develop the plate with a mixture of chloroform, ethanol and $15\%$ ammonium acetate solution $(85:15:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ . Spray evenly a mixture of methanol, acetic acid(100), sulfuric acid and anisaldehyde $(92:5:2:1)$ on the plate, and heat at $105\;^{\circ}\mathrm{C}$ for 5 minutes; the $R_{\mathrm{f}}$ values of spots obtained from the test solution and the standard solution are the same.  

Purity (1) Related substances —$\circleddash$ N,N -diacetylcystine: Perform the test as directed under the Purity (2) $\textcircled{1}$ under Erythromycin Stinoprate. However, weigh accurately about $0.25\mathrm{~g~}$ (potency) of Erythromycin Stinoprate Tablets according to the labeled potency, dissolve in methanol to make exactly $100\;\mathrm{mL}$ , and then filter. Pipet $3.0\;\mathrm{mL}$ of the filtrate, add methanol to make exactly $10.0\ \mathrm{mL}$ ,and use this solution as the test solution (NMT $0.7\%$ for erythromycin stinoprate).  

$$
\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{733.94}{963.20}
$$  

(2) Erythromycin propionate enol ether and other related substances— Perform the test as directed under the Purity (2) 2) under Erythromycin Stinoprate. However, weigh accurately about $0.2~\mathrm{g}$ (potency) of Erythromycin Stinoprate Tablets according to the labeled potency, add methanol to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution (NMT $1.0\%$ of erythromycin propionate enol ether and NMT $0.5\%$ of the total amount of other related substances relative to erythromycin stinoprate).  

Content $(\%)$ of erythromycin propionate enol ether RS $=$ Amount (mg) of erythromycin propionate enol ether  

$$
\begin{array}{r}{\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{733.94}{963.20}}\end{array}
$$  

accurately an amount equivalent to about $0.1~\mathrm{g}$ (potency), and dissolve in methanol to make exactly $100~\mathrm{mL}$ . Filter this solution, pipet an appropriate amount of the filtrate, dilute with $0.1\ \mathrm{mol/L}$ phosphate buffer solution $(\mathrm{pH}\;8.0)$ ,and use this solution as the test solution.  

Acetylcysteine —Perform the test as directed under the Acetylcysteine under Erythromycin Stinoprate. However, weigh accurately an amount of Erythromycin Stinoprate Tablets, equivalent to about $0.25\,\mathrm{~g~}$ (potency) according to the labeled potency, add acetonitrile, shake enough to mix, and then add another acetonitrile to make exactly $100~\mathrm{mL}$ . Filter this solution, pipet $20~\mathrm{mL}$ of the filtrate, add purified water to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $55~\mathrm{\mg}$ of acetylcysteine RS, and dissolve it in acetonitrile to make exactly $100~\mathrm{mL}$ . Pipet 20 mL of this solution, add purified water to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution.  

$=$ Amount (mg) of erythromycin propionate enol ether RS  

$$
\times\,\frac{S_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{733.94}{963.20}
$$  

![](images/27128ab7f4005ae3005bb3a28606457c7248e946804227cfecec3c41642aa646.jpg)  

Dissolution Perform the test with 1 tablet of Erythromycin Stinoprate Tablets at 100 revolutions per minute for 45 minutes according to Method 1 under the Dissolution, using $900\;\mathrm{mL}$ of phosphate buffer solution, $\mathrm{pH}\,6.9$ , as the dissolution medium. Take $20~\mathrm{mL}$ of the dissolved solution 45 minutes after starting the dissolution test, and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, and use the subsequent filtrate as the test solution. Separately, weigh accurately about $55~\mathrm{mg}$ (potency) of erythromycin propionate RS, dissolve in acetonitrile to make exactly 100 mL, and use this solution as the standard solution. Perform the test with $100\,\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Assay (4) under Erythromycin Stinoprate It meets the requirements when the dissolution rate of Erythromycin Stinoprate Tablets for 45 minutes is NLT $75\%$ of the labeled potency.  

Erythromycin propionate —Perform the test as directed under the Erythromycin propionate under Erythromycin Stinoprate. However, weigh accurately an amount of Erythromycin Stinoprate Tablets, equivalent to about $0.185~\mathrm{g}$ (potency) according to the labeled potency, dissolve in methanol to make $50~\mathrm{mL}$ , and use this solution as the test solution.  

![](images/3d836a7b0f4950c1a96d9a1719132c57d448ddcb413499d9cd190434a5e0cbc1.jpg)  
Packaging and storage Preserve in tight containers.  

$$
\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{900}{L a b l e d\;p o t e n c y\;(m g)\;i n\;1\;t a b l e n t}
$$  

Uniformity of dosage units Meets the requirements. Loss on drying NMT $5.0\%$ $\,\,\mathbf{\nabla}1.0\,\,\,\mathbf{\nabla}\mathbf{g}.$ , phosphorus pentoxide, $0.7\,\mathrm{kPa}$ ,$50\;^{\circ}\!C$ , 4 hours).  

![](images/ea702375462d07a22412f382b077df4e141119771f8ff1005c4cf330fb138a06.jpg)  

Assay Cylinder plate method —Perform the test as directed under the Assay under Erythromycin Stinoprate. However, weigh accurately the mass of NLT 20 Erythromycin Stinoprate Tablets, and then powder. Weigh  

Estazolam  

8-Chloro-6-phenyl-4 H-\`1,2,4-triazolo[4,3-a]-1,4- benzodiazepine [ 29975-16-4 ]  

Estazolam, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of estazolam $(\mathbf{C}_{16}\mathbf{H}_{11}\mathbf{C}\mathrm{l}\mathbf{N}_{4})$ ).  

Description Estazolam occurs as a white to pale yellowish white crystals or crystalline powder. It is odorless and has a bitter taste.  

It is soluble in methanol and in acetic anhydride, sparingly soluble in ethanol(95), and practically insoluble in water and in ether.  

Identification (1) Dissolve about $10~\mathrm{mg}$ of Estazolam in $3\,\textrm{m L}$ of sulfuric acid and examine the solution under ultraviolet light (wavelength of $365\ensuremath{\,\mathrm{\nm}})$ ); the resulting solution exhibits a yellowish green fluorescent color.  

(2) Determine the absorption spectra of the solutions of Estazolam and estazolam RS in $1~\mathrm{mol/L}$ hydrochloric acid (1 in 100000) as directed under Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Perform the test with Lorazepam as directed under the Flame Coloration (2); it exhibits a green color. Melting point Between 229 and $233\;^{\circ}\mathrm{C}$ Purity (1) Clarity and color of solution —Dissolve about $0.1\,\mathrm{~g~}$ of Estazolam in $10\,\mathrm{\mL}$ of ethanol(95); the resulting solution is colorless and clear.  

(2) Chloride —Dissolve $1.0\,\mathrm{~g~}$ of Estazolam in 10 mL of ethanol(95) by heating, add $40~\mathrm{mL}$ of water, cool with shaking in iced water, allow to stand until it reaches room temperature, and filter. To $30\;\mathrm{mL}$ of the filtrate, add $6~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ . Using this solution as the test solution, perform the test. Prepare the control solution with $0.25~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid and $6\;\mathrm{mL}$ of ethanol (NMT $0.015\%$ ). (3) Heavy metals— Proceed with $1.0~\mathrm{g}$ of Estazolam according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution $(\mathrm{NMT}\,\,20\,\,\mathrm{ppm})$ ).  

(4) Arsenic— Prepare the test solution with $1.0~\mathrm{g}$ of Estazolam according to Method 3 and perform the test $(\mathrm{NMT}\ 2\ \mathrm{ppm})$ ).  

(5) Related substances— Dissolve $0.2{\mathrm{~g~}}$ of Estazolam in $10\;\mathrm{mL}$ of methanol and use this solution as the test solution. Pipet $1\,\textrm{m L}$ of this solution, add methanol to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot 10 $\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel with fluorescent indicator for thin-layer chromatography, develop the plate with a mixture of hexane, chloroform and methanol $(5:3:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and airdry the plate.  Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $1.0\%$ ($\mathrm{~\,~1~g,~}105\ ^{\circ}\mathrm{C}$ , 4 hours). Residue on ignition NMT $0.1\%$ (2 g). Assay Weigh accurately about $0.25~\mathrm{g}$ of Estazolam, previously dried, dissolve in $100\,\mathrm{\mL}$ of acetic anhydride, and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). The endpoint of the titration is when the solution changes to the equivalence point 2. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=14.737\;\mathrm{mg}$ of ${\mathrm{C}}_{16}{\mathrm{H}}_{11}{\mathrm{ClN}}_{4}$  

![](images/a03ac7246b3e3c4c4fac3dd54d597d450403a689e8b411bc977a803401c631ad.jpg)  
Packaging and storage Preserve in well-closed containers.  

Estradiol $\mathrm{C_{18}H_{24}O_{2}}$ : 272.38 (17β)-Eestra-1,3,5(10)-triene-3,17-diol [ 50-28-2 ]Estradiol, when dried, contains NLT $97.0\%$ and NMT $103.0\%$ of Estradiol $\left(\mathbf{C}_{18}\mathrm{H}_{24}\mathbf{O}_{2}\right)$ .  

Description Estradiol occurs as white crystals or a crystalline powder and is odorless.   
It is freely soluble in 1,4-dioxane, soluble in acetone, sparingly soluble in ethanol(95), slightly soluble in sesame oil and practically insoluble in water.  

Identification (1) Determine the absorption spectra of solutions of Estradiol and estradiol RS, respectively, in ethanol(95) (1 in 20000) as directed under Ultravioletvisible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths. The difference of absorption maxima in each absorption spectra is NLT $3.0\%$ at about $280\;\mathrm{nm}$ .  

(2) Determine the infrared spectra of Estradiol and estradiol RS as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+76.0^{\circ}$ and $+83.0^{\circ}$ $\mathbf{(0.250~g}$ , calculated on the anhydrous basis, ethanol(95),  

25 mL, $100\;\mathrm{mm}$  

# Melting point Between 173 and $179\,^{\circ}\!\mathrm{C}$  

Purity Related substances —Weigh about $70~\mathrm{mg}$ of Estradiol, add a mixture of n-butyl chloride and methanol $(5:1)$ , shake vigorously, add a mixture of n-butyl chloride and methanol $(5:1)$ to make $10~\mathrm{mL}$ , and use this solution as the test solution. Perform the test with $10~\upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area by the automatic integration method and calculate the peak area, $A_{\mathrm{i}}$ of each related substance and the total area of all peaks AS by the percentage peak area method; the amount of each related substance is NMT $0.5\%$ , and the total amount of related substances is NMT $1.0\%$ .  

$$
\begin{array}{r}{=100\times\frac{A_{\mathrm{i}}}{A_{\mathrm{S}}}}\end{array}
$$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with porous silanized silica gel for liquid chromatography (3 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of isooctane, n-butyl chloride, and methanol $(45:4:1)$ .  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the test solution under the above operating conditions; the resolution between the peaks of estradiol and each related substance is NLT 1.0, and the number of theoretical plates and symmetry factor are NLT 800 and NMT 1.5, respectively.  

System repeatability: Repeat the test 5 times according to the above conditions with $10~\upmu\mathrm{L}$ each of the test solution; the relative standard deviation of the peak area of estradiol is NMT $2.0\%$ .  

Water NMT $3.5\%$ $\left(0.5\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Assay Weigh accurately about $0.1~\mathrm{g}$ of Estradiol, previously dried, and dissolve in methanol to make exactly $250~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add $5.0~\mathrm{mL}$ of the internal standard solution and $100~\mathrm{mL}$ of methanol and water to make exactly $200\;\mathrm{mL}$ and use this solution as the test solution. Separately, weigh accurately a sufficient amount each of estradiol RS (previously determined water contents) and estrone RS and dissolve separately in methanol to contain about $400\ \upmu\mathrm{g}$ of estradiol and $240~\upmu\mathrm{g}$ of estrone per mL. Pipet $10~\mathrm{mL}$ each of these solutions, add $5.0~\mathrm{mL}$ of the internal standard solution, $100~\mathrm{mL}$ of methanol and add water to make exactly $200~\mathrm{mL}$ and use these solutions as the standard solutions. Perform the test with $25~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $\mathrm{Q_{T}}$ and $\mathrm{Qs}$ , of estradiol to internal standard, respectively.  

$$
\begin{array}{r}{\mathrm{Amount}\left(\mathrm{mg}\right)\mathrm{of~estradiol}\left(\mathrm{C}_{18}\mathrm{H}_{24}\mathrm{O}_{2}\right)}\\ {=5\times C\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\qquad\qquad\qquad}\end{array}
$$  

$C$ : Final concentration of Estradiol in the standard solution $(\upmu\mathrm{g/mL)}$  

Internal standard solution —A solution of ethylparabene in methanol (0.6 in 1000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $205\;\mathrm{nm}$ ).  

Column: A stainless steel column about $3.9\ \mathrm{mm}$ in internal diameter and $30\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (about $5\;\mathrm{{\mum}}$ to $10\,\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile and water $(55:45)$ .  

Flow rate: $1\ \mathrm{mL/min}$ System suitability  

System performance: Proceed with $25~\upmu\mathrm{L}$ of the standard solution under the above conditions; the internal standard, estradiol, and estrone are eluted in this order with the resolution being NLT 2.0.  

System repeatability: Repeat the test 6 times with $25\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area ratio is NMT $2.0\%$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

# Estradiol Benzoate 에스트라디올벤조에이트  

![](images/0eec3eb4042b175caf013db5ba472c682330d5331f09fa2b3603319170a37db6.jpg)  

${\bf C}_{25}{\bf H}_{28}{\bf O}_{3}$ : 376.49 (17β)-3-Hydroxyestra-1,3,5(10)-trien-3-yl benzoate [ 50- 50-0 ]  

Estradiol Benzoate, when dried, contains NLT $97.0\%$ and NMT $101.0\%$ of estradiol benzoate Description Estradiol Benzoate occurs as a white crystalline powder and is odorless.  

It is sparingly in acetone, slightly soluble in methanol, ethanol(95) and ethanol(95), and practically insoluble in water.  

Identification (1) Add $2~\mathrm{mL}$ of sulfuric acid to $2~\mathrm{mg}$ of Estradiol Benzoate; the resulting solution exhibits a yellowish green color with blue fluorescence. Carefully add $2~\mathrm{mL}$ of water; the color of the solution changes to light orange. (2) Determine the infrared spectra of Estradiol Benzoate and estradiol benzoate RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+54^{\circ}$ and $+58^{\circ}$ (after drying, $0.1~\mathrm{g}$ , acetone, $10\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 191 and $198\,^{\circ}\mathbf{C}$ Purity (1) $3,\!I7\!a$ -Estradiol —Dissolve $5.0\,\mathrm{~mg~}$ each of Estradiol Benzoate and estradiol benzoate RS in acetone to make exactly $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Put exactly $2~\mathrm{mL}$ each of the test solution and standard solution in separate glass-stoppered test tube, add boiling stones, evaporate the acetone by heating on a steam bath, and dry the residue in a desiccator (in vacuum, phosphorus (V) oxide) for 1 hour. Add $1.0\,\mathrm{\mL}$ of dilute ironphenol TS to each test tube. Stopper the test tubes loosely, heat for 30 seconds on a steam bath, shake on a steam bath for several seconds, and heat for 2 minutes again. After cooling the solutions in ice again for 2 minutes, add $4.0\;\mathrm{mL}$ of diluted sulfuric acid (7 in 20) and mix well; the solution obtained from the test solution has no more intense than that from the standard solution.  

(2) Related substances —Dissolve $40~\mathrm{mg}$ of Estradiol Benzoate in $2\;\mathrm{mL}$ of acetone, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add acetone to make exactly $100\,\mathrm{\mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of chloroform and diethylamine $(19:1)$ as the developing solvent to a distance of about $15~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.5\%$ ($\mathrm{\Omega}^{0.5{\mathrm{~g~}}}$ , in vacuum, phosphorus (V) pentoxide, 4 hours).  

# Residue on ignition NMT $0.2\%$ (0.1 g).  

Assay Weigh accurately about $10~\mathrm{mg}$ each of Estradiol Benzoate and estradiol benzoate RS, previously dried, dissolve separately in methanol to make exactly $20~\mathrm{mL}$ Pipet $5~\mathrm{mL}$ each of these solutions, add exactly $5~\mathrm{mL}$ of the internal standard solution, then add methanol to make $20\;\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with 5 $\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ ,of the peak area of estradiol benzoate to that of the internal standard for the test solution and the standard solution, respectively.  

Internal standard solution —A solution of progesterone in methanol (13 in 80000).  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $230\;\mathrm{nm}$ ).   
Column: A stainless steel column $4~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;{\upmu\mathrm{m}}$ in particle diameter).   
Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of acetonitrile and water $(7:3)$ .  
Flow rate: Adjust the flow rate so that the retention time of estradiol benzoate is about 10 minutes.   
System suitability   
System performance: Proceed with $5\,\upmu\mathrm{L}$ of the  

standard solution according to the above conditions; the internal standard and estradiol benzoate are eluted in this order with the resolution being NLT 9.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution as directed in the above conditions; the relative standard deviation of the peak area ratios of estradiol benzoate to the peak area of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

# Estradiol Valerate 에스트라디올발레레이트  

![](images/7ee0d235a9b0ad7f630745e155a953c209e451c2639212304cd36120b1939796.jpg)  
$\mathrm{C}_{23}\mathrm{H}_{32}\mathrm{O}_{3}:356.50$  

(17β)-3-Hydroxyestra-1,3,5(10)-trien-17-yl pentanoate [979-32-8 ]  

Estradiol Valerate contains NLT $98.0\%$ and NMT $102.0\%$ of Estradiol Valerate $\left(\mathbf{C}_{23}\mathbf{H}_{32}\mathbf{O}_{3}\right)$ ).  

Description Estradiol Valerate occurs as a white crystalline powder, is odorless or has a slightly oily odor. It is soluble in castor oil, methanol, benzylbenzoate or 1,4-dioxane, sparingly soluble in sesame oil or peanut oil, and practically insoluble in water.  

Identification Determine the infrared spectra of Estradiol Valerate and estradiol valerate RS, prepared by adding chloroform and potassium bromide to Estradiol Valerate or estradiol valerate RS, then grinding and drying at 105 $^{\circ}\mathbf{C}.$ , as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibits similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+41^{\circ}$ and $+47^{\circ}$ $\left.0.5\ \mathrm{g}\right.$ ,calculated on the anhydrous basis, methanol, $20~\mathrm{mL}$ , 100 mm).  

Melting point Between 143 and $150\;^{\circ}\mathrm{C}$ (Method 1). Purity (1) Estradiol —Dissolve $50~\mathrm{mg}$ of Estradiol Valerate in $10\;\mathrm{mL}$ of acetone and use this solution as the test solution. Separately, dissolve $5~\mathrm{mg}$ of estradiol valerate RS in $100\,\mathrm{\mL}$ of acetone and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot 5 $\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of cyclohexane and ethyl acetate $(7:3)$ as the developing solvent to a distance of about $15~\mathrm{cm}$ and dry the plate at $90\;^{\circ}\!C$ for 30 minutes. Spray evenly a solution of sulfuric acid in methanol (3 in 10) on the plate and heat at $90\ ^{\circ}\mathbf{C}$ for 30 minutes; spots other than the principal spot from the test solution or the spot corresponding to estradiol are not more intense or not greater than the spots from the standard solution (NMT $1.0\%$ ).  

(2) Free acid —Neutralize $25~\mathrm{mL}$ of ethanol(95) in an Erlenmeyer flask with $0.01\ \mathrm{mol/L}$ sodium hydroxide VS to a pale blue color, using bromothymol blue TS. Weigh accurately about $0.50~\mathrm{g}$ of Estradiol Valerate and dissolve in the neutralized ethanol. Titrate with 0.01 $\mathrm{mol/L}$ sodium hydroxide VS to a pale blue color. (NMT $0.5\%$ of valeric acid)  

# Each mL of $0.01\;\mathrm{mol/L}$ sodium hydroxide VS $=1.021\ \mathrm{mg}$ of $C_{5}\mathrm{H}_{10}\mathrm{O}_{2}$  

(3) Related substances —Dissolve $0.1~\mathrm{g}$ of Estradiol Valerate in $10~\mathrm{mL}$ of acetone and use this solution as the test solution. Separately, weigh $10~\mathrm{mg}$ of estradiol valerate RS and add acetone to make $10~\mathrm{mL}$ . Pipet $0.1~\mathrm{mL}$ ,$0.5~\mathrm{mL}$ ,$1~\mathrm{mL}$ and $2~\mathrm{mL}$ of this solution and add acetone to each to make exactly $10\;\mathrm{mL}$ and use these solutions as the standard solutions (1),(2), (3) and (4). With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $20~\upmu\mathrm{L}$ each of the test solution and the standard solutions (1), (2), (3) and (4) on a plate of silica gel for thin-layer chromatography. Develop the plate with a mixture of cyclohexane and ether $(4:1)$ as the developing solvent to a distance of about $15~\mathrm{cm}$ and air-dry the plate. Spray evenly sulfuric acid in ethanol(95) (1 in 10) on the plate, heat the plate until burn and cool. Examine under ultraviolet light (main wavelength: $254~\mathrm{nm}$ and $366~\mathrm{nm}$ ). Compare the intensities of any spot other than the principal spot from the test solution with those from the standard solution; the relative intensity is NMT $2.0\%$ .  

# Water NMT $0.1\%$ ($\mathbf{\mathcal{S}\Sigma g}$ , direct titration).  

Assay Weigh accurately about $25~\mathrm{mg}$ of Estradiol Valerate and estradiol valerate RS, dissolve each in the internal standard solution to make exactly $25\,\mathrm{\mL}$ and use these solutions as the test solution and the standard solution, respectively. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratio of the peak area of Estradiol Valerate to that of the internal standard, $Q_{\mathrm{T}}$ and $Q_{S}$ .Internal standard solution —Testosterone benzoate solution in tetrahydrofuran (2 in 1000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm})$ .  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and $30\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (about $5\;\mathrm{{\mum}}$ to $10\,\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Dissolve $0.8~\mathrm{g}$ of ammonium nitrate in $300\;\mathrm{mL}$ of water, add $700\;\mathrm{mL}$ of acetonitrile and mix. Flow rate: $2\ \mathrm{mL/min}$  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; estradiol valerate and the internal standard are eluted in this order with the resolution being NLT 3.  

System repeatability: Repeat the test 6 times with $10\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area ratio is NMT $1.5\%$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

# Estradiol Valerate Injection 에스트라디올발레레이트주사액  

Estradiol Valerate Injection is an oily preparation for injection, and contains NLT $90.0\%$ and NMT $115.0\%$ of the labeled amount of estradiol valerate $\left(\mathbf{C}_{23}\mathbf{H}_{32}\mathbf{O}_{3}\right.$ :356.50).  

Method of preparation Prepare as directed under Injections, with Estradiol Valerate.  

Description Estradiol Valerate Injection occurs as a pale yellow distillate.  

Identification Add $0.5\ \mathrm{mL}$ of Estradiol Valerate Injection in a separatory funnel with $10~\mathrm{mL}$ of hexane and 10 $\mathrm{mL}$ of $80\%$ methanol, shake for 2 minutes to mix, and allow to stand to separate the layers. To $1~\mathrm{mL}$ of the bottom layer solution, add $1~\mathrm{mL}$ of Folin TS (dilute by adding $2~\mathrm{mL}$ of water to $1~\mathrm{mL}$ of stock solution when using) and $3\ \mathrm{mL}$ of sodium carbonate solution (1 in 5); the resulting solution exhibits a blue color.  

Purity Estradiol— Pipet an appropriate amount of Estradiol Valerate Injection according to the labeled amount, and add acetone to obtain a solution containing $30\%$ . To $1.0\;\mathrm{mL}$ of this solution, add the oil used in the injection to make exactly $10\;\mathrm{mL}$ , and use this solution as the estradiol solution. Perform the test with this solution and estradiol valerate injection as directed under the Thin Layer Chromatography. Spot $5\,\upmu\mathrm{L}$ each of these solutions on the plate made of silica gel for thin-layer chromatography. Proceed as directed under Estradiol of Estradiol Valerate (NMT $3.0\%$ ).  

Sterility Meets the requirements. Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Pipet an amount of Estradiol Valerate Injection equivalent to about $20~\mathrm{~mg~}$ of estradiol valerate $\left(\mathbf{C}_{23}\mathbf{H}_{32}\mathbf{O}_{3}\right)$ according to the labeled amount, wash the pipet with tetrahydrofuran, add $5.0\,\textrm{m L}$ of the internal standard solution, and then add tetrahydrofuran to make exactly $25~\mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately about $20~\mathrm{mg}$ of estradiol valerate RS, add $5.0~\mathrm{mL}$ of the internal standard solution, add tetrahydrofuran to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test as directed in the Assay of Estradiol Valerate.  

Amount (mg) estradiol valerate $(\mathbf{C}_{23}\mathbf{H}_{32}\mathbf{O}_{3})$ )$=$ Amount (mg) of estradiol valerate $\mathrm{RS}\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —Solution of testosterone benzoate in tetrahydrofuran (8 in 1000).  

Packaging and storage Preserve in light-resistant, hermetic containers.  

# Estradiol Valerate Tablets 에스트라디올발레레이트정  

Estradiol Valerate Tablets contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of estradiol valerate $(\mathrm{C}_{23}\mathrm{H}_{32}\mathrm{O}_{3}:356.50)$ .  

Method of preparation Prepare as directed under Tablets, with Estradiol Valerate.  

Identification Weigh an amount of Estradiol Valerate Tablets, equivalent to $10~\mathrm{mg}$ of estradiol valerate, according to the labeled amount, dissolve in $25\,\mathrm{\mL}$ of $80\%$ methanol, and filter. Use the filtrate as the test solution. Separately, weigh $10\,\mathrm{~mg}$ of estradiol valerate RS, add $80\%$ methanol to make $25~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of hexane and ethyl acetate $(8:2)$ as the developing solvent to a distance of about $10\;\mathrm{cm}$ , and air-dry the plate. Spray evenly the coloring agent (dissolve $20\,\mathrm{~g~}$ of toluenesulfonic acid in ethanol to make $100\;\mathrm{mL}$ ), and then examine the plate under ultraviolet light (main wavelength: 254 nm); the $R_{\mathrm{f}}$ values and the colors of the spots obtained from the test solution and the standard solution are the same.  

Disintegration Meets the requirements. Uniformity of dosage units Meets the requirements. Assay Weigh accurately the mass of NLT 20 tablets of Estradiol Valerate Tablets and powder. Weigh accurately an amount equivalent to about $2~\mathrm{mg}$ of estradiol valerate, add $1~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid, shake to mix, and warm on a steam bath at $50~^{\circ}\mathrm{C}$ for 10 minutes. Then, add $4.0\,\textrm{m L}$ of internal standard solution, warm for 20 minutes, filter, and use the filtrate as the test solution. Separately, weigh accurately about $0.1~\mathrm{g}$ of estradiol valerate RS and add the internal standard solution to make $200\;\mathrm{mL}$ . Take $20.0\;\mathrm{mL}$ of this solution, add $5.0\;\mathrm{mL}$ of 0.1 $\mathrm{mol/L}$ hydrochloric acid, and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions; determine the peak area ratios, $\mathrm{Q_{T}}$ and $\mathrm{Q}_{\mathrm{S}}$ , of estradiol to the peak area of the internal standard, respectively.  

Amount (mg) of estradiol valerate $\left(\mathbf{C}_{23}\mathbf{H}_{32}\mathbf{O}_{3}\right)$ $=$ Amount (mg) of estradiol valerate $\mathrm{RS}\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times\frac{1}{50}$ Internal standard solution —A solution of diflucortolone valerate in methanol (5 in 10000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.0\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of methanol and water (725: 275).   
Flow rate: 2.0 mL/min  

Packaging and storage Preserve in well-closed containers.  

![](images/5f7ecf1e8e5e870e78017b7fd45ac104a27540d9fe092d871a929044ea16d2d3.jpg)  

Estriol $\mathrm{C_{18}H_{24}O_{3}}$ : 288.38 $(16\upalpha,17\upbeta)$ -Estra-1,3,5(10)-triene-3,16,17-triol [ 50-27-1 ]Estriol, when dried, contains NLT $97.0\%$ and NMT $102.0\%$ of estriol $\left(\mathbf{C}_{18}\mathbf{H}_{24}\mathbf{O}_{3}\right)$ .  

Description Estriol occurs as a white crystalline powder and is odorless.  

It is sparingly soluble in methanol, slightly soluble in ethanol(95) or 1,4-Dioxane and practically insoluble in water or ether.  

Identification (1) Dissolve $10~\mathrm{mg}$ of Estriol in $100~\mathrm{mL}$ of ethanol(95) by warming, and use this solution as the test solution. Evaporate $1~\mathrm{mL}$ of this solution on a steam bath to dryness, add $5\,\textrm{m L}$ of a solution of sodium pphenolsulfonate in phosphoric acid (1 in 50), heat at $150\ ^{\circ}\mathrm{C}$ for 10 minutes, and cool; the resulting solution exhibits a purple color.  

(2) Dissolve $10~\mathrm{mg}$ of Estriol and estriol RS in 100 mL of ethanol(95) by warming, determine the absorption spectra as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Estriol and estriol RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+60^{\circ}$ and $+65^{\circ}$ (after drying, $80\;\mathrm{mg}$ , ethanol(99.5), $10\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 281 and $286\,^{\circ}\!\mathbf{C}$ Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Estriol according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution $(\mathrm{NMT}\,\,20\,\,\mathrm{ppm})$ ).  

(2) Related substances —Dissolve about $40~\mathrm{mg}$ of Estriol in $10~\mathrm{mL}$ of ethanol(95) by warming and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add ethanol(95) to make $100\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel for thin-layer chromatography. Develop the plate with a mixture of chloroform, methanol, acetone, and acetic acid(100) ( $:18:1:1:$ 1) as the developing solvent to a distance of about $15~\mathrm{cm}$ ,and air-dry the plate. Spray evenly diluted sulfuric acid (1 in 2) on the plate and heat at $105~^{\circ}\mathrm{C}$ for 15 minutes; the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

# Loss on drying NMT $0.5\%$ ($0.5\;\mathrm{g}$ ,$105\;^{\circ}\!C$ , 3 hours).  

Residue on ignition NMT $0.1\%$ (0.5 g). Assay Weigh accurately the average about $25~\mathrm{mg}$ each of Estriol and estriol RS, previously dried, dissolve separately in methanol to make exactly $50~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ each of these solutions, add exactly $5\ \mathrm{ml}$ of the internal standard solution, add methanol to make $100\;\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the ratio of the peak area of Estriol to that of the internal standard, $Q_{\mathrm{T}}$ and $Q_{\mathrm{S}}$ .  

# Amount (mg) of estriol $(\mathbf{C}_{18}\mathbf{H}_{24}\mathbf{O}_{3})$ )$=$ Amount (mg) of estriol $\mathrm{RS}{\times}\,\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$  

Internal standard solution —A solution of methyl benzoate in methanol (1 in 1000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of water and methanol (51:49).  

Flow rate: Adjust the flow rate so that the retention time of Estriol is about 10 minutes.  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; estriol and the internal standard are eluted in this order with the resolution being NLT 8.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area ratios of estriol to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers.  

# Estriol Tablets 에스트리올정  

Estriol Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of estriol $\left(\mathrm{C}_{18}\mathrm{H}_{24}\mathrm{O}_{3}\ :\right.$ 288.38).  

Method of preparation Prepare as directed under Tablets, with Estriol.  

Identification Weigh an amount of Estriol Tablets, previously powdered, equivalent to $2~\mathrm{mg}$ of estriol according to the labeled amount, add $20\,\mathrm{mL}$ of ethanol(95), shake to mix for 10 minutes, and centrifuge. Use the clear supernatant as the test solution. Perform the Identification (1) and (2) of Estriol with the test solution.  

Dissolution Perform the test with 1 tablet of Estriol Tablets at 50 revolutions per minute according to Method 2 under the Dissolution, using $900~\mathrm{mL}$ of water as the dissolution medium. Take NLT $20\;\mathrm{mL}$ of the dissolved solution 30 minutes after starting the test, and filter through a membrane filter with a pore size of NMT $0.8~{\upmu\mathrm{m}}$ . Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $\mathrm{~V~mL~}$ of the subsequent filtrate, add water to make exactly $\mathrm{V}^{\circ}\,\,\mathrm{mL}$ of solution containing about $0.1~\upmu\mathrm{g}$ of estriol $\left(\mathbf{C}_{18}\mathrm{H}_{24}\mathbf{O}_{3}\right)$ per mL according to the labeled amount, and use this solution as the test solution. Separately, weigh accurately about 10 mg of estriol RS, previously dried at $105~^{\circ}\mathrm{C}$ for 3 hours, and dissolve in methanol to make exactly $100~\mathrm{mL}$ . Pipet $5\ \mathrm{mL}$ of this solution and add water to make $100\ \mathrm{mL}$ .Pipet $2~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $100~\upmu\mathrm{L}$ each of the test solution and the standard solution according to the operating conditions under the Assay of Estriol, and measure the peak areas, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of estriol, respectively.  

It meets the requirements when the dissolution rate of Estriol Tablets in 30 minutes is NLT $80\%$ .  

Dissolution rate $(\%)$ of the labeled amount of estriol  

$$
\begin{array}{c}{{(\mathrm{C}_{18}\mathrm{H}_{24}\mathrm{O}_{3})}}\\ {{=W_{\mathrm{S}}\times\displaystyle\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\displaystyle\frac{V^{\prime}}{V}\times\displaystyle\frac{1}{\mathrm{C}}\times\displaystyle\frac{9}{10}}}\end{array}
$$  

# $W_{\mathrm{S}}$ : Amount (mg) of estriol RS  

$C$ : Labeled amount (mg) of estriol $\left(\mathbf{C}_{18}\mathbf{H}_{24}\mathbf{O}_{3}\right)$ ) in 1 tablet  

Uniformity of dosage units It meets the requirements when the Content uniformity test is performed according to the following procedure. Take 1 tablet of Estriol Tablets, add exactly $5~\mathrm{mL}$ of water, sonicate to disperse, and add exactly $15\,\mathrm{\mL}$ of methanol. Shake to mix for 15 minutes. Centrifuge this solution for 10 minutes, pipet a certain amount of the clear supernatant, and add methanol to obtain a solution having known concentration of about $5~\upmu\mathrm{g}$ of estriol $\left(\mathbf{C}_{18}\mathrm{H}_{24}\mathbf{O}_{3}\right)$ per mL. Pipet $5~\mathrm{mL}$ of this solution, add exactly $1~\mathrm{mL}$ of the internal standard solution, and use this solution as the test solution. Perform the test solution with $20~\upmu\mathrm{L}$ of the test solution under the Assay of Estriol as follow. However, prepare the internal standard solution with a solution of methyl benzoate in methanol (1 in 40000). Measure the average value from the peak area ratios of individual 10 tablets of Estriol Tablets; it meets the requirements when the deviation $(\%)$ between the value and the individual peak area ratio is within $15\%$ . Also, perform the test with another 20 tablets of Estriol Tablets when there is 1 tablet with a deviation $(\%)$ of more than $15\%$ and less than $25\%$ . Calculate the deviation $(\%)$ between the average value of total 30 tablets from the two tests and each peak area ratio; it meets the requirements when there is NMT 1 tablet with a deviation of more than $15\%$ and less than $25\%$ , and there are no tablets with a deviation of more than $25\%$ .Assay Weigh accurately NLT 20 tablets of Estriol Tablets, and powder. Weigh accurately an amount equivalent to about $1~\mathrm{mg}$ of estriol $\left(\mathbf{C}_{18}\mathrm{H}_{24}\mathbf{O}_{3}\right)$ , add exactly $5~\mathrm{mL}$ of water, sonicate to disperse, and add $25~\mathrm{mL}$ of methanol. Shake to mix for 10 minutes, centrifuge, and take the clear supernatant. Add $25\,\mathrm{\mL}$ of methanol, repeat the procedure 2 times in the same manner, combine the clear supernatant, and add $5.0\;\mathrm{mL}$ of the internal standard solution, and add methanol to make exactly $100\;\mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately about $25~\mathrm{mg}$ of estriol RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 3 hours, and dissolve in methanol to make exactly 100 mL. Pipet $4\;\mathrm{mL}$ of this solution, add $5.0\;\mathrm{mL}$ of the internal standard solution, add methanol to make exactly 100 mL, and use this solution as the standard solution. Perform the test with exactly $20~\upmu\mathrm{L}$ each of the test solution and the standard solution under the Assay of Estriol.  

$$
\begin{array}{c}{{\mathrm{Amount}\ (\mathrm{mg})\ \mathrm{of}\ \mathrm{estriol}\ (\mathrm{C}_{18}\mathrm{H}_{24}\mathrm{O}_{3})}}\\ {{=\mathrm{Amount}\ (\mathrm{mg})\ \mathrm{of}\ \mathrm{estriol}\ \mathrm{RS}\times{\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}}\times{\frac{1}{25}}}}\end{array}
$$  

Internal standard solution —A solution of methyl benzoate in methanol (1 in 5000).  

Packaging and storage Preserve in tight containers. Etacrynic Acid $\mathrm{C}_{13}\mathrm{H}_{12}\mathrm{Cl}_{2}\mathrm{O}_{4}$ : 303.14 [2,3-Dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid [ 58-54-8 ]  

![](images/56e101916bd52a43c8cc29a343eab69ea56fa470012d0e159bf30ad29a194867.jpg)  

Etacrynic Acid, when dried, contains NLT 98.0 and NMT $101.0\%$ of etacrynic acid $(\mathbf{C}_{13}\mathbf{H}_{12}\mathbf{C}\mathrm{l}_{2}\mathbf{O}_{4})$ ).  

Description Etacrynic Acid occurs as a white, crystalline powder. It is odorless and has a slightly bitter taste. It is very soluble in methanol, freely soluble in ethanol(95), acetic acid(100) and ether, and very slightly soluble in water.  

Identification (1) Dissolve $0.2\:\mathrm{g}$ of Etacrynic Acid in 10 mL of acetic acid(100), and to $5~\mathrm{mL}$ of this solution, add $0.1~\mathrm{mL}$ of bromine TS; the color of the test solution disappears. To the remaining $5~\mathrm{mL}$ of the solution, add 0.1 mL of potassium permanganate TS; the color of the test solution immediately changes to light orange.  

(2) Add $1~\mathrm{mL}$ of sodium hydroxide TS to $0.01\ \mathrm{g}$ of Etacrynic Acid, and heat on a steam bath for 3 minutes. After cooling, add $1\ \mathrm{mL}$ of chromotropic acid TS, and heat on a steam bath for 10 minutes; the solution exhibits an intense purple color.  

(3) Determine the absorption spectra of solutions of Etacrynic Acid and etacrynic acid RS in methanol (1 in 20000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(4) Perform the test with Etacrynic Acid as directed under the Flame Coloration (2); it exhibits a green color.  

# Melting point Between 121 and $125~^{\circ}\mathrm{C}$  

Purity (1) Clarity and color of solution— Dissolve $1.0~\mathrm{g}$ of Etacrynic Acid in $10~\mathrm{mL}$ of methanol; the solution is clear and colorless.  

(2) Heavy metals— Proceed with $1.0~\mathrm{g}$ of Etacrynic Acid according to Method 4 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution $(\mathrm{NMT}\,\,20\,\,\mathrm{ppm})$ ).  

(3) Arsenic —Proceed with $1.0~\mathrm{g}$ of Etacrynic Acid according to Method 3 and perform the test. Add $10~\mathrm{mL}$ of a solution of magnesium nitrate hexahydrate in ethanol(95) (1 in 50), then add $1.5\ \mathrm{mL}$ of hydrogen peroxide(30), and fire to burn $(\mathrm{NMT}\,\,2\,\,\mathrm{ppm}$ ).  

(4) Related substances —Dissolve about $0.20\ \mathrm{g}$ of Etacrynic Acid in $10\;\mathrm{mL}$ of ethanol(95) and use this solution as the test solution. Pipet $3\ \mathrm{mL}$ of this solution, add ethanol(95) to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of chloroform, ethyl acetate, and acetic acid(100) $(6:5:$ 2) as the developing solvent to a distance of about $15\;\mathrm{cm}$ ,and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.25\%$ ($1\ \mathrm{g}_{}$ , in vacuum, $60~^{\circ}\mathrm{C}_{!}$ , 2 hours).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\ensuremath~{~1~}~}\mathrm{g})$  

Assay Weigh accurately about $0.1\ \mathrm{g}$ of Etacrynic Acid, previously dried, put in an iodine bottle, dissolve in 20 mL of acetic acid(100), and add exactly $20~\mathrm{mL}$ of 0.05 $\mathrm{mol/L}$ bromine. To this solution, add $3\ \mathrm{mL}$ of hydrochloric acid, stopper tightly at once, shake, and allow to stand in a dark place for 60 minutes. Then, carefully add $50~\mathrm{mL}$ of water and $15\,\mathrm{\mL}$ of potassium iodide TS, stopper tightly immediately, shake well, and titrate the liberated iodine with $0.1\ \mathrm{mol/L}$ sodium thiosulfate VS (indicator: 1 mL of starch TS). Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in well-closed containers.  

# Ethambutol Hydrochloride 에탐부톨염산염  

![](images/47a3e625afeca5df2882a903558206ca7a657db923d73a2f7ac9bfd51a5598b0.jpg)  
$\mathrm{C}_{10}\mathrm{H}_{24}\mathrm{N}_{2}\mathrm{O}_{2}.$ ·2HCl: 277.23  

$(2S,2^{\circ}S)–2,2^{\circ}$ -(Ethane-1,2-diyldiimino)dibutan-1-ol dihydrochloride [ 1070-11-7 ]  

Ethambutol Hydrochloride, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of ethambutol hydrochloride $\mathrm{\bf\left(C_{10}H_{24}N_{2}O_{2}\cdot2H C l\right)}$ ).  

Description Ethambutol Hydrochloride occurs as white crystals or a crystalline powder, is odorless and has a bitter taste.  

It is very soluble in water, soluble in methanol and in ethanol(95), and practically insoluble in ether. The pH of a solution of Ethambutol Hydrochloride (1 in 20) in $20\;\mathrm{mL}$ of water is between 3.4 and 4.0.  

Identification (1) Determine the infrared spectra of Ethambutol Hydrochloride and ethambutol hydrochloride RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) An aqueous solution of Ethambutol Hydrochloride (1 in 30) responds to the Qualitative Analysis for chloride.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+5.5$ and $+6.1^{\circ}$ (after drying, $5.0\;\mathrm{g}$ , water, $50\;\mathrm{mL}$ ,$200\;\mathrm{mm}$ ).  

Melting point Between $200\,^{\circ}\!C$ and $204\,^{\circ}\!C$ Purity (1) Clarity and color of solution —Dissolve $1.0\;\mathrm{g}$ of Ethambutol Hydrochloride in $10~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Heavy metals— Proceed with $2.0~\mathrm{g}$ of Ethambutol Hydrochloride according to Method 1 and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT 10 ppm).  

(3) Arsenic —Prepare the test solution with $1.0~\mathrm{g}$ of Ethambutol Hydrochloride, according to Method 1 and perform the test (NMT 2 ppm).  

(4) Related substances —Dissolve $0.10~\mathrm{g}$ of Ethambutol Hydrochloride in $10~\mathrm{mL}$ of methanol and use this solution as the test solution. Separately, dissolve $2~\mathrm{mg}$ of ethambutol hydrochloride RS in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $20~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel for thin-layer chromatography. Develop the plate with a mixture of methanol and ammonia water(28) $(18:1)$ as the developing solvent to a distance of about $15~\mathrm{cm}$ , and airdry the plate. Spray evenly iodine chloroform solution TS for spray on the plate; the spots other than the principal spots from the test solution are not more intense than the spots from the standard solution $(2.0\%)$ .  

(5) 2-Aminobutanol —Weigh accurately about 50 mg of Ethambutol Hydrochloride, dissolve in water to make exactly $100\,\mathrm{\mL}$ and use this solution as the test solution.  Separately, dissolve adequate amount of 2- aminobutanol RS, weighed accurately, in water and dilute sequentially to make a solution containing $5~\upmu\mathrm{g}$ per mL and use this solution as the standard solution. Transfer 10 mL of the test solution into a $100{\-}\mathrm{mL}$ Erlenmeyer flask with glass stopper and add $10~\mathrm{mL}$ of water and $20~\mathrm{mL}$ of boric acid buffer solution. Separately, mix $10.0\;\mathrm{mL}$ of the test solution, $10.0\ \mathrm{mL}$ of the standard solution, and 20 mL of boric acid buffer solution in a $100{\-}\mathrm{mL}$ Erlenmeyer flask. While the contents in two flasks are mixed on shaker, quickly add $10~\mathrm{mL}$ of fluorescamine solution and stopper them and mix briefly. Perform the test after exactly 1 minute with these solutions as directed under the Fluorescence Spectroscopy. Determine the fluorescence intensity at $385~\mathrm{nm}$ of excitation wavelength and $485~\mathrm{nm}$ of emission wavelength: the fluorescence intensity obtained from the test solution is NMT that of the difference between two solutions (NMT $1.0\%$ ).  

Boric acid buffer solution —Weigh about $1.24\mathrm{~g~}$ of boric acid, dissolve in $90\,\mathrm{\mL}$ of water, adjust with 5 $\mathrm{mol/L}$ sodium hydroxide to $\mathrm{pH}\,9.0$ , and dilute with water to exactly $100\;\mathrm{mL}$ and mix.  

Fluorescamine solution —Transfer $5~\mathrm{\mg}$ of fluorescamine into a cylinder with stopper and scale line, and dissolve in $50\;\mathrm{mL}$ of acetone.  

Loss on drying NMT $0.5\%$ (1 $\mathsf{g},\,105\ ^{\circ}\mathrm{C}$ , 3 hours). Residue on ignition NMT $0.1\%$ (1 g). Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Ethambutol Hydrochloride, previously dried, dissolve in $50\;\mathrm{mL}$ of water, add $1\ \mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid TS and titrate with $0.1\ \mathrm{\mol/L}$ sodium hydroxide TS from the first equivalence point to the second equivalence point (potentiometric titration under the Titrimetry).  

Each mL of $0.1\;\mathrm{mol/L}$ sodium hydroxide VS  $=27.723~\mathrm{mg}$ of $\mathrm{C}_{10}\mathrm{H}_{24}\mathrm{N}_{2}\mathrm{O}_{2}$ ·2HCl  

Packaging and storage Preserve in tight containers.  

# Ethambutol Hydrochloride Tablets 에탐부톨염산염정  

Ethambutol Hydrochloride Tablets contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of eth  

ambutol hydrochloride $(\mathrm{C_{10}H_{24}N_{2}O_{2}}{\cdot}2\mathrm{HCl}:277.23)$  

# Method of preparation Prepare as directed under Tablets, with Ethambutol Hydrochloride.  

Identification (1) Weigh an amount of Ethambutol Hydrochloride Tablets, previously powdered, equivalent to $0.1\,\mathrm{~g~}$ of ethambutol hydrochloride, according to the labeled amount, add $3\ \mathrm{mL}$ of methanol, transfer into a glass mortar, and stir to mix. Again, add $5\ \mathrm{mL}$ of methanol make a suspension, and filter through a filter paper, previously moistened with methanol. Transfer the filtrate to a beaker containing $100~\mathrm{mL}$ of acetone, stir to mix, allow to stand for 15 minutes, and extract crystals. Discard the clear supernatant by inclining the container, and air-dry the crystals until there is no methanol odor. Determine the infrared spectra of these crystals and ethambutol hydrochloride RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit maxima at the same wavenumber.  

(2) An aqueous solution of the crystals (1 in 10), obtained from (1), responds to the Qualitative Analysis for chloride.  

Purity 2-Aminobutanol —Take an appropriate number of tablets, equivalent to $400~\mathrm{mg}$ of ethambutol hydrochloride, transfer in a beaker, add acetone until the tablets are submerged, and allow to stand for 15 minutes. Discard the acetone, then dry, powder the tablet with the coating removed, and add methanol, shake to mix, make exactly $100~\mathrm{mL}$ , and filter. Pipet $25~\mathrm{mL}$ of the filtrate, and dilute with water to make exactly $200~\mathrm{mL}$ . Allow to stand for 15 minutes, filter through a dried filter paper, discard the first turbid filtrate, and use the subsequent filtrate as the test solution. Proceed with this solution under the Purity (5) of Ethambutol Hydrochloride.  

Dissolution Perform the test with 1 tablet of Ethambutol Hydrochloride Tablets at 100 revolutions per minute according to Method 1 under the Dissolution, using $900\;\mathrm{mL}$ of water as the dissolution medium. Take the dissolved solution 45 minutes after starting the test, filter, and use the filtrate as the test solution. Separately, weigh an appropriate amount of ethambutol hydrochloride RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 2 hours, dissolve in water to make a solution containing $0.1~\mathrm{mg}$ per mL, and use this solution as the standard solution. Transfer $1~\mathrm{mL}$ each of the test solution, the standard solution and water to 3 glass-stoppered centrifuge tubes, add $5.0~\mathrm{mL}$ of bromocresol green solution and $10.0\ \mathrm{mL}$ of chloroform, respectively, close with the stoppers, and shake vigorously to mix. Allow to stand until the chloroform layer separates, discard the supernatant water layer, and filter the chloroform layer through cotton. Perform the test with these solutions as directed under the Ultraviolet-visible Spectroscopy, and measure the absorbance at the absorbance maximum wavelength at about $415~\mathrm{nm}$ .  

The acceptable dissolution criterion of Ethambutol Hydrochloride Tablets is NLT $75\%$ (Q) dissolved in 45 Phosphate buffer solution —Dissolve $38.0~\mathrm{g}$ of sodium dihydrogen phosphate dihydrate and $2.0\,\mathrm{~g~}$ of anhydrous sodium dihydrogen phosphate in water to make $1000\,\mathrm{mL}$ .  

Bromocresol green solution —Weigh $0.2\,\mathrm{~g~}$ of bromocresol green, dissolve in $30~\mathrm{mL}$ of water and $6.5~\mathrm{mL}$ of $0.1\;\mathrm{\mol/L}$ sodium hydroxide, add phosphate buffer solution to make $500~\mathrm{mL}$ , and mix. Then, add $0.1\ \mathrm{mol/L}$ hydrochloric acid to adjust the $\mathrm{pH}$ to $4.6\pm0.1$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately NLT 20 tablets of Ethambutol Hydrochloride Tablets, and powder. Weigh accurately about 30 mg of ethambutol hydrochloride $\mathrm{(C_{10}H_{24}N_{2}O_{2}{\cdot}2H C l)}$ , dissolve in water by shaking to mix, then add water to make exactly $100~\mathrm{mL}$ , and filter. Discard the first $10\;\mathrm{mL}$ of the filtrate, and use the subsequent filtrate as the test solution. Separately, weigh accurately about $30~\mathrm{mg}$ of ethambutol hydrochloride RS, dissolve in water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and measure the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of ethambutol hydrochloride in each solution.  

Amount $\left(\mathrm{mg}\right)$ of ethambutol hydrochloride $\mathrm{(C_{10}H_{24}N_{2}O_{2}{\cdot}2H C l)}$  

$=$ Amount (mg) of ethambutol hydrochloride $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $200\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with nitrile silica gel for liquid chromatography ( $5\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of a solution, obtained by mixing $1.0\;\mathrm{mL}$ of triethylamine and $1000~\mathrm{mL}$ of water to adjust the $\mathrm{pH}$ to 7.0 with phosphoric acid, and acetonitrile $(1:1)$ .  

Flow rate: $1.0\,\mathrm{mL/min}$ System suitability  

System performance: Proceed with $50~\upmu\mathrm{L}$ of the standard solution according to the conditions above; the symmetry factor is NMT 2.0.  

System repeatability: Repeat the test 6 times with $50~\upmu\mathrm{L}$ each of the standard solution according to the conditions above; the relative standard deviation of the peak areas of ethambutol hydrochloride is NMT $2.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

# Ethenzamide 에텐자미드  

![](images/3dc72fb93fc6bec6d67a926d8f03ea4dc11ffcbcc36ae5d7439ba1f02d24612f.jpg)  

2-Ethoxybenzamide $\mathrm{C}_{9}\mathrm{H}_{11}\mathrm{NO}_{2}$ : 165.19 2-Ethoxybenzamide [ 938-73-8 ]  
Ethenzamide, when dried, contains NLT $98.0\%$ and NMT $101\%$ of ethenzamide $\left(\mathrm{C}\mathrm{{sH}_{11}}\mathrm{{NO}_{2}}\right)$ .Description Ethenzamide occurs as white crystals or a crystalline powder.   
It is soluble in methanol, ethanol(95) or acetone and practically insoluble in water.   
It begins to sublime slightly at about $105\ ^{\circ}\mathrm{C}$ .  

Identification (1) Take $0.5~\mathrm{g}$ of Ethenzamide, add $5~\mathrm{mL}$ of sodium hydroxide TS and heat the mixture gently; the gas produced turns moistened red litmus paper to blue. (2) Take $0.2{\mathrm{~g~}}$ of Ethenzamide, add $10~\mathrm{mL}$ of hydrobromic acid and boil the mixture gently for 1 hour under a reflux condenser. Cool in ice-water, filter and collect the separated crystalline precipitate, wash 3 times with $5~\mathrm{mL}$ each of ice-water and dry in a desiccator (in vacuum, silica gel) for 2 hours; the precipitate melts between $158\;^{\circ}\mathrm{C}$ and $161\ ^{\circ}\mathrm{C}$ .  

(3) Determine the absorption spectra of solutions of Ethenzamide and ethenzamide RS in methanol (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(4) Determine the infrared spectra of Ethenzamide and ethenzamide RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 131 and $134\,^{\circ}\mathrm{C}$ .Purity (1) Chloride —Dissolve $0.5~\mathrm{g}$ of Ethenzamide in $30~\mathrm{mL}$ of acetone, add $6\;\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with 0.7 $\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ hydrochloric acid, $30\;\mathrm{mL}$ of acetone, 6 mL of dilute nitric acid and water to make $50~\mathrm{mL}$ (NMT $0.050\%$ ).  

(2) Sulfate —Dissolve $0.5\ \mathrm{g}$ of Ethenzamide in 30 mL of acetone and add $1~\mathrm{mL}$ of dilute hydrochloric acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $0.50~\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid, add $30~\mathrm{mL}$ of acetone, $1~\mathrm{mL}$ of dilute hydrochloric acid and water to 50  

mL (NMT $0.048\%$  

(3) Heavy metals —Proceed with $2.0\,\mathrm{~g~}$ of Ethenzamide according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution (NMT $10\,\mathrm{ppm})$ ).  

(4) Arsenic —Take $0.40~\mathrm{g}$ of Ethenzamide, add $0.3~\mathrm{g}$ of potassium nitrate and $0.5~\mathrm{g}$ of anhydrous sodium carbonate, mix thoroughly, ignite the mixture gradually. After cooling, dissolve the residue in $10\,\mathrm{\mL}$ of dilute sulfuric acid and heat the solution until white fumes are produced. After cooling, add water carefully to make 5 mL. Use this solution as the test solution (NMT 5 ppm). (5) Salicylamide —Dissolve $0.20~\mathrm{g}$ of Ethenzamide in $15\;\mathrm{mL}$ of dilute ethanol (2 in 3) and add 2 to 3 drops of dilute iron(III) chloride TS; the resulting solution does not exhibit a purple color.  

Loss on drying NMT $1.0\%$ ($1~\mathrm{g}$ , silica gel, 3 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $20~\mathrm{mg}$ each of Ethenzamide and ethenzamide RS, previously dried, and dissolve each in $70~\mathrm{mL}$ of ethanol(95) by warming.  After cooling, add ethanol(95) to make exactly $100~\mathrm{mL}$ . Pipet $5.0~\mathrm{mL}$ each of these solutions, add ethanol(95) to make exactly $50~\mathrm{mL}$ and use these solutions as the test solution and the standard solution, respectively.  Determine the absorbances, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ of the test solution and the standard solution, respectively, at ${290}\,\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy, using ethanol(95) as the blank.  

Amount (mg) of ethenzamide $\left(\boldsymbol{\mathbf{C}}\boldsymbol{\mathbf{{j}}}\mathbf{H}_{11}\boldsymbol{\mathbf{N}}\boldsymbol{\mathbf{O}}_{2}\right)$ )$=$ Amount (mg) of ethenzamide $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$ Packaging and storage Preserve in well-closed containers.  

# Anesthetic Ether 마취용에테르  

$$
\mathsf{C H}_{3}\mathsf{C H}_{2}\mathsf{O C H}_{2}\mathsf{C H}_{3}
$$  

$\mathrm{C_{4}H_{10}O:74.12}$  

Anesthetic Ether contains NLT $96.0\%$ and NMT $98.0\%$ (by specific gravity) of ether $\left(\boldsymbol{\mathbf{C}}_{4}\boldsymbol{\mathbf{H}}_{10}\boldsymbol{\mathbf{O}}\right)$ .Anesthetic Ether contains small quantities of ethanol(95) and water, and suitable stabilizers may be added. Anesthetic Ether is not to be used for anesthesia if it has been removed from the original container for more than 24 hours.  

Description Anesthetic Ether occurs as a colorless, clear, mobile liquid, and has a characteristic odor.  

It is miscible with ethanol(95).   
It is soluble in water.   
It is highly volatile and flammable.   
It is slowly oxidized by the action of air and light, producing peroxides.   
The vapor of Anesthetic Ether, when mixed with air and ignited, may explode violently.   
Boiling point —Between 35 and $37\ ^{\circ}\mathrm{C}$ .  

Specific gravity $d_{20}^{20}$ : Between 0.718 and 0.721. Purity (1) Characteristic odor —Put $10\;\mathrm{mL}$ of Anesthetic Ether in an evaporating dish and allow it to evaporate spontaneously to a volume of $1\,\textrm{m L}$ ; no characteristic odor is perceptible. Pour the remaining solution onto a piece of clean, odorless filter paper to evaporate ether; no characteristic odor is perceptible.  

(2) Acid —Put $10\;\mathrm{mL}$ of diluted ethanol(4 in 5) and $0.5~\mathrm{mL}$ of phenolphthalein TS in a glass-stoppered flask and add $0.02\mathrm{\mol/L}$ sodium hydroxide VS dropwise to produce a red color which persists for 30 seconds after mixing by shaking. To this solution, add $25~\mathrm{mL}$ of Anesthetic Ether, stopper the flask, shake gently, and add 0.40 mL of $0.02\;\mathrm{mol/L}$ sodium hydroxide VS while mixing by shaking; a red color develops.  

(3) Aldehyde —To $100\,\mathrm{\mL}$ of water in a glassstoppered flask, add $10\;\mathrm{mL}$ of Anesthetic Ether and $1~\mathrm{mL}$ of a solution of sodium bisulfite (1 in 1000), stopper tightly, shake vigorously for 10 seconds, and allow the mixture to stand in a cool place for 30 minutes, protected from light. Then, add $2\ \mathrm{mL}$ of starch TS and add 0.01 $\mathrm{mol/L}$ iodine VS dropwise until a pale blue color appears. To this solution, add about $2\mathrm{~g~}$ of sodium bicarbonate, shake to mix until the blue color disappears, and add 1 mL of diluted $0.01\ \mathrm{mol/L}$ iodine VS (9 in 40); the solution turns blue. Keep the temperature of the solution below $18\,^{\circ}\!C$ during the procedure.  

(4) Peroxide —Put $10~\mathrm{mL}$ of Anesthetic Ether in a Nessler tube, add $1~\mathrm{mL}$ of a freshly prepared solution of potassium iodide (1 in 10), allow to stand for 1 hour while shaking occasionally and protecting from light, then add $1~\mathrm{mL}$ of starch TS, and shake well to mix; no color is produced in the aqueous layer and in the ether layer.  

(5) Residue on evaporation —Evaporate $50~\mathrm{mL}$ of Anesthetic Ether and dry the residue at $105\;^{\circ}\mathrm{C}$ for 1 hour; the weight of the residue is NMT $1.0~\mathrm{mg}$ .  

Water NMT $0.2\%$ $\mathrm{[0.1~\,g}$ , volumetric titration, direct titration).  

Packaging and storage Preserve in light-resistant, tight containers at a temperature not exceeding $25~^{\circ}\!C$ , without filling up and protected from fire.  

# Ethinylestradiol 에티닐에스트라디올  

![](images/6049dbd910b2e4f12e03671fb6e481c8cdb1448ee86770f52ab010fa07f61b1a.jpg)  

${\bf C}_{20}{\bf H}_{24}{\bf O}_{2}$ : 296.40  

19-Nor- $17\upalpha$ -pregna-1,3,5(10)-trien-20-yne-3,17-diol [57-  
63-6 ]  

Ethinylestradiol, when dried, contains NLT $98.0\%$ and NMT $101.0\%$ of ethinylestradiol $\left(\mathbf{C}_{20}\mathbf{H}_{24}\mathbf{O}_{2}\right)$ .  

Description Ethinylestradiol occurs as white or pale yellow crystals or a crystalline powder and is odorless. It is freely soluble in pyridine and tetrahydrofuran, soluble in ethanol(95) and ether, and practically insoluble in water.  

It dissolves in sodium hydroxide TS. Identification (1) Dissolve $2~\mathrm{mg}$ of Ethinylestradiol in 1 mL of a mixture of sulfuric acid and ethanol(95) $(1:1)$ ;the solution exhibits a purplish red color with yellowish green fluorescence. Carefully add $2~\mathrm{mL}$ of water to this solution; the color of the solution changes to reddish purple.  

(2) Transfer $20~\mathrm{{mg}}$ of Ethinylestradiol to a glass stoppered test tube, dissolve in $10\,\mathrm{\mL}$ of a solution of potassium hydroxide (1 in 20), add $0.1~\mathrm{g}$ of benzoyl chloride, and shake. Collect the resulting precipitate by filtering. Recrystallize from methanol, and dry in a desiccator (in vacuum, phosphorus (V) pentoxide); the precipitate melts between 200 and $202~^{\circ}\mathrm{C}$ .  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-26^{\circ}$ and $-31^{\circ}$ (after drying, $0.1~\mathrm{g}$ , pyridine, $25~\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 180 and $186\ ^{\circ}\mathrm{C}$ or 142 and $146\,^{\circ}\!C$ .  

Purity Estrone —Dissolve $5~\mathrm{mg}$ of Ethinylestradiol in $0.5\ \ \mathrm{mL}$ of ethanol(95), and add $50~\mathrm{~mg}$ of mdinitrobenzene. Add $0.5\,\mathrm{\mL}$ of freshly prepared dilute potassium hydroxide-ethanol TS, allow to stand in a dark place for 1 hour, and add $10\;\mathrm{mL}$ of ethanol(95); the color of the solution is no more intense than that of the following control solution.  

Control solution —Proceed in the same manner in the preparation of the test solution, omitting Ethinylestradiol.  

Loss on drying NMT $0.5\%$ ($\mathrm{\Delta}[0.5~\mathrm{g}$ , in vacuum, phosphorus pentoxide, 4 hours).  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Ethinylestradiol, previously dried, dissolve in $40\,\textrm{m L}$ of tetrahydrofuran, add $10\,\mathrm{\mL}$ of a solution of silver nitrate (1 in 20) and titrate with $0.1\ \mathrm{mol/L}$ sodium hydroxide VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner, and make any necessary correction. Each mL of $0.1\;\mathrm{mol/L}$ sodium hydroxide VS $=29.640\ \mathrm{mg}$ of ${\bf C}_{20}{\bf H}_{24}{\bf O}_{2}$  

Packaging and storage Preserve in light-resistant, tight containers.  

# Ethinylestradiol Tablets 에티닐에스트라디올정  

tion as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ of ethinylestradiol RS, previously dried in a desiccator (in vacuum, phosphorus pentoxide) for 4 hours, dissolve in methanol to obtain a solution containing about $0.04~\upmu\mathrm{g}$ of ethinylestradiol $(\mathbf{C}_{20}\mathbf{H}_{24}\mathbf{O}_{2})$ ) per mL, and use this solution as the standard solution. To the glass-stoppered test tubes T, S and B, put exactly $4\;\mathrm{mL}$ of sulfuric acid-methanol TS, respectively, cool with ice, add exactly $1~\mathrm{mL}$ each of the test solution, the standard solution and methanol, and shake immediately. Allow to stand on a steam bath at $30~^{\circ}\mathrm{C}$ for 40 minutes, and then allow to stand on a steam bath at $20~^{\circ}\mathrm{C}$ for 5 minutes. Perform the test with these solutions as directed under the Fluorescence Spectroscopy. Determine the fluorescence intensity, $F_{\mathrm{T}},\;F_{\mathrm{S}}$ , and $F_{\mathrm{B}}$ at an excitation wavelength of $460\;\mathrm{mm}$ and a fluorescence wavelength of $493~\mathrm{mm}$ .  

Ethinylestradiol Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of ethinylestradiol $(\mathrm{C}_{20}\mathrm{H}_{24}\mathrm{O}_{2}:296.40)$ .  

Method of preparation Prepare as directed under Tablets, with Ethinylestradiol.  

Identification (1) Evaporate $5\ \mathrm{mL}$ of the test solution from the Assay to dryness, and dissolve the residue in 2 mL of a mixture of sulfuric acid and ethanol $(2:1)$ ; the resulting solution exhibits a pale red color and a yellow fluorescence. Add carefully $4~\mathrm{mL}$ of water to this solution; the color of the solution changes to purple.  

(2) Evaporate $10\,\mathrm{\mL}$ of the test solution from the Assay to dryness, add $0.2\;\mathrm{mL}$ of acetic acid(31) and $2~\mathrm{mL}$ of phosphoric acid to the residue, and heat on a steam bath for 5 minutes; the resulting solution exhibits a red color and a yellowish green fluorescence.  

# Disintegration Meets the requirements.  

Uniformity of dosage units It meets the requirements when the procedure for content uniformity is performed according to the following procedure.  

Transfer 1 tablet of Ethinylestradiol Tablets into a separatory funnel, add $10\;\mathrm{mL}$ of Solution 2 from the Disintegration, and shake to mix until disintegration. Add 10 mL of dilute sulfuric acid and $20~\mathrm{~mL}$ of chloroform, shake vigorously for 5 minutes to mix, and filter the chloroform layer through a filter paper containing $5~\mathrm{g}$ of anhydrous sodium sulfate into an Erlenmeyer flask. Extract the water layer twice with $20\,\mathrm{\mL}$ each of chloroform, proceed in the same manner, and combine with the previous filtrate. Evaporate gently on a steam bath while passing through nitrogen, add exactly $100~\mathrm{mL}$ of methanol to the residue, dissolve, and centrifuge, if necessary. Pipet $\upchi$ mL of the supernatant clear liquid, add methanol to obtain exactly $\mathrm{V}\,\mathrm{mL}$ of a solution containing about $0.04~\upmu\mathrm{g}$ of ethinylestradiol $\left(\mathbf{C}_{20}\mathbf{H}_{24}\mathbf{O}_{2}\right)$ per mL, and use this solu  

$$
\times\,\frac{\dot{F_{\mathrm{T}}}-\dot{F_{\mathrm{B}}}}{F_{\mathrm{S}}-F_{\mathrm{B}}}\times\frac{\dot{V}}{2500}\times\frac{1}{x}
$$  

Assay Weigh accurately the mass of NLT 20 tablets of Ethinylestradiol Tablets, and powder. Weigh accurately an amount equivalent to about $0.5~\mathrm{mg}$ of ethinylestradiol $(\mathbf{C}_{20}\mathbf{H}_{24}\mathbf{O}_{2})$ , transfer into a $50{\-}\mathrm{mL}$ beaker, add $2~\mathrm{mL}$ of water, and shake well to mix. Then add $3\ \mathrm{mL}$ of chloroform and shake well to mix. Add $4\ \mathrm{~g~}$ of diatomaceous earth for chromatography, mix well until the contents do not adhere to the wall, and use this as the sample. Add $5\textrm{g}$ of diatomaceous earth for chromatography, previously weighed, to a $200{\-}{\mathrm{mL}}$ beaker, put $4\ \mathrm{mL}$ of 1 mol/L hydrochloric acid TS to mix thoroughly. Prepare a column for chromatography about $25~\mathrm{mm}$ in internal diameter and about $30\;\mathrm{cm}$ in length with a glass wool at the bottom and $5\textrm{g}$ of anhydrous sodium sulfate on top. Put the well-mixed solution to the column by pressing appropriately with a glass rod to fill the column homogeneously until the layer reaches 60 to $80\ \mathrm{mm}$ . Use this as the chromatographic column. Add the sample, using a funnel, and pack appropriately and tightly. Add $0.5~\mathrm{g}$ of diatomaceous earth for chromatography to the sample sticking to the beaker, mix well, and transfer to the column. Again, wash the sample sticking to the beaker and the glass rod with glass wool, transfer to the column along with the glass wool, and press gently with a glass rod to make the height of the column to $110\textrm{-}130\textrm{m m}$ . Next, take $70~\mathrm{mL}$ of chloroform, and wash the inner wall of the column for chromatography. Collect the eluate at a rate of NMT 0.8 mL per minute for 1 minute. After the elution is complete, wash the bottom of the column with a small amount of chloroform, combine the washings with the eluate, add chloroform to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{\mg}$ of ethinylestradiol RS, previously dried in a desiccator (in vacuum, phosphorus pentoxide) for 4 hours, and dissolve in chloroform to make exactly $100~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add chloroform to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Pipet $6~\mathrm{mL}$ each of the test solution, the standard solution and chloroform, transfer into a separatory funnel, and add $20~\mathrm{mL}$ of isooctane. Then, add $10~\mathrm{mL}$ of a mixture of sulfuric acid and methanol $(7:3)$ , shake vigorously for 5 minutes, allow to stand in the dark for 15 minutes, and centrifuge. Perform the test with the obtained coloring solution as directed under the Ultravioletvisible Spectroscopy using a solution, proceeded with 6 mL of chloroform in the same manner, as the control solution. Determine the absorbances of each solution, $A_{\mathrm{T}}$ and $A_{S}$ , obtained from the test solution and the standard solution, at a wavelength of $540\;\mathrm{nm}$ .  

Packaging and storage Preserve in tight containers. 2-Ethylpyridine-4-carbothioamide [ 536-33-4 ]Ethionamide, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of ethionamide $\left(\mathbf{C}_{8}\mathbf{H}_{10}\mathbf{N}_{2}\mathbf{S}\right)$ .  

![](images/dd95dc9eb7a8407b5ce3b21157f851abbbc215e26feffa4d02168a4816659a00.jpg)  

Description Ethionamide occurs as yellow crystals or a crystalline powder and has a characteristic odor and taste. It is soluble in methanol and in acetic acid(100), sparingly soluble in ethanol(95), slightly soluble in ether, and practically insoluble in water.  

Identification (1) Determine the absorption spectra of Ethionamide and ethionamide RS in methanol (3 in 160000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Ethionamide and ethionamide RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between $161\ ^{\circ}\mathrm{C}$ and $165\,^{\circ}\mathrm{C}$ Purity (1) Acidity —Dissolve $3.0~\mathrm{g}$ of Ethionamide in 30 mL of methanol by warming, add $90~\mathrm{mL}$ of water, allow to stand in iced water for 1 hour, and filter. To $80~\mathrm{mL}$ of the filtrate, add $0.8~\mathrm{mL}$ of cresol red TS and $0.20~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ sodium hydroxide VS; the resulting solution exhibits a red color.  

(2) Heavy metals— Proceed with $1.0~\mathrm{g}$ of Ethionamide according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution $(\mathrm{NMT}\ 20\ \mathrm{ppm})$ ).  

(3) Arsenic —Proceed with $1.0\,\mathrm{~g~}$ of Ethionamide according to Method 3 and perform the test. Add $10~\mathrm{mL}$ of a solution of magnesium nitrate hexahydrate in ethanol(95) (1 in 50), then add $1.5\ \mathrm{mL}$ of hydrogen peroxide(30), and fire to burn (NMT 2 ppm).  

(4) Selenium —Weigh about $0.2{\mathrm{~g~}}$ of Ethionamide and combust as directed under the Oxygen Flask Combustion with $25~\mathrm{mL}$ of diluted nitric acid (1 in 30) as an absorbent. Use a combustion flask with a volume of 1000 mL, combust, wash the stopper and the inner wall of the flask with $10\,\mathrm{\mL}$ of water, and use $20~\mathrm{mL}$ of water to move the solution in the combustion flask into a $150{\-}\mathrm{mL}$ beaker. Heat lightly until it boils, boil for 10 minutes, allow it to cool down to room temperature, and use this solution as the test solution. Separately, pipet $6.0~\mathrm{mL}$ of standard selenium stock solution, add $25~\mathrm{mL}$ of diluted nitric acid (1 in 30) and $25~\mathrm{mL}$ of water, and use this solution as the standard solution. Add diluted ammonia water(28) (1 in 2) to each of the test and standard solutions, adjust the $\mathrm{pH}$ to 2.0, add water to dilute to $60~\mathrm{mL}$ ,and add $10~\mathrm{mL}$ of water to move to a separatory funnel. Then, wash the separatory funnel with $10~\mathrm{mL}$ of water. Add $0.2{\mathrm{~g~}}$ of hydroxylamine hydrochloride, dissolve by mixing, add $5.0~\mathrm{mL}$ of 2,3-diaminonaphthalene TS, and close the stopper. Mix by stirring and allow to stand at room temperature for 100 minutes. Add $5.0\;\mathrm{mL}$ of cyclohexane, shake well, and allow to stand. If the layer is separated, remove the water layer, centrifuge cyclohexane extract, remove water, and take the cyclohexane layer. With these solutions and a control solution prepared with water added to $25~\mathrm{mL}$ of diluted nitric acid (1 in 30) in the same way, perform the test as directed under the Ultraviolet-visible Spectroscopy. Determine the absorption at the absorption maximum wavelength around 380 nm; the absorption of the solution from the test solution is not greater than the absorption from the standard solution $(\mathrm{NMT}\,30\,\mathrm{ppm})$ ).  

(5) Related substances— Perform the test without exposure to daylight using light-resistant vessels. Dissolve $0.20~\mathrm{g}$ of Ethionamide in $10~\mathrm{mL}$ of methanol, and use this solution as the test solution. Pipet $0.5~\mathrm{mL}$ of this solution, add acetone to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution (1). Pipet $0.2~\mathrm{mL}$ of the test solution, add acetone to make exactly $100~\mathrm{mL}$ ,and use this solution as the standard solution (2). With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution, the standard solution (1) and (2) on a plate of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of ethyl acetate, hexane, and methanol $(6:2:1)$ to a distance of about $15~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution (1). The number of the spots other than the principal spot from the test solution which is more intense than the spot from the standard solution (2) is NMT one. Loss on drying NMT $0.5\%$ (1 g, $105\;^{\circ}\!C$ , 3 hours).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$  

Assay Weigh accurately about $0.3\,\mathrm{~g~}$ of Ethionamide, previously dried, dissolve in $50~\mathrm{mL}$ of acetic acid(100), and titrate with $0.1\;\mathrm{mol/L}$ perchloric acid VS (indicator: 2 mL of p-naphtholbenzein TS). The endpoint of titration is when the color of the solution changes from orange-red to dark orange-brown. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=16.624\;\mathrm{mg}$ of $\mathrm{C}_{8}\mathrm{H}_{10}\mathrm{N}_{2}\mathrm{O}$  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Ethosuximid 에토숙시미드  

![](images/19991d006c01e0578685f5e23283069bcb2ba3ccdb4c253874e238c3d180e64c.jpg)  

$\mathrm{C}_{7}\mathrm{H}_{11}\mathrm{NO}_{2}$ : 141.17  

3-Ethyl-3-methylpyrrolidine-2,5-dione [ 77-67-8 ]Ethosuximid contains NLT $98.5\%$ and NMT $101.0\%$ of Ethosuximid $(\mathbf{C}_{7}\mathbf{H}_{11}\mathbf{NO}_{2})$ , calculated on the anhydrous basis.  

Description Ethosuximid occurs as a white, paraffin-like solid or a powder. It is odorless or has a slight, characteristic odor.  

It is very soluble in methanol, ethanol(95), ether and $N{,}N.$ -dimethylformamide, and freely soluble in water.  

Melting point —About $48\ ^{\circ}\mathrm{C}$ Identification (1) Add $10~\mathrm{mL}$ of sodium hydroxide TS to about $0.2\;\mathrm{g}$ of Ethosuximid, and boil; the gas produced turns a moistened red litmus paper blue  

(2) Dissolve $50~\mathrm{{mg}}$ of Ethosuximide in $1\,\textrm{m L}$ of ethanol(95), add 3 drops of a solution of cupric acetate (1 in 100), warm slightly, and add 1 to 2 drops of sodium hydroxide TS; the resulting solution exhibits a purple color.  

(3) Determine the absorption spectra of ethanol(95) solutions of Ethosuximide and ethosuximide RS (1 in 2000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

Purity (1) Clarity and color of solution —Dissolve $1.0~\mathrm{g}$ of Ethosuximide in $10~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Chloride —Perform the test with about $1.0\ \mathrm{g}$ of Ethosuximide. Prepare the control solution with $0.30~\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ hydrochloric acid (NMT $0.011\%$ ).  

(3) Heavy metals— Proceed with about $1.0\,\mathrm{~g~}$ of Ethosuximide according to Method 1 and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(4) Arsenic —Prepare the test solution with about $1.0\ \mathrm{g}$ of Ethosuximide according to Method 1 and perform the test (NMT 2 ppm).  

(5) Acid anhydride —Dissolve about $0.50\ \mathrm{~g~}$ of Ethosuximide in $1~\mathrm{mL}$ of ethanol(95), add $1~\mathrm{mL}$ of hydroxylamine hydrochloride-iron(III) chloride TS, and allow to stand for 5 minutes. Add $3\;\mathrm{mL}$ of water and mix. Allow to stand for 5 minutes; the red to reddish purple color of this solution is not more intense than that of the following control solution.  

Control solution —Dissolve $70~\mathrm{mg}$ of succinic anhydride in ethanol(95) to make exactly $100~\mathrm{mL}$ . To 1.0 mL of this solution, add $1~\mathrm{mL}$ of hydroxylamine hydrochloride-iron(III) chloride TS and proceed in the same manner.  

(6) Cyanide —Dissolve $1.0~\mathrm{g}$ of Ethosuximide in 10 mL of ethanol(95), and add 3 drops of iron(II) sulfate TS, $1\,\mathrm{\mL}$ of sodium hydroxide TS and 2 to 3 drops of iron(III) chloride TS. Warm gently, and acidify with dilute sulfuric acid; no blue precipitates are formed and a blue color is not exhibited within 15 minutes.  

(7) Related substances —Weigh accurately $1.0~\mathrm{g}$ of Ethosuximide, dissolve in the mobile phase to make 10 mL, and use this solution as the test solution. Separately, weigh accurately $10.0~\mathrm{mg}$ each of ethosuximide RS and 2-ethyl-2-methylsuccinic acid, add the mobile phase to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions; the amount of 2-ethyl-2-methylsuccinic acid by equation (1) is NMT $0.1\%$ . Calculate the amount of each related substance by equation (2): NMT $0.1\%$ , and the total amount of related substances is NMT $0.5\%$ .  

$$
=\frac{c}{w}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\left(1\right)
$$  

C:Concentration $(\mathrm{{mg/mL})}$ of 2-ethyl-2- methylsuccinic acid in the standard solution  

W: Amount of Ethosuximide taken (g) $A_{\mathrm{T}}$ : Peak area of 2-ethyl-2-methylsuccinic acid obtained from the test solution  

$A_{S}$ : Peak area of 2-ethyl-2-methylsuccinic acid obtained from the standard solution  

$C$ : Concentration of Ethosuximide in the standard   
solution $(\mathrm{mg/mL})$   
$W$ : Amount of Ethosuximide taken (g)   
$A_{\mathrm{i}}$ : Peak area of each related substance obtained   
from the test solution   
A S: Peak area of Ethosuximide obtained from the   
standard solution  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $220\;\mathrm{nm}$ ).  

Column: A stainless steel column about $3.9\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography. Mobile phase: A mixture of $\mathrm{pH}\,3.0$ phosphate buffer solution and acetonitrile $(9:1)$ .  

Flow rate: $1\ \mathrm{mL/min}$ System suitability  

System performance: Weigh accurately a suitable amount each of 2-ethyl-2-methylsuccinic acid and ethosuximide RS, dissolve in the mobile phase to obtain a solution containing $2~\mathrm{~mg}$ of 2-ethyl-2-methylsuccinic acid and $10~\mathrm{{mg}}$ of ethosuximide per mL, and use this solution as the system suitability solution. Proceed with $10~\upmu\mathrm{L}$ of this solution under the above operating conditions; the resolution between the peaks of 2-ethyl-2- methylsuccinic acid and ethosuximide is NLT 6.6, the number of theoretical plates is NLT 2900, and the symmetry factor of the peak of ethosuximide is NMT 2.0.  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the system suitability solution under the above operating conditions; the relative standard deviation of the peak areas of ethosuximide and 2-ethyl-2- methylsuccinic acid is NMT $0.4\%$ , respectively.  

Phosphate buffer solution, pH 3.0 —To $4.1\ \mathrm{mL}$ of phosphoric acid add water to make $1000~\mathrm{mL}$ . To this solution, add sodium hydroxide TS to adjust the $\mathrm{pH}$ to 3.0. Water NMT $0.5\%$ ($\,2\ \mathrm{g}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Ethosuximide, previously dried, dissolve in $20\quad\mathrm{~mL~}$ of N,NDimethylformamide, and titrate with $0.1\ \mathrm{mol/L}$ tetramethylammonium hydroxide VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ tetramethylammonium hydroxide Packaging and storage Preserve in tight containers.  

# Ethyl Aminobenzoate 아미노벤조산에틸  

![](images/220b37cae4869c28810ec2a658537319f0de1868e4660308d9da35b1ff53901c.jpg)  

Benzocaine  

Ethyl 4-aminobenzoate [ 94-09-7 ]Ethyl Aminobenzoate, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of ethyl aminobenzoate $\left(\boldsymbol{\mathbf{C}}\boldsymbol{\mathbf{{H}}}_{11}\boldsymbol{\mathbf{N}}\boldsymbol{\mathbf{O}}_{2}\right)$ ).  

Description Ethyl Aminobenzoate occurs as white crystals or a crystalline powder. It is odorless and has a slightly bitter taste, numbing the tongue.   
It is freely soluble in ethanol(95) or in ether and very slightly soluble in water.   
It dissolves in dilute hydrochloric acid.  

Identification (1) Dissolve $10~\mathrm{mg}$ of Ethyl Aminobenzoate in $1\ \mathrm{mL}$ of dilute hydrochloric acid and $4~\mathrm{mL}$ of water; the resulting solution responds to the Qualitative Analysis for primary aromatic amines.  

(2) Dissolve $0.1~\mathrm{g}$ of Ethyl Aminobenzoate in $5~\mathrm{mL}$ of water with the aid of dilute hydrochloric acid added dropwise and add iodine TS dropwise; a brown precipitate is formed.  

(3) Warm $50~\mathrm{mg}$ of Ethyl Aminobenzoate with 2 drops of acetic acid(31) and 5 drops of sulfuric acid; the characteristic odor of ethyl acetate comes out.  

Melting point Between 89 and $91\ ^{\circ}\mathrm{C}$ Purity (1) Acid —Dissolve about $1.0~\mathrm{g}$ of Ethyl Aminobenzoate in $10~\mathrm{mL}$ of neutralized ethanol and add $10~\mathrm{mL}$ of water, 2 drops of phenolphthalein TS and $0.50~\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ sodium hydroxide solution; the resulting solution exhibits a red color.  

(2) Chloride —Dissolve $0.20~\mathrm{g}$ of Ethyl Aminobenzoate in ethanol(95) and add 2 to 3 drops each of dilute nitric acid and silver nitrate TS; there is no immediate change in the solution.  

(3) Heavy metals —Dissolve $2.0~\mathrm{g}$ of Ethyl Aminobenzoate in $20~\mathrm{mL}$ of ethanol(95) and add $2~\mathrm{mL}$ of dilute acetic acid and ethanol(95) to make $50~\mathrm{mL}$ . Perform the test using this solution as the test solution. Prepare the control solution as follows: to $2.0\ \mathrm{mL}$ of lead standard solution, add $2~\mathrm{mL}$ of dilute acetic acid and ethanol(95) to make $50\;\mathrm{mL}$ (NMT $10\,\mathrm{ppm})$ ).  

(4) Readily carbonizable substances —Perform the test with $0.5~\mathrm{g}$ of Ethyl Aminobenzoate. The color of this solution is not more intense than that of the matching fluid A.  

Loss on drying NMT $1.0\%$ ($1\;\mathrm{g}$ , silica gel, 3 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ Assay Weight accurately about $0.25\mathrm{~g~}$ of Ethyl Aminobenzoate, previously dried, dissolved in $10~\mathrm{mL}$ of hydrochloric acid and $70~\mathrm{mL}$ of water, add $10\;\mathrm{mL}$ of a solution of potassium bromide (3 in 10), and cool down to a temperature below $15~^{\circ}\mathbf{C}$ . Then, titrate with $0.1\ \mathrm{mol/L}$ sodium nitrite VS. (potentiometric titration or amperometric titration under the Titrimetry).  

Packaging and storage Preserve in well-closed containers.  

![](images/ad2ab520aa1be18923cb48cdb6f077a5ae481ed725c5d924ee9c758be3daecbc.jpg)  

Ethyl Linoleate  

$$
{\bf C}_{20}{\bf H}_{36}{\bf O}_{2}
$$  

308.50   
Ethyl (9 Z,12 Z)-9,12-octadecadienoic acid ester, [ 544-35- 4 ]  
Ethyl Linoleate contains NLT $88.0\%$ and NMT $101.0\%$ of ethyl linoleate $(\mathrm{C}_{20}\mathrm{H}_{36}\mathrm{O}_{2}:308.50)$ ).  

Description Ethyl Linoleate occurs as a colorless to pale yellow and clear liquid. It has a slightly characteristic odor.  

It is soluble in methanol, ethanol, ether, chloroform or petroleum ether.  

Identification To about $4\textrm{g}$ of Ethyl Linoleate, add 20 mL of potassium hydroxide-ethanol TS, and heat on a steam bath with a reflux condenser attached for 30 minutes. After cooling, add dilute hydrochloric acid to make the solution acidic. Transfer it to a separatory funnel, take the separated oil layer, wash with $2\;\mathrm{mL}$ of water, and add $10\,\mathrm{\mL}$ of ligroin for mixing. To this solution, add $3\mathrm{\g}$ of anhydrous sodium sulfate, allow the solution to stand for 10 minutes, and filter. Well shake and maintain the filtrate at between 10 and $15\ ^{\circ}\mathrm{C}$ , add $1\ \mathrm{mL}$ of bromine, and allow it to stand for 30 minutes with occasional shaking. Take the produced precipitate, wash with $3\ \mathrm{mL}$ of ligroin 3 times for recrystallization, dry in a desiccator, and determine the melting point of the dried material. The melting point is between 113 and $117\,^{\circ}\mathrm{C}$ .  

Specific gravity $\mathrm{d}_{20}^{20}$ : Between 0.875 and 0.885. Refractive index $[\alpha]_{\mathrm{D}}^{20}$ :Between 1.455 and 1.465. Saponification value Between 180 and 185.  

Acid value NMT 15.  

Iodine value Between 150 and 163 (when the test is performed with $0.15\;\mathrm{g}$ of Ethyl Linoleate).  

Purity (1) Chloride ―To $1.0\ \mathrm{g}$ of Ethyl Linoleate, add Ethanol to make $50~\mathrm{mL}$ , and add $1~\mathrm{mL}$ of silver nitrateethanol solution (1 in 50). The turbidity of the solution is not greater than the following control solution. Control solution: To $0.40~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ Hydrochloric Acid, add Ethanol to make $50~\mathrm{mL}$ and add $1\ \mathrm{mL}$ of silver nitrate-ethanol solution (1 in 50).  

(2) Heavy metals ―Dissolve $1.0~\mathrm{g}$ of Ethyl Linoleate in ethanol, add $2~\mathrm{mL}$ of dilute acetic acid and ethanol to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test with this solution. Prepare the control solution by adding $2~\mathrm{mL}$ of dilute acetic acid and $2.0~\mathrm{mL}$ of lead standard solution as well as ethanol to make 50 mL (NMT $20\,\mathrm{ppm}]$ ).  

(3) Arsenic ―To $1.0\,\mathrm{~g~}$ of Ethyl Linoleate, add 10 mL of diluted hydrochloric acid (1 in 2) and $20~\mathrm{mL}$ of ether, shake vigorously for 3 minutes to mix, allow to stand, and perform the test with this solution (NMT 2 ppm).  

(4) Peroxide ―Put $10.0~\mathrm{mL}$ of chloroform in a 250 mL stoppered flask and replace the air in the flask with dry carbon dioxide. Weigh accurately $1\textrm{g}$ of Ethyl Linoleate and put it in a glass cup. Put the glass cup in the flask and slowly shake to mix and dissolve. To this, add $15.0~\mathrm{mL}$ of acetic acid(100) and $1.0~\mathrm{mL}$ of saturated potassium iodide solution, stopper the flask, shake well for 1 minute to mix, and allow to stand in the dark for 5 minutes. Add $75~\mathrm{mL}$ of water, stopper the flask, shake vigorously to mix, and allow to stand in the dark for 5 minutes. Then, add $75\,\textrm{m L}$ of water, stopper the flask, shake vigorously to mix, and titrate with $0.01\ \mathrm{mol/L}$ sodium thiosulfate VS (indicator: starch TS). Perform a blank test in the same manner and make any necessary correction.  

$$
{\mathrm{Peroxide~value}}\,={\frac{\mathrm{(A-B)}}{{\mathrm{Amount}}\,({\mathrm{g}})\;{\mathrm{of}}\;{\mathrm{sample}}}}\times\,10
$$  

A: Consumed amount (mL) of $0.01\,\mathrm{\mol/L}$ sodium thiosulfate VS used for the sample  

B: Consumed amount (mL) of $0.01\;\mathrm{\mol/L}$ sodium thiosulfate VS used for the blank test  

Residue on ignition NMT $0.1\%$ (1 g). Put $1{\mathrm{~g~}}$ of Ethyl Linoleate in a crucible, previously weighed accurately its mass, and weigh accurately the mass. Heat with weak flame to boil, stop heating once boiling starts, and directly fire to burn. After cooling, wet the residue with 1 or 2 drops of sulfuric acid, carefully ignite to a constant mass, and weigh the mass of the residue.  

Assay Weigh accurately about $60~\mathrm{mg}$ of Ethyl Linoleate and put it in a glass cup. Heat potassium hydroxideglycerin solution at $100~^{\circ}\mathrm{C}$ and put $10\ \mathrm{mL}$ each of this solution to 3 stoppered test tubes (A, B and C). Place a thermometer in the stoppered test tube C. Put the 3 stoppered test tubes in a $180\pm3~^{\circ}\mathrm{C}$ oil bath and heat until the thermometer in the stoppered test tube C indicates $180\ ^{\circ}\mathrm{C}$ . Then, blow nitrogen gas into the stoppered test tubes A and B. Take the stoppered test tubes from the oil bath. Place the glass cup containing the sample in the stoppered tube A, place an empty glass cup in the stoppered test tube B, shake vigorously the 3 stoppered test tubes for 2 minutes, and place the 3 stoppered test tubes in the oil bath. When the temperature of the stoppered test tube reaches $175\ ^{\circ}\mathrm{C}$ , heat for exactly 45 minutes. For at least 30 minutes of this period, take care to maintain $180~^{\circ}\mathrm{C}$ . Take out the stoppered test tubes A and B from the oil bath and cool them down to $60~^{\circ}\mathrm{C}$ . Wash them with hot methanol, place each in a $100{\-}\mathrm{mL}$ volumetric flask, cool, and add methanol to make $100.0\;\mathrm{mL}$ each. To $10.0\,\textrm{m L}$ each of the solutions, add methanol to make $100.0\ \mathrm{mL}$ each, and use each of the resulting solutions as the solution A and solution B, respectively. Perform the test with the solution A, using the solution B for comparison, as directed under the Ultraviolet-visible Spectroscopy and determine the absorbance at the wavelength 268 nm, $A_{268}$ . Additionally, to $10.0~\mathrm{mL}$ each of the solutions A and B, add methanol to make $100~\mathrm{mL}$ each, and use these solutions as the solution $\mathrm{{A}}'$ and solution $\mathbf{B}^{\bullet}$ , respectively. Perform the test with the solution $\mathbf{A}^{\bullet}$ , using the solution $\mathbf{B}^{\bullet}$ for comparison, as directed under the Ultraviolet-visible Spectroscopy and determine the absorbance at the wavelength $233\;\mathrm{nm}$ ,$A_{233}$ .  

$$
=\frac{\mathrm{A}}{93.7}\times\,100
$$  

$$
\mathrm{A}=A_{233}\times{\frac{10}{\mathrm{W}}}-1206\times A_{268}\times{\frac{1}{\mathrm{W}}}
$$  

Potassium hydroxide-glycerin TS —Add glycerin to $17.5\mathrm{~g~}$ of potassium hydroxide and warm to dissolve to make $100\;\mathrm{mL}$ .  

Packaging and storage Preserve in light-resistant, tight  

# Ethyl Loflazepate 에틸로플라제페이트  

![](images/7e4ac47c8a4f856774330ad0cfe8fa0e5855f87efc0537af865f69fd840bd8d9.jpg)  

Ethyl Loflazepate $\mathrm{C_{18}H_{14}C l F N_{2}O_{3}}$ : 360.77 Ethyl 7-chloro-5-(2-fluorophenyl)-2,3 -dihydro-2-oxo1 H-1,4-benzodiazepine-3-carboxylic acid ester, [ 29177- 84-2 ]  

Ethyl Loflazepate contains NLT $98.0\%$ and NMT $102.0\%$ of ethyl loflazepate ( $\mathrm{\bf\{C}_{18}H_{14}C l F N_{2}O_{3}}$ : 360.77).  

Description Ethyl Loflazepate is white to pale yellow powder.  

It is freely soluble in chloroform, soluble in acetonitrile, slightly soluble in ethanol(95) and practically insoluble in water.  

Identification (1) Weigh $20~\mathrm{mg}$ of Ethyl Loflazepate, dissolve in dichloromethane to make $4~\mathrm{mL}$ , and use this solution as the test solution. Weigh $20~\mathrm{~mg~}$ of ethyl loflazepate RS, dissolve in dichloromethane to make 4 mL, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform, diisopropyl ether and ethanol(95) $(14:5:1)$ as the developing solvent, and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the $R_{\mathrm{f}}$ value and the color of the spots obtained from the test solution and the standard solution are the same.  

(2) Determine the infrared spectra of Ethyl Loflazepate and ethyl loflazepate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Determine the absorption spectra with a solution of Ethyl Loflazepate in ethanol(95) (1 in 100000); it exhibits maxima at wavelengths of about $231\ \mathrm{nm}$ and 318 nm.  

Purity (1) Clarity and color of solution —Dissolve $0.5~\mathrm{g}$ of Ethyl Loflazepate in chloroform to make $10~\mathrm{mL}$ ; the solution is clear.  

(2) Heavy metals —Proceed with $4.0\,\mathrm{~g~}$ of Ethyl Loflazepate as directed under Method 4 and perform the test. Prepare the control solution with $4.0\,\textrm{m L}$ of lead standard solution (NMT 40 ppm).  

(3) Related substances —Dissolve $20~\mathrm{mg}$ of Ethyl Loflazepate in dichloromethane to make exactly $4~\mathrm{mL}$ ,and use this solution as the test solution. Separately, weigh accurately $20~\mathrm{mg}$ of ethyl loflazepate RS, dissolve in dichloromethane to make exactly $4~\mathrm{mL}$ , and use this solution as the standard solution I. Pipet $1\,\textrm{m L}$ of the standard solution I, add dichloromethane to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution II. Pipet $2\ \mathrm{mL}$ of the standard solution II, dilute with the same solvent to make exactly $5~\mathrm{mL}$ , and use this solution as the standard solution III. Pipet $2~\mathrm{mL}$ of the standard solution III, dilute with the same solvent to make exactly $10~\mathrm{mL}$ , and use this solution as the standard solution IV. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solutions on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform, diisopropyl ether and ethanol(95) $(14:5:1)$ as the developing solvent, air-dry the plate, and examine it under ultraviolet light (main wavelength: $254\;\;\mathrm{nm}\rangle$ ); The spots other than the principal spot obtained from the test solution are not more intense nor greater than the spots obtained from the standard solution II.  

# Residue on ignition NMT $0.2\%$ (1 g).  

Assay Weigh accurately about $0.2\ \mathrm{~g~}$ of Ethyl Loflazepate, dissolve in $40\,\textrm{m L}$ of a mixture of acetic anhydride and acetic acid(100) $(3:1)$ , and titrate with 0.1 $\mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=36.08~\mathrm{mg}$ of $\mathrm{C_{18}H_{14}C l F N_{2}O_{3}}$  

Packaging and storage Preserve in tight containers.  

# Ethyl Loplazepate Tablets 에틸로플라제페이트정  

Ethyl Loplazepate Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of ethyl loflazepate $\mathrm{(C_{18}H_{14}C l F N_{2}O_{3}}$ : 360.77).  

Method of preparation Prepare as directed under Tablets, with Ethyl Loflazepate.  

Identification Weigh an amount of Ethyl Loplazepate Tablets, equivalent to about $4~\mathrm{mg}$ of ethyl loflazepate. Add $5\ \mathrm{mL}$ of acetonitrile, shake to mix, then filter, and use the filtrate as the test solution. Separately, dissolve 20 mg of ethyl loflazepate RS in $25~\mathrm{mL}$ of acetonitrile, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $.0\ \upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of chloroform, diisopropyl ether and ethanol(95) $(14:5:1)$ ) as the developing solvent to a distance of about $12\ \mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\,\mathrm{\nm}$ ); the colors and $R_{\mathrm{f}}$ values of the spots obtained from the test solution and the standard solution are the same.  

Disintegration Meets the requirements.  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of NLT 20 tablets of Ethyl Loplazepate Tablets, and powder. Weigh accurately an amount, equivalent to about $8~\mathrm{mg}$ of ethyl loflazepate $(\mathrm{C}_{18}\mathrm{H}_{14}\mathrm{ClFN}_{2}\mathrm{O}_{3})$ , and add ethanol(95) to make exactly $100\;\mathrm{mL}$ . Filter this solution, discard the first $20\;\mathrm{mL}$ of the filtrate, pipet $10~\mathrm{mL}$ of the subsequent filtrate, add ethanol(95) to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about 20 mg of ethyl loflazepate RS, and dissolve in ethanol(95) to make exactly $100~\mathrm{mL}$ . Pipet $4~\mathrm{mL}$ of this solution, add ethanol(95) to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test of the test solution and the standard solution as directed under the Ultraviolet-visible Spectroscopy using ethanol(95) as a control solution, and determine the absorbances, $\mathrm{A_{T}}$ and A S, at a wavelength of $231\ \mathrm{nm}$ .  

Amount (mg) of ethyl loflazepate $\left({\bf C}_{18}\mathrm{H}_{14}\mathrm{ClFN}_{2}{\bf O}_{3}\right)$ $=$ Amount $(\mathrm{mg})$ of ethyl loflazepate $\mathrm{RS}\times(A_{\mathrm{T}}/A_{\mathrm{S}})\times0.4$ Packaging and storage Preserve in tight containers.  

![](images/9069e9e7a8fd353c968aca199b09390fb8b455a8f4ac6ea546079f0a0fc5ecb1.jpg)  

Ethylene Oxide $C_{2}\mathrm{H}_{4}\mathrm{O}:44.05$ Ethylene Oxide, [ 75-21-8 ]  
Ethylene Oxide contains NLT $99.0\%$ and NMT $101.0\%$ of ethylene oxide $\left({\bf C}_{2}{\bf H}_{4}{\bf O}\right)$ .Description Ethylene Oxide occurs as a colorless and clear liquid at 0 to $5\;^{\circ}\mathrm{C}$ .  
It has a weak ether odor when vaporized.   
It is very soluble in water, ethanol(95), acetone or ether at 0 to $5\;^{\circ}\mathrm{C}$ .  

Identification To $1\ \mathrm{mL}$ of Ethylene Oxide, previously cooled to 0 to $5~^{\circ}\mathrm{C}$ , add $1~\mathrm{mL}$ of water, 2 drops of phenolphthalein TS and $4~\mathrm{mL}$ of sodium chloride solution (1 in 5), and allow to stand for 5 minutes; the solution exhibits a reddish purple color.  

Purity (1) Aldehyde ―In a $250{\-}\mathrm{mL}$ Erlenmeyer flask, add about $100~\mathrm{mL}$ of water and cool to 0 to $5~^{\circ}\mathrm{C}$ in iced water. To this, add $10~\mathrm{mL}$ of $0.2\ \mathrm{mol/L}$ sodium bisulfite and allow to stand for 30 minutes in iced water. Titrate with $0.05\;\mathrm{mol/L}$ iodine VS, previously cooled to 0 to $5\;^{\circ}\mathrm{C}$ (indicator: $2~\mathrm{mL}$ of starch TS). However, the endpoint of titration is when the blue color persists for 1 minute. Perform a blank test in the same manner and make any necessary correction (NMT $0.03\%$ of acetaldehyde).  

$$
={\frac{(B-A)\times0.0022}{10\times G}}\times100
$$  

A : Consumed amount (mL) of $0.05\;\mathrm{mol/L}$ iodine VS $B$ : Amount (mL) of $0.05\;\mathrm{mol/L}$ iodine VS consumed for the blank test  

$G$ : Specific gravity of ethylene oxide at 0 to $5\;^{\circ}\mathrm{C}$ (2) Chloride ―Perform the test with $4.0~\mathrm{mL}$ of Ethylene Oxide, previously cooled to 0 to $5~^{\circ}\mathrm{C}$ , as directed under the Chloride. Prepare the control solution with 1.0 mL of $0.01\;\mathrm{mol/L}$ hydrochloric acid VS (NMT $0.01\%$ ). Water NMT $0.05\%$ $20.0~\mathrm{mL}$ of Ethylene Oxide previously cooled to 0 to $5~^{\circ}\mathrm{C}$ , volumetric titration, direct titration).  

The above test should be performed at 0 to $5\;^{\circ}\mathrm{C}$ Acidity Evaporate $68.0\;\mathrm{mL}$ of Ethylene Oxide, previously cooled to 0 to $5~^{\circ}\mathrm{C}$ , to the volume of about $50~\mathrm{mL}$ in a fume chamber to eliminate carbon dioxide. Titrate with $0.1\ \mathrm{mol/L}$ sodium hydroxide VS (indicator: 3 to 4 drops of phenolphthalein TS) (NMT $0.005\%$ as acetic acid).  

Residue on evaporation Evaporate $20~\mathrm{mL}$ of Ethylene Oxide, previously cooled to 0 to $5~^{\circ}\mathrm{C}$ , in a crucible, previously measured in the mass, in a fume chamber and dry at $105\pm2~^{\circ}\mathrm{C}$ for 1 hour. Place in a desiccator, allow to stand for 30 minutes, cool to the room temperature, and measure the mass (NMT $0.03\%$ ).  

$$
=\cfrac{A-B-C}{20\times G}\times100
$$  

A : Mass (g) of the crucible measured after placing the sample in it and heating  

$B$ : Mass $(\mathrm{g})$ of the crucible $C$ : Mean mass (g) of the blank test mass difference $G$ : Specific gravity of ethylene oxide at 0 to $5\;^{\circ}\mathrm{C}$ Assay Connect and fix Ethylene Oxide to a connector, attach the needle valve for flow rate control, and allow to stand for NLT 30 minutes. Slowly open the needle valve for flow rate control, exhaust the Ethylene Oxide into a container containing water, and control bubbles so that 3 to 4 bubbles appear per second. Introduce the gas to the gas collector for 2 minutes, inject the conversion valve for 2 seconds, and perform the test as directed under the Gas Chromatography according to the following conditions.  

Operating conditions  

Detector: A thermal conductivity detector (TCD) Column: A column about $4\;\mathrm{mm}$ in internal diameter and about $3\,\textrm{m}$ in length, packed with 80- to 100-mesh divinylbenzene-ethylene glycol-dimethylacrylate copolymer for gas chromatography.  

Column temperature: $120\ ^{\circ}\mathrm{C}$   
Detector temperature: $225\ ^{\circ}\mathrm{C}$   
Carrier gas: Helium   
Flow rate: Between 40 mL/min and 50 mL/min.  

Packaging and storage Preserve in tight containers.  

# Ethylmorphine Hydrochloride Hydrate 에틸모르핀염산염수화물  

![](images/5abdad76569951e880f6ac5aa1b06f25532ee22e9911f058d7b3946e4239a336.jpg)  

Ethylmorphine Hydrochloride  

$\mathrm{C}_{19}\mathrm{H}_{23}\mathrm{NO}_{3}$ ·HCl· $2\mathrm{H}_{2}\mathrm{O}$ : 385.88 $(4R,4\mathrm{a}R,7S,7\mathrm{a}R,12\mathrm{b}S)$ -9-Ethoxy-3-methyl-2,4,4a,7,7a,13- hexahydro$1H$ -4,12-methanobenzofuro[3,2-  

Ethylmorphine Hydrochloride Hydrate contains NLT $98.0\%$ and NMT $101.0\%$ of ethylmorphine hydrochloride ( $\mathrm{{C}_{19}H_{23}N O_{3}}$ ·HCl: 349.85), calculated on the anhydrous basis.  

Description Ethylmorphine Hydrochloride Hydrate occurs as white to pale yellow crystals or a crystalline powder.  

It is very soluble in methanol or acetic acid(100), freely soluble in water, soluble in ethanol(95), sparingly soluble in acetic anhydride and practically insoluble in ether. It is affected by light.  

Melting point —About $123\ ^{\circ}\mathrm{C}$ (with decomposition). Identification (1) Determine the absorption spectra of aqueous solutions of Ethylmorphine Hydrochloride Hydrate and ethylmorphine hydrochloride RS (1 in 10000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelength.  

(2) Determine the infrared spectra of Ethylmorphine Hydrochloride Hydrate and ethylmorphine hydrochloride RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Ethylmorphine Hydrochloride Hydrate (1 in 50) responds to the Qualitative Analysis (2) for chloride.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-103^{\circ}$ and $-106^{\circ}$ $\left.\mathrm{0.4~g}\right.$ calculated on the anhydrous basis, water, $20\,\mathrm{\mL}$ , 100 mm).  

$\mathbf{pH}$ Dissolve $0.10\,\mathrm{~g~}$ of Ethylmorphine Hydrochloride Hydrate in $10~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 4.0 and 6.0.  

Purity Related substances —Dissolve $0.20\ \mathrm{g}$ of Ethylmorphine Hydrochloride Hydrate in $10\,\mathrm{\mL}$ of diluted ethanol (1 in 2) and use this solution as the test solution. Pipet $0.5~\mathrm{mL}$ of this solution, add diluted ethanol (1 in 2) to make exactly $100\,\mathrm{\mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of ethanol(99.5), toluene, acetone and ammonia water(28) $(14:14:7:1)$ as a developing solvent to a distance of about $10\;\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Water Between $8.0\%$ and $10.0\%$ ($\mathbf{0.25\,\mathrm{~g~}}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.1\%$ (0.5 g).  

Assay Weigh accurately about $0.5\mathrm{~g~}$ of Ethylmorphine Hydrochloride Hydrate, dissolve in $50\;\mathrm{mL}$ of a mixture of acetic anhydride and acetic acid(100) $(7:3)$ , and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=34.985~\mathrm{mg}$ of $\mathrm{C}_{19}\mathrm{H}_{23}\mathrm{NO}_{3}$ ·HCl  

Packaging and storage Preserve in light-resistant, tight containers.  

# Etizolam 에티졸람  

![](images/d0dee0d808603c65e4895cf381853adc8a7e23ae417e808df2db0d8117d85970.jpg)  

Etizolam $\mathrm{C_{17}H_{15}C l N_{4}S:342.85}$ 7-(2-Chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12- tetraazatricyclo[8.3.0.02,6}]trideca-2(6),4,7,10,12- pentaene [ 40054-69-1 ]Etizolam contains NLT $98.5\%$ and NMT $101.0\%$ of etizolam $(\mathbf{C}_{17}\mathbf{H}_{15}\mathbf{C}\mathrm{lN}_{4}\mathbf{S})$ ). Description Etizolam occurs as a white to pale yellowish white crystalline powder.  

It is soluble in ethanol(99.5), sparingly soluble in acetonitrile or acetic anhydride, and practically insoluble in water.  

Identification (1) Determine the absorption spectra of the solutions of Etizolam and etizolam RS in ethanol(99.5) (1 in 100000) as directed under the Ultravioletvisible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Etizolam and etizolam RS as directed in potassium bromide disk method under the Mid-infrared Absorption Spectrophotometry; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 146 and $149\,^{\circ}\mathrm{C}$ Purity (1) Heavy metals Proceed with $2.0~\mathrm{g}$ of Etizolam according to Method 2 and perform the test Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution (NMT 10 ppm).  

(2) Related substances Dissolve $20~\mathrm{mg}$ of Etizolam in $50~\mathrm{mL}$ of acetonitrile, and use this solution as the test solution. Take exactly $1.0\ \mathrm{mL}$ of this solution and add acetonitrile to make exactly $20\,\mathrm{\mL}$ . Pipet $1\ \mathrm{mL}$ of this solution, add acetonitrile to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine the peak area of each solution as directed in the automatic integration method; each peak area other than that of etizolam from the test solution is not greater than the peak area of etizolam from the standard solution.  

Detector: An ultraviolet absorption photometer (wavelength: $240\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $1.36\mathrm{~g~}$ of potassium dihydrogen phosphate in water to make $1000\,\mathrm{\mL}$ , and add diluted phosphoric acid (1 in 10) to adjust the $\mathrm{pH}$ to 3.5. To $550\;\mathrm{mL}$ of this solution, add $450\;\mathrm{mL}$ of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of etizolam is about 6 minutes.  

# System suitability  

Test for required detectability: Pipet $2~\mathrm{mL}$ of the standard solution and add acetonitrile to make exactly 20 mL. Confirm that the peak area of etizolam obtained from $10~\upmu\mathrm{L}$ of this solution is equivalent to 8 to $12\%$ of the peak area of etizolam from the standard solution.  

System performance: Dissolve $0.02\,\mathrm{~g~}$ each of Epizolam and ethylparaben in the mobile phase to make $50~\mathrm{mL}$ . To $1~\mathrm{mL}$ of this solution, add the mobile phase to make $50~\mathrm{mL}$ . Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above conditions; ethylparaben and etizolam are eluted in this order with the resolution being NLT 3.0. System repeatability: Repeat the test 6 times with $10\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area of etizolam is NMT $2.0\%$ .  

Time span of measurement: About 5 times the retention time of etizolam after the solvent peak.  

Loss on drying NMT $0.5\%$ ($1~\mathrm{g}$ ,$105\ ^{\circ}\mathrm{C}$ , 3 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.3~\mathrm{g}$ of Etizolam, previously dried, dissolve in $70~\mathrm{mL}$ of a mixture of acetic anhydride and acetic acid(100) $(7:3)$ , and titrate with 0.1 $\mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). The endpoint of the titration is the second inflection point. Perform a blank test in the same way and make a necessary correction.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Etodolac 에토돌락  

![](images/a5b6b48da098262128c69213582c551f25501e24676c2658d10d9fbca7e0cc63.jpg)  
$\mathrm{C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}$ : 287.35  

2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1- yl)acetic acid [ 41340-25-4 ]  

Etodolac contains NLT $98.0\%$ and NMT $102.0\%$ of etodolac $\left(\mathbf{C}_{17}\mathbf{H}_{21}\mathbf{N}\mathbf{O}_{3}\right)$ , calculated on the anhydrous basis. Description Etodolac occurs as white to pale yellow crystals or a crystalline powder.  

It is freely soluble in methanol or ethanol(99.5) and practically insoluble in water.  

A solution of Etodolac in methanol (1 in 50) shows no optical rotation.  

Melting point —About $147\ ^{\circ}\mathrm{C}$ (with decomposition). Identification (1) Determine the absorption spectra of solutions of Etodolac and etodolac RS in ethanol(99.5) (1 in 200000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Etodolac and etodolac RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Purity (1) Chloride —Dissolve about $0.5\mathrm{~g~}$ of Etodolac in $30\;\mathrm{mL}$ of methanol, add water to make $50\;\mathrm{mL}$ , and use this solution as the test solution. Prepare the control solution by adding $30~\mathrm{mL}$ of methanol and water to $0.42~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid to make $50~\mathrm{mL}$ (NMT $0.03\%$ ).  

(2) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Etodolac according to Method 2 and perform the test. Prepare the control solution with $1.0\,\mathrm{\mL}$ of lead standard solution (NMT 10 ppm).  

(3) Methanol and ethanol —Dissolve about $0.5~\mathrm{g}$ of Etodolac, weighed accurately, in $5.0~\mathrm{mL}$ of the internal standard solution, and use this solution as the test solution. Separately, pipet $5~\mathrm{mL}$ each of methanol and ethanol(95), add $N{,}N$ -dimethylformamide to make exactly $200~\mathrm{~mL~}$ . Pipet $5.0\ \mathrm{\mL}$ of this solution, add $N,N\!-$ dimethylformamide to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard stock solution. Pipet $10.0~\mathrm{mL}$ of the standard stock solution, add $5.0\,\textrm{m L}$ of the internal standard, dilute with $N,N_{\!}$ -dimethylformamide to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $1\,\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Gas Chromatography according to the following conditions, and calculate the ratios, $Q_{\mathrm{T}}$ and $Q\mathrm{s}$ , of the peak areas of methanol and ethanol in Etodolac to that of the internal standard for the test solution and the standard solution, respectively. The contents of methanol and ethanol is NMT $0.1\%$ , respectively.  

$$
=500\times{\frac{C}{W}}\times{\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}}
$$  

C: Concentration $(\mathrm{mg/mL})$ ) of ethanol or methanol in the standard solution  

W: Weight (mg) of Etodolac in the test solution Internal standard solution —Dissolve a suitable quantity of 2-propanol in $N,N_{\!}$ -dimethylformamide to make a solution with a concentration of $2.5\ \upmu\mathrm{L}/\mathrm{mL}$ . Pipet $5.0\;\mathrm{mL}$ of this solution, and dilute this solution with $N,N\!\cdot$ -dimethylformamide to make exactly $100\;\mathrm{mL}$ .  

Operating conditions  

Detector: A hydrogen flame ionization detector Column: A fused silica capillary column $0.32\;\mathrm{mm}$ in internal diameter and $25\textrm{m}$ in length, coated with a $5~{\upmu\mathrm{m}}$ film of $1\%$ vinyl– ${}_{-5\%}$ phenylmethylpolysiloxane for gas chromatography.  

Carrier gas: Helium Flow rate: $50\;\mathrm{mL/min}$ Sample injection port temperature: $200\,^{\circ}\!C$ Detector temperature: $300\,^{\circ}\mathrm{C}$ Column temperature: Maintain the temperature of $45\ ^{\circ}\mathrm{C}$ for 5 minutes, then raise to $280~^{\circ}\!C$ at the rate of 30 $^\circ C$ per minute, and maintain at $280\,^{\circ}\!C$ for 27 minutes.  

System suitability  

System performance: Proceed with $1~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; methanol, ethanol, and 2-propanol are eluted in this order with the resolution between their peaks being NLT 1.0. (4) Related substances —Dissolve $25~\mathrm{~mg~}$ of Etodolac, weighted accurately, in acetonitrile to make exactly $250~\mathrm{mL}$ , and use this solution as the test solution. Perform the test with $20~\upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions. Each peak area of any peak other than the major peak from the test solution is NMT $0.5\%$ to the total area of all peaks, and the total area is NMT $2.0\%$ .  

$$
=\,100\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}
$$  

$A_{\mathrm{T}}$ : Each peak area of the peaks other than the principle peak  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $214\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B in stages or gradient elution as follows. For the first 5 minutes, use mixture of $60\%$ solution A and $40\%$ solution B as the mobile phase. For the next 30 minutes, change the mixture ratio as linear gradient to finally make mixture of $20\%$ solution A and $80\%$ solution B. Adjust mobile phase to $40\%$ of solution B before injection of the test solution and the standard solution, and keep re-equilibrium.  

Mobile phase A: Mix $0.6\ \mathrm{mL}$ of phosphoric acid with $100\;\mathrm{mL}$ of water.  

Mobile phase B: Mix $0.6~\mathrm{mL}$ of phosphoric acid with $100\;\mathrm{mL}$ of acetonitrile.  

Flow rate: $1\ \mathrm{mL/min}$ System suitability  

System performance: Dissolve suitable amount each of etodolac related substance I RS and etodolac RS in acetonitrile to make solutions containing $10~\upmu\mathrm{g}$ of etodolac related substance I RS and $0.2~\mathrm{mg}$ of etodolac RS per mL, respectively. Proceed with $20~\upmu\mathrm{L}$ of this solution as directed under the above operating conditions; etodolac related substance I and etodolac are eluted in this order with the resolution between their peaks being NLT 3.0.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of the solution according to the above conditions; the relative standard deviation of the ratio of the peak area is NMT $3\%$ .  

Water NMT $0.5\%$ ($\mathbf{\nabla}^{2}\,\mathbf{g}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.23\mathrm{~g~}$ of Etodolac, dissolve in $60~\mathrm{mL}$ of methanol, and titrate with $0.1\ \mathrm{mol/L}$ tetrabutylammonium hydroxide VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $1\ \mathrm{mol/L}$ tetrabutylammonium hydroxide VS $=28.735~\mathrm{mg}$ of $\mathrm{C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}$  

Packaging and storage Preserve in tight containers. Etodolac Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of etodolac $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right.$ :287.36).  

Method of preparation Prepare as directed under Tablets, with Etodolac.  

Identification The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Dissolution Perform the test with 1 tablet of Etodolac Tablets at 100 revolutions per minute according to Method 1 under the Dissolution, using $1000\,\mathrm{\mL}$ of $\mathsf{p H}\,\,6.8$ phosphate buffer solution as the dissolution medium. Take $20\,\mathrm{\mL}$ of the dissolved solution 30 minutes after starting the test, and filter through a membrane filter with a pore size of NMT $0.8\ \upmu\mathrm{m}$ . Discard the first $10~\mathrm{mL}$ of the filtrate and use the subsequent filtrate as the test solution. Separately, weigh accurately about $25~\mathrm{~mg~}$ of etodolac RS, dissolve in the dissolution medium to make exactly $100~\mathrm{mL}$ , pipet $5~\mathrm{mL}$ of this solution, and add the dissolution medium to make exactly $50~\mathrm{mL}$ . Use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of the test solution and the standard solution as directed under the Ultraviolet-visible Spectroscopy at the absorbance maximum wavelength of about $274~\mathrm{nm}$ , using the dissolution medium as a control solution.  

The acceptable dissolution criterion is NLT $80\%$ of Etodolac Tablets dissolved in 30 minutes.  

Dissolution rate $(\%)$ of the labeled amount of etodolac  

$$
\begin{array}{c}{\mathrm{{(C_{17}H_{21}N O_{3})}}}\\ {=W_{\mathrm{{S}}}\times\displaystyle\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\displaystyle\frac{100}{\mathrm{C}}}\end{array}
$$  

$W_{S}$ : Amount $(\mathrm{mg})$ of etodolac RS $C$ : Labeled amount $\left(\mathrm{mg}\right)$ of etodolac $\left(\mathbf{C}_{17}\mathbf{H}_{21}\mathbf{N}\mathbf{O}_{3}\right)$ ) in 1 tablet  

Uniformity of dosage units It meets the requirements when the Content uniformity test is performed according to the following procedure. Take 1 tablet of Etodolac Tablets, add $10\,\mathrm{\mL}$ of phosphate buffer solution, and shake to mix until disintegration. Then, add phosphate buffer solution to make exactly $100\;\mathrm{mL}$ , and centrifuge. Take $\chi\,\textrm{m L}$ of the clear supernatant, add phosphate buffer solution to obtain $V\,\mathrm{mL}$ of a solution having known concentration of about $25~\mathrm{~\mug~}$ of etodolac $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right)$ per mL, and use this solution as the test solution. Separately, weigh accurately about $25~\mathrm{mg}$ of the etodolac RS, and dissolve in phosphate buffer solution to make exactly $100~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add phosphate buffer solution to make $100~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution as directed under the Ultraviolet-visible Spectroscopy at the absorbance maximum wavelength at about $274\;\mathrm{nm}$ .  

Assay Weigh accurately the mass of NLT 20 tablets of Etodolac Tablets, and powder. Weigh accurately an amount, equivalent to about $0.1\ \ \mathrm{~g~}$ of etodolac $\left(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right)$ , add $30\,\mathrm{\mL}$ of the mobile phase, shake to mix for 15 minutes, and sonicate for 5 minutes to mix. After cooling, add $50~\mathrm{mL}$ of the mobile phase to make exactly $50~\mathrm{mL}$ . Allow to stand for 10 minutes, then take $10.0~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and filter. Use the filtrate as the test solution. Separately, weigh accurately about $20~\mathrm{~mg~}$ of etodolac RS, dissolve in the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of etodolac in each solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $274\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $3~{\upmu\mathrm{m}}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile, water, and phosphoric acid $(500:500:0.25)$ .  

Flow rate: $1.5\;\mathrm{mL/min}$ System suitability  

System performance: Dissolve an appropriate amount of etodolac related substance I RS and etodolac RS in acetonitrile to make a solution containing $10~\upmu\mathrm{g}$ of etodolac related substance I RS and $0.2~\mathrm{mg}$ of etodolac RS per mL. Proceed with $20~\upmu\mathrm{L}$ of this solution as directed under the above conditions; etodolac related substance I and etodolac are eluted in this order with the resolution being NLT 3.0.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of the solution according to the above conditions; the relative standard deviation of the peak area is NMT $3\%$ .  

Packaging and storage Preserve in tight containers.  

# Etodolac Micronized 미분화에토돌락  

![](images/fff1be6a7d2a0c8b3d449c351336270576eb6c7759ec69f88a9088b597498008.jpg)  

Etodolac Micronized $\mathrm{C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}$ : 287.36 (1 S)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole1-acetic acid, [ 87249-11-4 ]  

Etodolac Micronized contains NLT $97.0\%$ and NMT $101.0\%$ of etodolac $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right)$ ), calculated on the anhydrous basis.  

Description Etodolac Micronized occurs as a white fine crystalline powder.  

It is very soluble in polyethylene glycol 400, freely soluble in ethanol, methanol or chloroform and practically insoluble in water.  

Melting point —Between 145 and $148\,^{\circ}\mathrm{C}$ Identification (1) Perform the test with Etodolac Micronized as directed in article (2) of the Purity; the spots obtained from the test solution and the standard solution show the same $R_{\mathrm{f}}$ value and color.  

(2) Determine the infrared spectra of Etodolac Micronized and etodolac RS as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Purity (1) Heavy metals— Proceed with $1.0\ \mathrm{~g~}$ of Etodolac Micronized as directed under Method 2 and perform the test. Prepare the control solution with $1.0\;\mathrm{mL}$ of lead standard solution (NMT 10 ppm).  

(2) Related substances —Weigh accurately about $0.1\ \mathrm{g}$ of Etodolac Micronized, add acetone to make 100 mL, and use this solution as the test solution. Separately, weigh accurately $0.10~\mathrm{g}$ of etodolac RS, dissolve in acetone to make $100~\mathrm{mL}$ , and use this solution as the standard solution. To $25.0\,\textrm{m L}$ of the standard solution, add acetone to make $100~\mathrm{mL}$ , and use this solution as the diluted standard solution. Perform the test with the test solution, the standard solution and the diluted standard solution as directed under the Thin Layer Chromatography. Immerse a plate made of silica gel for thin-layer chromatography (with florescent agent) in a solution prepared by dissolving $0.5\,\mathrm{~g~}$ of ascorbic acid in a mixture of water and ethanol (1 in 5) to make $100\,\mathrm{\mL}$ , and air-dry the plate. Apply $25\,\upmu\mathrm{L}$ each of the test solution and the standard solution and $2~\upmu\mathrm{L}$ of the diluted standard solution on the plate. Develop the plate with a mixture of toluene, acetic acid and ethanol $(70:50:30)$ as the developing solvent to a distance of $16\;\mathrm{cm}$ to $18~\mathrm{cm}$ , and airdry the plate for 30 minutes. Examine the plate under ultraviolet light (main wavelength: $254\,\mathrm{\nm}$ ); the spots other than the principal spot from the test solution are not greater or more intense than the spot from the diluted standard solution.  

Particle size Place a small amount of Etodolac Micronized on a microscope slide, add 1 to 2 drops of mineral oil, mix well, and disperse. Then, cover it with a coverslip and measure the particle size with a microscope with a magnification of 40 to 400 times. Measure the size of all particles in the micrometer range of particle size measurement, and repeat the test more than three times; the average particle size should be NMT $8~{\upmu\mathrm{m}}$ , and the percentage of the number of particles NMT $20\ \upmu\mathrm{m}$ should be NLT $95\%$ .  

Assay Weigh accurately about $0.1\,\mathrm{~g~}$ of Etodolac Micronized and dissolve in methanol to make $100.0\,\mathrm{\mL}$ .Pipet $1.0~\mathrm{mL}$ of this solution and add methanol to make $50.0~\mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately $0.1~\mathrm{g}$ of etodolac RS and proceed in the same manner as in the preparation of the test solution. Use the resulting solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution according to the following conditions as directed under the Liquid Chromatography, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of etodolac in each solution.  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).   
Mobile phase: A mixture of buffer solution, methanol and acetonitrile $(68:19:13)$ .  
Flow rate: $1.0\,\mathrm{mL/min}$  

Buffer solution —To 0.5 mol/L potassium dihydrogen phosphate, add $200~\mathrm{mL}$ of water to make $1000\,\mathrm{mL}$ .  

# Packaging and storage Preserve in tight containers.  

# Etodolac Micronized Capsules 미분화에토돌락캡슐  

Etodolac Micronized Capsules contain NLT $90.0\%$ and NMT $110.0\%$ the labeled amount of etodolac $(\mathrm{C_{10}H_{21}N O_{3}:287.36})$ .  

Method of preparation Prepare as directed under Capsules, with Etodolac Micronized.  

Identification The retention times of the major peaks from the test solution and standard solution obtained under the Assay are the same.  

Dissolution Perform the test with 1 capsule of Etodolac Micronized Capsules at 100 revolutions per minute according to Method 1, using $900~\mathrm{mL}$ of phosphate buffer solution $({\mathrm{pH}}\ 7.5)$ as the dissolution medium. Take the dissolved solution 45 minutes after the start of the dissolution, filter, take $4.0\ \mathrm{mL}$ of the filtrate, and add phosphate buffer solution $(\mathrm{pH}\,7.5)$ to make $25.0\ \mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately about $0.1\ \mathrm{g}$ of etodolac RS, dissolve in phosphate buffer solution $(\mathrm{pH}\,7.5)$ , make the same concentration as the test solution, and use this solution as the standard solution. Determine the absorbances, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of the test solution and the standard solution, at $278~\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy, using phosphate buffer solution $(\mathrm{pH}\ 7.5)$ as the control solution. It meets the requirements if the dissolution rate in 45 minutes is NLT $75\%$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the contents of NLT 20 capsules of Etodolac Micronized Capsules and powder. Weigh an amount equivalent to about $50~\mathrm{mg}$ of etodolac $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right)$ , add $0.1\ \mathrm{mol/L}$ sodium hydroxide to make $100\,\mathrm{\mL}$ , sonicate for 30 minutes, and centrifuge. Take $1.0~\mathrm{mL}$ of the clear supernatant, add the mobile phase to make $50.0~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of etodolac RS, add $0.1\ \mathrm{mol/L}$ sodium hydroxide to make $100.0\;\mathrm{mL}$ . Take an appropriate amount of this solution to obtain a solution having known concentration of $10~\upmu\mathrm{g}$ per mL, and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak area of etodolac, $A_{\mathrm{T}}$ and $A_{S}$ , respectively.  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of phosphate buffer (pH 4.75) and acetonitrile buffer $(55:45)$ .  
Flow rate: $1.0\,\mathrm{mL/min}$  

# Packaging and storage Preserve in tight containers.  

# Etodolac Micronized Tablets 미분화에토돌락정  

Etodolac Micronized Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of etodolac $(\mathrm{C_{17}H_{21}N O_{3}:287.36})$ .  

Method of preparation Prepare as directed under Tablets, with Etodolac Micronized.  

Identification The major peaks obtained from the test solution and the standard solution under the Assay are the same in the retention time.  

Dissolution Perform the test with 1 tablet of Etodolac Micronized Tablets at 100 revolutions per minute according to Method 1 under the Dissolution, using $900~\mathrm{mL}$ of phosphate buffer solution, $\mathrm{pH}\,7.5$ , as the dissolution medium. Take the dissolved solution 45 minutes after starting of the dissolution test, filter, take $4.0~\mathrm{mL}$ of the filtrate, add phosphate buffer solution, $\mathrm{pH}\,7.5$ , to make 25.0 mL, and use this solution as the test solution. Separately, weigh accurately about $0.1\ \mathrm{g}$ of etodolac RS, dissolve in phosphate buffer solution, $\mathrm{pH}\ 7.5$ , to make it the same concentration as the test solution, and this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ ,of the test solution and the standard solution at a wavelength of $278~\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy, using phosphate buffer solution, $\mathrm{pH}\,7.5$ , as the control solution. Meets the requirements if the dissolution rate of Etodolac Micronized Tablets for 45 minutes is NLT $75\%$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately NLT 20 tablets of Etodolac Micronized Tablets, and powder. Weigh accurately a portion of this powder, equivalent to about $50\,\mathrm{~mg}$ of etodolac $\left(\mathsf{C}_{17}\mathrm{H}_{21}\mathrm{NO}_{3}\right)$ , add $0.1\ \mathrm{mol/L}$ sodium hydroxide solution to make $100.0~\mathrm{mL}$ , sonicate for 30 minutes, and centrifuge. Take $1.0\ \mathrm{mL}$ of the clear supernatant, add the mobile phase to make $50.0~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about 50 mg of etodolac RS, and dissolve in $0.1\ \mathrm{mol/L}$ hydrochloric acid to make $100.0~\mathrm{mL}$ . Take an appropriate amount of this solution, prepare a solution containing $10~\upmu\mathrm{g}$ per mL, and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution according to the following conditions as directed under the Liquid Chromatography, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of etodolac for each solution.  

Detector: An ultraviolet absorption photometer (wavelength: $225\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4\,\textrm{m m}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).   
Mobile phase: A mixture of phosphate buffer solu  

tion, $\mathrm{pH}\,4.75$ , and acetonitrile $(55:45)$ .Flow rate: $1.0\,\mathrm{mL/min}$  

Phosphate buffer solution, pH 4.75 —Add water to $100\,\mathrm{\mL}$ of $0.5\,\mathrm{\mol/L}$ potassium dihydrogen phosphate solution to make $1000~\mathrm{mL}$ , and adjust the $\mathrm{pH}$ to 4.75 with potassium hydroxide solution.  

Packaging and storage Preserve in tight containers. Loss on drying $0.5\%$ ($\mathrm{~1~g,~}105\ ^{\circ}\mathrm{C,}$ 2 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.2{\mathrm{~g~}}$ of Etofylline Nicotinate, previously dried, dissolve in $50~\mathrm{mL}$ of acetic acid(100) for non-aqueous titration, and titrate with 0.1 mol/L perchloric acid VS as directed in the potentiometric titration under the Titrimetry. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=16.47~\mathrm{mg}$ of $\mathrm{C_{15}H_{15}N_{5}O_{4}}$  

Packaging and storage Preserve in tight containers.  

# Etofylline Nicotinate 에토필린니코티네이트  

# Etofylline Nicotinate Injection 에토필린니코티네이트주사액  

![](images/d1719d340a8d9ffcd33ba7219b7a552d6362ae3aaafec9434fc5d93ea52c92f7.jpg)  

Etofylline Nicotinate $\mathrm{C_{15}H_{15}N_{5}O_{4}}$ : 329.31 2-(1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo$.7H$ -purin7-yl)ethyl 3-pyridinecarboxylic acid ester, [ 13425-39-3 ]Etofylline Nicotinate, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of etofylline nicotinate $\left({\bf C}_{15}\mathrm{H}_{15}\mathrm{N}_{5}\mathrm{O}_{4}\right)$ .  

Description Etofylline Nicotinate occurs as a white crystalline powder, is odorless and has a bitter taste.  

Identification (1) Add 10 drops of $3\%$ hydrogen peroxide and 3 drops of hydrochloric acid to $10~\mathrm{mg}$ of Etofylline Nicotinate, mix well, and evaporate to dryness. Add a few drops of $10\%$ ammonia water to the residue on evaporation; it exhibits dark red color.  

(2) Determine the absorption spectrum as directed under the Ultraviolet-visible Spectroscopy with a solution of Etofylline Nicotinate in hydrochloric acid (1 in 10000); it exhibits a maximum at about $268\;\mathrm{nm}$ .  

Melting point Between 151 and $152\ ^{\circ}\mathrm{C}$ Purity (1) Clarity and color of solution— Weigh $2.0~\mathrm{g}$ of Etofylline Nicotinate in $10~\mathrm{mL}$ of chloroform; the resulting solution is clear and colorless.  

(2) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Etofylline Nicotinate as directed under Method 1 and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT $10\,\mathrm{ppm}$ ).  

Etofylline Nicotinate Injection is an aqueous injection and contains NLT $95.0\%$ and NMT $105.0\%$ of etofylline nicotinate $\mathrm{(C_{15}H_{15}N_{5}O_{4}\,;\,329.31}$ ).  

Method of preparation Prepare as directed under Injections, with Etofylline Nicotinate.  

Identification (1) To an amount of Etofylline Nicotinate Injection equivalent to $10~\mathrm{mg}$ of etofylline nicotinate, add 10 drops of $3\%$ hydrogen peroxide and 3 drops of hydrochloric acid, shake to mix, evaporate in an evaporating dish until a reddish brown residue forms, and add a few drops of $10\%$ ammonia water; the solution exhibits a dark red color.  

(2) Take an amount of Etofylline Nicotinate Injection equivalent to $25~\mathrm{mg}$ of etofylline nicotinate according to the labeled amount, extract in $100~\mathrm{mL}$ of chloroform, and add chloroform to $10\;\mathrm{mL}$ of the extract to make $100.0\;\mathrm{mL}$ . Use this solution as the test solution. Separately, dissolve $10~\mathrm{mg}$ of etofylline nicotinate RS in $100~\mathrm{mL}$ of chloroform and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thinlayer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform and methanol $\left(9:\right.$ 1) as the developing solvent to a distance of about $10\;\mathrm{cm}$ ,and air-dry the plate. Spray evenly a phosphomolybdic acid ethanol solution on the plate, dry at $120~^{\circ}\mathrm{C}$ and apply iodine vapor to the plate; the $R_{\mathrm{f}}$ values and colors of spots obtained from the test solution and the standard solution are the same.  

(3) Take an amount of Etofylline Nicotinate Injection, equivalent to $10\,\mathrm{~mg~}$ of etofylline nicotinate, add $0.05~\mathrm{mol/L}$ hydrochloric acid to make exactly $100\ \mathrm{mL}$ ,and filter. Take $10~\mathrm{mL}$ of the filtrate, add $0.05\;\mathrm{mol/L}$ hydrochloric acid to make $100.0\ \mathrm{mL}$ , and measure the absorbance spectrum as directed under Ultraviolet-visible Spectroscopy; it exhibits a maximum around $268~\mathrm{nm}$ .  

Sterility Meets the requirements. Bacterial endotoxins Less than 3 EU per mg of etofylline nicotinate.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Take an amount of Etofylline Nicotinate Injection equivalent to $0.1\ \mathrm{g}$ of etofylline nicotinate $\left({\bf C}_{15}\mathrm{H}_{15}\mathrm{N}_{5}\mathrm{O}_{4}\right)$ according to the labeled amount, place in a $125~\mathrm{mL}$ separatory funnel, then extract 3 times with $30~\mathrm{mL}$ of chloroform each time. Combine the chloroform extract and filter with cotton wool to make $100~\mathrm{mL}$ . Pipet $3\ \mathrm{mL}$ of this solution and evaporate the chloroform to dryness completely on a steam bath. Add $0.05\,\mathrm{\mol/L}$ hydrochloric acid to the residue and shake to dissolve to make exactly $500~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $0.1\,\mathrm{~g~}$ of etofylline nicotinate RS, previously dried at $105\ ^{\circ}\mathrm{C}$ for 2 hours, and dissolve in $0.05~\mathrm{mol/L}$ hydrochloric acid TS to make exactly $100\;\mathrm{mL}$ . Pipet $3\;\mathrm{mL}$ of this solution, add $0.05\;\mathrm{mol/L}$ hydrochloric acid TS to make exactly $500~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution at the wavelength of $268\ \mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy, using $0.05\;\mathrm{\mol/L}$ hydrochloric acid as a control solution.  

Amount (mg) of etofylline nicotinate $\left({\bf C}_{15}{\bf H}_{15}{\bf N}_{5}{\bf O}_{4}\right)$ $=$ Amount $(\mathrm{mg})$ ) of etofylline nicotinate $\mathrm{RS}\times(A_{\mathrm{T}}\,/\,A_{\mathrm{S}})$  

Packaging and storage Preserve in hermetic containers.  

![](images/2e4ed63d55fd0e840b3264a4b9b29a455226caba88173683611529360fda2593.jpg)  

Etoposide $\mathrm{C}_{29}\mathrm{H}_{32}\mathrm{O}_{13}$ : 588.56   
(5 S,5a R,8a R,9 R)-5-[[ $(2R,4{\mathrm{a}}R,6R,7R,8R,8{\mathrm{a}}S)–7,8-$   
Dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2- d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-   
dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H  
[2]benzofuro[6,5-f][1,3]benzodioxol-8-one [ 33419-42-0 ]Etoposide contains NLT $98.0\%$ and NMT $102.0\%$ of etoposide $(\mathbf{C}_{29}\mathbf{H}_{32}\mathbf{O}_{13})$ , calculated on the anhydrous basis.  

Description Etoposide occurs as white crystals or a crystalline powder.  

It is sparingly soluble in methanol, slightly soluble in ethanol(99.5), and very slightly in water.   
Melting point —About $260\ ^{\circ}\mathrm{C}$ .  

Identification (1) Determine the absorption spectra of Etoposide and etoposide RS in methanol (1 in 10000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Etoposide and etoposide RS as directed in the paste method under Infrared Spectrophotometry: both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-100^{\circ}$ and $-105^{\circ}\:(0.1\mathrm{~g~}$ ,calculated on the anhydrous basis, methanol, $20~\mathrm{mL}$ , 100 mm).  

Purity (1) Heavy metals —Proceed about $2.0~\mathrm{g}$ of Etoposide according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 10 ppm).  

(2) Related substances —Dissolve $50~\mathrm{mg}$ of Etoposide in $10\;\mathrm{mL}$ of methanol, add the mobile phase to make $50~\mathrm{mL}$ , and use this solution as the test solution. Pipet 2 mL of this solution, add the mobile phase to it make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area by the automatic integration method: the area of any peak other than etoposide obtained with the test solution is not greater than 1/5 times the peak area of etoposide obtained with the standard solution. The total area of all peaks other than the peak of etoposide obtained with the test solution is not greater than $1/2$ times the peak area of etoposide obtained with the standard solution.  

Operating conditions  

For the detector, column, column temperature, mobile phase and flow rate, proceed as directed in the operating conditions under the Assay.  

System suitability  

System performance: Proceed as directed under the system suitability under the Assay.  

Test for required detectability: Weigh accurately 1 mL of the standard solution and add the mobile phase to make exactly $10\;\mathrm{\mL}$ . Confirm that the peak area of Etoposide obtained from $50~\upmu\mathrm{L}$ of this solution is within the range between $7\%$ and $13\%$ of the peak area of Etoposide in the standard solution.  

System repeatability: Repeat the test 6 times with $50\,\textrm{\textmu L}$ of the standard solution according to the above operating conditions; the relative standard deviation of the peak area for Etoposide is NMT $2.0\%$ .  

Time span of measurement: About 3 times the retention time of etoposide after the solvent peak.  

Water NMT $4.0\%$ $\left[0.5\,\mathrm{~g~}\right]$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.1\%$ ($\,[\,{\bf\rho}_{1}\,{\bf g})$  

Assay Weigh accurately about $25~\mathrm{mg}$ each of Etoposide and etoposide RS (previously determined the water), dissolve separately in and dilute with methanol to make exactly $25~\mathrm{mL}$ each. Pipet $10~\mathrm{mL}$ each of these solutions, add exactly $5\;\mathrm{mL}$ of the internal standard solution and the mobile phase to make exactly $50~\mathrm{mL}$ and use these solutions as the test solution and standard solution, respectively. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and measure the ratio of the peak area of etoposide to that of the internal standard, $Q_{\mathrm{T}}$ and $Q_{S}$ .  

Amount (mg) of Etoposide $(\mathbf{C}_{29}\mathbf{H}_{32}\mathbf{O}_{13})$ $=$ Amount (mg) of etoposide RS, as calculated on the anhydrous basis $\times\,\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —A solution of 2,6- dichlorophenol in methanol (3 in 2500).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $290\;\mathrm{nm}$ ).  

Column: A stainless steel column about $3.9\ \mathrm{mm}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with phenylsilyl silica gel for liquid chromatography ( $10~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $6.44\,\mathrm{~g~}$ of sodium sulfate decahydrate in diluted acetic acid(100) (1 in 100) to make $1000\,\mathrm{mL}$ , and add $250\;\mathrm{mL}$ of acetonitrile.  

Flow rate: Adjust the flow rate so that the retention time of etoposide is about 20 minutes.  

# System suitability  

System performance: Dissolve $10~\mathrm{{mg}}$ of Etoposide in $2~\mathrm{mL}$ of methanol, add $8\ \mathrm{mL}$ of the mobile phase, and mix well. Add $0.1~\mathrm{mL}$ of diluted acetic acid(100) (1 in 25) and $0.1\;\mathrm{mL}$ of phenolphthalein TS, and add sodium hydroxide TS until the color of the solution changes to faintly red. After allowing to stand for 15 minutes, add $0.1~\mathrm{mL}$ of diluted acetic acid(100)(1 in 25). Proceed with $10~\upmu\mathrm{L}$ of this solution under the above operating conditions; the resolution between the peak having the relative retention time of about 1.3 with respect to etoposide is NLT 3.0.  

System repeatability: Repeat the test 6 times with $50~\upmu\mathrm{L}$ of the standard solution according to the above operating conditions; the relative standard deviation of the peak area for Etoposide is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

# Famotidine 파모티딘  

![](images/ddc340a8a649a9a5ef058b7c339158a1d6f0fede5b83de6055d2255bce424ff1.jpg)  

Famotidine $\mathrm{C_{8}H_{15}N_{7}O_{2}S_{3}:337.45}$ 3-[({2-[(Diaminomethylidene)amino]-1,3-thiazol-4- yl}methyl)sulfanyl]- $.N^{\prime}$ -sulfamoylpropanimidamide [76824-35-6 ]Famotidine, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ ).  

Description Famotidine occurs as white to yellowish white crystals.  

It is freely soluble in acetic acid(100), slightly soluble in ethanol(95), very slightly soluble in water.   
It dissolves in $0.5\;\mathrm{mol/L}$ hydrochloric acid TS.   
It is gradually colored by light.   
Melting point —About $164\,^{\circ}\mathrm{C}$ (with decomposition).  

Identification (1) Determine the absorption spectra of solutions of Famotidine and famotidine RS in $0.05\;\mathrm{mol/L}$ potassium dihydrogen phosphate TS (1 in 50000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Famotidine and famotidine RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Purity (1) Clarity and color of solution— Dissolve $0.5~\mathrm{g}$ of Famotidine in $10~\mathrm{mL}$ of $0.5~\mathrm{mol/L}$ hydrochloric acid TS; the solution is clear and colorless to pale yellow.  

(2) Heavy metals— Proceed with $2.0\ \mathrm{~g~}$ of Famotidine according to Method 2 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT $10\,\mathrm{ppm}$ ).  

(3) Related substances— Dissolve $0.20\,\mathrm{~g~}$ of Famotidine in $10~\mathrm{mL}$ of acetic acid(100), and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, and add acetic acid(100) to make exactly $100\,\mathrm{\mL}$ . Pipet 1 mL, $2~\mathrm{mL}$ and $3\ \mathrm{mL}$ of this solution, and add acetic acid(100) to make exactly $100\;\mathrm{mL}$ each, and use these solutions as the standard solutions (1), (2) and (3). With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution, the standard solution (1), the standard solution (2), the standard solution (3) on the plate made of silica gel for thin-layer chromatography $\ensuremath{\left\langle5\ \upmu\mathrm{m}\right.\right.}$ to $7~{\upmu\mathrm{m}}$ in particle diameter, with fluorescent indicator). Then, dry with the aid of a current of nitrogen. Next, develop the plate using a mixture of ethyl acetate, methanol, toluene and ammonia water(28) $(40:25:20:2)$ as the developing solvent to a distance of about $8~\mathrm{{cm}}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm})$ ); the spots other than the principal spot and the spot of the starting point obtained from the test solution are not more intense than the spots from the standard solution (3). The total intensity of the spots other than the principal spot and the spot of the starting point obtained from the test solution are NMT $0.5\%$ , as compared to intensities of the spots obtained from the standard solutions (1) and (2).  

Loss on drying NMT $0.5\%$ ($1\;\mathrm{g}.$ , in vacuum, phosphorus pentoxide, $80\,^{\circ}\mathrm{C}$ , 4 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.3~\mathrm{g}$ of Famotidine, previously dried, dissolve in $50~\mathrm{mL}$ of acetic acid(100), and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of perchloric acid VS $=16.873~\mathrm{mg}$ of $\mathrm{C_{8}H_{15}N_{7}O_{2}S_{3}}$ Packaging and storage Preserve in light-resistant, tight containers.  

# Famotidine for Injection 주사용파모티딘  

Famotidine for injection is a preparation for injection, which is dissolved before use. Famotidine for injection contains NLT $94.0\%$ and NLT $106.0\%$ of the labeled amount of famotidine $(\mathrm{C_{8}H_{15}N_{7}O_{2}S_{3}:337.45})$ .  

Method of preparation Prepare as directed under Injections, with Famotidine.  

Description Famotidine for injection occurs as a porous mass or a powder.  

Identification Weigh an amount of Famotidine for injection, equivalent to $10~\mathrm{mg}$ of famotidine according to the labeled amount, dissolve in $50\;\mathrm{mL}$ of $0.05\;\mathrm{mol/L}$ potassium dihydrogen phosphate TS, then to $5~\mathrm{mL}$ of the resulting solution, add 0.05 mol/L potassium dihydrogen phosphate TS to make $50~\mathrm{mL}$ . Determine the absorption spectra of this solution as directed under Ultraviolet-visible Spectroscopy; it exhibits a maximum absorption between $263~\mathrm{nm}$ and $267\;\mathrm{nm}$ .  

$\mathbf{pH}$ Dissolve an amount of Famotidine for injection equivalent to $20~\mathrm{mg}$ (potency) of famotidine, and dissolve in $1~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 4.9 and 5.5.  

Purity (1) Clarity and color of solution ―Weigh an amount of Famotidine for injection equivalent to about 20 mg of famotidine according to the labeled amount, and dissolved in $1~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Related substances― Take a number of Famotidine for injection, equivalent to about $0.1\,\mathrm{~g~}$ of famotidine (C8H15N7O2S3), dissolve each content in water, wash the inside of the container with water, combine the solutions of the contents with the washings, add water to the combined solution to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with 5 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area of these solutions by the automatic integration method: the total area of the peaks other than the major peak from the test solution is not larger than the major peak from the standard solution.  

# Operating conditions  

For the detector, column, column temperature, mobile phase, flow rate and system performance, proceed as directed in the operating conditions under the Assay.  

Detection sensitivity: Adjust the detection sensitivity so that the peak height of famotidine obtained from 5 $\upmu\mathrm{L}$ of the standard solution is between $5\;\mathrm{mm}$ and $10\;\mathrm{mm}$ .System suitability   
System performance: Proceed as directed under the system suitability under the Assay.   
Test for required detectability: Pipet $2~\mathrm{mL}$ of the standard solution, and add water to make exactly $20~\mathrm{mL}$ .Confirm that the peak area of famotidine obtained from 5 $\upmu\mathrm{L}$ of this solution is $8\%$ to $12\%$ of the peak area of famotidine obtained from the standard solution.   
System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution according to the above operating conditions; the relative standard deviation of the peak area of famotidine is NMT $2.0\%$ .  

Time span of measurement: About 2 times the retention time of famotidine after the solvent peak.  

Water NMT $1.5\%$ $\mathrm{[0.1~g}$ , coulometric titration). Sterility Meets the requirements. Bacterial endotoxins Less than 15 EU per mg of Famotidine for Injection.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Uniformity of dosage units Meets the requirements. Assay Take a number of Famotidine for injection equivalent to about $0.1\,\mathrm{~g~}$ of famotidine $\left(\mathrm{C_{8}H_{15}N_{7}O_{2}S_{3}}\right)$ , dissolve the contents in water, wash each container with water, add the washings to the initial fluid, and add water to make exactly $100~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add $5.0~\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $50\;\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of famotidine RS (previously dried at $80\ ^{\circ}\mathrm{C}$ for 4 hours in a phosphorus pentoxide desiccator) and dissolve in the mobile phase to make exactly $50\,\mathrm{\mL}$ . Pipet $5\ \mathrm{mL}$ of this solution, add $5.0\;\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with 5 $\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $\mathrm{Q_{T}}$ and $\mathrm{Q}_{\mathrm{S}}$ , of famotidine to the internal standard, respectively.  

Amount (mg) of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ )$=$ Amount (mg) of famotidine $\mathrm{RS}\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times2$ Internal standard solution —To $5~\mathrm{mL}$ of a solution of methyl $p$ -hydroxybenzoate in methanol (1 in 500), add water to make $50\;\mathrm{mL}$ .  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve $2\,\mathrm{~\textit~{~g~}~}$ of sodium 1- heptanesulfonate in $900~\mathrm{\mL}$ of water, add acetic acid(100) to adjust the $\mathrm{pH}$ to 3.0, and add water to make $1000\,\mathrm{\mL}$ . To this solution, add $240\,\mathrm{\mL}$ of acetonitrile and $40\,\mathrm{mL}$ of methanol.  

Flow rate: Adjust the flow rate so that the retention time of famotidine is about 6 minutes.   
System suitability  

System performance: Proceed with $5\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; famotidine and the internal standard are eluted in this order with the resolution being NLT 11.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of ratios of the peak area of famotidine to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in hermetic containers.  

# Famotidine Tablets 파모티딘정  

Famotidine Tablets contain NLT $94.0\%$ and NMT $106.0\%$ of the labeled amount of famotidine $(\mathrm{C_{8}H_{15}N_{7}O_{2}S_{3}:337.45})$ ).  

Method of preparation Prepare as directed under Tablets, with Famotidine.  

Identification Weigh an amount of Famotidine Tablets, previously powdered, equivalent to $10~\mathrm{mg}$ of famotidine according to the labeled amount, add $50\,\mathrm{\mL}$ of 0.05 $\mathrm{mol/L}$ potassium dihydrogen phosphate TS, shake well to mix, and then centrifuge. To $5~\mathrm{mL}$ of the clear supernatant, add $0.05\;\mathrm{mol/L}$ potassium dihydrogen phosphate TS to make $50\,\mathrm{mL}$ , and determine the absorption spectrum of the solution as directed under Ultraviolet-visible Spectroscopy; it exhibits a maximum absorption between 263 nm and $267\;\mathrm{nm}$ .  

Purity Related substances —Take NLT 10 Famotidine Tablets, add $200~\mathrm{mL}$ of diluent, and disintegrate by shaking well to mix. To this solution, add $200~\mathrm{mL}$ of methanol, mix at 300 revolutions per minute for 1 hour, add diluent to make exactly $1000\;\mathrm{mL}$ , and then filter. Pipet an amount of this solution equivalent to $10~\mathrm{~mg}$ of famotidine, add diluent to make $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately 10 mg of famotidine RS, add $20~\mathrm{mL}$ of methanol, sonicate for 5 minutes, and then add diluent to make exactly 100 mL. Use this solution as the standard solution. Perform the test with $50\,\textrm{\textmu L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine the peak area of each solution by the automatic integration method, and calculate the amount of each related substance in the test solution; the famotidine related substance I {3-[2-(diaminomethyleneamino)-1,3-thiazol4-yl methylsulfonyl]phenyl}- $\cdot N\cdot$ -sulfamoyl-propanamide} is NMT $1.0\%$ , and famotidine related substance II {3-[2- (diaminomethyleneamino)-1,3-thiazol-4-yl methylthio]propanoic acid}, famotidine related substance III {3- [2-(diaminomethyleneamino)-1,3-thiazol-4-yl methylthio]- ${\mathcal{N}}.$ -sulfamoyl-propanamide}, and famotidine related substances IV {3-[2-(diaminomethyleneamino)-1,3- thiazol-4-yl methylthio]-propanamide} are NMT $0.5\%$ and the total amount of related substances is NMT $1.5\%$ However, the peak area of famotidine related substance IV is obtained by dividing the area determined with the automatic integration method by the correction factor 1.3. stance III and famotidine, and between famotidine and famotidine related substance IV, are NLT 1.3, respectively, and the mass distribution ratio of the famotidine peak is NLT 2.0.  

System repeatability: Repeat the test 6 times with $50\,\textrm{\textmu L}$ each of the standard solution according to the above conditions; the relative standard deviation is NMT $2.0\%$ .  

$$
=\mathrm{\nabla{100}}\times{\frac{C_{S}}{C\times N}}\times{\frac{A_{\mathrm{i}}}{A_{S}}}
$$  

$C_{\mathrm{{S}}}$ : Concentration $(\mathrm{mg/mL})$ of famotidine in the standard solution  

$C:$ : Labeled amount (g) of famotidine in 1 tablet $N!$ : Number of tablets used in the preparation of the test solution  

$A_{\mathrm{T}}$ : Peak area of each related substance in the test solution  

$A_{S}$ : Peak area of famotidine in the standard solution Diluent —Dissolve $6.8\ \mathrm{~g~}$ of potassium dihydrogen phosphate in $750\;\mathrm{\mL}$ of water, adjust $\mathrm{pH}$ with 1 mol/L potassium hydroxide to 6.0, and add water to make $1000\,\mathrm{mL}$ .  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $275\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of buffer solution and acetonitrile $(93:7)$ .  

Flow rate: About 1.4 mL/min System suitability  

Test for required detectability: To $10~\mathrm{{mg}}$ of famotidine, add $1~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid, heat at $80~^{\circ}\mathrm{C}$ for 30 minutes, and then cool to room temperature. Then, add $2~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ sodium hydroxide TS, heat at $80\ ^{\circ}\mathrm{C}$ for 30 minutes, then cool to room temperature, and then neutralize with $1~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid. Add diluent to make $50~\mathrm{mL}$ . Pipet $10\;\mathrm{mL}$ of this solution, transfer into a solution of $5~\mathrm{{mg}}$ of famotidine dissolved in $8\;\mathrm{mL}$ of methanol, then add diluent to make $50~\mathrm{mL}$ . Take $25~\mathrm{mL}$ of this solution, add diluent to make $50~\mathrm{mL}$ , and use this solution as the system suitability stock solution. Take 1 to $1.5\ \mathrm{mL}$ of this solution, add 1 drop of hydrogen peroxide TS, and use this solution as the system suitability solution. Proceed with 50 $\upmu\mathrm{L}$ of this solution according to the above conditions; the relative retention time of famotidine related substances I, II, III, and IV to the retention time of the famotidine peak are 0.4, 0.7, 0.8, and 1.2, respectively.  

System performance: Proceed with $50~\upmu\mathrm{L}$ of the system suitability solution according to the above conditions; the resolutions between famotidine related subBuffer solution —Dissolve 13.6 gof sodium acetate trihydrate in $750~\mathrm{mL}$ of water, add $1\ \mathrm{mL}$ of triethylamine, adjust the $\mathrm{pH}$ to 6.0 with acetic acid(100), and then add water to make $1000\;\mathrm{mL}$ .  

Dissolution Perform the test with 1 tablet of Famotidine Tablets at 50 revolutions per minute according to Method 2, using $900\,\mathrm{\mL}$ of $\mathrm{pH}\ 4.5\ 0.1\ \mathrm{mol/L}$ phosphate buffer solution as the dissolution medium. Take $20~\mathrm{mL}$ of the dissolved solution 30 minutes after starting the test, and filter through a membrane filter with a pore size of NMT $0.8~{\upmu\mathrm{m}}$ . Discard the first $10\;\mathrm{mL}$ of the filtrate and use the subsequent filtrate as the test solution. Separately, weigh accurately $20~\mathrm{mg}$ of Famotidine RS, add buffer solution to make exactly $100~\mathrm{mL}$ . Pipet $5.0~\mathrm{mL}$ of this solution, add the buffer solution to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, AT and AS, of the test solution and the standard solution at the absorbance maximum wavelength near $265~\mathrm{nm}$ as directed under Ultraviolet-visible Spectrophotometry.  

It meets the requirements if the dissolution rate of Famotidine Tablets in 30 minutes is NLT $75\%$ .  

Dissolution rate $(\%)$ of the labeled amount of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$  

$C$ :Labeled amount (mg) of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ in 1 tablet  

Uniformity of dosage units It meets the requirements when the procedure for content uniformity is performed according to the following method.  

Take 1 tablet of Famotidine Tablets, add $2~\mathrm{mL}$ of water, shake to disintegrate. Add methanol, shake well to mix, then add methanol to make exactly $V\;\mathrm{mL}$ of a solution containing about $0.2~\mathrm{mg}$ of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ per mL, and centrifuge. Pipet $10\;\mathrm{mL}$ of the clear supernatant, add $2.0\ \mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $20~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $0.1~\mathrm{g}$ of famotidine RS, previously dried in a phosphorus pentoxide desiccator in vacuum at $50~^{\circ}\mathrm{C}$ for 4 hours, and dissolve in methanol to make exactly $100~\mathrm{{mL}}$ . Pipet 10 mL of this solution, add $2.0~\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $20~\mathrm{mL}$ ,and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under Liquid Chromatography according to the operating conditions described in the Assay and calculate the ratios, QT and QS, of the peak area of famotidine to that of the internal standard.  

Internal standard solution —To $5~\mathrm{mL}$ of a solution of methyl $p$ -hydroxybenzoate in methanol (1 in 500), add water to make $50\;\mathrm{mL}$ .  

Assay Take a certain number of Famotidine Tablets equivalent to $0.2{\mathrm{~g~}}$ of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ , add 50 mL of water, and disintegrate by shaking well to mix. Next, add $100~\mathrm{mL}$ of methanol, shake well to mix, then add methanol to make exactly $200~\mathrm{mL}$ , and centrifuge. Pipet $5~\mathrm{mL}$ of the clear supernatant, add exactly $5~\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $0.1\,\mathrm{~g~}$ of famotidine RS, previously dried in a phosphorus pentoxide desiccator in vacuum at $80\ ^{\circ}\mathrm{C}$ for 4 hours, and dissolve in methanol to make exactly $100\,\mathrm{\mL}$ . Pipet $5\ \mathrm{mL}$ of this solution, add exactly $5~\mathrm{mL}$ of the internal standard solution, add the mobile phase to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak area ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of famotidine to the peak area of the internal standard, respectively.  

# Amount (mg) of famotidine $\mathrm{(C_{8}H_{15}N_{7}O_{2}S_{3})}$ )$=$ Amount (mg) of famotidine $\mathrm{RS}\!\times\!\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times2$  

Internal standard solution —To $5~\mathrm{mL}$ of a solution of methyl $p$ -hydroxybenzoate in methanol (1 in 500), add water to make $50\;\mathrm{mL}$ .  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Dissolve $2\,\mathrm{~\textit~{~g~}~}$ of sodium 1- heptanesulfonate in $900~\mathrm{\mL}$ of water, add acetic acid(100) to adjust the pH to 3.0, and add water to make $1000\,\mathrm{\mL}$ . To this solution, add $240\,\mathrm{\mL}$ of acetonitrile and $40\,\mathrm{mL}$ of methanol.  

Flow rate: Adjust the flow rate so that the retention time of famotidine is about 6 minutes.  

System suitability System performance: Proceed with $5\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; famotidine and the internal standard are eluted in this order with the resolution being NLT 11.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the peak area of famotidine is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers. Felodipine $\mathrm{C_{18}H_{19}C l_{2}N O_{4}}$ : 384.25 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl1,4-dihydropyridine-3,5-dicarboxylate [ 72509-76-3 ]  

![](images/83870b79175041fd544151aebee223ff3c864296f6722a70e7ef4adf29981d37.jpg)  

Felodipine contains NLT $98.0\%$ and NMT $101.0\%$ of felodipine ( $\mathrm{\bf\{C}_{18}H_{19}C l_{2}N O_{4})}$ , calculated on the dried basis.  

Description Felodipine occurs as a pale yellow to yellow crystalline powder. It is freely soluble in acetone or ethanol(95), slightly soluble in heptane, and practically insoluble in water.  

Identification (1) Determine the infrared spectra of Felodipine and felodipine RS, previously dried, as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Purity (1) Clarity and color of solution —Dissolve $1.0~\mathrm{g}$ of Felodipine in methanol to make $50~\mathrm{mL}$ , perform the test with this solution as directed under the Ultravioletvisible Spectroscopy using methanol as a control solution, and determine the absorbance at the wavelength of $440\;\mathrm{nm}$ with a layer length of $5\;\mathrm{{cm}}$ ; it is NMT 0.2.  

(2) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Felodipine according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{\mL}$ of lead standard solution (NMT 20 ppm).  

(3) Related substances —With $40\,\textrm{\textmu L}$ of the test solution prepared according to the Assay, perform the test as directed under the Liquid Chromatography according to the following conditions, and determine the peak area from the test solution; each peak area other than the major peak from the test solution is NMT $1.0\%$ , and the sum of peak areas of these peaks is NMT $1.5\%$ relative to the major peak area.  

$$
=\,100\times{\frac{A_{\mathrm{i}}}{A_{\mathrm{S}}}}
$$  

$A_{\mathrm{T}}$ : Each peak area other than the major peak $A_{S}$ : Total area of all peaks  

Operating conditions  

Proceed as directed under the operating conditions under the Assay.  

Time span of measurement: NLT 2 times the retention time of felodipine.  

Loss on drying NMT $0.5\%$ (1 g, $105\;^{\circ}\!C$ , 3 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ Assay Weigh accurately about $30~\mathrm{mg}$ each of Felodipine and felodipine RS, dissolve each in the mobile phase to make exactly $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Prepare the test solution and the standard solution before use. Perform the test with $40~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of felodipine in each solution.  

Amount (mg) of felodipine $\mathrm{(C_{18}H_{19}C l N O_{4})}$ )$=$ Amount (mg) of felodipine $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$ Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Mobile phase: A mixture of phosphate buffer solution, acetonitrile and methanol $(2:2:1)$ .  

Flow rate: 1 mL/min System suitability  

System performance: Dissolve $0.15\,\mathrm{~g~}$ of felodipine in a mixture of $25~\mathrm{mL}$ of t-butyl alcohol and $25~\mathrm{mL}$ of $1~\mathrm{mol/L}$ perchloric acid, add $10~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ cerium ferric sulfate TS, allow to stand for 15 minutes, and add $3.5\;\mathrm{mL}$ of $10\;\mathrm{mol/L}$ sodium hydroxide TS. Neutralize with $2\ \mathrm{mol/L}$ sodium hydroxide TS. Transfer this mixture into a separatory funnel, add $25~\mathrm{mL}$ of dichloromethane, shake, and take the lower layer. Evaporate the lower layer to dryness on a steam bath with the aid of a current of nitrogen. Dissolve $10~\mathrm{mg}$ of the residue (felodipine oxide) and $5~\mathrm{mg}$ of felodipine RS in the mobile phase to make $100~\mathrm{mL}$ . Take $1.0~\mathrm{mL}$ of this solution, and add the mobile phase to make $100~\mathrm{mL}$ . Proceed with $20~\upmu\mathrm{L}$ of this solution according to the above conditions; felodipine oxide and felodipine are eluted in this order with the resolution not being less than 2.5. Proceed with $40~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor of the felodipine peak is NMT 1.5. Detection sensitivity: Adjust the detection sensitivity so that the height of the two peaks obtained from the solution in the system performance is NLT $20\%$ of the full scale.  

Phosphate buffer solution —Dissolve $6.9~\mathrm{g}$ of sodium dihydrogen phosphate dihydrate in $400~\mathrm{mL}$ of water, add $8~\mathrm{mL}$ of $1~\mathrm{mol/L}$ phosphoric acid, and add water to make $1000\;\mathrm{mL}$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

![](images/90f1d684f380e02a384d63abcf98906e42b89334800d2a42b2934b64964e3222.jpg)  

Fenofibrate $\mathrm{C}_{20}\mathrm{H}_{21}\mathrm{ClO}_{4}:360.83$ Propan-2-yl 2-{4-[(4-chlorophenyl)carbonyl] phenoxy}- 2-methylpropanoate [ 49562-28-9 ]  

Fenofibrate contains NLT $98.5\%$ and NMT $101.0\%$ of fenofibrate $\left({\bf C}_{20}{\bf H}_{21}{\bf C}{\bf l O}_{4}\right)$ , calculated on the dried basis. Description Fenofibrate occurs as a white crystalline powder. It is very soluble in dichloromethane, slightly soluble in ethanol(95), and practically insoluble in water.  

Identification Determine the infrared spectra of Fenofibrate and fenofibrate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 79 and $82\,^{\circ}\!C$ Purity (1) Clarity and color of solution— Dissolve 0.50 g of Fenofibrate in acetone to make exactly $10~\mathrm{mL}$ ; the resulting solution is clear.  

(2) Acid— Dissolve $1.0~\mathrm{g}$ of Fenofibrate in $50\;\mathrm{mL}$ of ethanol previously neutralized with $0.2\,\mathrm{~mL~}$ of phenolphthalein TS. To this solution, add dropwise $0.1\ \mathrm{mol/L}$ sodium hydroxide solution until the resulting solution exhibits a pink color; the consumed amount is NMT 0.2 mL.  

(3) Chloride— To $5.0~\mathrm{g}$ of Fenofibrate, add $25~\mathrm{mL}$ of water, heat at $50\ ^{\circ}\mathrm{C}$ for 10 minutes, cool, and filter. To $5~\mathrm{mL}$ of the filtrate, add $6~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ , and perform the test. Prepare the control solution by adding $6\;\mathrm{mL}$ of dilute nitric acid, 0.30 mL of $0.01\ \mathrm{mol/L}$ hydrochloric acid, and water to make $50\;\mathrm{mL}$ (NMT $0.01\%$ ).  

(4) Sulfate— To $5.0~\mathrm{g}$ of Fenofibrate, add $25~\mathrm{mL}$ of water, heat at $50\;^{\circ}\mathrm{C}$ for 10 minutes, cool, and filter. To 10 mL of the filtrate, add $1~\mathrm{mL}$ of dilute hydrochloric acid and water to make $50~\mathrm{mL}$ . Prepare the control solution by adding $1\,\mathrm{\mL}$ of dilute hydrochloric acid, $0.42\,\mathrm{~mL~}$ of $0.005\,\mathrm{\mol/L}$ sulfuric acid, and water to make $50\;\mathrm{\mL}$ (NMT $0.01\%$ ).  

(5) Heavy metals —Proceed with $1.0\,\mathrm{~g~}$ of Fenofibrate and perform the test as directed under Method 2. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of the lead standard solution (NMT 20 ppm).  

(6) Related substances— Dissolve about $100~\mathrm{mg}$ of Fenofibrate in the mobile phase to make exactly $100\;\mathrm{mL}$ ,and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, and add the mobile phase to make exactly $100\,\mathrm{\mL}$ . Pipet $1\,\textrm{m L}$ of this solution, add the mobile phase to make exactly $10\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20\;\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine each peak area of each solution according to the automatic integration method and determine the amount of each related substance; fenofibrate related substance I with the relative retention time of 0.3 for fenofibrate obtained from the test solution and fenofibrate related substance II with the relative retention time of 0.4 are NMT $0.1\%$ , and fenofibrate related substance III with the relative retention time of 1.3 is NMT $0.1\%$ .Any other individual unidentified related substances are NMT $0.1\%$ , and the total related substances are NMT $0.5\%$ . However, exclude any peaks smaller than $0.05\%$ .  

$$
{}=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times{}r f\times{\frac{1}{10}}
$$  

$A_{\mathrm{T}}$ : Peak area of each related substance obtained from the test solution   
A S: Peak area of fenofibrate obtained from the standard solution   
$r f\!\!\!/$ : The correction factor for each related substance for fenofibrate peak  

Fenofibrate related substance I: 0.78   
Fenofibrate related substance II: 1.02   
Fenofibrate related substance III: 1.27   
Other related substances: 1.00  

# Operating conditions  

Detector: An ultraviolet absorption photometer  

(wavelength: $286\;\mathrm{nm}^{\phantom{\dagger}}$ ).  

Column: A stainless steel column about $4.0\ \mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile and water $(7:3)$ (adjust the pH with phosphoric acid).  

Flow rate: $1.0\,\mathrm{mL/min}$ System suitability  

Test for required detectability: Pipet $5~\mathrm{mL}$ of the standard solution, and add the mobile phase to make exactly $10~\mathrm{mL}$ . Proceed with $20~\upmu\mathrm{L}$ of this solution according to the above conditions; confirm that the signal-tonoise ratio of the torsemide peak is NLT 10.  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor of the fenofibrate peak is between 0.8 and 2.0.  

System repeatability: Repeat the test 6 times with $20\,\textrm{\textmu L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area of fenofibrate is NMT $10.0\%$ .  

Loss on drying NMT $0.5\%$ $(0.5\mathrm{~g},\,60\,\,^{\circ}\!C$ , in vacuum, constant mass).  

# Residue on ignition NMT $0.1\%$ $\mathrm{~\textit~{~1~}~}\mathrm{g})$  

Assay Weigh accurately about $25~\mathrm{{mg}}$ each of Fenofibrate and fenofibrate RS, dissolve in the mobile phase to make exactly $25~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution (1), respectively. Also, weigh $10.0~\mathrm{mg}$ of fenofibrate RS, $10.0~\mathrm{mg}$ of fenofibrate related substance I RS, $10.0\,\mathrm{~mg~}$ of fenofibrate related substance II RS, and $20.0~\mathrm{mg}$ of fenofibrate related substance III RS, and dissolve in the mobile phase to make exactly $100~\mathrm{mL}$ . To $1.0~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution (2). Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution (1) as directed under the Liquid Chromatography according to the operating conditions for testing related substances, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fenofibrate in each solution.  

# Amount (mg) of fenofibrate $(\mathbf{C}_{20}\mathbf{H}_{21}\mathbf{C}\mathrm{lO}_{4})$ )$=$ Amount (mg) of fenofibrate $\begin{array}{r}{\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\end{array}$  

# System suitability  

Detection sensitivity: Adjust the sensitivity so that the peak heights obtained by performing the test with 5 $\upmu\mathrm{L}$ of standard solution (2) according to the above conditions are NLT $50\%$ of the full scale of the data collection device.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the standard solution (1) according to the above conditions; the relative standard deviation of the peak area of fenofibrate is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Fenoprofen Calcium Dihydrate 페노프로펜칼슘수화물  

![](images/174d418fe362d6c76c4c92e6d74f90804c495b158d4831dd512b12c8e3b56609.jpg)  

Fenoprofen Calcium $\mathrm{C_{30}H_{26}C a O_{6}\mathrm{\cdot2H_{2}O_{3}}}$ 558.63 Calcium 2-(3-phenoxyphenyl)propanoate dihydrate [152864-45-4 ]  

Fenoprofen Calcium Dihydrate contains NLT $97.0\%$ and NMT $103.0\%$ of fenoprofen calcium $\mathrm{(C_{30}H_{26}C a O_{6}\colon522.60)}$ , calculated on the anhydrous basis. Description Fenoprofen Calcium Dihydrate occurs as a white crystalline powder.  

It is slightly soluble in n-hexanol, methanol, or water, and practically insoluble in chloroform.  

Identification (1) Mix $1{\mathrm{~g~}}$ of Fenoprofen Calcium Dihydrate with $50~\mathrm{mL}$ of acetic acid(31), heat, filter, and add $2\mathrm{mL}$ of ammonium oxalate TS to the filtrate; a white precipitate develops, and dissolve the precipitate in 3 mol/L hydrochloric acid TS.  

(2) Heavy metals —Proceed with $2.0\ \mathrm{~g~}$ of Fenoprofen Calcium Dihydrate according to Method 2 and perform the test. Prepare the control solution with 2.0 mL of lead standard solution (NMT 10 ppm).  

(2) Determine the infrared spectra of Fenoprofen Calcium Dihydrate and fenoprofen calcium dihydrate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Related substances —Weigh accurately about $0.2\,\mathrm{~g~}$ of Fenoprofen Calcium Dihydrate, dissolve in a mixture of water and acetonitrile $(1:1)$ to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $20~\mathrm{mg}$ of fenoprofen calcium dihydrate RS and dissolve in a mixture of water and acetonitrile $(1:1)$ to make exactly $100~\mathrm{mL}$ . To $5.0\;\mathrm{mL}$ of this solution, add a mixture of water and acetonitrile $(1:$ 1) to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, determine each peak area from each solution by the automatic integration method, and calculate the amount of each related substance; the amount of each related substance is NMT amount $0.5\%$ , and the total amount of related substances is NMT $2.0\%$ .  

Purity (1) Calcium —Weigh accurately about $0.75\mathrm{~g~}$ of Fenoprofen Calcium Dihydrate, add ethanol(95), and dissolve by heating if necessary. Add ethanol(95) to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Put $70~\mathrm{mL}$ of water, $2~\mathrm{mL}$ of sodium hydroxide solution (1 in 10) and $0.3~\mathrm{g}$ of hydroxynaphthol in a 150- mL beaker to mix, add about $1\ \mathrm{mL}$ of the test solution, and titrate with $0.05\;\mathrm{\mol/L}$ ethylenediaminetetraacetic acid disodium salt VS until the resulting solution exhibits a blue color. To this solution, add $10.0\ \mathrm{mL}$ of the test solution, and titrate with $0.05~\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS until the resulting solution exhibits a blue color (between $7.3\%$ and $8.0\%$ , calculated on the anhydrous basis).  

Each mL of $0.05\;\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS $=2.004~\mathrm{mg}$ of Ca  

$$
=\ 10000\times{\frac{C}{W}}\times{\frac{A_{\mathrm{i}}}{A_{\mathrm{S}}}}
$$  

C: Concentration $(\mathrm{mg/mL})$ of fenoprofen calcium in the standard solution  

W: Amount (mg) of Fenoprofen Calcium Dihydrate taken from the test solution  

$A_{\mathrm{i}}$ : Peak area of each related substance obtained from the test solution  

$A_{S}$ : Peak area of fenoprofen obtained from the standard solution  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $270\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.  

Mobile phase A: A mixture of water and acetic acid(31) $(98:2)$ .  

Mobile phase B: A mixture of acetonitrile and acetic acid(31) $(98:2)$ .  

![](images/4603204ddbcb7f0c8a324453f8a34fd9a3a3d79d4301acdacd6d9d53a33da348.jpg)  

# Flow rate: $1.5\;\mathrm{mL/min}$ System suitability  

System performance: Dissolve $2~\mathrm{~mg}$ of 3- phenoxybenzoic acid and $2~\mathrm{mg}$ of fenoprofen calcium dihydrate RS in a mixture of water and acetonitrile $(1:1)$ to make $100\,\mathrm{\mL}$ . Proceed with $20\,\textrm{\textmu L}$ of this solution according to the above conditions; the relative retention times of 3-phenoxybenzoic acid peak and fenoprofen peak are 0.89 and 1.0, respectively, the resolution between these peaks is NLT 9.0, and the symmetry factor of the fenoprofen peak is NMT 2.0. Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the symmetry factor of the fenoprofen peak is NMT 2.0. System repeatability: Repeat the test 5 times with $20\,\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area of temazepam is NMT $2.0\%$ .  

Water Between $5.0\%$ and $8.0\%$ ($\textbf{l g}$ , volumetric titration, direct titration).  

Assay Weigh accurately about $70~\mathrm{~mg~}$ each of Fenoprofen Calcium Dihydrate and fenoprofen calcium dihydrate RS, add $0.5~\mathrm{mL}$ of $0.5\;\mathrm{mol/L}$ hydrochloric acid TS and $2~\mathrm{mL}$ of acetone, dissolve in a mixture of methanol and water $(7:3)$ to make exactly $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the peak areas, $A_{\mathrm{T}}$ and $A_{\mathrm{{S}}}.$ , of fenoprofen in each solution.  

Amount (mg) of fenoprofen calcium $[(\mathbf{C}_{15}\mathrm{H}_{13}\mathbf{O}_{3})_{2}\mathbf{C}\mathrm{a}]$  

$$
\mathbf{\zeta}=\ 100\times C\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}
$$  

C: Amount (mg) of fenoprofen calcium in fenoprofen calcium dihydrate RS, calculated on the anhydrous basis  

# Operating conditions  

Detector: An ultraviolet absorption photometer (272 Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile, water, and phosphoric acid $(50:49.6:0.4)$ .  

Flow rate: $2\;\mathrm{mL/min}$  

# System suitability  

System performance: Dissolve $5~\mathrm{~\,~mg~}$ of fenoprofen calcium dihydrate RS and $5~\mathrm{mg}$ of gemfibrozil in a mixture of methanol and water $(7:3)$ to make 5 mL. Proceed with $20~\upmu\mathrm{L}$ of this solution according to the above conditions; the relative retention times of fenoprofen peak and gemfibrozil peak are about 0.5 and 1.0, respectively, and the resolution between these peaks is NLT 8. Also, proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plate obtained from the fenoprofen peak is NLT 3000.  

System repeatability: Repeat the test 5 times with $20\,\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area of fenoprofen is NMT $2.0\%$ .  

Packaging and storage Preserve in tight containers.  

# Fenoterol Hydrobromide 페노테롤브롬화수소산염  

![](images/eeb9ef76c9d13040ec55e441cce2da40137ab65b933310da5f62367816e8eb83.jpg)  
C17 H21 NO 4 ·HBr : 384.27  

5-[1-Hydroxy-2-[1-(4-hydroxyphenyl)propan-2- ylamino]ethyl]benzene-1,3-diolhydrobromide [ 1944-12- 3 ]  

Fenoterol Hydrobromide contains NLT $99.0\%$ and NMT $101.0\%$ of fenoterol hydrobromide $\mathrm{(C_{17}H_{21}N O_{4}{\cdot}H B r)}$ ), calculated on the dried basis.  

Description Fenoterol Hydrobromide occurs as a white crystalline powder.  

It is soluble in water or ethanol(95). Identification (1) Determine the infrared spectra of Fenoterol Hydrobromide and fenoterol hydrobromide RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) An aqueous solution of Fenoterol Hydrobromide (1 in 100) responds to the Qualitative Analysis (1) for bromide.  

$\mathbf{pH}$ Dissolve $2.0~\mathrm{g}$ of Fenoterol Hydrobromide in water to make exactly $50\;\mathrm{mL}$ ; the $\mathrm{pH}$ of this solution is between 4.2 and 5.2.  

Purity (1) Clarity and color of solution —Dissolve $2.0~\mathrm{g}$ of Fenoterol Hydrobromide in water to make exactly 50 mL; the resulting solution is clear and colorless.  

(2) Iron —Proceed with $1.0\ \mathrm{g}$ of Fenoterol Hydrobromide according to Method 3 and perform the test as directed under Method A. Prepare the control solution with $0.5\;\mathrm{mL}$ of iron standard solution $(\mathrm{NMT}\,5\,\mathrm{ppm})$ ). (3) Phenone —Dissolve $2.0{\mathrm{~g~}}$ of Fenoterol Hydrobromide in water to make $50~\mathrm{mL}$ . Determine the absorbance of this solution at the wavelength of $330\ \mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy; it is NMT 0.42 (NMT $0.2\%$ ).  

(4) Isomer —Dissolve $25.0\,\mathrm{~mg~}$ each of Fenoterol Hydrobromide and fenoterol hydrobromide RS in water to make exactly $10\;\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Prepare the test solution and the standard solution before use. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Calculate the amount of isomer by determining the heights, $(H_{\mathrm{T}})$ and $(H_{\mathrm{S}})$ , of the peak eluting immediately after the major peak obtained from the test solution; it is NMT $4.0\%$ .  

Content $(\%)$ of isomer $=$ Content $(\%)$ of isomer indicated on the reference standards ×$\frac{H_{\mathrm{T}}}{H_{\mathrm{S}}}$ Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $280\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: To $10~\mathrm{\mL}$ of $0.9~\mathrm{\,w/v\%}$ potassium dihydrogen phosphate, add $690~\mathrm{mL}$ of $2.4~\mathrm{w}/\mathrm{v}\%$ dibasic sodium phosphate 12-hydrate solution, mix, and add phosphoric acid to adjust the pH to 8.5. Add $300~\mathrm{mL}$ of methanol, and mix.  

Flow rate: 1.0 mL/minute. Adjust the retention time of the major peak to be NMT 20 minutes.  

# System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution under the above conditions; adjust the sensitivity so that the peak height of the isomer eluting immediately after the major peak is NLT $10\%$ of the full scale. The height of the valley between the major peak and the isomer peak obtained from the standard solution is NMT $4\%$ of the full scale.  

Loss on drying NMT $0.5\%$ $\mathrm{~\,~1~g,~}105\ ^{\circ}\mathrm{C}$ , constant mass). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ ). Assay Weigh accurately about $0.6~\mathrm{g}$ of Fenoterol Hydrobromide, dissolve in $50~\mathrm{mL}$ of water, add $5\ \mathrm{mL}$ of dilute nitric acid and $25.0\,\textrm{m L}$ of $0.1\,\mathrm{\mol/L}$ silver nitrate solution, and titrate with $0.1\mod/\mathrm{L}$ ammonium thiocyanate VS while shaking to mix until the resulting solution exhibits an orange color (indicator: $2~\mathrm{mL}$ of ammonium iron(III) sulfate TS). Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Fenoterol Hydrobromide Tablets 페노테롤브롬화수소산염정  

Fenoterol Hydrobromide Tablets contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of fenoterol hydrobromide $(\mathrm{C_{17}H_{21}N O_{4}}{\cdot}\mathrm{HBr}{\cdot}\,384.27)$ ).  

Method of preparation Prepare as directed under Tablets, with Fenoterol Hydrobromide.  

Identification Weigh an amount of Fenoterol Hydrobromide Tablets, equivalent to about $50~\mathrm{mg}$ of fenoterol hydrobromide according to the labeled amount, extract with $5~\mathrm{mL}$ of water, then filter, and use this solution as the test solution. Weigh $50~\mathrm{mg}$ of fenoterol hydrobromide RS, add water to make $5~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with the test solution and the standard solution as directed under the Thin Layer Chromatography. Spot the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of 2-butanol, formic acid and water $(75~:~15~:~10)$ , and air-dry the plate. Spray evenly a diazobenzenesulfonic acid TS on the plate, and heat at $105\;^{\circ}\mathrm{C}$ for 10 minutes; the $R_{\mathrm{f}}$ values and colors of the spots from the test solution and the standard solution are the same.  

Dissolution Perform the test with 1 tablet of Fenoterol Hydrobromide Tablets at 50 revolutions per minute according to Method 2, using $900~\mathrm{mL}$ of water as the dissolution medium. Take the medium 15 minutes after starting the test, and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $V\,\mathrm{mL}$ of the subsequent filtrate, add water to make $V^{\prime}\,\mathrm{mL}$ of a solution containing about $2~\upmu\mathrm{g}$ of fenoterol hydrobromide $\mathrm{(C_{17}H_{21}N O_{4}{\cdot}H B r)}$ per mL according to the labeled amount, and use this solution as the test solution. Separately, weigh accurately about $20\,\mathrm{~mg~}$ of fenoterol hydrobromide RS, and dissolve in water to make $100~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $100~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fenoterol hydrobromide in each solution. The dissolution rate in 15 minutes is NLT $80\%$ .  

Dissolution rate $(\%)$ of the labeled amount of fenoterol hydrobromide $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{4}\right)$ )  

$$
=W_{S}\times{\frac{V^{\prime}}{V}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\times{\frac{1}{\mathrm{C}}}\times9
$$  

$W_{S}$ : Amount (mg) of fenoterol hydrobromide RS  

$C$ : Labeled amount (mg) of fenoterol hydrobromide $\left({\bf C}_{17}\mathrm{H}_{21}\mathrm{NO}_{4}\right)$ in 1 tablet  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $276\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of $\mathrm{pH}\,3.2$ buffer solution and acetonitrile $(100:27)$ .  

Flow rate: $1.0\,\mathrm{mL/min}$  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of NLT 20 Fenoterol Hydrobromide Tablets, and powder. Weigh accurately an amount equivalent to about $2.5~\mathrm{mg}$ of fenoterol hydrobromide $\mathrm{(C_{17}H_{21}N O_{4}{\cdot}H B r)}$ ), add water to make exactly $100~\mathrm{mL}$ , then filter, and use the filtrate as the test solution. Separately, weigh accurately about $25~\mathrm{{mg}}$ of fenoterol hydrobromide RS, and add water to make exactly $100~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fenoterol hydrobromide in each solution.  

Amount (mg) of fenoterol hydrobromide $\mathrm{(C_{17}H_{21}N O_{4}{\cdot}H B r)}$ $=$ Amount (mg) of fenoterol hydrobromide $\mathrm{RS}\times\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{1}{10}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $276\,\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of $\mathrm{pH}\,3.2$ buffer solution and acetonitrile $(100:27)$ .  

Flow rate: $1.0\,\mathrm{mL/min}$ System suitability  

System repeatability: Repeat the test 6 times with $10~\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak areas of fenoterol hydrobromide is NMT $1.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

# Fentanyl Citrate 펜타닐시트르산염  

![](images/2d77274a0036e1278b446b0197c40afb01ba4f0211413b6bb1cc951e5b3b4efe.jpg)  
$\mathrm{C_{22}H_{28}N_{2}O{\cdot}C_{6}H_{8}O_{7}}$ : 528.59  

2-Hydroxypropane-1,2,3-tricarboxylic acid ; $N$ -phenyl$.N.$ -[1-(2-phenylethyl)piperidin-4-yl]propanamide [ 990-73-8 ]Fentanyl Citrate contains NLT $98.0\%$ and NMT $101.0\%$ of fentanyl citrate $\left({\bf C}_{22}\mathrm{H}_{28}\mathrm{N}_{2}\mathrm{O}\cdot{\bf C}_{6}\mathrm{H}_{8}\mathrm{O}_{7}\right)$ , calculated on the dried basis.  

Description Fentanyl Citrate occurs as white crystals or a crystalline powder.  

It is freely soluble in methanol or acetic acid(100), sparingly soluble in water or ethanol(95), and very slightly soluble in ether.  

Identification (1) Dissolve $50~\mathrm{mg}$ each of Fentanyl Citrate and fentanyl citrate RS in $10\;\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid TS and ethanol(95) to make $100~\mathrm{mL}$ . Determine the absorption spectra of these solutions as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Fentanyl Citrate and fentanyl citrate RS, previously dried, as directed in the potassium bromide disk method under the Midinfrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Fentanyl Citrate (1 in 100) responds to the Qualitative Analysis (1) for citrate.  

# Melting point Between 150 and $154\,^{\circ}\!C$  

$\mathbf{pH}$ Dissolve $0.10~\mathrm{g}$ of Fentanyl Citrate in $10~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 3.0 and 5.0.  

Purity (1) Heavy metals —Proceed with $0.5~\mathrm{g}$ of Fentanyl Citrate according to Method 2 and perform the test. Prepare the control solution with $1.0\;\mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(2) Related substances —Dissolve $0.10\mathrm{~g~}$ of Fentanyl Citrate in $5~\mathrm{mL}$ of methanol, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add methanol to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot 5 $\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of 1-butanol, water and acetic acid(31) $(3:$ $1:1\rangle$ ) as the developing solvent to a distance of about 10 cm, and air-dry the plate. Spray evenly Dragendorff's TS for spraying on the plate; the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.5\%$ ($\mathbf{0.2\thetag}$ , in vacuum, silica gel, $60\ ^{\circ}\mathrm{C}$ , 2 hours).  

Residue on ignition NMT $0.2\%$ (0.5 g). Assay Weigh accurately about $75~\mathrm{mg}$ of Fentanyl Citrate, dissolve in $50~\mathrm{mL}$ of acetic acid(100), and titrate with $0.02\;\mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.02\;\mathrm{mol/L}$ perchloric acid VS $=10.572\;\mathrm{mg}$ of $\mathrm{C_{22}H_{28}N_{2}O{\cdot}C_{6}H_{8}O_{7}}$  

Packaging and storage Preserve in light-resistant, tight containers.  

# Fenticonazole Nitrate 펜티코나졸질산염  

![](images/a0c8f59ae5de7fb324978cba379bb91f4bd6ce364d087d8651c97e5fc73f9258.jpg)  
and enantiomer  

$\mathrm{C_{24}H_{20}C l_{2}N_{2}O S{\cdot}H N O_{3}:518.41}$ 1-{2-(2,4-Dichlorophenyl)-2-[4-(phenylthio) benzyloxy]ethyl}- $1H$ -imidazole nitrate [ 73151-29-8 ]  

Fenticonazole Nitrate contains NLT $99.0\%$ and NMT $101.0\%$ of fenticonazole nitrate $(\mathrm{C_{24}H_{20}C l_{2}N_{2}O S{\cdot}H N O_{3})}$ ), calculated on the dried basis.  

Description Fenticonazole Nitrate occurs as a white crystalline powder.  

It is freely soluble in methanol or N,N -dimethylformamide, sparingly soluble in ethanol(95), and practically insoluble in water.  

Identification (1) Determine the absorption spectra of solutions of Fenticonazole Nitrate and fenticonazole nitrate RS in ethanol(95) (1 in 50000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths. (2) Determine the infrared spectra of Fenticonazole Nitrate and fenticonazole nitrate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Weigh an amount of Fenticonazole Nitrate, equivalent to $1~\mathrm{mg}$ of nitrate ions, add a mixture of 0.1 mL of nitrobenzene and $0.2~\mathrm{mL}$ of sulfuric acid, allow to stand for 5 minutes, and cool with iced water. Add gently $5\;\mathrm{mL}$ of water while stirring, add $5~\mathrm{mL}$ of $10\;\mathrm{mol/L}$ sodium hydroxide TS and $5\;\mathrm{mL}$ of acetone, shake to mix, and allow to stand; the upper layer exhibits an intense purple color.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-0.10^{\circ}$ and $+\:0.10^{\circ}$ (0.1 g, methanol, $10\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Melting point Between 134 and $137\,^{\circ}\mathrm{C}$ Purity (1) Toluene —Weigh exactly $0.2{\mathrm{~g~}}$ of Fenticonazole Nitrate, transfer into a $10\,\mathrm{\mL}$ vial, disperse with exactly $5~\mathrm{mL}$ of water, and use this solution as the test solution. Separately, mix $4.0~\mathrm{mg}$ of toluene with water to make $1000~\mathrm{{mL}}$ . Transfer $5~\mathrm{mL}$ of this solution into a 10 mL vial, and use this solution as the standard solution. Perform the test with the test solution and the standard solution as directed under the Gas Chromatography according to the following conditions. Use a headspace sample injection apparatus. Determine the amount of toluene according to the standard addition method; it is NMT $100\,\mathrm{{ppm}}$ .  

Operating conditions Detector: A flame ionization detector Column: A tube about $0.32\;\mathrm{mm}$ in internal diameter and about 25 min length, coated with poly(cyanopropyl)(7)phenyl(7)methyl(86)siloxane for ga s chromatography with a thickness of $1.2\;\upmu\mathrm{m}$ .  

Headspace conditions: Equilibrium temperature of $90\;^{\circ}\!C$ , equilibrium time of 1 hour.  

Column temperature: $80\,^{\circ}\mathrm{C}$ Injection port temperature: $180\,^{\circ}\mathrm{C}$ Detector temperature: $220\,^{\circ}\mathrm{C}$ Carrier gas: Helium Split ratio: About $1:25$ .Column head pressure: $40\,\mathrm{kPa}$  

Injection volume: Maintain each liquid at $90~^{\circ}\!C$ for 1 hour, and inject $1~\mathrm{mL}$ in the form of vapor into the column.  

(2) Related substances —Weigh accurately $25.0~\mathrm{mg}$ of Fenticonazole Nitrate, add the mobile phase to make exactly $25~\mathrm{mL}$ , and use this solution as the test solution. To $1.0~\mathrm{mL}$ of the test solution, add the mobile phase to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution (1). To $10.0\ \mathrm{mL}$ of the standard solution (1), add the mobile phase to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution (2). Pipet $1.0~\mathrm{mL}$ of the standard solution (1), add the mobile phase to make exactly $10\;\mathrm{mL}$ , and use this solution as the standard solution (3). To $5.0\;\mathrm{mL}$ of the test solution, add $5~\mathrm{mg}$ of fenticonazolerelatedsubstanceIRS{(RS)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-  

(phenylsulfanyl)benzyl]imidazolium nitrate}, and dissolve in the mobile phase to make exactly $100~\mathrm{mL}$ . To $2.0~\mathrm{mL}$ of this solution, add $2.0~\mathrm{mL}$ of the mobile phase to make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution (4). Perform the test with $10\,\upmu\mathrm{L}$ each of the test solution and the standard solution (1) as directed under the Liquid Chromatography according to the following operating conditions, and determine the areas of each peak according to the automatic integration method; the peak area other than the major peak and nitric acid ion peak (corresponding to the void volume of column) obtained from test solution is NMT the major peak area obtained from the standard solution (2) $(0.2\%)$ , and the total area of these peaks is NMT the major peak area obtained from standard solution (1) $(0.5\%)$ . However, exclude any peak having an area smaller than the major peak area obtained from the standard solution (3).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $229\;\mathrm{nm}$ ).  

Column: A stainless steel column, about $4\textrm{m m}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\cdot\ensuremath{\mathrm{\;10\;\mum}}$ in particle diameter).  

Mobile phase: A mixture of acetonitrile and phosphate buffer solution $(70:30)$ .  

Flow rate: $1.0\,\mathrm{mL/min}$  

# System suitability  

Inject $10~\upmu\mathrm{L}$ of the standard solution (2), and adjust the sensitivity so that the peak height of fenticonazole is at least $10\%$ of the full scale of the data collection device. Inject $10~\upmu\mathrm{L}$ each of the standard solution (3) and the standard solution (4) separately. In the chromatogram obtained from the standard solution (4), the resolution between fenticonazole related substance I and fenticonazole is NLT 2, and in the chromatogram obtained from the standard solution (3), a signal-to-noise ratio is NLT 5. Phosphate buffer solution —Dissolve $3.4~\mathrm{g}$ of potassium dihydrogen phosphate in $900\,\mathrm{\mL}$ of water, adjust $\mathrm{pH}$ with phosphoric acid to 3.0, and add water to make $1000\,\mathrm{mL}$ .  

Loss on drying NMT $0.5\%$ ($1\;\mathrm{g}_{}$ , in vacuum, $60\ ^{\circ}\mathrm{C}$ , constant mass).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $0.45\mathrm{~g~}$ of Fenticonazole Nitrate, dissolve with $50~\mathrm{mL}$ of a mixture of 2-butanone and acetic acid(100) $(1:1)$ , and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction. Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Ferric Hydroxide Polymaltose Complex 폴리말토오스수산화제이철착염  

Ferric Hydroxide Polymaltose Complex contains NLT $24.0\%$ and NMT $32.0\%$ of iron (Fe: 55.85).  

Description Ferric Hydroxide Polymaltose Complex occurs as a brown amorphous powder and is odorless. It is soluble in water and insoluble in organic solvents.  

Identification (1) Ionized iron —Weigh an amount of Ferric Hydroxide Polymaltose Complex, equivalent to $5\;\mathrm{g}$ of iron according to the labeled amount, add $80~\mathrm{mL}$ of water, dissolve at $70\ ^{\circ}\mathrm{C}$ for 1 hour while shaking, add water to make $100~\mathrm{{mL}}$ , and filter the solution. Use the filtrate as the test solution. To the solution of $1~\mathrm{mL}$ of the test solution in $4~\mathrm{mL}$ of water, add $1~\mathrm{mL}$ of $2~\mathrm{mol/L}$ ammonia TS, and mix; a brown precipitate does not form. (2) Iron —Mix with $1~\mathrm{mL}$ of the test solution of (1), $20~\mathrm{mL}$ of water and $5~\mathrm{mL}$ of hydrochloric acid, and heat on a steam bath for 5 minutes. After cooling, neutralize with excess $25\%$ ammonia water, and filter. Wash the produced ferric hydroxide precipitate with water, dissolve the precipitate in a small amount of $2\ \mathrm{mol/L}$ hydrochloric acid, and add water to make $20~\mathrm{mL}$ . To this solution, add $1~\mathrm{mL}$ of hydroxylamine hydrochloride TS, allow to stand for 30 minutes, and add $o$ -phenanthroline ethanol solution (1 in 50); the resulting solution exhibits an dark red color. (3) Polymaltose —To $1\,\textrm{m L}$ of the test solution of (1), add $4~\mathrm{mL}$ of water and $0.5~\mathrm{mL}$ of hydrochloric acid, heat on a steam bath for 5 minutes, cool rapidly, add 2 mL of $25\%$ ammonia water and $5\;\mathrm{mL}$ of freshly prepared hydrogen sulfide TS, and mix. Remove excess hydrogen sulfide by boiling, cool, and filter. To $5\ \mathrm{mL}$ of the filtrate, add $1~\mathrm{mL}$ of hydrochloric acid, heat on a steam bath for 15 minutes, and cool immediately. Add $4~\mathrm{mL}$ of $20\%$ sodium hydroxide solution and $5\,\textrm{m L}$ of Fehling's TS, mix, boil for 1 minute, and cool immediately; a red $\mathrm{Cu2O}$ precipitate forms.  

$\mathbf{pH}$ Weigh an amount of Ferric Hydroxide Polymaltose Complex, equivalent to $5\textrm{g}$ of iron according to the labeled amount, add $80~\mathrm{mL}$ of water, dissolve at $70~^{\circ}\!C$ for 1 hour while shaking, and add water to make $100\;\mathrm{mL}$ ; the $\mathrm{pH}$ of the filtrate is between 5.5 and 7.5.  

Purity (1) Polymaltose —Between $25.0\%$ and $50.0\%$ Weigh an amount of Ferric Hydroxide Polymaltose Complex, equivalent to $5\textrm{g}$ of iron, add $80~\mathrm{mL}$ of water, dissolve at $70~^{\circ}\mathrm{C}$ for 1 hour while shaking, add water at $20~^{\circ}\!C$ to make $100\;\mathrm{mL}$ , and filter. To $2.0\;\mathrm{mL}$ of this solution, add water to make $100~\mathrm{mL}$ . To $20~\mathrm{mL}$ of this solution, add water to make $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, transfer $0.10~\mathrm{g}$ of the anhydrous glucose into a $100{\-}\mathrm{mL}$ volumetric flask, and add water to make $100~\mathrm{mL}$ . Take $20~\mathrm{mL}$ of this solution, add water to make $100~\mathrm{mL}$ , and use it as the standard solution. Prepare 6 stoppered test tubes, separately add $1~\mathrm{mL}$ of water for 2 test tubes, $1~\mathrm{mL}$ of the test solution for 2 test tubes, and $1\ \mathrm{mL}$ of the standard solution for 2 test tubes. Add $10~\mathrm{mg}$ of anthrone solution to each tube, mix well, and close the stopper. After warming on a steam bath for exactly 10 minutes, take it out, and cool. Next, shake for 5 minutes to mix, perform the test as directed under the Ultraviolet-visible Spectroscopy using water as the control solution, and determine the absorbances, $A_{\mathrm{T}}$ and $A_{\mathrm{{S}}}$ , at the absorbance maximum wavelength of between $600~\mathrm{nm}$ and $605~\mathrm{nm}$ from the test solution and the standard solution.  

# Ferric Hydroxide Polymaltose Complex Solution  

# 폴리말토오스수산화제이철착염액  

Ferric Hydroxide Polymaltose Complex Solution contains NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of iron (Fe: 55.85) in the ferric hydroxide polymaltose complex.  

Method of preparation Prepare as directed under Liquids, with Ferric Hydroxide Polymaltose Complex.  

Identification Take $0.25~\mathrm{mL}$ of Ferric Hydroxide Polymaltose Complex Solution, add $1\ \mathrm{mL}$ of $4~\mathrm{mol/L}$ sulfuric acid, and heat until it becomes transparent yellow. Add $0.1\ \mathrm{mol/L}$ potassium ferrocyanide TS; the resulting solution exhibits a blue color.  

pH Between 5.0 and 7.0.  

$$
=\frac{A_{\mathrm{T}}\times1\bar{0}0\,(m\dot{g})\stackrel{.}{\times}162}{A_{\mathrm{S}}\times180}
$$  

(2) Sodium chloride —NMT $6.0\%$ . Transfer 10.0 mL of the test solution of (1) into a $100{\-}\mathrm{mL}$ beaker, add $60\;\mathrm{mL}$ of water and $0.2\;\mathrm{mL}$ of nitric acid, shake well, and titrate with $0.1\ \mathrm{mol/L}$ silver nitrate VS using the potentiometric titration. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ silver nitrate VS $=5.850\;\mathrm{mg}$ of NaC1  

Loss on drying NMT $5.0\%$ ($^{\mathrm{~1~g~}}$ , in vacuum, $20\ ^{\circ}\mathrm{C}$ phosphorus pentoxide, 2 hours).  

Assay After mixing $10~\mathrm{g}$ of Ferric Hydroxide Polymaltose Complex well, weigh accurately $0.3\mathrm{~g~}$ of the mixed drug, transfer into a $200{\-}{\mathrm{mL}}$ beaker, add $10\;\mathrm{mL}$ of hydrochloric acid, and heat on a steam bath for 1 to 2 minutes while shaking to mix. After the solution is completely dissolved, take it out, and allow to stand for 5 minutes. Add $100\;\mathrm{mL}$ of water and $10\;\mathrm{mL}$ of acetic acid(100), and adjust the $\mathrm{pH}$ to between 2.2 and 2.5 with $30\%$ sodium hydroxide solution. Add $2.5~\mathrm{mL}$ of $2\%$ pyrocatechol sodium salt solution as the indicator, titrate with freshly prepared $0.1\ \mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS at between 40 and $50~^{\circ}\mathrm{C}$ until the green color of the solution turns yellow. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS $=5.585~\mathrm{mg}$ of Fe  

Packaging and storage Preserve in tight containers. Purity To $0.25\,\mathrm{~mL~}$ of Ferric Hydroxide Polymaltose Complex Solution, add $4~\mathrm{mL}$ of water and $1\,\textrm{m L}$ of 2 mol/L ammonia TS, and shake to mix; a brown precipitate $\left(\mathrm{Fe}(\mathrm{OH})_{3}\right)$ ) does not form.  

Assay Take $5.0\,\textrm{m L}$ of Ferric Hydroxide Polymaltose Complex Solution, add $10~\mathrm{\mL}$ of hydrochloric acid, shake well to mix, and heat until the solution becomes yellow. Add $100~\mathrm{mL}$ of water and $10~\mathrm{mL}$ of acetic acid(100), and adjust the $\mathrm{pH}$ to between 2.2 and 2.5 with $30\%$ sodium hydroxide solution. Add $0.2\ \mathrm{mL}$ of hydrogen peroxide, immediately add $2.5~\mathrm{mL}$ of $2\%$ pyrocatechol sodium salt solution, and titrate with $0.05\,\mathrm{\mol/L}$ ethylenediaminetetraacetic acid disodium salt VS while maintaining the temperature at 40 to $50~^{\circ}\mathrm{C}$ . The endpoint of the titration is when the color of this solution changes from green to yellow. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.05\;\mathrm{mol/L}$ ethylenediaminetetraacetic acid disodium salt VS $=2.7925\ \mathrm{mg}$ of Fe  

Packaging and storage Preserve in tight containers.  

# Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets 폴리말토오스수산화제이철착염·폴산정  

Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of iron (Fe: 55.85) and NLT $90.0\%$ and NMT $150.0\%$ of folic acid $\mathrm{(C_{19}H_{19}N_{7}O_{6}}$ : 441.40).  

Method of preparation Prepare as directed under Tablets, with Ferric Hydroxide Polymaltose Complex and Folic Acid.  

Identification (1) Ferric hydroxide polymaltose complex —Perform the test with Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets as directed under the Analysis for Minerals.  

(2) Folic acid —Perform the test with Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets as directed under the Analysis for Vitamins.  

Disintegration Meets the requirements. Uniformity of dosage units Meets the requirements. Assay (1) Ferric hydroxide polymaltose complex —Weigh accurately the mass of NLT 20 Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets, then powder, and perform the test as directed under the Analysis for Minerals.  

(2) Folic acid —Weigh accurately the mass of NLT 20 Ferric Hydroxide Polymaltose Complex and Folic Acid Tablets, and perform the test as directed under the Analysis for Vitamins.  

Packaging and storage Preserve in tight containers. Ferrous fumarate $\mathrm{C_{4}H_{2}F e O_{4}:169.90}$ Iron(II) $(E)$ -but-2-enedioate [ 141-01-5 ]Ferrous fumarate, when dried, contains NLT $97.0\%$ and NMT $101.0\%$ of ferrous fumarate $\left({\bf C}_{4}\mathrm{H}_{2}\mathrm{FeO}_{4}\right)$ .  

![](images/0c4688960f797af6f671c72af684b12dec28d68c96500b504084c92df4da6478.jpg)  

Description Ferrous fumarate occurs as an orange to reddish brown powder and is odorless.   
It is slightly soluble in water and very slightly soluble in ethanol(95).  

The solubility of Ferrous Fumarate in dilute hydrochloric acid is decreased by separation of fumarate.  

Identification (1) Add $25~\mathrm{mL}$ of diluted hydrochloric acid (1 in 2) to $1.5\ \mathrm{g}$ of Ferrous fumarate, add water to make $50~\mathrm{mL}$ , and heat until the solution completely dissolves. After cooling, filter using a glass filter, wash the precipitate with diluted hydrochloric acid (3 in 100), and dry at $105\ ^{\circ}\mathrm{C}$ . Determine the infrared spectra of this precipitate and fumarate RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wave numbers.  

(2) The filtrate obtained in (1) responds to the Qualitative Analysis for ferrous salt.  

Purity (1) Sulfate —Put $1.0~\mathrm{g}$ of Ferrous Fumarate in a $250{\-}{\bmod{L}}$ beaker, add $100\,\mathrm{\mL}$ of water, and heat on a steam bath while adding hydrochloric acid dropwise until the solution completely dissolves (about $2~\mathrm{mL}$ of hydrochloric acid is consumed). Filter, if necessary, and add water to the filtrate to make $100\;\mathrm{mL}$ . Heat this solution to boiling, add $10\,\mathrm{\mL}$ of barium chloride TS, heat for 2 hours on a steam bath, put a lid, and allow to stand for 16 hours. If crystals of ferrous fumarate form, dissolve by heating the solution on a steam bath. Filter the solution with filter paper for assay, add ammonium sulfide TS to the filtrate, and wash with warm water until the black precipitate is no longer produced. Transfer the residue into a crucible, previously weighed along with the filter paper, carbonize the filter paper without burning, and ignite the crucible and its contents at $600\;^{\circ}\mathrm{C}$ to a constant mass. $1~\mathrm{mg}$ of the residue corresponds to $0.412\,\mathrm{~mg}$ of sulfate $\mathrm{(SO_{4})}$ (NMT $0.2\%$ ).  

(2) Arsenic —Put $2.0\,\mathrm{~g~}$ of Ferrous Fumarate in a beaker and add $10\,\mathrm{\mL}$ of water and $10\,\mathrm{\mL}$ of sulfuric acid. Heat the fumaric acid and precipitate completely, cool, add $20~\mathrm{mL}$ of water, and filter in a $50{\-}\mathrm{mL}$ volumetric flask. Wash the precipitate with water, combine the washings in a volumetric flask, and add water to the gauge line to mix. Use $25.0\;\mathrm{mL}$ of this solution as the test solution and perform the test. Prepare the control solution with $3.0\;\mathrm{mL}$ of arsenic standard solution (NMT $3\;\mathrm{ppm}$ ). (3) Ferric ion —Weigh accurately about $2.0\,\mathrm{~g~}$ of Ferrous Fumarate, put in a $250{\-}{\bmod{L}}$ Erlenmeyer flask with a stopper, add $25~\mathrm{mL}$ of water and $4~\mathrm{mL}$ of hydrochloric acid, and heat on a hot plate until it completely dissolves. Stopper and cool to room temperature. Add $3{\mathrm{~g~}}$ of potassium iodide, stopper, shake to mix, and allow to stand for 5 minutes in the dark. Remove the stopper, add $75~\mathrm{mL}$ of water, then titrate with $0.1\;\mathrm{mol/L}$ sodium thiosulfate solution (indicator $:\,3\,\mathrm{~mL~}$ of starch TS). NMT 7.16 of 0.1 mol/L sodium thiosulfate is consumed (NMT $2.0\%$ ).  

(4) Mercury— Proceed with the following procedure using a light-resistant container. Weigh accurately about $1{\mathrm{~g~}}$ of Ferrous Fumarate, add $30~\mathrm{mL}$ of diluted nitric acid (1 in 10), and dissolve while heating on a steam bath. Cool quickly in an ice bath and filter using a filter washed with pre-diluted nitric acid (1 in 10) and water. To the filtrate, add $20~\mathrm{mL}$ of sodium citrate solution (1 in 4) and $1~\mathrm{mL}$ of hydroxylamine hydrochloride TS, and use this solution as the test solution. Separately, prepare the control solution with $3.0\ \mathrm{mL}$ of mercury standard solution, $30\;\mathrm{mL}$ of diluted nitric acid (1 in 4), $5\;\mathrm{mL}$ of sodium citrate solution (1 in 4) and $1~\mathrm{mL}$ of hydroxylamine hydrochloride. Add ammonia TS to the control solution to adjust the pH to 1.8, and adjust the $\mathrm{pH}$ of the test solution to 1.8 with sulfuric acid, and transfer each to a separatory funnel. Perform the test with the test solution and the control solution as directed below. Extract 2 times using $5~\mathrm{mL}$ of dithizone solution for extraction and then $5~\mathrm{mL}$ of chloroform, and transfer the chloroform extract to another separatory funnel. To the extract, add $10\,\mathrm{\mL}$ of diluted hydrochloric acid (1 in 2), shake to mix, allow to stand, and then discard the chloroform layer. Wash the acid-extract with $3\,\textrm{m L}$ of chloroform and discard the washings. Add $0.1~\mathrm{mL}$ of ethylenediaminetetraacetic acid disodium salt solution (1 in 50) and $2~\mathrm{mL}$ of $6\;\mathrm{mol/L}$ acetic acid, mix, and slowly add $5\;\mathrm{mL}$ of ammonia TS. Close the lid of the separatory funnel, cool it under running cold water, open the lid, and transfer the contents into a beaker. Adjust the $\mathrm{pH}$ of the test solution and the control solution to 1.8 in the same way as the above, and transfer them to separatory funnels again. Add $5.0~\mathrm{mL}$ of diluted dithizone solution for extraction, shake vigorously to mix, and allow to stand. Compare the color of the chloroform layers of the test solution and the control solution using a diluted dithizone solution for extraction as a control solution; the color obtained from the test solution is not more intense than that from the control solution (NMT 3 ppm).  

Mercury standard stock solution —Transfer 135.4 mg of mercury(II) chloride to a $100{\-}\mathrm{mL}$ volumetric flask, dissolve in $0.5\ \mathrm{mol/L}$ sulfuric acid TS, fill to the gauge line, and mix. This solution contains $0.1\,\mathrm{~g~}$ of mercury $\mathrm{(Hg)}$ in $100\;\mathrm{mL}$ .  

Mercury standard solution —Take $1.0\,\mathrm{~mL~}$ of the mercury standard stock solution immediately before use, put in a $1000{\-}\mathrm{mL}$ volumetric flask, add $0.5\;\mathrm{mol/L}$ sulfuric acid TS, fill up to the gauge line, and mix. $1~\mathrm{mL}$ of this solution contains $1\ \upmu\mathrm{g}$ of mercury $\mathrm{(Hg)}$ .  

Diluted dithizone solution for extraction —Dilute 5 mL of dithizone solution for extraction with $25~\mathrm{mL}$ of chloroform before use.  

(5) Lead —Put $1.0\ \mathrm{g}$ of Ferrous Fumarate in a 50- mL beaker, add $6~\mathrm{mL}$ of nitric acid and $10~\mathrm{mL}$ of perchloric acid, cover with a watch glass, and heat to evaporate until completely dry. Cool, then dissolve the residue by adding $10~\mathrm{mL}$ of $9~\mathrm{mol/L}$ hydrochloric acid, and then use about $10\;\mathrm{mL}$ of water to transfer to a $50{\-}\mathrm{mL}$ volumetric flask. Add $20\,\mathrm{\mL}$ of ascorbic acid-sodium iodide TS and $5.0\;\mathrm{mL}$ of trioctylphosphine oxide solution, shake for 30 seconds to mix, and allow to stand to separate. Then, add water so that the organic solvent layer reaches the neck portion of the flask, shake to mix again, and allow to stand to separate. Use the organic solvent layer as the test solution. Separately, take $5\mathrm{mL}$ of lead standard solution, and add water to make exactly $100~\mathrm{mL}$ . Pipet $2~\mathrm{mL}$ of this solution and put in a $50{\-}\mathrm{mL}$ beaker. To this beaker and a beaker for blank test, add $6\;\mathrm{mL}$ of nitric acid and 10 mL of perchloric acid, and heat to evaporate to dryness. Cool, dissolve the residue in $10~\mathrm{mL}$ of $9~\mathrm{mol/L}$ hydrochloric acid, and use about $10~\mathrm{mL}$ of water to transfer to $50{\-}\mathrm{mL}$ flasks, respectively. To each flask, add $20~\mathrm{mL}$ of ascorbic acid-sodium iodide TS and 5.0 mL of trioctylphosphine oxide solution, shake for 30 seconds to mix, and allow to stand to separate. Then add water so that the organic solvent layer reaches the neck portion of the flask, shake to mix again, allow to stand to separate. Use the organic solvent layers as the standard solution $(2.0\ \upmu\mathrm{g/mL)}$ and the blank test solution, respectively. Perform the test with the test solution and the standard solution as directed under Atomic Absorption Spectroscopy according to the following conditions; the absorbance of the test solution is not greater than that of the standard solution (NMT $0.001\%$ ). Use 4-methyl-2- pentanone to adjust absorbance to 0; the absorbance of the blank test solution is NMT $20\%$ of the difference between the absorbance of the standard solution and the absorbance of the blank test solution.  

Gas: Air–acetylene   
Lamp: Lead hollow-cathode lamp   
Wavelength: $283.3\;\mathrm{nm}$  

Trioctylphosphine oxdie solution —Dissolve $5.0~\mathrm{g}$ of trioctylphosphine oxide in 4-methyl-2-pentanone to make $100\;\mathrm{mL}$ .  

(6) Cadmium —Weigh $2.0\,\mathrm{~g~}$ of Ferrous Fumarate and dissolve in $10\;\mathrm{mL}$ of hydrochloric acid and $80\;\mathrm{mL}$ of water, and heat gently as needed. After cooling, filter as needed, add water to make $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, pipet $2.0~\mathrm{mL}$ of cadmium standard solution, add hydrochloric acid to make exactly $10\,\mathrm{\mL}$ , and use this solution as the standard solution. Perform the test with the test solution and the standard solutions as directed under Atomic Absorption Spectroscopy according to the following conditions; the absorbance of the test solution is NMT that of the standard solution (NMT $10\,\mathrm{ppm})$ ).  

Gas: Air–acetylene   
Lamp: Cadmium hollow-cathode lamp   
Wavelength: $228.8\;\mathrm{nm}$  

# Loss on drying NMT $1.5\%$ ($\mathrm{~l~g,~}105~^{\circ}\mathrm{C}$ , 16 hours).  

Assay Weigh accurately about $0.15\ \mathrm{~g~}$ of Ferrous Fumarate, previously dried, add $7.5\ \ \mathrm{mL}$ of dilute sulfuric acid, dissolve by heating and cool, then add $25~\mathrm{mL}$ of water, and immediately titrate with $0.1\ \mathrm{mol/L}$ cerium sulfate VS (indicator $:0.1\ \mathrm{mL}$ of ferroin TS). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ cerium sulfate VS $=16.990\;\mathrm{mg}$ of $\mathrm{C}_{4}\mathrm{H}_{2}\mathrm{FeO}_{4}$  

Packaging and storage Preserve in well-closed containers.  

# Ferrous Gluconate Hydrate 글루콘산제일철수화물  

![](images/0d6ccfccf8832c3a32520cbbdc5afa626bd8fabfa95f55aeea75e8190e6a3c9d.jpg)  

Ferrous Gluconate $\mathrm{C_{12}H_{22}F e O_{14}{\cdot}2H_{2}O:482.17}$ $\mathrm{Iron}(2\!+\!);(2R,3S,\!4R,5R)\!-\!2,\!3,\!4,\!5,\!6-$ pentahydroxyhexanoate; dihydrate [ 6047-12-7 ]  

Ferrous Gluconate Hydrate contains NLT $97.0\%$ and NMT $102.0\%$ of ferrous gluconate $\left({\bf C}_{12}{\bf H}_{22}{\mathrm{FeO}}_{14}\right.$ 446.14), calculated on the dried basis.  

Description Ferrous Gluconate Hydrate occurs as a yellowish gray or light yellowish green fine powder or granule with a faint odor of burning sugar.  

$1.0\;\mathrm{g}$ of Ferrous Gluconate Hydrate dissolves in $10\;\mathrm{mL}$ of warm water and is practically insoluble in ethanol(95). Its aqueous solution (1 in 20) is acidic.  

Identification (1) Weigh $10~\mathrm{{mg}}$ of Ferrous Gluconate Hydrate and dissolve in $10~\mathrm{mL}$ of water to use it as the test solution. If necessary, warm it in a $60~^{\circ}\mathrm{C}$ water bath. Separately, dissolve $10~\mathrm{mg}$ of ferrous gluconate hydrate RS in $10~\mathrm{mL}$ of water and use this solution as the standard solution. Perform the test with these solutions as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Next, develop the plate with a mixture of ethanol(95), water. ammonia water(28) and ethyl acetate $(50:30:10:10)$ as a developing solvent to a distance of about $15~\mathrm{cm}$ , dry the plate at $110\ ^{\circ}\mathrm{C}$ for 20 minutes, and cool it. Dissolve $2.5\mathrm{~g~}$ of ammonium heptamolybdate tetrahydrate in $50~\mathrm{mL}$ of $1\,\mathrm{\mol/L}$ sulfuric acid, add $1.0~\mathrm{g}$ of cerium sulfate, shake to dissolve, and add $1~\mathrm{mol/L}$ sulfuric acid to make $100\ \mathrm{mL}$ . Spray this solution evenly on the plate and heat at $110\mathrm{~}^{\circ}\mathrm{~C~}$ for 10 minutes; the color and $R_{\mathrm{f}}$ values of the spots obtained from the test and standard solutions are the same.  

(2) Add potassium hexacyanoferrate(III) TS to the aqueous solution of Ferrous Gluconate Hydrate (1 in 200); a dark blue precipitate is formed.  

Purity (1) Chloride —Proceed with $1.0\,\mathrm{~g~}$ of Ferrous Gluconate Hydrate and perform the test. Prepare the control solution with $1.0\;\mathrm{mL}$ of $0.02\;\mathrm{mol/L}$ hydrochloric acid (NMT $0.07\%$ ).  

(2) Sulfate —Proceed with $1.0\,\mathrm{~g~}$ of Ferrous Gluconate Hydrate and perform the test. Prepare the control solution with $1.0~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ sulfuric acid (NMT $0.1\%$ ).  

(3) Oxalic acid —Dissolve $1.0\,\mathrm{~g~}$ of Ferrous Gluconate Hydrate in $10~\mathrm{mL}$ of water, add $2~\mathrm{mL}$ of hydrochloric acid, extract each with $50\;\mathrm{mL}$ and $20~\mathrm{mL}$ of ether, and combine all the extracts. To the combined extracts, add $10~\mathrm{mL}$ of water and evaporate ether on a steam bath. Add 1 drop of $6~\mathrm{mol/L}$ acetic acid and $1~\mathrm{mL}$ of calcium acetate hydrate solution (1 in 20); the solution does not become turbid within 5 minutes.  

(4) Lead —Weigh $1.0\textbf{g}$ of Ferrous Gluconate Hydrate, put it in $50{\-}\mathrm{mL}$ volumetric flask, add $10~\mathrm{mL}$ of 9 mol/L hydrochloric acid, about $10\;\mathrm{mL}$ of water, $20\;\mathrm{mL}$ of ascorbic acid-sodium iodide TS, and $5\;\mathrm{mL}$ of 4-methyl-2- pentanone solution of trioctylphosphine oxide (5 in 100), shake for 30 seconds, and allow to stand until the layers separate. Next, add water to the neck of the volumetric flask, shake it again, and allow it to stand. Take the organic solvent layer and use it as the test solution. Separately, put exactly $5.0~\mathrm{mL}$ of lead nitrate standard stock solution into a volumetric flask, dilute with water to make $100~\mathrm{mL}$ , transfer exactly $2.0\ \mathrm{mL}$ of this solution into a volumetric flask, and then prepare the standard solution in the same way as the test solution. Perform the test with the test solution and the standard solution as directed under the Atomic Absorption Spectroscopy according to the following conditions; the absorbance of the test solution is less than that of the standard solution (NMT $0.001\%$ ).  

Gas: Air–acetylene   
Lamp: Lead hollow-cathode lamp   
Wavelength: $283.8\;\mathrm{nm}$  

(5) Mercury —Proceed with the following procedure using a light-resistant container. Weigh accurately about $1{\mathrm{~g~}}$ of Ferrous Gluconate Hydrate, add $30~\mathrm{mL}$ of diluted nitric acid (1 in 10), and dissolve while heating on a steam bath. Cool quickly in an ice bath and filter using a filter washed with pre-diluted nitric acid (1 in 10) and water. To the filtrate, add $20~\mathrm{mL}$ of sodium citrate solution (1 in 4) and $1~\mathrm{mL}$ of hydroxylamine hydrochloride TS and use this solution as the test solution. Separately, prepare the control solution with $3.0\,\mathrm{~mL~}$ of mercury standard solution, $30~\mathrm{mL}$ of diluted nitric acid (1 in 4), 5 mL of sodium citrate solution (1 in 4) and $1\ \mathrm{mL}$ of hydroxylamine hydrochloride. Put the test solution and the control solution each into a separatory funnel, adjust the $\mathrm{pH}$ to 1.8 using sulfuric acid, extract twice with $5~\mathrm{mL}$ of dithizone solution for extraction and then with $5~\mathrm{mL}$ of chloroform, and transfer the chloroform extract to another separatory funnel. To the extract, add $10~\mathrm{mL}$ of diluted hydrochloric acid (1 in 2), shake to mix, allow to stand, and then discard the chloroform layer. Wash the acidextract with $3\ \mathrm{mL}$ of chloroform and discard the solution used for washing. Add $0.1\,\mathrm{~mL~}$ of ethylenediaminetetraacetic acid disodium salt solution (1 in 50) and $2~\mathrm{mL}$ of $6\;\mathrm{mol/L}$ acetic acid, mix, and slowly add $5\;\mathrm{mL}$ of ammonia TS. Close the lid of the separatory funnel, cool it under running cold water, open the lid, and transfer the contents into a beaker. Adjust the pH of the test solution and the control solution to 1.8 in the same way as the above, and transfer them to separatory funnels again. Add 5.0 mL of diluted dithizone solution for extraction, shake vigorously, and allow to stand. Compare the color of the chloroform layers of the test solution and the control solution using a diluted dithizone solution for extraction as a control solution; the color obtained from the test solution is not more intense than that from the control solution (NMT 3 ppm).  

Mercury standard stock solution —Transfer 135.4 mg of mercury(II) chloride into a $100{\-}\mathrm{mL}$ volumetric flask, dissolve in $0.5\;\mathrm{mol/L}$ sulfuric acid TS, fill up to the gauge line, and mix. This solution contains $0.1\ \mathrm{g}$ of mercury $\mathrm{(Hg)}$ in $100\;\mathrm{mL}$ .  

Mercury standard solution —Before use, take 1.0 mL of the mercury standard stock solution, put it in a $1000{\-}\mathrm{mL}$ volumetric flask, add $0.5\,\mathrm{\mol/L}$ sulfuric acid TS, fill up to the gauge line, and mix. $1~\mathrm{mL}$ of this solution contains $1~\upmu\mathrm{g}$ of mercury $\mathrm{(Hg)}$ .  

Before using diluted dithizone solution for extraction, dilute $5\;\mathrm{mL}$ of dithizone solution for extraction with $25~\mathrm{mL}$ of chloroform.  

(6) Ferric ion —Weigh accurately about $5\textrm{g}$ of Ferrous Gluconate Hydrate and dissolve it in a mixture of $100\ \mathrm{mL}$ of water and $10\,\mathrm{\mL}$ of hydrochloric acid, and add $3.0\mathrm{~g~}$ of potassium iodide. Shake well to mix and allow to stand in the dark place for 5 minutes. Then, titrate any free iodine with $0.1\ \mathrm{mol/L}$ sodium thiosulfate VS (indicator: $3\;\mathrm{mL}$ of starch TS). Perform a blank test in the same manner and make any necessary correction (NMT $2.0\%$ ).  

exactly $100~\mathrm{mL}$ . To $5\mathrm{mL}$ of this solution, add $2~\mathrm{mL}$ of Ferring's TS, and boil for 1 minute; a red precipitate is not formed within 1 minute.  

Loss on drying Between $6.5\%$ and $10.0\%$ $(1~\mathrm{g},~105~^{\circ}\mathrm{C},$ ,16 hours).  

Assay Weigh accurately about $1.5\,\mathrm{~g~}$ of Ferrous Gluconate Hydrate, put it in a $300{\mathrm{-mL}}$ Erlenmeyer flask, and dissolve in a mixture of $75~\mathrm{mL}$ of water and $15~\mathrm{mL}$ of dilute sulfuric acid. Add $0.25\mathrm{~g~}$ of zinc powder, stopper the flask with a Bunsen valve, and allow to stand at room temperature for 20 minutes or until the solution becomes colorless. Filter the solution through a filtering crucible (Gooch crucible) containing an asbestos mat coated with a thin layer of zinc dust, and wash the crucible and the contents with $10~\mathrm{mL}$ of dilute sulfuric acid and then with $10~\mathrm{mL}$ of water. To the filtrate, add 1,10-phenanthroline monohydrate TS, and immediately titrate the filtrate with $0.1\ \mathrm{mol/L}$ cerium sulfate VS in a suction flask. Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in tight containers.  

# Ferrous Gluconate Tablets 글루콘산제일철정  

Each mL of $0.1\ \mathrm{mol/L}$ sodium thiosulfate VS $=5.585~\mathrm{mg}$ of $\mathrm{Fe}^{+3}$  

Each mL of $0.1\;\mathrm{mol/L}$ cerium sulfate solution $=44.61~\mathrm{mg}$ of $\mathrm{C_{12}H_{22}F e O_{14}}$  

(7) Arsenic —Weigh $1.0\,\mathrm{~g~}$ of Ferrous Gluconate Hydrate, put it in $100\;\mathrm{mL}$ round bottom flask, add $40\;\mathrm{mL}$ of $4.5~\mathrm{mol/L}$ sulfuric acid and $2~\mathrm{mL}$ of potassium bromide solution (3 in 10), and connect it to a distillation device equipped with an ice water cooler. Heat the test sample to dissolve and start distillation. Perform the test using $25~\mathrm{mL}$ of the distillate as the test solution (NMT 3 ppm).  

(8) Reducing sugars —Weigh $0.5~\mathrm{g}$ of Ferrous Gluconate Hydrate, dissolve it in $10\,\mathrm{\mL}$ of water, slightly warm it up, and add $1~\mathrm{mL}$ of ammonia TS to make it alkaline. Precipitate iron through hydrogen sulfide in this solution, allow to stand for 30 minutes, filter, and wash the precipitate twice with $5~\mathrm{mL}$ of water. Then, combine the filtrate and the solution used for washing, make the combined solution acidic with hydrochloric acid, and add another $2~\mathrm{mL}$ of dilute hydrochloric acid. Boil this solution until the steam does not turn the lead acetate paper black, and if necessary, boil further to concentrate to about $10\,\mathrm{\mL}$ . After cooling, add $5\ \mathrm{mL}$ of sodium carbonate TS and $20~\mathrm{mL}$ of water, filter, wash the residue with water, combine the filtrate and the solution used for washing, add water to make the combined solution to Ferrous Gluconate Tablets contains NLT $93.0\%$ and NMT $107.0\%$ of the labeled amount of ferrous gluconate hydrate $(\mathrm{C_{12}H_{22}F e O_{14}}\mathrm{\cdot2H_{2}O}:482.17)$ .  

Method of preparation Prepare Ferrous Gluconate Tablets as directed under Tablets, with Ferrous Gluconate Hydrate.  

Identification Powder Ferrous Gluconate Tablets, weigh an appropriate amount of the powder, equivalent to $1\ \mathrm{g}$ of ferrous gluconate hydrate, according to the labeled amount, dissolve in $100~\mathrm{mL}$ of water, and filter. Take an appropriate amount of the filtrate, add water, dilute it to the corresponding concentration, and perform the test as directed under the Identification for Ferrous Gluconate Hydrate.  

Dissolution Perform the test with 1 tablet of Ferrous Gluconate Tablets at 150 revolutions per minute according to Method 1 under the dissolution using $900~\mathrm{mL}$ of dissolution medium 1. Take the dissolved solution 80 minutes after the start of the dissolution, filter it, and use the filtrate as the test solution. If necessary, dilute the test solution to a suitable concentration using the dissolution medium. Separately, weigh accurately an appropriate amount of ferrous gluconate hydrate RS, dissolve in the dissolution medium, and prepare the standard solution containing the same concentration of iron as the test solution. Determine the absorbances of the test solution and the standard solution according to the following conditions, as directed under the Atomic Absorption Spectroscopy, and calculate the content of iron using the calibration curve obtained from the absorbance of the standard solution.  

Gas: Air–acetylene   
Lamp: Iron hollow-cathode lamp   
Wavelength: 248.3 nm  

It meets the requirements when the dissolution rate of Ferrous Gluconate Tablets in 80 minutes is NLT $80\%$ .  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately NLT 20 tablet of Ferrous Gluconate Tablets and powder them. Weigh accurately an appropriate amount of the powder equivalent to about 1.5 g of ferrous gluconate hydrate $(\mathrm{C_{12}H_{22}F e O_{14}{\cdot}2H_{2}O)}$ , put in a $300{\mathrm{-mL}}$ Erlenmeyer flask, dissolve in a mixture of $75~\mathrm{mL}$ of water and $15~\mathrm{mL}$ of dilute sulfuric acid, and hereinafter proceed as directed under the Assay of Ferrous Gluconate Hydrate.  

Each mL of $0.1\ \mathrm{mol/L}$ cerium sulfate VS $=48.22~\mathrm{mg}$ of $\mathrm{C_{12}H_{22}F e O_{14}{\cdot}2H_{2}O}$  

Packaging and storage Preserve in tight containers.  

# Ferrous Sulfate Hydrate 황산철수화물  

Ferrous Sulfate FeSO 4 ·7H 2 O: 278.02 Iron $(2+)$ sulfate heptahydrate [ 7782-63-0 ]  

Ferrous Sulfate Hydrate contains NLT $98.0\%$ and NMT $104.0\%$ of ferrous sulfate hydrate $\mathrm{(FeSO_{4}{\cdot}7H_{2}O)}$ ). Description Ferrous Sulfate Hydrate occurs as pale green crystals or a crystalline powder. It is odorless and astringent.  

It is freely soluble in water and practically insoluble in ether. It easily effloresces in dry air, and its crystal surface changes to yellowish brown in the humid air.  

Identification An aqueous solution of Ferrous Sulfate Hydrate (1 in 10) responds to the Qualitative Analysis for ferrous salt and sulfate.  

Purity (1) Clarity and color of solution ―Dissolve $1.0~\mathrm{g}$ of Ferrous Sulfate Hydrate in $20~\mathrm{mL}$ of water and $1~\mathrm{mL}$ of dilute sulfuric acid; the resulting solution is clear.  

(2) Acid —To $5.0\,\mathrm{~g~}$ of powdered Ferrous Sulfate Hydrate, add $50~\mathrm{mL}$ of ethanol(95), shake for 2 minutes, and filter. To $25~\mathrm{mL}$ of the filtrate, add $50\;\mathrm{mL}$ of water, 3 drops of bromothymol blue TS, and $0.5~\mathrm{~mL}$ of dilute sodium hydroxide TS; the resulting solution exhibits a blue color.  

(3) Mercury —Perform the test using a lightresistant container. Weigh accurately about $1~\mathrm{g}$ of Ferrous Sulfate Hydrate, add $30\,\textrm{m L}$ of diluted nitric acid (1 in 10), and dissolve while heating on a steam bath. Cool quickly in an ice bath and filter using a filter washed with pre-diluted nitric acid (1 in 10) and water. To the filtrate, add $20\;\mathrm{mL}$ of sodium citrate solution (1 in 4) and $1~\mathrm{mL}$ of hydroxylamine hydrochloride TS, and use this solution as the test solution. Separately, prepare the control solution with $3.0~\mathrm{mL}$ of mercury standard solution, $30~\mathrm{mL}$ of diluted nitric acid (1 in 4), $5~\mathrm{mL}$ of sodium citrate solution (1 in 4), and $1\ \mathrm{mL}$ of hydroxylamine hydrochloride. To the control solution, add ammonia TS to adjust the $\mathrm{pH}$ to 1.8. To the test solution, add sulfuric acid to adjust the $\mathrm{pH}$ to 1.8. Transfer each solution into two separation funnels. Perform the test with the test solution and the control solution as follows. Extract 2 times each with $5~\mathrm{mL}$ of extracting dithizone solution and $5\,\textrm{m L}$ of chloroform, transfer chloroform extract into another separation funnel. To the extract, add $10\,\mathrm{\mL}$ of diluted hydrochloric acid (1 in 2), shake to mix, allow to stand, and then discard the chloroform layer. Wash the acid extract with 3 mL of chloroform and discard the solution used for washing. Add $0.1~\mathrm{mL}$ of ethylenediaminetetraacetic acid disodium salt solution (1 in 50) and $2~\mathrm{mL}$ of $6~\mathrm{mol/L}$ acetic acid, mix, and slowly add $5~\mathrm{mL}$ of ammonia TS. Close the lid of the separatory funnel, cool it under running cold water, open the lid, and transfer the contents into a beaker. Adjust the $\mathrm{pH}$ of the test solution and the control solution to 1.8 in the same way as the above, and transfer them to separatory funnels again. Add $5.0~\mathrm{mL}$ of diluted dithizone solution for extraction, shake vigorously, and allow to stand. Compare the color of the chloroform layers of the test solution and the control solution using a diluted dithizone solution for extraction as a control solution; the color obtained from the test solution is not more intense than that from the control solution (NMT 3 ppm). Mercury standard stock solution —Transfer 135.4 mg of mercury(II) chloride into a $100{\-}\mathrm{mL}$ volumetric flask, dissolve in $0.5\;\mathrm{mol/L}$ sulfuric acid TS, fill up to the gauge line, and mix. This solution contains $0.1~\mathrm{g}$ of mercury $\mathrm{(Hg)}$ in $100\;\mathrm{mL}$ .  

Mercury standard solution —Before use, take 1.0 mL of the mercury standard stock solution, transfer into a $1000{\mathrm{-mL}}$ volumetric flask, add $0.5\,\mathrm{\mol/L}$ sulfuric acid TS, fill up to the gauge line, and mix. $1~\mathrm{mL}$ of this solution contains $1\ \upmu\mathrm{g}$ of mercury $\left(\mathrm{Hg}\right)$ .  

Diluted dithizone solution for extraction —Before use, dilute $5~\mathrm{mL}$ of dithizone solution for extraction with $25~\mathrm{mL}$ of chloroform.  

(4) Lead —Transfer about $1.0\ \mathrm{g}$ of Ferrous Sulfate Hydrate into a $50{\-}\mathrm{mL}$ volumetric flask, add $10~\mathrm{mL}$ of 9 mol/L hydrochloric acid, about $10\;\mathrm{mL}$ of water, $20\;\mathrm{mL}$ of ascorbic acid-sodium iodide TS, and $5~\mathrm{mL}$ of a solution of 4-methyl-2-pentanone solution in trioctylphosphine oxide (5 in 100), shake for 30 seconds, and allow to stand until the layers separate. Next, add water to the neck of the volumetric flask, shake it again, and allow to stand. Take the organic solvent layer and use this solution as the test solution. Separately, transfer exactly $5.0~\mathrm{mL}$ of lead nitrate standard stock solution into a volumetric flask, dilute with water to make $100~\mathrm{{mL}}$ , transfer exactly 2.0 mL of this solution into a volumetric flask, and proceed in the same manner as the test solution. Use this solution as the standard solution. Determine the absorbances of the test solution and the standard solution according to the following conditions, as directed under Ultravioletvisible Spectrophotometry; the absorbance of the solution obtained from the test solution is not greater than that from the standard solution.  

Gas: Air–acetylene   
Lamp: Lead hollow-cathode lamp   
Wavelength: 283.8 nm  

(5) Arsenic —Prepare the test solution with $1.0~\mathrm{g}$ of Ferrous Sulfate Hydrate, according to Method 1, and perform the test (NMT 2 ppm).  

Assay Weigh accurately about $0.7\ \mathrm{g}$ of Ferrous Sulfate Hydrate, add $20\,\mathrm{\mL}$ of water, $20\,\mathrm{\mL}$ of dilute sulfuric acid TS, and $2~\mathrm{mL}$ of phosphoric acid, and titrate immediately with $0.02\;\mathrm{mol/L}$ potassium permanganate VS. Each mL of $0.02\;\mathrm{mol/L}$ potassium permanganate VS $=27.80\ \mathrm{mg}$ of $\mathrm{FeSO}_{4}{\cdot}7\mathrm{H}_{2}\mathrm{O}$  

Packaging and storage Preserve in tight containers.  

# Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules 건조황산제일철·폴산· $\lambda|\mathfrak{o}\mathfrak{h}$ 노코발라민·DL-세린캡슐  

Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules contain ferrous sulfate $\mathrm{(FeSO_{4}}$ :151.90) equivalent to NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount, folic acid $\mathrm{(C_{19}H_{19}N_{7}O_{6}}$ : 441.40) and cyanocobalamin $\mathrm{(C_{63}N_{88}C o_{14}O_{14}P}$ : 1355.37) equivalent to NLT $90.0\%$ and NMT $150.0\%$ of the labeled amount, and DL-serine $\mathrm{(C_{3}H_{7}N O_{3}}$ : 105.10) NLT $90.0\%$ and NMT $130.0\%$ of the labeled amount.  

Method of preparation Prepare as directed under Capsules, with Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine.  

Identification (1) Ferrous sulfate ―Weigh an amount of the contents of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules, equivalent to $0.25~\mathrm{g}$ of ferrous sulfate according to the labeled amount, add water and hydrochloric acid to acidify, and add water again to make $50~\mathrm{mL}$ ; the solution responds to the Qualitative Analysis for ferrous salt and sulfate.  

(2) Folic acid ―Perform the test with the contents of 5 capsules of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules as directed under the Analysis for Vitamins.  

(3) Cyanocobalamin ―Perform the test with the contents of 5 capsules of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules as directed under the Analysis for Vitamins.  

(4) DL-serine ―Add the contents of 5 capsules of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules to a G4 glass filter, and wash several times with petroleum ether until the fat of the residue is completely removed. Carefully dry the residue at $65\ ^{\circ}\mathrm{C}_{!}$ ,dissolve in $50~\mathrm{mL}$ of water, and use this solution as the test solution. Separately, dissolve $0.13~\mathrm{g}$ of DL-serine RS in $100~\mathrm{mL}$ of water, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel with fluorescence indicator for thin-layer chromatography. Next, develop the plate with a mixture of methanol and water $(70:30)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Spray ninhydrin-ethanol solution evenly on the plate, and heat at $100~^{\circ}\mathrm{C}$ for 10 minutes; the $R_{f}$ values of the spots obtained from the test and standard solutions are the same.  

Disintegration Meets the requirements.  

# Uniformity of dosage units Meets the requirements.  

Assay (1) Ferrous sulfate ―Weigh accurately the mass of the contents of NLT 20 capsules of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules. Weigh accurately about $0.4\,\mathrm{~g~}$ of ferrous sulfate $\mathrm{(FeSO_{4})}$ , dissolve in a mixture of $20\ \mathrm{~mL}$ of dilute sulfuric acid and $80~\mathrm{mL}$ of freshly boiled and cooled water, and filter. Wash the beaker and the residue on the filter paper with a small amount of the mixture of $20~\mathrm{mL}$ of dilute sulfuric acid and $80\,\textrm{m L}$ of freshly boiled and cooled water, combine the washings with the filtrate, and immediately titrate with $0.1\,\mathrm{\mol/L}$ cerium sulfate VS (indicator: $o$ -Phenanthroline TS). Perform a blank test in the same manner and make any necessary correction.  

# Each mL of $0.1\;\mathrm{mol/L}$ cerium sulfate VS $=15.190\;\mathrm{mg}$ of $\mathrm{FeSO_{4}}$  

(2) Folic acid and cyanocobalamin ―Weigh accurately the mass of the contents of NLT 20 tablets of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DLSerine Capsules and perform the test as directed under the Analysis for Vitamins.  

(3) DL-serine ―Weigh accurately the mass of the contents of NLT 20 tablets of Dried Ferrous Sulfate, Folic Acid, Cyanocobalamin and DL-Serine Capsules and perform the test as directed under the Identification and Assay for Amino Acids.  

Packaging and storage Preserve in well-closed containers.  

Finasteride, dissolve in a mixture of acetonitrile and water $(1:1)$ to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Perform the test with $15\ \upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions, determine the peak areas according to the automatic integration method, and calculate the amount of each related substance; it is NMT $0.5\%$ , and total amount of all related substances is NMT $1.0\%$ .  

Content $(\%)$ of each related substance  

# Finasteride 피나스테리드  

![](images/f230548d7b8c4c8a2b29f7790436b50beb112a921b44f0d36150b9cc36aed60f.jpg)  

Finasteride $\mathrm{C}_{23}\mathrm{H}_{36}\mathrm{N}_{2}\mathrm{O}_{2}$ : 372.54 $(1S,3\mathrm{a}S,3\mathrm{b}S,5\mathrm{a}R,9\mathrm{a}R,9\mathrm{b}S,11\mathrm{a}S)$ -N-tert -Butyl-9a, 11adimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11- dodecahydroindeno[5,4-f]quinoline-1-carboxamide [98319-26-7 ]  

Finasteride contains NLT $98.5\%$ and NMT $101.0\%$ of finasteride $(\mathbf{C}_{23}\mathrm{H}_{36}\mathrm{N}_{2}\mathbf{O}_{2}$ : 372.55), calculated on the anhydrous basis.  

Description Finasteride occurs as a white or grayish white crystalline solid.  

It is freely soluble in ethanol(95) or chloroform, and very slightly soluble in water.  

Melting point —About $257\ ^{\circ}\mathrm{C}$ Identification (1) Determine the infrared spectra of Finasteride and finasteride RS, as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.  

Optical rotation $[\alpha]_{405\mathrm{nm}}^{25}$ : Between $-56.0^{\circ}$ and $-60.0^{\circ}$ $_{(0.1\mathrm{~g~}}$ calculated on the anhydrous basis, methanol, 10 mL, $100\;\mathrm{mm}$ ).  

Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Finasteride according to Method 2 and perform the test. Prepare the control solution with $1.0\,\mathrm{\mL}$ of lead standard solution (NMT $10\,\mathrm{ppm})$ ).  

(2) Related substances— Weigh accurately $0.1\ \mathrm{g}$ of  

$$
=\,100\times{\frac{A_{\mathrm{i}}}{A_{\mathrm{S}}}}
$$  

# $A_{\mathrm{i}}$ : Peak area of each related substance  

$A_{S}$ : Total area of peaks obtained from the test solution  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm})$ .  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $30\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( ${}^{4}\ensuremath{\,\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: A mixture of water, tetrahydrofuran and acetonitrile $(8:1:1)$ .  

Column temperature: A constant temperature of about $60\ ^{\circ}\mathrm{C}$ .  

Flow rate: About $1.5\;\mathrm{mL/min}$ System suitability  

System performance: Weight $10~\mathrm{mg}$ of finasteride TS, dissolve in a mixture of water and acetonitrile $(1:1)$ to make $10~\mathrm{mL}$ . Proceed with $15~\upmu\mathrm{L}$ of this solution according to the above conditions; the number of theoretical plates and the symmetry factor of the peak of finasteride are NLT 10000 plates and NMT 1.3, respectively.  

Water NMT $0.3\%$ ($1{\mathrm{~g~}}$ , volumetric titration, direct titration).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $20~\mathrm{mg}$ each of Finasteride and finasteride RS, dissolve in a mixture of water and acetonitrile (1 in 1) to make exactly $100\,\mathrm{\mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas of finasteride, $A_{\mathrm{T}}$ and $A_{S}$ , from each solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer  

(wavelength: $215\;\mathrm{nm}$  

Column: A stainless steel column about $3.0\ \mathrm{mm}$ in internal diameter and $30~\mathrm{cm}$ in length, packed with octylsilyl silica gel for liquid chromatography ( $3\;{\upmu\mathrm{m}}$ in particle diameter).  

Mobile phase: A mixture of water and tetrahydrofuran $(4:1)$ .  
Flow rate: About $3\ \mathrm{mL/min}$ .  
System suitability   
System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plates and the symmetry factor of the peak of finasteride are NLT 1800 plates and NMT 1.3, respectively.   
System repeatability: Repeat the test 5 times with  

$10\,\upmu\mathrm{L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area is NMT $1.0\%$ .  

Packaging and storage Preserve in tight containers.  

# Flavin Adenine Dinucleotide Sodium 플라빈아데닌디뉴클레오티드나트륨  

![](images/ef54af2d928a561258c26e850e31c73e15c5afb928c94b1cf9088b3b09a06186.jpg)  

Flavin Adenine Dinucleotide Sodium  

$\mathrm{C_{27}H_{31}N_{9}N a_{2}O_{15}P_{2}:829.51}$ Disodium adenosine 5'-(3-{D-ribo-5-[7,8-dimethyl-2,4- dioxo-3,4-dihydrobenzo[g]pteridin$10(2H)$ -yl]-2,3,4- trihydroxypentyl} dihydrogen diphosphate) [ 84366-81-4 ]Flavin Adenine Dinucleotide Sodium contains NLT $93.0\%$ and NMT $101.\%$ of flavin adenine dinucleotide sodium $\mathrm{(C_{27}H_{31}N_{9}N a_{2}O_{15}P_{2})}$ , calculated on the anhydrous basis.  

Description Flavin Adenine Dinucleotide Sodium occurs as an orange yellow to pale yellowish brown powder. It is odorless or has a slightly characteristic odor and has a slightly bitter taste.   
It is freely soluble in water and practically insoluble in methanol, ethanol(95), ethylene glycol or ether.   
It is hygroscopic.   
It is decomposed by light.  

Identification (1) An aqueous solution of Flavin Adenine Dinucleotide Sodium (1 in 100000) is pale yellowish green and has an intense yellowish green fluorescence. To $5~\mathrm{mL}$ of the solution, add $20\mathrm{mg}$ of sodium hydrosulfite; the color and fluorescence of the solution disappear, but reappear slowly upon shaking the mixture in air. This fluorescence disappears upon the addition of dilute hydrochloric acid or sodium hydroxide TS dropwise.  

(2) Determine the infrared absorption spectrum of Flavin Adenine Dinucleotide Sodium and flavin adenine dinucleotide sodium RS as directed in the potassium bromide disk method under Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wave numbers.  

(3) Take $0.1\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium, add $10~\mathrm{mL}$ of nitric acid, evaporate on a steam bath to dryness, and ignite. Boil the residue with $10\,\mathrm{\mL}$ of diluted nitric acid (1 in 50) for 5 minutes. Cool, then neutralize with ammonia TS and filter as needed; the solution responds to the Qualitative Analysis for sodium salt and Qualitative Analysis (1) and (3) for phosphate.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-21.0^{\circ}$ and $-25.5^{\circ}$ (0.3g calculated on the anhydrous basis, water, $20\,\mathrm{\mL}$ , 100 mm).  

$\mathbf{pH}$ Dissolve $1.0~\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium in $100\;\mathrm{mL}$ of water; the $\mathrm{pH}$ of the solution is between 5.5 and 6.5.  

Purity (1) Clarity and color of solution— Dissolve 0.20 $\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium in $10\ \mathrm{mL}$ of water; the resulting solution is clear and yellow.  

(2) Free phosphoric acid —Weigh accurately about $20~\mathrm{mg}$ of Flavin Adenine Dinucleotide Sodium, dissolve in $10~\mathrm{mL}$ of water, and use this solution as the test solution. Separately, pipet $2~\mathrm{mL}$ of phosphoric acid RS, add $10~\mathrm{mL}$ of water, and use this solution as the standard solution. Add $2~\mathrm{mL}$ of diluted perchloric acid (100 in 117) to each of the test solution and the standard solution, add $1\,\mathrm{\mL}$ of ammonium molybdate TS and $2\,\textrm{m L}$ of 2,4- diaminophenol hydrochloride TS, shake to mix, add water to make exactly $25\,\mathrm{\mL}$ , and allow to stand for 30 minutes at $20\pm1~^{\circ}\mathrm{C}$ . With these solutions and the control solution prepared with $2~\mathrm{mL}$ of water in the same way, perform the test according to Ultraviolet-visible Spectroscopy. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution, respectively, at wavelength $730\ \mathrm{nm}$ ; the amount of free phosphoric acid is NMT $0.25\%$ .  

$$
=\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\frac{1}{W}\times5.16
$$  

W: Amount (mg) of Riboflavin Sodium Phosphate calculated on the anhydrous basis  

(3) Heavy metals —Weigh $1.0~\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium according to Method 2 and perform the test. Prepare the control solution with $2.0~\mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm})$ ). (4) Arsenic —Proceed with $2.0\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium according to Method 3 and perform the test (NMT 1 ppm).  

(5) Related substances —Dissolve about $0.10\mathrm{~g~}$ of Flavin Adenine Dinucleotide Sodium in $200\ \mathrm{mL}$ of the mobile phase and use this solution as the test solution. Perform the test with $20~\upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions. Measure the peak area A of flavin adenine dinucleotide sodium and the total area S of the other peaks; $\mathrm{S/(A+S)}$ is NMT 0.10.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $260\;\mathrm{nm}$ ).  

Follow the operating conditions under Assay 1) Procedure (B) for the column, column temperature, mobile phase, flow rate and time span of measurement.  

System suitability  

Test system performance as directed in System suitability under Assay 1) Procedure B).  

Test for required detectability: Pipet $2~\mathrm{mL}$ of the test solution, add the mobile phase to make exactly 20 mL, and use this solution as the system suitability solution. Confirm that the peak area of flavin adenine dinucleotide sodium obtained from $20~\upmu\mathrm{L}$ of this solution is equivalent to between $8\%$ and $12\%$ of the peak area of flavin adenine dinucleotide sodium obtained from the standard solution.  

System repeatability: Repeat the test 6 times with $20~\upmu\mathrm{L}$ each of the system suitability solution according to the above conditions; the relative standard deviation of the peak areas of flavin adenine dinucleotide sodium is NMT $1.0\%$ .  

Water Put $50~\mathrm{mL}$ of a mixture of methanol for water determination and ethylene glycol for water determination (1:1) in a dry flask for titration and titrate with a test solution for water determination to the endpoint. Weigh accurately about $0.1\,\mathrm{~g~}$ of Flavin Adenine Dinucleotide Sodium, quickly transfer into the titration flask, add a certain amount of the excess test solution for water determination, stir to mix for 10 minutes, and perform the test; the water content is NMT $10.0\%$ .  

Assay (1) Procedure —(i) Total amount of flavin: Perform the procedure using light-resistant containers. Separately, weigh accurately about $0.1\,\mathrm{~g~}$ of Flavin Adenine Dinucleotide Sodium and dissolve in water to make exactly $200~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add $5~\mathrm{mL}$ of zinc chloride TS, heat for 30 minutes on a steam bath, and cool. Then add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Separately, weigh accurately about $50~\mathrm{mg}$ of riboflavin RS (previously dried at $105~^{\circ}\mathrm{C}$ for 2 hours), dissolve in $200\,\mathrm{\mL}$ of diluted acetic acid(100) (1 in 100) by warming, cool, and add water to make exactly $500~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ of this solution, add water to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. With the test solution and the standard solution, perform the test as directed under the Ultraviolet-visible Spectroscopy using water as the control solution, and determine the absorbances, $\mathrm{A_{T}}$ and A S, at the wavelength of $450\;\mathrm{nm}$ .  

$$
\begin{array}{c}{{\mathrm{Total\;amount\;(mg)\;of\;flavin}}}\\ {{=\mathrm{Amount\;(mg)\;of\;riboflavin\;RS}\times\frac{A_{\mathrm{T}}}{A_{S}}\times\frac{4}{5}}}\end{array}
$$  

(ii) Peak area ratio of flavin adenine nucleotide: Weigh accurately about $0.1~\mathrm{g}$ of Flavin Adenine Dinucleotide Sodium, dissolve in water to make exactly $200~\mathrm{mL}$ ,and use this solution as the test solution. Perform the test with $5\,\upmu\mathrm{L}$ of the test solution as directed under the Liquid Chromatography according to the following conditions. Measure the respective peak areas using the automatic integration method, and determine the peak area $A$ of flavin adenine dinucleotide sodium and the sum of the other peak areas S.  

Peak area ratio of flavin adenine dinucleotide sodium  

$$
={\frac{1.08A}{1.08A+S}}
$$  

# Operating conditions  

Detector: A visible absorption photometer (wavelength: $450\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and $15~\mathrm{cm}$ to $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;\upmu\mathrm{m}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\ ^{\circ}\mathrm{C}$ .  

Mobile phase: A mixture of potassium dihydrogen phosphate solution (17 in 500) and methanol $(4:1)$ .  

Flow rate: Adjust the flow rate so that the retention time of flavin adenine dinucleotide sodium is about 10 minutes.  

# System suitability  

Test for required detectability: Pipet $2~\mathrm{mL}$ of the test solution, add water to make exactly $20~\mathrm{mL}$ , and use this solution as the system suitability solution. Weigh accurately $2~\mathrm{mL}$ of this solution and make $20~\mathrm{mL}$ . Confirm that the peak area of flavin adenine dinucleotide sodium obtained from $5~\upmu\mathrm{L}$ of this solution is equivalent to between $8\%$ and $12\%$ of the peak area of flavin adenine dinucleotide sodium obtained from the standard solution.  

System performance: Dissolve $20~\mathrm{~mg~}$ each of Flavin Adenine Dinucleotide Sodium and sodium riboflavinphosphate in $100~\mathrm{mL}$ of water. Proceed with $5~\upmu\mathrm{L}$ of this solution according to the above conditions; flavin adenine dinucleotide sodium and riboflavin phosphate are eluted in this order with the resolution being NLT 2.0.  

System repeatability: Repeat the test 6 times with $5~\upmu\mathrm{L}$ each of the system suitability solution according to the above conditions; the relative standard deviation of the peak areas of flavin adenine dinucleotide sodium is  

NMT $1.0\%$  

Time span of measurement: About 4.5 times the retention time of flavin adenine dinucleotide sodium.  

# (2) Calculation formula  

Amount (mg) of flavin adenine dinucleotide sodium $\left({\bf C}_{27}{\mathrm{H}}_{31}{\mathrm{N}}_{9}{\mathrm{N}}{\mathrm{a}}_{2}{\mathrm{O}}_{15}{\mathrm{P}}_{2}\right)$ $=f_{\mathrm{T}}{\times f_{\mathrm{R}}}\times2.2040$  

$f_{\mathrm{T}}$ : Total amount $\mathrm{(mg)}$ of flavin in Flavin Adenine Dinucleotide Sodium obtained from the Procedure (i)  

fR: Peak area ratio of flavin adenine nucleotide in Flavin Adenine Dinucleotide Sodium obtained from the Procedure (ii)  

Packaging and storage Preserve in light-resistant, tight containers.  

# Flavoxate Hydrochloride 플라복세이트염산염  

![](images/814d6b9ecad682389270af455a1f368d1113ff9e93c4b19e81549a1cb26ea94e.jpg)  

$\mathrm{C}_{24}\mathrm{H}_{25}\mathrm{NO}_{4}\cdot\mathrm{HCl}:427.92$ 2-(1-Piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene8-carboxylate hydrochloride [ 3717-88-2 ]  

Flavoxate Hydrochloride, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of propranolol hydrochloride $(\mathrm{C}_{24}\mathrm{H}_{25}\mathrm{NO}_{4}\cdot\mathrm{HCl})$ ).  

Description Flavoxate Hydrochloride occurs as white crystals or a crystalline powder.  

It is sparingly soluble in acetic acid(100) or chloroform, slightly soluble in water or ethanol(95), and practically insoluble in acetonitrile or ether.  

Identification (1) Determine the absorption spectra of the solutions of Flavoxate Hydrochloride and flavoxate hydrochloride RS in $0.01\ \mathrm{mol/L}$ hydrochloric acid TS (1 in 50000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Flavoxate Hydrochloride and flavoxate hydrochloride RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy, respectively; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) An aqueous solution of Flavoxate Hydrochloride (1 in 100) responds to the Qualitative Analysis for chlo  

ride.  

Purity (1) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Flavoxate Hydrochloride according to Method 2 and perform the test. Prepare the control solution with $2.0\,\mathrm{~mL~}$ of lead standard solution (NMT 10 ppm).  

(2) Arsenic —Proceed with $2.0{\mathrm{~g~}}$ of Flavoxate Hydrochloride according to Method 4, and perform the test (NMT 1 ppm).  

(3) Related substances ―Dissolve $80~\mathrm{mg}$ of Flavoxate Hydrochloride in $10~\mathrm{mL}$ of chloroform and use this solution as the test solution. Pipet $1\ \mathrm{mL}$ of this solution and add chloroform to make exactly $20~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add chloroform to make exactly $20~\mathrm{mL}$ ,and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a plate made of silica gel with fluorescent indicator for thin-layer chromatography. Next, develop the plate with a mixture of 1- butanol, water and acetic acid(100) $(3:1:1)$ as the developing solvent to a distance of about $12~\mathrm{cm}$ and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than those from the standard solution.  

Loss on drying NMT $1.0\%$ ($\textbf{l g}$ , in vacuum, silica gel, 2 hours).  

# Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~}~}\mathrm{g})$  

Assay Weigh accurately about $0.6\mathrm{~g~}$ of Flavoxate Hydrochloride, previously dried, add $10\,\mathrm{\mL}$ of acetic acid(100) and $40~\mathrm{mL}$ of acetonitrile, and dissolve. Add 50 mL of acetic anhydride and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid VS $=42.79~\mathrm{mg}$ of $\mathrm{C}_{24}\mathrm{H}_{25}\mathrm{NO}_{4}$ ·HCl  

![](images/f2f0ca2fc325ca9a48e9612dd7459d8d341f40bf53ffa4d1e013343cdcdd3243.jpg)  
Packaging and storage Preserve in tight containers.  

Flomoxef Sodium C15 H17 F2 N6 NaO 7 S2   
518.45  

Sodium (6 R,7 R)-7-[[2-   
(difluoromethylsulfanyl)acetyl]amino]-3-[[1-(2-   
hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8- oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate [92823-03-5 ]  
Flomoxef Sodium contains NLT $870~\upmu\mathrm{g}$ (potency) and NMT 985 μg (potency) of flomoxef $(\mathrm{C_{15}H_{18}F_{2}N_{6}O_{7}S_{2}:496.47})$ ) per mg, calculated on the anhydrous basis. Description Flomoxef Sodium occurs as a white to pale yellowish white crystalline powder.   
It is very soluble in water, freely soluble in methanol, and sparingly soluble in ethanol(99.5).  

Identification (1) Weigh about $0.01\ \mathrm{g}$ of Flomoxef Sodium and decompose as directed under the Oxygen Flask Combustion, using a mixture of $0.5\,\mathrm{\mL}$ of $0.01\ \mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as the absorbent. To $2~\mathrm{mL}$ of this test solution, add $1.5~\mathrm{mL}$ of a mixture of alizarin complexone TS, acetic acid, potassium acetate buffer solution $(\mathrm{pH}\,4.3)$ and cerium(III) nitrate TS $(1:1:1)$ ; the solution exhibits a bluish purple color.  

(2) Determine the absorption spectra of each aqueous solution of Flomoxef Sodium and flomoxef sodium RS (3 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Flomoxef Sodium and flomoxef sodium RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(4) Determine the $^{1}\mathrm{H}$ spectrum of a solution of Flomoxef Sodium in deuterium oxide for nuclear magnetic resonance spectroscopy (1 in 10) as directed under the Nuclear Magnetic Resonance Spectroscopy, using sodium 3-trimethylsilylpropanesulfonate as the internal reference compound; the acquired spectrum exhibits a singlet A at around $\delta\ 3.5\ \mathrm{ppm}$ , a singlet or sharp multiplet B at around $\delta\,3.7\;\mathrm{ppm}$ and a singlet C at around $\delta\ 5.2\ \mathrm{ppm}$ . The ratio of the integrated intensity of these signals, $\mathrm{A:B:C}$ , is about $3:2:1$ .  

(5) Flomoxef Sodium responds to the Qualitative Analysis (1) for sodium salt.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-8^{\circ}$ and $-13^{\circ}$ ($1\;\mathrm{g}$ calculated on the anhydrous basis, a mixture of water and ethanol(99.5) $(4:1)$ , 50 mL, $100\;\mathrm{mm}$ ).  

$\mathbf{pH}$ Dissolve $0.5\mathrm{~g~}$ (potency) of Flomoxef Sodium in 5 mL of water; the pH of the solution is between 4.0 and 5.5.  

Purity (1) Clarity and color of solution —Dissolve $1.0\;\mathrm{g}$ of Flomoxef Sodium in $10\,\mathrm{\mL}$ of water; the resulting solution is colorless to pale yellow and clear. (2) Heavy metals —Place about $1.0\ \mathrm{g}$ of Flomoxef Sodium in a quartz crucible, proceed according to Method 2, and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(3) Arsenic —To $1.0~\mathrm{g}$ of Flomoxef Sodium, add 5 mL of sulfuric acid and $5\;\mathrm{mL}$ of nitric acid and heat carefully. Continue heating, adding $2~\mathrm{mL}$ of nitric acid occasionally until the solution is colorless to pale yellow. After cooling, add $10\,\mathrm{\mL}$ of ammonium oxalate TS and concentrate the solution from $2~\mathrm{mL}$ to $3\ \mathrm{mL}$ by heating until white fumes evolve. After cooling, add water to make $10~\mathrm{mL}$ and perform the test using this solution as the test solution; the color of the solution is not more intense than the reference color.  

Reference color: Proceed to prepare a solution in the same manner as the test solution without Flomoxef Sodium, transfer $10\,\mathrm{\mL}$ of this solution to the bottle of the generator apparatus, add exactly $2~\mathrm{mL}$ of arsenic standard solution, and proceed in the same manner as the test solution (NMT 2 ppm).  

(4) 1-(2-hydroxyethyl)-1H-tetrazol-5-thiol —Use the test solution prepared under the Assay as the test solution. Separately, weigh accurately about $20~\mathrm{mg}$ of 1-(2- hydroxyethyl)- $1H\cdot$ -tetrazol-5-thiol and dissolve in water to make exactly $100\;\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add exactly $25~\mathrm{mL}$ of the internal standard solution and water to make $50\;\mathrm{mL}$ and use this solution as the standard solution.  Perform the test with each $5~\upmu\mathrm{L}$ of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and calculate the ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of the peak area of 1- (2-hydroxyethyl)- $\cdot1H$ -tetrazol-5-thiol to that of the internal standard. The amount of 1-(2-hydroxyethyl)- $\cdot1H\cdot$ -tetrazol-5-thiol is NMT $1.0\%$ of Flomoxef Sodium, calculated on the anhydrous basis.  

Amount (mg) of 1-(2-hydroxyethyl)- $1H$ -tetrazol-5-thiol $(\mathbf{C}_{3}\mathrm{H}_{6}\mathrm{N}_{4}\mathrm{O}\mathrm{S})$  

$$
\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times\frac{1}{10}
$$  

Internal standard solution —$-m$ -cresol solution (3 in 1000).  

Operating conditions   
Proceed as directed under the operating conditions under the Assay.  

System suitability Proceed as directed under the system suitability under the Assay.  

Water NMT $1.5\%$ ($\mathrm{~\ensuremath~{~0.5~\mathrm{~g~}~}~}$ , volumetric titration, direct titration).  

Sterility It meets the requirements when used in sterile preparations (excluding in case of a manufacturing process of a sterile preparation with a terminal sterilization process). Use a diluent containing $0.1\%$ polysorbate 80 as the rinsing fluid.  

Bacterial endotoxins Less than $0.025\;\mathrm{EU/mg}$ (potency) of flomoxef, when used in a sterile preparation.  

Assay Weigh accurately each $50~\mathrm{mg}$ (potency) of Flomoxef Sodium and flomoxef sodium RS, dissolve in the internal standard solution to make exactly $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution, respectively. Perform the test with $5~\upmu\mathrm{L}$ of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and calculate the ratios, $Q_{\mathrm{T}}$ and $Q_{\mathrm{S}}$ , of the peak area of flomoxef to that of the internal standard for the test solution and the standard solution, respectively.  

Amount [μg (potency)] of flomoxef $(\mathrm{C}_{15}\mathrm{H}_{18}\mathrm{F}_{2}\mathrm{N}_{6}\mathrm{O}_{7}\mathrm{S}_{2})$ )$=$ Potency $\mathrm{(\upmug)}$ of flomoxef trimethylammonium RS $\mathrm{RS}{\times}\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —$\cdot m$ -cresol solution (3 in 1000).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength $246\;\mathrm{nm})$ ).  

Column: A stainless steel column, about $4\textrm{m m}$ in internal diameter and $20~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography $(5~{\upmu\mathrm{m}}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $25\ ^{\circ}\mathbf{C}$ .  

Mobile phase: Dissolve $6.94\mathrm{~g~}$ of potassium dihydrogen phosphate, $3.22\,\mathrm{~g~}$ of disodium hydrogen phosphate dodecahydrate and 1.60 gof tetra-nbutylammonium bromide in water to make $1000~\mathrm{\mL}$ Add $250\;\mathrm{mL}$ of methanol to $750\;\mathrm{mL}$ of this solution.  

Flow rate: Adjust the flow rate so that the retention time of flomoxef is about 9 minutes.  

# System suitability  

System performance: Perform the test with $5~\upmu\mathrm{L}$ of the standard solution according to the above operating conditions; flomoxef and the internal standard are eluted in this order, and the peak resolution is NLT 10.  

System repeatability: Repeat the test 3 times with $5~\upmu\mathrm{L}$ of the standard solution under the above operating conditions; the relative standard deviation of the ratio of the peak area of flomoxef to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, tight containers (at below $5\;^{\circ}\mathrm{C}_{.}$ ).  

# Flomoxef Sodium for Injection 주사용플로목세프나트륨  

Flomoxef Sodium for Injection is an injection to be dissolved before use and contains NLT $90.0\%$ and NLT $110.0\%$ of the labeled amount of flomoxef $(\mathrm{C}_{15}\mathrm{H}_{18}\mathrm{F}_{2}\mathrm{N}_{6}\mathrm{O}_{7}\mathrm{S}_{2}:496.47)$ .  

Method of preparation Prepare as directed under Injections, with Flomoxef Sodium.  

Description Flomoxef Sodium for Injection occurs as a hard, white to pale yellowish white mass or a powder.  

Identification Perform the test with Flomoxef Sodium for Injection as directed under the Identification (3) under Flomoxef Sodium.  

$\mathbf{pH}$ Dissolve an amount of Flomoxef Sodium for Injection, equivalent to $0.5\;\mathrm{g}$ (potency) of flomoxef sodium, in $5~\mathrm{mL}$ of water; the $\mathrm{pH}$ of this solution is between 4.0 and 5.5.  

Purity (1) Clarity and color of solution —Dissolve an amount of Flomoxef Sodium for Injection equivalent to $1.0~\mathrm{g}$ (potency) of flomoxef sodium according to the labeled amount, in $10\;\mathrm{mL}$ of water; the solution is clear and colorless to pale yellow.  

(2) 1-(2-hydroxyethyl)-1H-tetrazole-5-thiol —Use the test solution obtained in Assay as the test solution. Separately, weigh accurately about $20~\mathrm{~mg~}$ of 1-(2- hydroxyethyl)- $\cdot1H\!\cdot$ -tetrazol-5-thiol and dissolve in water to make exactly $100\;\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution, add exactly $25~\mathrm{mL}$ of the internal standard solution and water to make $50\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $5~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak area ratio, $Q_{\mathrm{T}}$ and $Q\mathrm{s}$ , of 1- 2(hydroxyethyl)- $1H\cdot$ -tetrazole-5-thiol to the peak area of the internal standard. The amount of 1-(2-hydroxyethyl)- $1H\cdot$ -tetrazole-5-thiol is NMT $10\,\mathrm{~mg~}$ per $\mathrm{g}$ (potency) of Flomoxef Sodium for Injection.  

Amount (mg) of 1-2(2-hydroxyethyl)- $1H\cdot$ -tetrazole-5- thiol $(\mathrm{C}_{3}\mathrm{H}_{6}\mathrm{N}_{4}\mathrm{O}\mathrm{S})$  

$=$ Potency (mg) of 1-(2-hydroxyethyl)- $1H$ -tetrazol-5-thiol $\times\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}\times\frac{1}{10}$  

Internal standard solution —m-Cresol solution (3 in 1000).  

Operating conditions  

Perform the test according to the operating conditions as directed under the Assay under Flomoxef Sodium.  

Test for required detectability: Pipet $1~\mathrm{mL}$ of the standard solution, and add water to make exactly $20~\mathrm{mL}$ Confirm that the peak area of 1-methyl$1H$ -tetrazole-5- thiol obtained from $5~\upmu\mathrm{L}$ of this solution is $3.5\%$ to $6.5\%$ of the peak area of 1-methyl$1H\cdot$ -tetrazole-5-thiol obtained from $5\,\upmu\mathrm{L}$ of the standard solution.  

System performance: Proceed with $5~\upmu\mathrm{L}$ of the standard solution according to the above conditions; 1-(2- hydroxyethyl)- $1H\cdot$ -tetrazol-5-thiol and the internal standard are eluted in this order with the resolution being NLT 20.  

System repeatability: Repeat the test 3 times with $5~\upmu\mathrm{L}$ each of the standard solution (1) according to the above conditions; the relative standard deviation of the peak area of 1-methyl$1H\cdot$ -tetrazole-5-thiol is NMT $1.0\%$ .Water NMT $1.5\%$ $\left(0.5\,\mathrm{~g~}\right.$ , volumetric titration, direct titration).  

Sterility Meets the requirements. Bacterial endotoxins Less than 0.025 EU per mg (potency) of flomoxef.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Uniformity of dosage units Meets the requirements. Assay Take NLT 10 units of Flomoxef Sodium for Injection, weigh accurately the mass of the contents, and determine the average weight of the contents. Thinly spread about $1{\mathrm{~g~}}$ of the contents on a petri dish, and allow it to stand in a humidistat with a saturated solution of magnesium bromide, protected from light, to bring the water to equilibrium. Measure the water content of $0.1\,\mathrm{~g~}$ of the content as directed under Water.  Weigh accurately an amount of Flomoxef Sodium for Injection, equivalent to about $50~\mathrm{mg}$ (potency) of flomoxef sodium, dissolve in exactly $50~\mathrm{mL}$ of the internal standard solution, and add water to make $100~\mathrm{mL}$ . Use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ (potency) of flomoxef triethylammonium RS, dissolve in exactly 50 mL of the internal standard solution, add water to make $100\ \mathrm{mL}$ , and use this solution as the standard solution. Perform the test as directed under the Assay of Flomoxef Sodium.  

Potency $\mathrm{(\upmug)}$ of flomoxef $\left(\mathrm{C_{15}H_{18}F_{2}N_{6}O_{7}S_{2}}\right)$ $=$ Potency $\mathrm{(\upmug)}$ of flomoxef triethylammonium RS $\mathrm{RS}{\times}\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —$\cdot m$ -cresol solution (3 in 1000).  

# Flubendazole 플루벤다졸  

![](images/58e0085fc11129d801fc693ac6dc5e2b1d6c3370640f7b2c75ebdd7e4bc32dd8.jpg)  

Flubendazole $\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}\mathrm{O}_{3}$ : 313.28   
Methyl $N_{}$ -[6-(4-fluorobenzoyl)- $\cdot1H$ -benzimidazol-2-   
yl]carbamate [ 31430-15-6 ]  
Flubendazole contains NLT $99.0\%$ and NMT $101.0\%$ of flubendazole $({\bf C}_{16}{\bf H}_{12}{\bf F}{\bf N}_{3}{\bf O}_{3})$ ), calculated on the dried basis. Description Flubendazole occurs as a white powder. It is practically insoluble in water, dichloromethane or ethanol(95).   
It shows crystalline polymorphism.  

Identification Determine the infrared spectra of Flubendazole and flubendazole RS as directed in the potassium bromide disk method under Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Purity Related substances —Dissolve $0.10\ \mathrm{~g~}$ of Flubendazole in $N,N.$ -dimethylformamide to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. To 1.0 mL of the test solution, add $N,N\!.$ -dimethylformamide to make exactly $100~\mathrm{mL}$ . To $5.0~\mathrm{mL}$ of this solution, add $N,N.$ -dimethylformamide to make exactly $20~\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. The area of peaks of the related substances, each of which the relative retention time to flubendazole is between 1.2 and 1.3, is not greater than the major peak area from the standard solution $(0.25\%)$ , and the total area of peaks other than the major peak from the test solution is not greater than 6 times the major peak area from the standard solution $(1.5\%)$ . However, exclude any peak having an area smaller than 0.2 times the major peak area obtained from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $250\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $10~\mathrm{cm}$ in length, packed with base-deactivated octadecylsilanized silica gel for liquid chromatography ( $3\;{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of about $40\ ^{\circ}\mathrm{C}$ .  

Mobile phase: Control the mixing ratio of mobile phase A and mobile phase B stepwise or via the gradient elution as follows.  

Mobile phase A: Dissolve $7.5\,\mathrm{~g~}$ of ammonium acetate in water to make $1000\;\mathrm{mL}$ .  
Mobile phase B: Acetonitrile  

![](images/ef8af0011bcb6480eba90e78790caab09e590cb81bd31de4b02a02e1d904da2f.jpg)  

Flow rate: 1.2 mL/min  

Loss on drying NMT $0.5\%$ (1 g, $105\;^{\circ}\!C$ , 4 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~}~g~})$  

Assay Weigh accurately about $0.25\mathrm{~g~}$ of Flubendazole, dissolve in $3\ \mathrm{mL}$ of formic acid, add $50~\mathrm{mL}$ of a mixture of 2-butanone and acetic acid(100) $(7:1)$ , and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid $=31.330\;\mathrm{mg}$ of $\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}\mathrm{O}_{3}$  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Flubendazole Suspension 플루벤다졸현탁액  

Flubendazole Suspension contains NLT $90.0\%$ and NMT $105.0\%$ of the labeled amount of flubendazole $(\mathrm{C_{16}H_{12}F N_{3}O_{3}:313.28}$ ).  

Method of preparation Prepare as directed under Suspensions, with Flubendazole.  

Identification (1) Shake Flubendazole Suspension well to mix, take an amount of Flubendazole Suspension, equivalent to $25~\mathrm{mg}$ of flubendazole. Add it to $10~\mathrm{mL}$ of formic acid, shake well to mix, and add isopropanol to make $25~\mathrm{mL}$ . Filter and use the filtrate as the test solution. Separately, weigh $25~\mathrm{mg}$ of flubendazole RS, dissolve in $10~\mathrm{mL}$ of formic acid, add isopropanol to make $25\,\mathrm{\mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescence indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform, methanol and ammonia water(28) $(45:4:1)$ as the developing solvent to a distance of about $15\ \mathrm{cm}$ , and air-dry the plate. Expose the plate under ultraviolet light (main wavelength: $254~\mathrm{nm})$ ) or spray Dragendorff's TS onto the plate; the $R_{f}$ values and colors of the spots from the test solution and the standard solution are the same.  

(2) Determine the absorption spectra of the test solution and the standard solution as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelength.  

pH Between 4.5 and 6.5.  

Assay Shake Flubendazole Suspension well to mix, and pipet an amount of Flubendazole Suspension, equivalent to $50~\mathrm{{mg}}$ of flubendazole $(\mathbf{C}_{16}\mathrm{H}_{12}\mathrm{F}\mathbf{N}_{3}\mathbf{O}_{3})$ . Add it to 10 mL of formic acid, shake well to mix, add isopropanol to make exactly $100~\mathrm{mL}$ , and filter. Discard the first $10~\mathrm{mL}$ of the filtrate, pipet $10~\mathrm{mL}$ of the subsequent filtrate, add isopropanol to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of flubendazole RS, dissolve in $10~\mathrm{mL}$ of formic acid, and add isopropanol to make exactly 100 mL. Pipet $2~\mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution at the wavelength of $310\;\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy, using isopropanol as a control solution.  

Amount (mg) of flubendazole $({\bf C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}{\bf O}_{3})$ )$=$ Amount (mg) of flubendazole $\mathrm{RS}\times(A_{\mathrm{T}}\,/\,A_{\mathrm{S}})$  

Packaging and storage Preserve in tight containers.  

# Flubendazole Tablets 플루벤다졸정  

Flubendazole Tablets contain NMT $95.0\%$ and NLT $105.0\%$ of the labeled amount of flubendazole $(\mathrm{C_{16}H_{12}F N_{3}O_{3}:313.28})$ .  

Method of preparation Prepare as directed under Tablets, with Flubendazole.  

Identification (1) Weigh an amount of Flubendazole Tablets, equivalent to $20~\mathrm{mg}$ of flubendazole according to the labeled amount, dissolve with $2~\mathrm{mL}$ of formic acid, and add chloroform to make $25~\mathrm{mL}$ . Filter this solution, and use the filtrate as the test solution. Separately, weigh $20~\mathrm{mg}$ of flubendazole RS, dissolve with $2~\mathrm{mL}$ of formic acid, add chloroform to make $25~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate in a mixture of chloroform, methanol and formic acid $(18:1:1)$ to a distance of about $15~\mathrm{cm}$ and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots from the test solution and the standard solution are the same in $R_{\mathrm{f}}$ value.  

(2) Perform the test as directed under the Assay; the test solution shows the maximum absorbance at the same wavelength as the standard solution.  

Disintegration Meets the requirements.  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of NLT 20 tablets of Flubendazole Tablets, and powder them. Weigh accurately an amount of the powder equivalent to about $0.1\ \mathrm{g}$ of flubendazole $(\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{F}\mathrm{N}_{3}\mathrm{O}_{3})$ , add $10~\mathrm{mL}$ of formic acid, dissolve by warming on a steam bath for 15 minutes, and add isopropanol to make exactly $100~\mathrm{mL}$ . Filter this solution, take exactly $1~\mathrm{mL}$ of the filtrate, add isopropanol to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $0.1\,\mathrm{~g~}$ of flubendazole RS, proceed in the same manner with the test solution, and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution at the wavelength of $311\,\mathrm{\nm}$ as directed under the Ultraviolet-visible Spectroscopy, using $10\%$ formic acid-isopropanol as a control solution.  

Amount $(\mathrm{mg})$ ) of flubendazole $\small(\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{F}\mathrm{N}_{3}\mathrm{O}_{3})$ $=$ Amount (mg) of flubendazole $\mathrm{RS}\times(A_{\mathrm{T}}\,/\,A_{\mathrm{S}})$  

Packaging and storage Preserve in well-closed containers.  

# Fluconazole Capsules 플루코나졸캡슐  

azole RS in $5\;\mathrm{mL}$ of methanol and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescence indicator for thin-layer chromatography. Develop the plate with a mixture of dichloromethane, methanol and ammonia $(80:20:1)$ as the developing solvent, and air-dry the plate. Next, develop the plate with a mixture of ethyl acetate, isopropanol and ammonia $(72:28:1)$ as the developing solvent, and airdry the plate. Spray evenly hexachloroplatinic(IV) acidpotassium iodide TS on the plate and examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the $R_{f}$ values of the spots obtained from the test solution and the standard solution are the same.  

# Uniformity of dosage units Meets the requirements.  

Fluconazole Capsules contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of fluconazole $\left(\mathrm{C}_{13}\mathrm{H}_{12}\mathrm{F}_{2}\mathrm{N}_{6};\,306.27\right)$ ).  

Dissolution Perform the test with 1 capsule of Fluconazole Capsules at 100 revolutions per minute according to Method 2 under the Dissolution, using $500\,\mathrm{\mL}$ of 0.1 $\mathrm{mol/L}$ hydrochloric acid with a sinker. Take $20\;\mathrm{mL}$ of the dissolved solution after 30 minutes from starting the test and filter. Discard the first $1~\mathrm{mL}$ of the filtrate and use the subsequent filtrate as the test solution. Separately, weigh accurately about $40~\mathrm{mg}$ of fluconazole RS, transfer to a $250{\-}{\bmod{L}}$ volumetric flask, add $0.1\,\mathrm{\mol/L}$ hydrochloric acid to make $250~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ , of the test solution and the standard solution, respectively, at the wavelength of $261~\mathrm{nm}$ as directed under the Ultraviolet-visible Spectroscopy. Meets the requirements if the dissolution rate of Fluconazole Capsules in 30 minutes is NLT $80\%$ .  

Method of preparation Prepare as directed under Capsules, with Fluconazole.  

Dissolution rate $(\%)$ with respect to the labeled amount of fluconazole $\left(\mathbf{C}_{13}\mathbf{H}_{12}\mathbf{F}_{2}\mathbf{N}_{6}\right)$  

Identification Weigh an amount of contents equivalent to about $50~\mathrm{mg}$ of fluconazole according to the labeled amount of Fluconazole Capsules, dissolve in $5\,\textrm{m L}$ of methanol, centrifuge, and use the clear supernatant as the test solution. Separately, dissolve about $50~\mathrm{mg}$ of flucon  

$$
=W_{\mathrm{S}}\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\times{\frac{1}{\mathrm{C}}}\times200
$$  

Ws: Amount (mg) of fluconazole RS   
$C$ :Labeled amount (mg) of fluconazole   
$\left({\bf C}_{13}{\bf H}_{12}{\bf F}_{2}{\bf N}_{6}\right)$ in 1 capsule  

Assay Weigh accurately the mass of NLT 20 capsules of Fluconazole Capsules. Weigh accurately an amount equivalent to about $50~\mathrm{mg}$ of fluconazole $\left(\mathbf{C}_{13}\mathbf{H}_{12}\mathbf{F}_{2}\mathbf{N}_{6}\right)$ and add the mobile phase to make $100\;\mathrm{mL}$ . Take $10.0\;\mathrm{mL}$ of the filtrate, add the mobile phase to make $100\;\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of fluconazole RS and dissolve in the mobile phase to make $100~\mathrm{mL}$ . To $10.0\ \mathrm{mL}$ of this solution, add the mobile phase to make exactly $100~\mathrm{mL}$ ,and use this solution as the standard solution. Perform the test with $50~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fluconazole in each solution.  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $210\;\mathrm{nm}$ ).   
Column: A stainless-steel column about $4\,\textrm{m m}$ in internal diameter and about $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).   
Mobile phase: A mixture of water and methanol $(75:25)$ .  
Flow rate: 2 mL/min  

Packaging and storage Preserve in well-closed containers.  

![](images/e203109899c457942fe3a30e4e7d8219d81dd37352f94b704f627de92787cccf.jpg)  

Flucytosine $\mathrm{C_{4}H_{4}F N_{3}O}$ : 129.09 6-Amino-5-fluoropyrimidin$\mathcal{I}(1H)$ -one [ 2022-85-7 ]Flucytosine, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of flucytosine $\left({\bf C}_{4}\mathrm{H}_{4}\mathrm{FN}_{3}{\bf O}\right)$ . It also contains NLT $14.0\%$ and NMT $15.5\%$ of fluorine (F: 19.00).  

Description Flucytosine occurs as a white or almost white, crystalline powder and is odorless.   
It is sparingly soluble in water, slightly soluble in methanol, acetic acid(100), acetic anhydride or ethanol(95), and practically insoluble in ether.   
It dissolves in $0.1\;\mathrm{mol/L}$ hydrochloric acid TS.   
Dissolve $1.0~\mathrm{g}$ of Flucytosine in $100~\mathrm{mL}$ of water; the pH of the solution is between 5.5 and 7.5.   
It is slightly hygroscopic.  

Melting point —About $295\ {}^{\circ}\mathrm{C}$ (with decomposition). Identification (1) To $5~\mathrm{mL}$ of aqueous solution of Flucytosine (1 in 500), add $0.2~\mathrm{mL}$ of bromine TS; a yellowish brown color of the test solution immediately disappears. Further add $2~\mathrm{mL}$ of barium hydroxide TS; a violet precipitate is formed.  

(2) Weigh about $0.1\,\mathrm{~g~}$ of Flucytosine as directed under the Oxygen Flask Combustion, using a mixture of $0.5\ \mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as the absorbent; the resulting test solution responds to the Qualitative Analysis (2) for fluoride.  

(3) Determine the absorption spectra of solutions of Flucytosine and flucytosine RS in $0.1\ \mathrm{mol/L}$ hydrochloric acid TS (1 in 125000) as directed under the Ultravioletvisible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

Purity (1) Clarity and color of solution —Dissolve $1.0~\mathrm{g}$ of Flucytosine in $100~\mathrm{mL}$ of water; the solution is clear and colorless.  

(2) Chloride —To $1.0~\mathrm{g}$ of Flucytosine, add $80~\mathrm{mL}$ of water, and dissolve by heating on a steam bath. After cooling, take $40~\mathrm{mL}$ of this solution, add $6~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $0.20\,\mathrm{\mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid $(\mathrm{NMT}\,0.014\%)$ .  

(3) Fluoride —Weigh about $0.10\,\mathrm{~g~}$ of Flucytosine and dissolve in $10.0\ \mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ diluted sodium hydroxide TS (1 in 20). To $5.0~\mathrm{mL}$ of this solution, add 10 mL of a mixture of alizarin complexone TS, acetic acidpotassium acetate buffer solution $\left(\mathrm{pH}\ 4.3\right)$ and ceri$\mathrm{{um}(I I I)}$ nitrate TS $(1:1:1)$ , add water again to make exactly $20\,\mathrm{\mL}$ , allow to stand for 1 hour, and use this solution as the test solution. Separately, add $5.0\ \mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ diluted sodium hydroxide TS (1 in 20) to 4.0 mL of standard fluorine solution, add $10\;\mathrm{mL}$ of a mixture of alizarin complexone TS, acetic acid-potassium acetate buffer solution $(\mathrm{pH}\,4.3)$ and cerium(III) nitrate TS ( $\lfloor1:1:$ 1), and proceed in the same manner as the test solution. Use this solution as the standard solution. Perform the test with these solutions as directed under the Ultravioletvisible Spectroscopy using a solution obtained by proceeding with $5.0~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ diluted sodium hydroxide TS (1 in 20) in the same manner as the blank; the absorbance of the test solution at $600\ \mathrm{nm}$ is not greater than that of the standard solution (NMT $0.048\%$ ).  

(4) Heavy metals —Weigh about $1.0~\mathrm{g}$ of Flucytosine according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(5) Arsenic —Weigh about $1.0~\mathrm{g}$ of Flucytosine according to Method 2 and perform the test (NMT 2 ppm). (6) Related substances —Dissolve $50.0~\mathrm{mg}$ of Flucytosine in $5~\mathrm{mL}$ of methanol solution (1 in 2) and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution and add methanol solution (1 in 2) to make exactly $25\,\mathrm{\mL}$ . Pipet $1\,\textrm{m L}$ of this solution and add methanol solution (1 in 2) to make exactly $20\;\mathrm{mL}$ . Use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $20~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of ethyl acetate, methanol and water $(5:3:2)$ as the developing solvent to a distance of about $12~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); spots other than the principal spot obtained from the test solution is not more intense than the spots obtained from the standard solution.  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay (1) Flucytosine —Weigh accurately about $0.2~\mathrm{g}$ of Flucytosine, previously dried, dissolve in $40\;\mathrm{mL}$ of acetic acid(100) and $100\,\mathrm{\mL}$ of acetic anhydride, and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid $=12.909\;\mathrm{mg}$ of $\mathrm{C}_{4}\mathrm{H}_{4}\,\mathrm{FN}_{3}\mathrm{O}$  

(2) Fluorine —Weigh accurately about $10\,\mathrm{~mg~}$ of Flucytosine, previously dried, and perform the test as directed under the Assay of fluorine under the Oxygen Flask Combustion, using a mixture of $0.5\,\mathrm{\mL}$ of 0.01 mol/L sodium hydroxide TS and $20~\mathrm{mL}$ of water as the absorbent.  

Packaging and storage Preserve in light-resistant, tight containers.  

![](images/bf544e75d49d33d302ba231b487b9e303056595b497d08b595e76180cf07e20c.jpg)  

200000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths. Further, determine the absorption spectra of solutions of Fludiazepam and fludiazepam RS in methanol (1 in 20000); both spectra exhibit similar intensities of absorption at the same wavelengths. (3) Determine the infrared spectra of Fludiazepam and fludiazepam RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(4) Perform the test with Fludiazepam as directed under the Flame Coloration (2); it exhibits a green color. It is very soluble in chloroform, freely soluble in methanol, ethanol, acetic acid(100) or ether, and practically insoluble in water.  

Identification (1) Proceed with $10~\mathrm{mg}$ of Fludiazepam as directed under the Oxygen Flask Combustion, using a mixture of $0.5\ \mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as the absorbent; the resulting test solution responds to the Qualitative Analysis (2) for fluoDescription Fludiazepam occurs as white to pale yellow crystals or crystalline powder.  

(2) Determine the absorption spectra of solutions of Fludiazepam and fludiazepam RS in methanol (1 in Fludiazepam $\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{ClN}_{2}\mathrm{O}$ : 302.73 7-Chloro-5-(2-fluorophenyl)-1-methyl$1H\cdot$ -benzo[e][1,4]diazepin-2(3H)-one [ 3900-31-0 ]Fludiazepam, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of fludiazepam $\left({\bf C}_{16}\mathrm{H}_{12}{\bf C}\mathrm{lN}_{2}{\bf O}\right)$ .  

# Melting point Between 91 and $94\,^{\circ}\!C$  

Purity (1) Chloride —Dissolve $1.0~\mathrm{g}$ of Fludiazepam in $50~\mathrm{mL}$ of ether, add $50~\mathrm{mL}$ of water, shake to mix, and collect the water layer. Wash the water layer twice each time with $20\;\mathrm{mL}$ of ether and filter the water layer. To 20 mL of the filtrate, add $6\;\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $0.40~\mathrm{\mL}$ of $0.01\;\mathrm{\mol/L}$ hydrochloric acid TS (NMT $0.036\%$ ).  

(2) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Fludiazepam according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 10 ppm).  

(3) Related substances —Dissolve $0.10\mathrm{~g~}$ of Fludiazepam in $20~\mathrm{mL}$ of chloroform and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution and add chloroform to make exactly $50~\mathrm{mL}$ . Pipet $2~\mathrm{mL}$ of this solution, add chloroform to make exactly $20~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $20~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of chloroform and ethyl acetate $(10:7)$ as the developing solvent to a distance of about $12\ \mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.3\%$ ($^{\mathrm{~1~g~}}$ , in vacuum, $60~^{\circ}\mathrm{C}$ , 3 hours).  

Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ , platinum crucible). Assay Weigh accurately about $0.5\,\mathrm{~g~}$ of Fludiazepam, previously dried, dissolve in $50~\mathrm{mL}$ of acetic acid(100), and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction. Each mL of $0.1\;\mathrm{mol/L}$ perchloric acid  

# Fludrocortisone Acetate 플루드로코르티손아세테이트  

![](images/c0c066ab7dbe6e06a0fe5bbfd935c168fab1f11721ceb125055a51f2d847fc68.jpg)  

Fludrocortisone Acetate $_{\mathrm{C}_{23}\mathrm{H}_{31}\mathrm{FO}_{6}}$ : 422.49 2-((8 S,9 R,10 S,11 S,13 S,14 S,17 R)-9-fluoro-11,17-   
dihydroxy-10,13-dimethyl-3-oxo  
2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro$1H\cdot$ -cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate [514-36-3 ]  
Fludrocortisone Acetate contains NLT $97.0\%$ and NMT $103.0\%$ of fludrocortisone acetate ( $\left({\bf C}_{23}\mathrm{H}_{31}\mathrm{FO}_{6}\right)$ ,calculated on the dried basis. Description Fludrocortisone Acetate occurs as white to pale yellow crystals or a crystalline powder, which has no odor or slight odor.   
It is hygroscopic.   
It is sparingly soluble in ethanol(95) or chloroform, slightly soluble in ether, and practically insoluble in water.  

Identification Determine the infrared spectra of Fludrocortisone Acetate and fludrocortisone acetate RS as directed in the paste method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+131^{\circ}$ and $+138^{\circ}$ (after drying, $0.1~\mathrm{g}$ , acetone, $20\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity (1) Heavy metals —Proceed with $0.5~\mathrm{g}$ of Fludrocortisone Acetate according to Method 2 and perform the test. Prepare the control solution with $1.5\,\mathrm{\mL}$ of lead standard solution (NMT $30\,\mathrm{ppm})$ ).  

(2) Related substances —Weigh accurately about 20 mg of Fludrocortisone Acetate, dissolve exactly in $10\;\mathrm{mL}$ of the mobile phase, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add the mobile phase to it make exactly $50\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine the peak area of each solution according to the automatic integration method; the total area of peaks other than fludrocortisone acetate from the test solution is not greater than 1/4 the peak area of fludrocortisone acetate from the standard solution. The total area of the peaks other than fludrocortisone acetate from the test solution is not greater than $1/\textit{2}$ the peak area of fludrocortisone acetate from the standard solution.  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4.6\mathrm{mm}$ in internal diameter and $20~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5~{\upmu\mathrm{m}}$ in particle diameter).   
Column temperature: A constant temperature of about $25\ ^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of water and tetrahydrofuran $(13:7)$ .  
Flow rate: Adjust the flow rate so that the retention time of fludrocortisone acetate is about 10 minutes.  

# System suitability  

Test for required detectability: Pipet $5~\mathrm{mL}$ of the standard solution, and add the mobile phase to make exactly $100~\mathrm{mL}$ . Confirm that the peak area of fludrocortisone acetate obtained from $20\,\textrm{\textmu L}$ of this solution is equivalent to $4.0\%$ to $6.0\%$ of the peak area of fludrocortisone acetate obtained from the standard solution.  

System performance: Dissolve $2~\mathrm{~mg~}$ each of Fludrocortisone Acetate and hydrocortisone acetate in the mobile phase to make $50~\mathrm{mL}$ . Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above conditions; hydrocortisone acetate and fludrocortisone acetate are eluted in this order with the resolution being NLT 1.5.  

System repeatability: Repeat the test 6 times with $20\,\mathrm{\,\,\upmuL}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area of fludrocortisone acetate is NMT $2.0\%$ .  

Time span of measurement: About 2 times the retention time of fludrocortisone beginning after the solvent peak  

Loss on drying NMT $1.0\%$ ($1{\mathrm{~g~}}$ ,$100~^{\circ}\mathrm{C}$ , in vacuum, 2 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay Weigh accurately about $25~\mathrm{mg}$ each of Fludrocortisone Acetate and fludrocortisone acetate RS, previously dried in vacuum for 2 hours at $100\,^{\circ}\mathrm{C}$ , dissolve in chloroform to make exactly $250~\mathrm{mL}$ , pipet $10~\mathrm{mL}$ of the resulting solutions, and add chloroform to make exactly 50 mL. Use these solutions as the test solution and the standard solution. Pipet $10~\mathrm{mL}$ each of the test solution and the standard solution, put them in the $25~\mathrm{mL}$ volumetric flasks, respectively, add $1.0~\mathrm{mL}$ of a solution obtained by dissolving $50~\mathrm{mg}$ of blue tetrazolium in $10~\mathrm{mL}$ of methanol, and shake to mix. Mix with $1.0\,\mathrm{\mL}$ of a mixture of tetramethylammonium hydroxide TS and methanol $(1:4)$ , allow to stand for 10 minutes, then add a solution of hydrochloric acid in methanol (1 in 100) to make exactly $25~\mathrm{mL}$ . With these solutions, perform the test as directed under the Ultraviolet-visible Spectroscopy and determine the absorbances, $A_{\mathrm{T}}$ and $A_{\mathrm{{S}}}$ , at the absorbance maximum wavelength of around $525\,\textrm{n m}$ , using a solution prepared with $10~\mathrm{mL}$ of chloroform in the same manner as the control solution.  

Amount (mg) of Fludrocortisone Acetate $(\mathbf{C}_{23}\mathbf{H}_{31}\mathbf{F}\mathbf{O}_{6})$ $=$ Amount (mg) of fludrocortisone acetate $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$ Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Flufenamic Acid Capsules 플루페남산캡슐  

Flufenamic Acid Capsules contain NLT $95.0\%$ and NMT $105.0\%$ of the labeled amount of flufenamic acid $(\mathbf{C}_{14}\mathrm{H}_{10}\mathbf{F}_{3}\mathbf{NO}_{2}:281.23)$ ).  

Method of preparation Prepare as directed under Capsules, with Flufenamic Acid.  

Identification Weigh a portion of Flufenamic Acid Capsules, equivalent to $0.3\;\mathrm{g}$ of flufenamic acid, extract twice with $30\;\mathrm{mL}$ each of ether, combine the ether extracts, and wash with $10~\mathrm{mL}$ of water. Evaporate the ether extracts on a steam bath to dryness, dry the residue at $105\ ^{\circ}\mathrm{C}$ , and perform the following test.  

(1) Dissolve $20~\mathrm{mg}$ of the residue in $15~\mathrm{mL}$ of chloroform, and examine under ultraviolet light; it exhibits strong bluish white fluorescence.  

(2) Transfer 0.5 mL of chromic acidsulfuric acid TS to a small test tube, heat on a steam bath for 5 minutes; the side of the test tube is moistened transparently without stickiness. Add 1 to $2~\mathrm{mg}$ of the residue, heat on a steam bath for 5 minutes; the side of the test tube is not moistened and the solution does not flow easily.  

(3) With a solution prepared by dissolving $5.0~\mathrm{mg}$ of the residue in $500~\mathrm{mL}$ of a solution of hydrochloric acid in methanol (3.7 in 1000), determine the absorption spectrum as directed under the Ultraviolet-visible Spectroscopy; it exhibits a maximum at wavelengths around $287~\mathrm{nm}$ and $344\;\mathrm{nm}$ .  

Purity Related substances— Use a solution of the residue in $5\%$ ethanol obtained from the Identification as the test solution, and prepare $0.01\%$ ethanol solution and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography, develop the plate with a mixture of toluene, tetrahydrofuran and acetic acid(100) (90 : $25:1)$ as the developing solvent to a distance of about 15 cm, and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\ \mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spot from the standard solution. Disintegration Meets the requirements. Uniformity of dosage units Meets the requirements. Assay Weigh accurately the mass of the contents of NLT 20 capsules of Flufenamic Acid Capsules. Weigh accurately about $0.6~\mathrm{g}$ of flufenamic acid $\left({\bf C}_{14}\mathrm{H}_{10}\mathrm{F}_{3}\mathrm{NO}_{2}\right)$ ), dissolve in $100~\mathrm{mL}$ of ethanol(99.5), previously neutralized with a solution of chromium trioxide in saturated sulfuric acid solution, and titrate with $0.1\mod/\mathrm{L}$ sodium hydroxide VS (indicator: phenol red TS). Perform a blank test in the same manner and make any necessary correction.  

Packaging and storage Preserve in tight containers. Flumequine $\mathrm{C}_{14}\mathrm{H}_{12}\mathrm{F}\mathrm{NO}_{3}$ : 261.25 (RS )-9-Fluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid [ 42835- 25-6 ]  

![](images/72e66ec15eaa7542a6fc2d906bdc902f2dc9c1504b8bf65fded20fd696ece2a6.jpg)  

Flumequine contains NLT $99.0\%$ and NMT $101.0\%$ of flumequine $\left({\bf C}_{14}\mathrm{H}_{12}\mathrm{FNO}_{3}\right)$ , calculated on the dried basis.  

Description Flumequine occurs as a white fine crystalline powder.  

It is sparingly soluble in dichloromethane, very slightly soluble in methanol and practically insoluble in water. It soluble in dilute sodium hydroxide TS.  

Identification (1) Mix 5 mg of Flumequine with $45~\mathrm{mg}$ of magnesium oxide, and incinerate for about 5 minutes until a white residue is obtained. After cooling, add $1~\mathrm{mL}$ of water and 2 drops of phenolphthalein TS to make it colorless, add about $2\,\textrm{m L}$ of dilute hydrochloric acid, filter, and use this solution as the test solution. Mix the test solution with $0.1~\mathrm{mL}$ of alizarin S TS and $0.1~\mathrm{mL}$ of zirconium nitrate solution, allow to stand for 5 minutes, and compare with the blank test solution proceeded in the same manner as the test solution; the test solution turns red to yellow while the blank test solution remains red. (2) Determine the infrared spectra of Flumequine and flumequine RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Dissolve $5~\mathrm{~mg}$ of Flumequine in dichloromethane to make $10~\mathrm{mL}$ , and use this solution as the test solution. Separately, dissolve $5~\mathrm{mg}$ of flumequine RS in dichloromethane to make $10\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography (with fluorescence agent). Develop the plate with a mixture of ethanol(95), water and $9~\mathrm{mol/L}$ ammonia water $(90:10:10)$ as the developing solvent to a distance of about $15~\mathrm{cm}$ , and airdry the plate. Examine the plate under ultraviolet light (main wavelength: $254\mathrm{nm})$ ); the $R_{f}$ values of the principal spots obtained from the test solution and the standard solution are the same.  

Zirconium nitrate solution —Dissolve $0.1~\mathrm{~mg~}$ of zirconium nitrate in a mixture of $60~\mathrm{mL}$ of hydrochloric acid and $40\;\mathrm{mL}$ of water.  

9 mol/L ammonia water —Add water to $67~\mathrm{g}$ of 13.5 $\mathrm{mol/L}$ ammonia water to make $100\;\mathrm{mL}$ .  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-0.10^{\circ}$ and $+0.10^{\circ}$ (5.0 $\mathrm{g},0.5\,\mathrm{mol/L}$ sodium hydroxide TS, $50\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity (1) Clarity and color of solution —Dissolve $5.0\;\mathrm{g}$ of Flumequine in $0.5\,\mathrm{\mol/L}$ sodium hydroxide TS to make $50\,\mathrm{mL}$ ; the solution is clear.  

(2) Heavy metals —Proceed with $2.0\ \mathrm{~g~}$ of Flumequine according to Method 2 and perform the test. Prepare the control solution with $2.0~\mathrm{mL}$ of lead standard solution (NMT $10\,\mathrm{ppm}$ ).  

(3) Related substances —Dissolve $35.0\ \mathrm{~mg~}$ of Flumequine in $N,N\!.$ -dimethylformamide to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, dissolve $5.0~\mathrm{mg}$ of flumequine RS and $5.0~\mathrm{mg}$ of flumequine related substance I RS [( RS )-9-fluoro-5- methyl-1-oxo-6,7-dihydro$I H{,}5H\cdot$ -benzo[i.j]qunolizine-2- carboxylate (flumequine ethyl ester)] in N,N -dimethylformamide to make exactly $100\,\mathrm{\mL}$ . Use this solution as the standard solution (1). To $1.0\ \mathrm{mL}$ of the test solution, add $N,N\!.$ -dimethylformamide to make exactly $200~\mathrm{mL}$ , and use this solution as the standard solution (2). Perform the test with $10~\upmu\mathrm{L}$ each of the blank test solution (dimethylformamide), the test solution, the standard solution (1) and the standard solution (2) as directed under the Liquid Chromatography according to the following conditions. The area of peaks other than the major peak obtained from the test solution is not greater than the major peak area from the standard solution (2) $(0.5\%)$ and the total area of peaks other than the major peak obtained from the test solution is not more than twice the major peak area from the standard solution (2) $(1.0\%)$ . However, exclude the peaks obtained from $N,N_{\mathrm{-}}$ dimethylformamide and any peak with an area less than 0.1 times the major peak area from the standard solution (2).  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $250\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $15~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (5 $\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of potassium dihydrogen phosphate buffer solution and methanol $(51:49)$ .  

Flow rate: $0.8\;\mathrm{mL/min}$ System suitability  

System performance: Proceed with the standard solution (1) according to the above conditions; the retention times of flumequine related substance I and flumequine are about 11 minutes and 13 minutes, respectively, with the resolution between the peaks of flumequine and flumequine related substance I being NLT 2.0.  

Potassium dihydrogen phosphate buffer solution —Dissolve $1.36\,\mathrm{~g~}$ of potassium dihydrogen phosphate in water to make $1000\,\mathrm{mL}$ .  

Loss on drying NMT $0.5\%$ $\mathrm{~1~g,~}105\ ^{\circ}\mathrm{C,}$ , 3 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{0.5~g}$ , platinum crucible).  

Assay Weigh accurately about $0.5~\mathrm{g}$ of Flumequine, dissolve in $50\,\mathrm{\mL}$ of $N{,}N$ -dimethylformamide, and titrate with $0.1\ \mathrm{mol/L}$ tetramethylammonium hydroxide VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\;\mathrm{mol/L}$ tetrabutylammonium hydroxide $=26.126\ \mathrm{mg}$ of $\mathrm{C}_{14}\mathrm{H}_{12}\mathrm{F}\mathrm{NO}_{3}$  

Packaging and storage Preserve in well-closed containers.  

Flunarizine Dihydrochloride 플루나리진염산염  

![](images/ea0bab4b584975dc84c6b091634b077a0da3fc5eca807e538a90bdb513c68d66.jpg)  

Flunarizine Dihydrochloride  

$\mathrm{C}_{26}\mathrm{H}_{26}\mathrm{F}_{2}\mathrm{N}_{2}.$ ·2HCl: 477.42 1-[Bis(4-fluorophenyl)methyl]-4-[ $(2E)$ -3-phenylprop-2- enyl]piperazine dihydrochloride, [30484-77-6 ]  

Flunarizine Dihydrochloride, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of flunarizine dihydrochloride $\left(\mathrm{C}_{26}\mathrm{H}_{26}\mathrm{F}_{2}\mathrm{N}_{2}{\cdot}2\mathrm{HCl}\right)$ and NLT $7.2\%$ and NMT $8.8\%$ of fluorine (F: 19.00).  

Description Flunarizine Dihydrochloride occurs as a white to pale yellowish white powder.  

It is soluble in ethanol(95), sparingly soluble in methanol, acetic acid(100) or chloroform, slightly soluble in water or acetic anhydride, and practically insoluble in ether.  

Melting point —About $209\ ^{\circ}\mathrm{C}$ .Identification (1) Weigh $15~\mathrm{mg}$ of Flunarizine Dihydrochloride, and prepare the test solution as directed under the Oxygen Flask Combustion using $20~\mathrm{mL}$ of water as the absorbent. The resulting test solution responds to the Qualitative Analysis for fluoride.  

(2) Dissolve $10~\mathrm{mg}$ of Flunarizine Dihydrochloride in $10~\mathrm{mL}$ of water, add dilute nitric acid, shake to mix, allow to stand for 5 minutes, and filter. The filtrate responds to the Qualitative Analysis for chloride.  

(3) Dissolve $3~\mathrm{mg}$ of Flunarizine Dihydrochloride in $3\,\mathrm{\mL}$ of citric acid-acetic acid TS, and heat for 10 minutes on a steam bath; the resulting solutions exhibits a reddish purple color.  

(4) Determine the absorption spectrum as directed under the Ultraviolet-visible Spectroscopy using a solution of Flunarizine Dihydrochloride in methanol (1 in 100000); it exhibits a maximum between $252\;\mathrm{nm}$ and 256 nm.  

Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Flunarizine Dihydrochloride according to Method 2 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT 20 ppm).  

(2) Related substances —Weigh $0.4~\mathrm{g}$ of Flunarizine Dihydrochloride, dissolve in methanol to make exactly 10 mL, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution and add methanol to make exactly $50\;\mathrm{mL}$ .Pipet $5\,\textrm{m L}$ of this resulting solution, add methanol to make exactly $50\;\mathrm{mL}$ , and use this solution as the standard solution. Perform the test with these solutions as directed under the Thin Layer Chromatography. Spot $5\,\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of tetrahydrofuran, water, methanol and ammonia water(28) $(40:30:30:1)$ ) as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot obtained from the test solution are not more intense than the spot from the standard solution.  

Loss on drying NMT $0.5\%$ ($\textbf{l g}$ , in vacuum, phosphorus pentoxide, $60\,^{\circ}\mathrm{C}$ , 3 hours).  

Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ , platinum crucible). Assay (1) Flunarizine dihydrochloride —Weigh accurately about $0.25\mathrm{~g~}$ of Flunarizine Dihydrochloride, previously dried, dissolve in $20~\mathrm{mL}$ of acetic acid(100) and $50\,\mathrm{\mL}$ of acetic anhydride, and titrate with $0.1\,\mathrm{\mol/L}$ perchloric acid VS (potentiometric titration under the Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

(2) Fluorine —Weigh accurately about $4~\mathrm{\mg}$ of Flunarizine Dihydrochloride, previously dried, and perform the test as directed under the assay of fluorine under the Oxygen Flask Combustion, using $15~\mathrm{mL}$ of water as the absorbent.  

Packaging and storage Preserve in light-resistant, tight containers.  

# Flunarizine Dihydrochloride Capsules 플루나리진염산염캡슐  

Flunarizine Dihydrochloride Capsules contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of flunarizine dihydrochloride $\left({\bf C}_{26}{\bf H}_{26}{\bf F}_{2}\right.{\bf N}_{2}$ ·2HCl: 477.42).  

Method of preparation Prepare as directed under Capsules, with Flunarizine Dihydrochloride.  

Identification (1) Weigh an amount of Flunarizine Dihydrochloride Capsules, equivalent to $10~\mathrm{mg}$ of flunarizine dihydrochloride RS, according to the labeled amount. Dissolve in $10~\mathrm{mL}$ of methanol, filter, and use the filtrate as the test solution. Separately, weigh $10~\mathrm{mg}$ of flunarizine dihydrochloride RS, dissolve in $10~\mathrm{mL}$ of methanol, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel for thin-layer chromatography (with a fluorescent indicator). Next, develop the plate with a mixture of $n$ -heptane, methanol, ethyl acetate and acetic acid(100) $(7:1.5:1.5:0.1)$ (as the developing solvent) to a distance of about $15\ \mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\,\mathrm{\nm}$ ); the spots from the test solution exhibits $R_{f}$ values and color corresponding to that of the test solution.  

(2) Determine the absorption spectra of the test solution and the standard solution from the Assay as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit the same maximum absorption at the same wavelength.  

Dissolution Take 1 capsule of Flunarizine Dihydrochloride Capsules and perform the test at 100 revolutions per minute according to Method 2 under the Dissolution, using $600~\mathrm{mL}$ of the first fluid for the Disintegration as the dissolution medium. Take the dissolved solution 45 minutes after staring the test, filter, and use the filtrate as the test solution. Separately, weigh accurately about 25 mg of flunarizine dihydrochloride RS and dissolve in methanol to make exactly $50\;\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add the dissolution medium to make exactly $50~\mathrm{mL}$ ,and use this solution as the standard solution. With the test solution and the standard solution, perform the test as directed under the Ultraviolet-visible Spectroscopy using the dissolution medium as a control solution, and determine the absorbances, $\mathrm{Ar}$ and A S, at $252~\mathrm{nm}$ . Meets the requirements if the dissolution rate of Flunarizine Dihydrochloride Capsules in 45 minutes is NLT $70\%$ .  

Dissolution rate $(\%)$ of flunarizine dihydrochloride $\left(\mathbf{C}_{26}\mathrm{H}_{26}\mathrm{F}_{2}\mathrm{N}_{2}{\cdot}2\mathrm{HCl}\right)$   
$=$ Amount (mg) of flunarizine dihydrochloride RS $\times\left(A_{\mathrm{T}}\,/\,A_{\mathrm{S}}\right)\times\left(1\;/\;C\right)\times24\$  

$C$ : Labeled amount (mg) of flunarizine dihydrochloride in 1 capsule  

Uniformity of dosage units It meets the requirements when the Content uniformity test is performed according to the following procedure. Perform the test with 1 capsule of Flunarizine Dihydrochloride Capsules as directed under the Assay.  

Assay Weigh accurately the mass of the contents of NLT 20 capsules of Flunarizine Dihydrochloride Capsules. Weigh accurately about $10\,\mathrm{\mg}$ of flunarizine dihydrochloride $(\mathrm{C}_{26}\mathrm{H}_{26}\mathrm{F}_{2}\mathrm{N}_{2}\cdot2\mathrm{HCl})$ , add $10\,\mathrm{\mL}$ of $0.1\,\mathrm{\mol/L}$ hydrochloric acid TS and $40~\mathrm{mL}$ of isopropanol, and dissolve by warming on a steam bath. After cooling, add isopropanol to make exactly $100~\mathrm{mL}$ , and filter through a filter paper. Pipet $10~\mathrm{mL}$ of this solution, add $10~\mathrm{mL}$ of the $0.1\ \mathrm{mol/L}$ hydrochloric acid TS, add isopropanol to make exactly $100~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $20\,\mathrm{~mg~}$ of flunarizine dihydrochloride RS, add $20~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid TS and $40~\mathrm{mL}$ of isopropanol, and dissolve by warming on a steam bath. After cooling, add isopropanol to make exactly $100~\mathrm{mL}$ . Pipet $5~\mathrm{mL}$ of this solution and add $10~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ hydrochloric acid TS. Then, add isopropanol to make exactly $100~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $\mathrm{A_{T}}$ and $\mathrm{A}_{\mathrm{S}}$ , of the test solution and standard solution, respectively, at $252\,\textrm{n m}$ as directed under the Ultraviolet-visible Spectroscopy, using isopropanol as a control solution.  

Amount (mg) of flunarizine dihydrochloride $\left(\mathrm{C}_{26}\mathrm{H}_{26}\mathrm{F}_{2}\mathrm{N}_{2}{\cdot}2\mathrm{HCl}\right)$ $=$ Amount (mg) of flunarizine dihydrochloride RS $\times\,(A_{\mathrm{T}}\,/\,A_{\mathrm{S}})\!\times\!0.5$  

Packaging and storage Preserve in well-closed containers.  

# Flunitrazepam 플루니트라제팜  

![](images/041e7fab3bfdab1de6f7846b27798076b506b0387a71a5a21d445d82b14f6746.jpg)  

Flunitrazepam $\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{F}\mathrm{N}_{3}\mathrm{O}_{3}$ : 313.28 5-(2-Fluorophenyl)-1-methyl-7-nitro$1H\cdot$ -benzo[e][1,4]diazepin$\cdot2(3H)$ -one [ 1622-62-4 ]Flunitrazepam, when dried, contains NLT $99.0\%$ and NMT $101.0\%$ of flunitrazepam $({\bf C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}{\bf O}_{3})$ ).  

Description Flunitrazepam occurs as a white to pale yellow crystalline powder.   
It is freely soluble in acetic acid(100), soluble in acetic anhydride or acetone, slightly soluble in ethanol(99.5) or ether and practically insoluble in water.  

Identification (1) Determine the absorption spectra of solutions of Flunitrazepam and flunitrazepam RS in ethanol(99.5) (1 in 100000) as directed under the Ultravioletvisible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(2) Determine the infrared spectra of Flunitrazepam and flunitrazepam RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Melting point Between 168 and $172\ ^{\circ}\mathrm{C}$ Purity (1) Chloride —To $1.0~\mathrm{g}$ of Flunitrazepam, add 50 mL of water, allow to stand for 1 hour with occasional shaking, and filter. Take $20~\mathrm{mL}$ of the filtrate, add $6~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $0.25~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid solution (NMT $0.022\%$ ).  

(2) Heavy metals —Proceed with $2.0~\mathrm{g}$ of Flunitrazepam in a platinum crucible according to Method 4 and perform the test. Prepare the control solution with $2.0\;\mathrm{mL}$ of lead standard solution (NMT $10\,\mathrm{ppm}$ ).  

(3) Related substances— Dissolve $50.0~\mathrm{mg}$ of Flunitrazepam in $10\;\mathrm{mL}$ of acetone and use this solution as the test solution. Pipet $2~\mathrm{mL}$ of this solution and add acetone to make exactly $20~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add acetone to make exactly $25~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on a thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of 1,2- dichloroethane, ether and ammonia water(28) $200:100:$ 3) as the developing solvent to a distance of about $12\;\mathrm{cm}$ ,and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\ \mathrm{nm}$ ); the number of spots other than the principal spot from the test solution is NMT 2 and they are not more intense than the spot from the standard solution.  

Loss on drying NMT $0.5\%$ ($1\;\mathrm{g}$ ,$105\ ^{\circ}\mathrm{C}$ , 4 hours). Residue on ignition NMT $0.1\%$ ($\mathrm{~\textit~{~1~g~}~}$ , platinum crucible). Assay Weigh accurately about $0.5\mathrm{~g~}$ of Flunitrazepam, previously dried, dissolve in $20~\mathrm{mL}$ of acetic acid(100), add $50~\mathrm{mL}$ of acetic anhydride, and titrate with $0.1\ \mathrm{mol/L}$ perchloric acid VS (potentiometric titration under Titrimetry). Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ perchloric acid VS $=31.33~\mathrm{mg}$ of $\mathrm{C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}\mathrm{O}_{3}$  

Packaging and storage Preserve in light-resistant, tight containers.  

# Flunitrazepam Tablets 플루니트라제팜정  

Flunitrazepam Tablets contain NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of flunitrazepam $(\mathrm{C_{16}H_{12}F N_{3}O_{3}:313.28}$ ).  

Method of preparation Prepare as directed under Tablets, with Flunitrazepam.  

Identification Weigh an amount of Flunitrazepam Tablets, equivalent to $10~\mathrm{{mg}}$ of flunitrazepam according to the labeled amount, add $5\ \mathrm{mL}$ of chloroform, shake to mix, centrifuge, and use the clear supernatant as the test solution. Separately, dissolve $20~\mathrm{mg}$ of flunitrazepam RS in $10\,\mathrm{\mL}$ of chloroform, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Develop the plate with a mixture of ether, nitromethane, heptane and ammonia water(28) $(60:30:15:2)$ (as the developing solvent) to a distance of about $15\ \mathrm{cm}$ , and air-dry the plate. Spray evenly $2~\mathrm{mol/L}$ sodium hydroxide TS on the plate; the spots obtained from the standard solution exhibits $R_{\mathrm{f}}$ values corresponding to that of the test solution.  

Disintegration Meets the requirements.  

# Uniformity of dosage units Meets the requirements.  

Assay Weigh accurately the mass of NLT 20 tablets of Flunitrazepam Tablets, and powder. Weigh accurately an amount of the powder equivalent to about $5~\mathrm{mg}$ of flunitrazepam $(\mathbf{C}_{16}\mathrm{H}_{12}\mathrm{F}\mathbf{N}_{3}\mathbf{O}_{3})$ , add $2~\mathrm{mL}$ of water, and allow to stand for 2 minutes. Then, add $95\%$ ethanol to make $100\;\mathrm{mL}$ . Centrifuge this solution, pipet $10\;\mathrm{mL}$ of the clear supernatant, add ethanol(95) to make exactly $50~\mathrm{mL}$ , and use this solution as the test solution. Weigh accurately about $50~\mathrm{{mg}}$ of flunitrazepam RS, add $2~\mathrm{mL}$ of water, allow to stand for 2 minutes, and add ethanol(95) to make exactly $100~\mathrm{{mL}}$ . Pipet $1\ \mathrm{mL}$ of this solution, add ethanol(95) to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. Determine the absorbances, $A_{\mathrm{T}}$ and $A_{S}$ of the test solution and the standard solution, at the wavelength of $309~\mathrm{nm}$ as directed under the Ultravioletvisible Spectroscopy, using ethanol(95) as a control solution.  

Amount (mg) flunitrazepam $({\bf C}_{16}\mathrm{H}_{12}\mathrm{FN}_{3}{\bf O}_{3})$ $=$ Amount (mg) of flunitrazepam $\mathrm{RS}\times(A_{\mathrm{T}}\,/\,A_{\mathrm{S}})\times0.1$ Fluocinolone Acetonide ${\mathrm{C}_{24}}{\mathrm{H}_{30}}{\mathrm{F}_{2}}{\mathrm{O}_{6}}$ : 452.49 2-{(6 S,8 S,9 R,10 S,11 S,13 S,14 S,16 R,17 S)-6,9-difluoro-11- ihydroxy-16,17-[(2-propylidene) bis (oxy)]-10,13- dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17- dodecahydro$\cdot3H\cdot$ -cyclopenta[a] phenanthren-17-yl)}-2-  

![](images/36e88ed2e63a0592f94ca59c7322b54b08508fd857acb502867e3ad78fe0f137.jpg)  
Packaging and storage Preserve in tight containers.   
Fluocinolone Acetonide 플루오시놀론아세토니드  

oxoethanol [ 67-73-2 ]  

Fluocinolone Acetonide, when dried, contains NLT $97.0\%$ and NMT $102.0\%$ of fluocinolone acetonide $(\mathbf{C}_{24}\mathbf{H}_{30}\mathbf{F}_{2}\mathbf{O}_{6})$ ).  

Description Fluocinolone Acetonide occurs as white crystals or a crystalline powder. It is odorless.  

It is freely soluble in acetic acid(100) and acetone, soluble in ethanol(99.5), sparingly soluble in methanol or chloroform, slightly soluble in acetonitrile, very slightly soluble in ether and practically insoluble in water.  

Melting point —266 to $274\;^{\circ}\mathrm{C}$ (with decomposition). Identification (1) To $2~\mathrm{mg}$ of Fluocinolone Acetonide, and add $2~\mathrm{mL}$ of dilute nitric acid; the solution turns yellow.  

(2) Dissolve $0.01\ \mathrm{g}$ of Fluocinolone Acetonide in 1 mL of methanol, add $1~\mathrm{mL}$ of Fehling’s TS, and heat; a red precipitate is produced.  

(3) Weigh $10~\mathrm{{mg}}$ of Fluocinolone Acetonide, and prepare the test solution as directed under the Oxygen Flask Combustion with a mixture of $0.5\,\mathrm{~mL~}$ of 0.01 $\mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as an absorbent; the test solution responds to the Qualitative Analysis for fluoride.  

(4) Determine the infrared spectra of Fluocinolone Acetonide and fluocinolone acetonide RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers. If any difference appears between the spectra, dissolve Fluocinolone Acetonide and fluocinolone acetonide RS in acetone, respectively, then evaporate the acetone to dryness, and repeat the test with the residues. Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ Between $+98^{\circ}$ and $+108^{\circ}$ (after drying, $0.1~\mathrm{g}$ , methanol, $10\,\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity Related substance —Dissolve $15~\mathrm{mg}$ of Fluocinolone Acetonide in $25~\mathrm{mL}$ of the mobile phase, and use this solution as the test solution. Pipet $2~\mathrm{mL}$ of this solution, add the mobile phase to it make exactly $100~\mathrm{{mL}}$ ,and use this solution as the standard solution. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions. Determine the peak areas in each solution as directed in the automatic integration method; the total area of peaks other than the major peak from the test solution is not greater than the major peak area from the standard solution.  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about 15 to $25~\mathrm{cm}$ in length, packed with silica gel for liquid chromatography $5~{\upmu\mathrm{m}}$ in particle diameter).  

Column temperature: A constant temperature of  

about $30\ ^{\circ}\mathbf{C}$ .  

Mobile phase: A mixture of water-saturated chloroform, methanol and acetic acid(100) $(200:3:2)$ .  

Flow rate: Adjust the flow rate so that the retention time of fluocinolone acetonide is about 12 minutes.  

System suitability  

Test for required detectability: Take exactly $5~\mathrm{mL}$ of the standard solution, and add the mobile phase to make exactly $100~\mathrm{mL}$ . Confirm that the major peak area of obtained from $20~\mathrm{mL}$ of this solution is equivalent to $4\%$ to $6\%$ of that obtained from $20~\upmu\mathrm{L}$ of the standard solution.  

System performance: Dissolve $15~\mathrm{~mg}$ each of Fluocinolone Acetonide and triamcinolone acetonide in $25~\mathrm{mL}$ of the mobile phase. To $5\;\mathrm{mL}$ of this solution, add the mobile phase to make $20~\mathrm{mL}$ . Proceed with $20~\upmu\mathrm{L}$ of this solution according to the above operating conditions; triamcinolone acetonide and fluocinolone acetonide are eluted in this order with the resolution being NLT 1.9.  

System repeatability: Repeat the test 6 times with $20\,\mathrm{\,\,\upmuL}$ of the standard solution according to the above operating conditions; the relative standard deviation of the peak area ratios of fluocinolone acetonide is NMT $1.0\%$ .  

Time span of measurement: A range of about 2 times the retention time of fluocinolone acetonide after the solvent peak.  

Loss on drying NMT $1.0\%$ ($\mathbf{0.2\thetag}$ , in vacuum, $105\ ^{\circ}\mathrm{C}$ , 3 hours).  

Residue on ignition NMT $0.1\%$ ($\mathrm{0.2~g}$ , platinum crucible).  

Assay Weigh accurately about $20~\mathrm{mg}$ each of Fluocinolone Acetonide and fluocinolone acetonide RS, previously dried, dissolve in $40~\mathrm{mL}$ of the mobile phase, add exactly $10\,\mathrm{\mL}$ of the internal standard solution each, and add the mobile phase to make $100~\mathrm{mL}$ . Use these solutions as the test solution and standard solution, respectively. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the ratios of the peak area, $Q_{\mathrm{T}}$ and $Q_{S}$ , of fluocinolone acetonide to that of internal standard, respectively.  

Amount (mg) of fluocinolone acetonide $(\mathbf{C}_{24}\mathbf{H}_{30}\mathbf{F}_{2}\mathbf{O}_{6})$ $=$ amount (mg) of fluocinolone acetonide $\mathrm{RS}{\times}\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —A solution of ethylparaben in methanol (1 in 2500).  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\;\ensuremath{\upmu\mathrm{m}}\right.\right.}$ in particle diameter).  

Column temperature: A constant temperature of about $40\,^{\circ}\mathrm{C}$ .  
Mobile phase: A mixture of water and acetonitrile $(7:3)$ .  
Flow rate: Adjust the flow rate so that the retention time of fluocinolone acetonide is about 20 minutes.   
System suitability  

System performance: Dissolve $5~\mathrm{mg}$ each of isopropyl p-hydroxybenzoate and propyl p-hydroxybenzoate in $50~\mathrm{mL}$ of acetonitrile, and add water to make $100~\mathrm{mL}$ .Proceed with $20\,\textrm{\textmu L}$ of this solution according to the above operating conditions; isopropyl p-hydroxybenzoate and propyl ${\bf p}\mathrm{.}$ -hydroxybenzoate are eluted in this order with the resolution being NLT 1.9.  

System repeatability: Repeat the test 6 times with $20\,\mathrm{\upmuL}$ of the standard solution according to the above operating conditions; the relative standard deviation of the peak area ratios of fluocinolone acetonide is NMT $1.0\%$ .  

Packaging and storage Preserve in light-resistant, tight containers.  

# Fluocinolone Acetonide Cream 플루오시놀론아세토니드크림  

Fluocinolone Acetonide Cream contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of fluocinolone acetonide $(\mathrm{C}_{24}\mathrm{H}_{30}\mathrm{F}_{2}\mathrm{O}_{6}:452.49)$ ).  

Method of preparation Prepare as directed under Creams, with Fluocinolone Acetonide.  

Identification Weigh an amount of Fluocinolone Acetonide Cream, equivalent to about $0.5~\mathrm{mg}$ of fluocinolone acetonide, according to the labeled amount, put in a centrifuge tube, disperse in $5\;\mathrm{mL}$ of water, and add $10\;\mathrm{mL}$ of chloroform. Shake to mix, and then centrifuge. Discard the water layer, add $10\;\mathrm{mL}$ of water, shake, and then centrifuge. Dehydrate $2\,\textrm{m L}$ of the chloroform extract by adding about $0.2{\mathrm{~g~}}$ of anhydrous sodium sulfate, and use this solution as the test solution. Separately, dissolve 5 mg of fluocinolone acetonide RS in $100\ \mathrm{mL}$ of chloroform, and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $50~\upmu\mathrm{L}$ each of the test solution and the standard solution onto a thin-layer chromatographic plate made of silica gel with fluorescence indicator for thin-layer chromatography. Next, develop the plate with a mixture of chloroform and diethylamine $(2:1)$ as the developing solvent to a distance of about 12 cm, and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the color and $R_{f}$ values of the principal spots from the test solution and standard solution are the same.  

Assay Weigh accurately an amount of Fluocinolone Acetonide Cream, equivalent to about $0.75~\mathrm{~mg~}$ of fluocinolone acetonide $({\bf C}_{24}{\bf H}_{30}{\bf F}_{2}{\bf O}_{6})$ , according to the labeled amount, add about $10\,\mathrm{\mL}$ of acetonitrile, and dissolve by warming on a steam bath. Transfer to a 25- mL volumetric flask, using $2~\mathrm{mL}$ each of acetonitrile 3 times. Add $3.0~\mathrm{mL}$ of the internal standard solution and $5.0\;\mathrm{mL}$ of water to mix, then add acetonitrile to the gauge line, cool in iced water, and centrifuge. Use the clear supernatant as the test solution. Separately, weigh accurately an appropriate amount of fluocinolone acetonide RS, previously dried at $105~^{\circ}\mathrm{C}$ for 3 hours, and dissolve in acetonitrile to prepare a solution containing $300~\upmu\mathrm{g}$ per mL. Pipet $5~\mathrm{mL}$ each of this solutions, add $6.0~\mathrm{mL}$ of the internal standard solution and $15.0\;\mathrm{mL}$ of water, and then add acetonitrile to make exactly $50~\mathrm{mL}$ . Use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the peak area ratios, $\mathrm{Q_{T}}$ and $\mathrm{Qs}$ , of fluocinolone acetonide to that of the internal standard, respectively.  

Amount (mg) of fluocinolone acetonide $(\mathbf{C}_{24}\mathbf{H}_{30}\mathbf{F}_{2}\mathbf{O}_{6})$ $=$ Amount (mg) of fluocinolone acetonide $\mathrm{RS}{\times}\,\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —A solution of norethindrone in acetonitrile (2 in 10000).  

Operating conditions   
Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and $30\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5~{\upmu\mathrm{m}}$ to $10\;\upmu\mathrm{m}$ in particle diameter).  

# Flow rate: $2\ \mathrm{mL/min}$  

System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the resolution between the peak of the internal standard and the peak of fluocinolone acetonide is NLT 2.0.  

System repeatability: Repeat the test 6 times with $10\,\textrm{\textmu L}$ each of the standard solution according to the above conditions; the relative standard deviation of the peak area ratio of fluocinolone acetonide to the peak area of the internal standard is NMT $1.5\%$ .  

Packaging and storage Preserve in tight containers.  

Fluocinonide 플루오시노니드  

![](images/d73d5b76fd1c566f214af4e2a8e9c81c696f5c3a678ae3456add1b33231cb56b.jpg)  

Fluocinonide ${\mathrm{C}}_{26}{\mathrm{H}}_{32}{\mathrm{F}}_{2}{\mathrm{O}}_{7}$ : 494.53 2-{(6 S,8 S,9 R,10 S,11 S,13 S,14 S,16 R,17 S)-6,9-difluoro-11- hydroxy-16,17-[(2-propylidene) bis (oxy)]-10,13- dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17- dodecahydro$.3H\cdot$ -cyclopenta[a]phenanthren-17-yl)}-2- oxoethyl acetate [ 356-12-7 ]  

Fluocinonide, when dried, contains NLT $97.0\%$ and NMT $103.0\%$ of fluocinonide $({\bf C}_{26}\mathrm{H}_{32}\mathrm{F}_{2}{\bf O}_{7})$ ).  

Description Fluocinonide occurs as white crystals or a crystalline powder.  

It is sparingly soluble in chloroform, slightly soluble in acetonitrile, methanol, ethanol(95) or ethyl acetate, very slightly soluble in ether, and practically insoluble in water.  

Identification (1) To $10~\mathrm{mg}$ of Fluocinonide, add $4~\mathrm{mL}$ of water and $1~\mathrm{mL}$ of Fehling’s TS, and heat; a red precipitate is produced.  

(2) Weigh $10~\mathrm{mg}$ of Fluocinonide, and prepare the test solution as directed under the Oxygen Flask Combustion with a mixture of $0.5~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as an absorbent; the test solution responds to the Qualitative Analysis for fluoride. (3) Determine the absorption spectra of solutions of Fluocinonide and fluocinonide RS in methanol (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(4) Determine the infrared spectra of Fluocinonide and fluocinonide RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers. If any difference appears between the absorption spectra, dissolve Fluocinonide and fluocinonide RS in ethyl acetate, respectively, evaporate ethyl acetate to dryness, and perform the test with the residue in the same manner.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $-81^{\circ}$ and $+89^{\circ}$ $\mathbf{\nabla}[0.2{\textbf{g}}$ after drying, chloroform, $20\,\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity Related substance —Dissolve $10~\mathrm{mg}$ of Fluocinonide in $2\;\mathrm{mL}$ of chloroform, and use this solution as the test solution. Pipet $1.0\ \mathrm{mL}$ of this solution, add chloroform to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and standard solution on a thin-layer chromatographic plate made of silica gel for thin-layer chromatography. Develop the plate with a mixture of chloroform and methanol $(97:3)$ as the developing solvent to a distance of about $12~\mathrm{cm}$ , and air-dry the plate. Spray evenly alkaline blue tetrazolium TS on the plate; the spots other than the principal spot obtained from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $1.0\%$ ($\mathrm{~5~g~}$ ,$105\ ^{\circ}\mathrm{C}$ , 3 hours). Residue on ignition NMT $0.1\%$ $\left.0.5\ \mathrm{g}\right.$ , platinum crucible).  

Assay Weigh accurately about $20~\mathrm{mg}$ each of Fluocinonide and fluocinonide RS, previously dried, dissolve each in $50~\mathrm{mL}$ of acetonitrile, add $8.0~\mathrm{mL}$ of the internal standard solution, respectively, and add the water to make exactly $100~\mathrm{mL}$ . Use these solutions as the test solution and standard solution, respectively. Perform the test with $20~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the ratios of the peak area, $Q_{\mathrm{T}}$ and $Q\mathrm{s}$ , of fluocinonide to that of internal standard, respectively.  

Internal standard solution —A solution of propyl benzoate in acetonitrile (1 in 100).  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).   
Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and $25~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $\ensuremath{\left\langle5\ \upmu\mathrm{m}\right.\right.}$ in particle diameter).   
Column temperature: A constant temperature of about $40\ ^{\circ}\mathbf{C}$ .  
Mobile phase: A mixture of acetonitrile and water (1: 1).   
Flow rate: Adjust the flow rate so that the retention time of fluocinonide is about 8 minutes.  

System suitability  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above operating conditions; fluocinonide and the internal standard are eluted in this order with the resolution being NLT 6.  

System repeatability: Repeat the test 6 times with $20\,\mathrm{\,\,\upmuL}$ of the standard solution according to the above conditions; the relative standard deviation of the ratios of the peak area of fluocinonide to that of the internal standard is NMT $1.0\%$ .  

Packaging and storage Preserve in well-closed containers.  

# Fluorescein Sodium 플루오레세인나트륨  

![](images/d9b8e3cfb317d9fc4e55ad2a63ebbf379cb4e124ef69247419274f4ac376c884.jpg)  

Fluorescein Sodium $\mathrm{C_{20}H_{10}N a_{2}O_{5}}$ : 376.27 2-(6-Hydroxy-3-oxo$\cdot3H$ -xanthen-9-yl)benzoic acid [ 518- 47-8 ]  

Fluorescein Sodium contains NLT $98.5\%$ and NMT $101.0\%$ of fluorescein sodium $\left({\bf C}_{20}{\bf H}_{10}{\bf N}{\bf a}_{2}{\bf O}_{5}\right)$ ), calculated on the dried basis.  

Description Fluorescein Sodium is an orange powder, and is odorless and tasteless.   
It is freely soluble in water, methanol or ethanol(95), and practically insoluble in ether.   
It is hygroscopic.  

Identification (1) An aqueous solution of Fluorescein Sodium (1 in 100) has a strong green fluorescence. Add a large quantity of water but the fluorescence remains. Acidify the solution with hydrochloric acid, and the fluorescence disappears. Then render the solution alkaline with sodium hydroxide TS; the fluorescence reappears. (2) Place an aqueous solution of Fluorescein Sodium (1 in 2000) dropwise on a piece of filter paper; a yellow spot develops. Expose the filter paper, while moist, to the bromine gas for 1 minute and then to ammonia gas; the spot exhibits a red color.  

(3) Ignite $0.5~\mathrm{g}$ of Fluorescein Sodium to carbonize. After cooling, add $20\;\mathrm{mL}$ of water to the residue, shake to mix, and filter; the filtrate responds to the Qualitative Analysis for sodium salt.  

Purity (1) Clarity and color of solution ―Dissolve $1.0~\mathrm{g}$ of Fluorescein Sodium in $10~\mathrm{mL}$ of water; the resulting solution is clear and exhibits a red color.  

(2) Chloride —Dissolve $0.15\mathrm{~g~}$ of Fluorescein Sodium in $20~\mathrm{mL}$ of water, add $6\;\mathrm{mL}$ of dilute nitric acid and water to make $30~\mathrm{mL}$ , and filter. To $20\;\mathrm{mL}$ of the filtrate, add $2~\mathrm{mL}$ of dilute nitric acid and water to make $50~\mathrm{mL}$ .Use this solution as the test solution and perform the test. Prepare the control solution with $1.0~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ hydrochloric acid (NMT $0.355\%$ ).  

(3) Sulfate —Dissolve $0.20~\mathrm{g}$ of Fluorescein Sodium in $30~\mathrm{mL}$ of water, add $2.5~\mathrm{mL}$ of dilute nitric acid and water to make $40~\mathrm{mL}$ , and filter. Add water to $20~\mathrm{mL}$ of the filtrate to make $50~\mathrm{mL}$ . Use this solution as the test solution and perform the test. Prepare the control solution with $1.0\;\mathrm{mL}$ of $0.005\;\mathrm{mol/L}$ sulfuric acid (NMT $0.480\%$ ). (4) Zinc —Dissolve $0.1\ \mathrm{g}$ of Fluorescein Sodium in $10~\mathrm{mL}$ of water, add $2~\mathrm{mL}$ of hydrochloric acid, and filter. To the filtrate, add $0.1\,\mathrm{~mL~}$ of potassium hexacyanoferrate(II) TS; no turbidity is produced immediately. (5) Related substances —Weigh $0.20~\mathrm{g}$ of Fluorescein Sodium, dissolve in exactly $10~\mathrm{mL}$ of methanol and use this solution as the test solution. With this solution, perform the test as directed under the Thin Layer Chromatography. Spot $5~\upmu\mathrm{L}$ of the test solution on the thinlayer chromatographic plate made of silica gel for thinlayer chromatography. Develop the plate with a mixture of chloroform, methanol and ammonia water(28) $30:\$ $15:1_{.}$ as the developing solvent to a distance of about 10 cm, and air-dry the plate; any colored spot other than the principal spot does not appear.  

Loss on drying NMT $10.0\%$ $(1\;\;\mathrm{g},\;105\;\;^{\circ}\mathrm{C},$ , constant mass).  

Assay Weigh accurately about $0.5~\mathrm{g}$ of Fluorescein Sodium, transfer to a separatory funnel, dissolve in $20~\mathrm{mL}$ of water, and add $5~\mathrm{mL}$ of dilute hydrochloric acid. Extract 4 times with $20\,\mathrm{\mL}$ of a mixture of 2-methyl-1- propanol and chloroform $(1:1)$ . Wash each extract successively with $10~\mathrm{mL}$ of water. Evaporate the combined extracts on a steam bath with the aid of a current of air. Dissolve the residue in $10\;\mathrm{mL}$ of ethanol(99.5), evaporate the solution to dryness on a steam bath, dry the residue at $105~^{\circ}\mathrm{C}$ for 1 hour, and weigh as fluorescein ( $\mathrm{{C}_{20}\mathrm{{H}_{12}\mathrm{{O}_{5}}}}$ :332.31).  

Amount (mg) of fluorescein sodium $\left({\bf C}_{20}{\mathrm{H}}_{10}{\mathrm{Na}}_{2}{\mathrm{O}}_{5}\right)$ $=$ Amount (mg) of fluorescein $(\mathrm{C}_{20}\mathrm{H}_{12}\mathrm{O}_{5})\times1.1323$ Packaging and storage Preserve in tight containers.  

# Fluorometholone 플루오로메톨론  

![](images/63fd584fd028a07011003da8156b618d7e195cdaf6596676c254c2eea751c631.jpg)  

Fluorometholone $\mathrm{C}_{22}\mathrm{H}_{29}\mathrm{FO}_{4}$ : 376.46 (6 S,8 S,9 R,10 S,11 S,13 S,14 S,17 R)-17-Acetyl-9-fluoro11,17-dihydroxy-6,10,13-trimethyl6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- $.3H.$ -cyclopenta[a]phenanthren-3-one [ 426-13-1 ]Fluorometholone, when dried, contains NLT $97.0\%$ and NMT $103.0\%$ of fluorometholone $(\mathrm{C}_{^{22}}\mathrm{H}_{^{29}}\mathrm{FO}_{4})$ ).  

Description Fluorometholone occurs as a white to pale yellowish white crystalline powder, and is odorless.  

It is freely soluble in pyridine, slightly soluble in methanol, ethanol(95) or tetrahydrofuran, and practically insoluble in water or ether.  

Identification (1) Proceed with $7~\mathrm{mg}$ of Fluorometholone as directed under the Oxygen Flask Combustion, using a mixture of $0.5~\mathrm{mL}$ of $0.01\;\mathrm{mol/L}$ sodium hydroxide TS and $20\;\mathrm{mL}$ of water as the absorbent; the resulting test solution responds to the Qualitative Analysis (2) for fluoride.  

(2) Determine the absorption spectra of solutions of Fluorometholone and fluorometholone RS (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

(3) Determine the infrared spectra of Fluorometholone and fluorometholone RS, previously dried, as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

Optical rotation $[\alpha]_{\mathrm{D}}^{20}$ : Between $+52^{\circ}$ and $+60^{\circ}$ ($\mathrm{[0.1~g}$ after drying, pyridine, $10\;\mathrm{mL}$ ,$100\;\mathrm{mm}$ ).  

Purity (1) Heavy metals —Proceed with $1.0~\mathrm{g}$ of Fluorometholone according to Method 3 and perform the test. Prepare the control solution with $2.0\ \mathrm{mL}$ of lead standard solution (NMT $20\,\mathrm{ppm}$ ).  

(2) Related substances —Dissolve $20~\mathrm{mg}$ of Fluorometholone in $10\,\mathrm{\mL}$ of tetrahydrofuran and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add tetrahydrofuran to make exactly $100\;\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $25~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of dichloromethane, acetone and methanol $(45:5:1)$ as the developing solvent to a distance of about $12~\mathrm{cm}$ , and airdry the plate. Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $1.0\%$ ($\mathrm{0.2~g}$ , in vacuum, phosphorus pentoxide, $60\ ^{\circ}\mathrm{C}$ , 3 hours).  

Residue on ignition NMT $0.2\%$ ($\mathrm{.}2\mathrm{~g~}$ , platinum crucible).  

Assay Weigh accurately about $0.10\mathrm{~g~}$ each of Fluorometholone and fluorometholone RS, previously dried, and dissolve each in methanol to make exactly $100~\mathrm{mL}$ .Pipet $5~\mathrm{mL}$ each of these solutions, and add diluted methanol (7 in 10) to make exactly $50~\mathrm{mL}$ . Pipet $10~\mathrm{mL}$ each of these solutions, add exactly $10\,\mathrm{\mL}$ of the internal standard solution each, add again diluted methanol (7 in 10) to make $100~\mathrm{mL}$ , and use these solutions as the test solution and the standard solution. Perform the test with $25~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions, and calculate the ratios, $Q_{\mathrm{T}}$ and $Q_{S}$ , of the peak area of fluorometholone to that of the internal standard.  

Amount (mg) of fluorometholone $(\mathrm{C}_{22}\mathrm{H}_{29}\mathrm{FO}_{4})$ $=$ amount (mg) of fluorometholone $\mathrm{RS}{\times}\frac{Q_{\mathrm{T}}}{Q_{\mathrm{S}}}$ Internal standard solution —A solution of butyl phydroxybenzoate in methanol (1 in 10000).  

# Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column, about $4\textrm{m m}$ in internal diameter and $25~\mathrm{cm}$ to $30~\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography ( $5\;\upmu\mathrm{m}$ in particle diameter).  

Column temperature: A constant temperature of about $35\;^{\circ}\mathrm{C}$ .  

System performance: Proceed with $20~\upmu\mathrm{L}$ of the standard solution according to the above conditions; fluorometholone and the internal standard are eluted in this order with the resolution between their peaks being NLT 4.  

Packaging and storage Preserve in light-resistant, wellclosed containers.  

# Fluorometholone and Tetrahydrozoline Hydrochloride Ophthalmic Suspension 플루오로메톨론·테트라히드로졸린염산염점안현탁액  

Fluorometholone and Tetrahydrozoline Hydrochloride Ophthalmic Suspension contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of fluorometholone $(\mathrm{C}_{22}\mathrm{H}_{29}\mathrm{FO}_{4}:376.47)$ and tetrahydrozoline hydrochloride $(\mathbf{C}_{13}\mathrm{H}_{16}\mathrm{N}_{2}\cdot\mathrm{HCl}:236.75)$ .  

Method of preparation Prepare as directed under Ophthalmic Solutions, with Fluorometholone and Tetrahydrozoline Hydrochloride.  

Identification (1) Fluorometholone —Shake Fluorometholone and Tetrahydrozoline Hydrochloride Ophthalmic Suspension vigorously to mix, put $4\;\mathrm{mL}$ in a separatory funnel, add $1\,\mathrm{\textbf{g}}$ of sodium chloride, and shake vigorously until the sodium chloride is dissolved. Add 2 mL of $1~\mathrm{mol/L}$ hydrochloric acid, extract 5 times with 20 mL of ethyl acetate, add the extract to a $250{\-}\mathrm{mL}$ round flask, and evaporate to dryness in an evaporator. Dissolve the residue in $4~\mathrm{mL}$ of methanol, and use this solution as the test solution. Separately, weigh $20\,\mathrm{~mg~}$ of fluorometholone RS, dissolve in methanol to make $20~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $25~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescence indicator for thin-layer chromatography. Next, develop the plate with a mixture of toluene, methanol and ethyl acetate $(4:1:1)$ as the developing solvent to a distance of about $10\ \mathrm{cm}$ ,and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\;\mathrm{nm}$ ) or spray evenly a coloring agent onto the plate, and heat at $110\ \ ^{\circ}\mathrm{C}$ for 10 minutes; the $R_{f}$ value and color of the spots obtained from the test solution and the standard solution are the same.  

Coloring agent: While cooling with iced water, add carefully $10~\mathrm{mL}$ of sulfuric acid into a beaker containing $10~\mathrm{mL}$ of methanol. This test solution can be stored in a tight container for 1 week.  

# Particulate contamination: Visible particles Meets the requirements.  

# Particulate matter in Ophthalmic solutions Meets the requirements.  

Assay (1) Fluorometholone —Perform the test as directed under the section on Fluorometholone ophthalmic suspension in the US Pharmacopeia (USP).  

(2) Tetrahydrozoline hydrochloride —Perform the test as directed under the section on tetrahydrozoline hydrochloride ophthalmic solution in the US Pharmacopeia (USP).  

# Packaging and storage Preserve in tight containers.  

![](images/e129ef7f15671c564d5f60061356283f0beb71a1220edf3fcfec72e9fdf6247b.jpg)  

(2) Tetrahydrozoline hydrochloride —Take $10\,\mathrm{\mL}$ of Fluorometholone and Tetrahydrozoline Hydrochloride Ophthalmic Suspension, filter through a filter paper, and then take $8.0~\mathrm{mL}$ of the filtrate to put in a separatory funnel. Add $2~\mathrm{mL}$ of $2\ \mathrm{mol/L}$ sodium hydroxide solution and $2\mathrm{~g~}$ of sodium chloride, and shake vigorously until the sodium chloride is dissolved. Extract this 5 times with 10 mL of ethyl acetate, add the extracts to a $100{\-}\mathrm{mL}$ round flask, and evaporate to dryness in an evaporation concentrator. Dissolve the residue in $2~\mathrm{mL}$ of ethanol, and use this solution as the test solution. Separately, weigh accurately about $50~\mathrm{mg}$ of tetrahydrozoline hydrochloride RS, dissolve in ethanol to make exactly $50~\mathrm{mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $25~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescence indicator for thinlayer chromatography. Next, develop the plate using a mixture of methanol, acetic acid and water $(8:1:1)$ as the developing solvent to a distance of about $10~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254\ \mathrm{\nm}$ ) or spray evenly Dragendorff's TS onto the plate; the $R_{f}$ values and color of the spots obtained from the test solution and the standard solution are the same.  

Fluorouracil $\mathrm{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathrm{O}_{2}$ : 130.08 5-Fluoropyrimidine-2,4 $(1H,3H)$ -dione [ 51-21-8 ]  

Fluorouracil, when dried, contains NLT $98.5\%$ and NMT $101.0\%$ of fluorouracil $(\mathbf{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathbf{O}_{2})$ . It also contains NLT $13.1\%$ and NMT $16.1\%$ of fluorine (F: 19.00). Description Fluorouracil occurs as white crystals or a crystalline powder, which is odorless.  

It is freely soluble in $N,N\!.$ -dimethylformamide, sparingly soluble in water, slightly soluble in ethanol(95) and practically insoluble in ether.  

Melting point —About $282^{\circ}\mathbf{C}$ (with decomposition). Identification (1) To $5\ \mathrm{mL}$ of an aqueous solution of Fluorouracil (1 in 500), add $0.2\ \mathrm{mL}$ of bromine TS; the color of the test solution disappears. Again, add $2~\mathrm{mL}$ of barium hydroxide TS; a purple precipitate is formed.  

(2) Weigh $10~\mathrm{{mg}}$ of Fluorouracil, and prepare the test solution as directed under the Oxygen Flask Combustion with a mixture of $0.5~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ sodium hydroxide TS and $20~\mathrm{mL}$ of water as an absorbent; the test solution responds to the Qualitative Analysis for fluoride. (3) Determine the absorption spectra of solutions of solutions of Fluorouracil and fluorouracil RS in 0.1 mol/L hydrochloric acid TS (1 in 100000) as directed under the Ultraviolet-visible Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavelengths.  

Purity (1) Clarity and color of solution —Dissolve 0.20 $\mathrm{g}$ of Fluorouracil in $20~\mathrm{mL}$ of water by warming; the so  

lution is clear and colorless.  

(2) Fluoride —Weigh $1.10\,\mathrm{~g~}$ of Fluorouracil and dissolve in $10.0~\mathrm{mL}$ of $0.1\ \mathrm{mol/L}$ dilute sodium hydroxide (1 in 20). To $5.0\;\mathrm{mL}$ of this solution, add $10~\mathrm{mL}$ of a mixture of alizarin complexone TS, acetic acid-potassium acetate buffer solution $(\mathrm{pH}\,4.3)$ and cerium(III) nitrate TS $(1:1:1)$ , add water to make exactly $20\,\mathrm{\mL}$ , allow to stand for 1 hour, and use this solution as the test solution. Separately, add $5.0~\mathrm{mL}$ of $0.01\ \mathrm{mol/L}$ dilute sodium hydroxide TS (1 in 20) to $1.0\ \mathrm{mL}$ of standard fluorine solution, add $10~\mathrm{mL}$ of a mixture of alizarin complexone TS, acetic acid-potassium acetate buffer solution $(\mathrm{pH}\,4.3)$ and cerium(III) nitrate TS $(1:1:1)$ , and proceed in the same manner as the test solution. Use this solution as the standard solution. Determine the absorbance of these solutions as directed under the Ultraviolet-visible Spectroscopy using a solution obtained by proceeding with 5.0 mL of $0.01\ \mathrm{mol/L}$ dilute sodium hydroxide TS (1 in 20) in the same manner as the standard solution as a control; the absorbance of the test solution at $600~\mathrm{nm}$ not greater than that of the standard solution (NMT $0.012\%$ ).  

(3) Heavy metals —Proceed with $1.0\,\mathrm{~g~}$ of Fluorouracil according to Method 2 and perform the test. Prepare the control solution with $2.0\,\textrm{m L}$ of lead standard solution (NMT 20 ppm).  

(4) Arsenic —Put $1.0~\mathrm{g}$ of Fluorouracil into a crucible, add $10\;\mathrm{mL}$ of a solution of magnesium nitrate in ethanol(95) (1 in 10), ignite with ethanol(95) to combust, and then incinerate by heating at 750 to $850~^{\circ}\mathrm{C}$ . If a carbonized substance remains in this method, moisten with a small amount of nitric acid, and incinerate by ignition. Cool, add $10~\mathrm{mL}$ of dilute hydrochloric acid to the residue, dissolve by warming on a steam bath, use this solution as the test solution, and perform the test (NMT 2 ppm).  

(5) Related substances —Weigh $0.10\,\mathrm{~g~}$ of Fluorouracil, dissolve in $10~\mathrm{mL}$ of water, and use this solution as the test solution. Pipet $1~\mathrm{mL}$ of this solution, add water to make exactly $200\,\mathrm{\mL}$ , and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Spot $10~\upmu\mathrm{L}$ each of the test solution and the standard solution on the thin-layer chromatographic plate made of silica gel with fluorescent indicator for thin-layer chromatography. Develop the plate with a mixture of ethyl acetate, acetone and water $(7:4:1)$ as the developing solvent to a distance of about $12~\mathrm{cm}$ , and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the spots other than the principal spot from the test solution are not more intense than the spots from the standard solution.  

Loss on drying NMT $0.5\%$ ($1\ \mathrm{g}.$ , in vacuum, $80~^{\circ}\mathbf{C},$ , 4 hours).  

# Residue on ignition NMT $0.1\%$ (1 g).  

Assay (1) Fluorouracil —Weigh accurately about $0.2{\mathrm{~g~}}$ of Fluorouracil, previously dried, dissolve in $20\,\mathrm{\mL}$ of N,N -dimethylformamide, and titrate with $0.1\ \mathrm{mol/L}$ tetramethylammonium hydroxide VS (indicator: 3 drops of thymol blue-dimethylformamide TS). However, the endpoint of the titration is when this solution changes from yellow to bluish green and then finally to blue. Perform a blank test in the same manner and make any necessary correction.  

Each mL of $0.1\ \mathrm{mol/L}$ tetramethylammonium hydroxide $=13.008\;\mathrm{mg}$ of $\mathrm{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathrm{O}_{2}$  

(2) Fluorine —Weigh accurately about $4~\mathrm{\mg}$ of Fluorouracil, previously dried, and perform the test as directed under the Assay of fluorine under the Oxygen Flask Combustion, using a mixture of $0.5\,\mathrm{\mL}$ of 0.01 mol/L sodium hydroxide TS and $20~\mathrm{mL}$ of water as an absorbent.  

Packaging and storage Preserve in tight containers.  

# Fluorouracil Cream 플루오로우라실크림  

Fluorouracil Cream contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of fluorouracil $(\mathrm{C_{4}H_{3}F N_{2}O_{2}}:130.08)$ .  

Method of preparation Prepare as directed under Creams, with Fluorouracil. Sodium hydroxide may be added to adjust the $\mathrm{pH}$ of Fluorouracil Cream.  

Identification Weigh an amount of Fluorouracil Cream, equivalent to $5~\mathrm{mg}$ of fluorouracil, according to the labeled amount, put in an Erlenmeyer flask with a stopper, add $50\,\mathrm{\mL}$ of ethanol(95), and shake to mix. Use this solution as the test solution. Separately, weigh $5~\mathrm{mg}$ of fluorouracil RS, dissolve in $50\,\mathrm{\mL}$ of ethanol(95), and use this solution as the standard solution. With these solutions, perform the test as directed under the Thin Layer Chromatography. Using $100~\upmu\mathrm{L}$ each of the test solution and the standard solution, spot $20~\upmu\mathrm{L}$ each of the solution 5 times at the line $3\ \mathrm{cm}$ from the bottom end of a thinlayer chromatographic plate made of silica gel for thinlayer chromatography. Develop the plate with a mixture of ethyl acetate, methanol and ammonia water(28) $(75:$ $25:1)$ as the developing solvent to a distance of about 15 cm, and air-dry the plate. Examine the plate under ultraviolet light (main wavelength: $254~\mathrm{nm}$ ); the $R_{f}$ value and the color of the spots obtained from the test solution and the standard solution are the same.  

Assay Weigh accurately an amount of Fluorouracil Cream, equivalent to about $10~\mathrm{~mg~}$ of fluorouracil $(\mathbf{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathbf{O}_{2})$ , add $20~\mathrm{mL}$ of methanol, shake to mix, and add water to make $100~\mathrm{mL}$ . Pipet $1~\mathrm{mL}$ of this solution, add water to make $10\;\mathrm{mL}$ , filter, and use the filtrate as the test solution. Separately, weigh accurately about $10\;\mathrm{mg}$ of fluorouracil RS, previously dried, dissolve in water to make $100\;\mathrm{mL}$ , pipet $1~\mathrm{mL}$ of this solution, and add water to make $10\;\mathrm{mL}$ . Use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the operating conditions under Fluorouracil injection, and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fluorouracil.  

Amount (mg) of fluorouracil $(\mathrm{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathrm{O}_{2})$ )$=$ Amount (mg) of fluorouracil $\begin{array}{r}{\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}}\end{array}$ Packaging and storage Preserve in tight containers.  

# Fluorouracil Injection 플루오로우라실주사액  

Fluorouracil Injection is an aqueous solution for injection and contains NLT $90.0\%$ and NMT $110.0\%$ of the labeled amount of fluorouracil $(\mathrm{C_{4}H_{3}F N_{2}O_{2}}:130.08)$ .Method of preparation Prepare as directed under Injections, with Fluorouracil by adding sodium hydroxide.  

Description Fluorouracil Injection occurs as a clear, colorless liquid.  

Identification (1) The retention times of the major peaks from the test solution and the standard solution obtained under the Assay are the same.  

(2) Take an amount of Fluorouracil Injection equivalent to about $0.1\,\mathrm{~g~}$ of fluorouracil according to the labeled amount, carefully acidify with acetic acid(100), and shake the solution to precipitate fluorouracil. Collect the precipitate, wash with $1~\mathrm{mL}$ of water, and dry at $80\,^{\circ}\mathrm{C}$ for 4 hours in a desiccator (phosphorus pentoxide). Determine the infrared spectra of the precipitate and Fluorouracil RS, respectively, as directed in the paste method under Infrared Spectrophotometry: both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(3) Proceed as directed under the Identification (1) under Fluorouracil.  

pH Between 8.6 and 9.4. Sterility Meets the requirements. Bacterial endotoxins Less than 0.33 EU per mg of fluorouracil.  

Particulate contamination: Visible particles Meets the requirements.  

Insoluble particulate matter in injections Meets the requirements.  

Extractable volume of injections Meets the requirements.  

Assay Pipet an amount of fluorouracil injection equivalent to about $50~\mathrm{mg}$ of fluorouracil $\left({\bf C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}{\bf O}_{2}\right)$ ) according to the labeled amount, and add water to make exactly $100~\mathrm{mL}$ . Take $5~\mathrm{mL}$ of this solution, add water to make $250~\mathrm{mL}$ , and use this solution as the test solution. Separately, weigh accurately about $10~\mathrm{mg}$ of fluorouracil RS, previously dried, dissolve in water to make $100\;\mathrm{mL}$ , pipet $5~\mathrm{mL}$ of this solution, add water to make $50~\mathrm{mL}$ and use this solution as the standard solution. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and the standard solution as directed under the Liquid Chromatography according to the following conditions and determine the peak areas, $A_{\mathrm{T}}$ and $A_{S}$ , of fluorouracil for the test solution and the standard solution, respectively.  

Amount (mg) of fluorouracil $(\mathbf{C}_{4}\mathrm{H}_{3}\mathrm{FN}_{2}\mathbf{O}_{2})$ )$=$ Amount (mg) of fluorouracil $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}\times\!5$ Detector: An ultraviolet absorption photometer (wavelength: $254\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4\textrm{m m}$ in internal diameter and $30\;\mathrm{cm}$ in length, packed with octadecylsilanized silica gel for liquid chromatography (3 to $10\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: Water Flow rate: $1.0\,\mathrm{mL/min}$ System suitability  

System performance: Proceed with $10~\upmu\mathrm{L}$ of the standard solution according to the above conditions; the number of theoretical plates of the fluorouracil peak is NLT 2500.  

System repeatability: Repeat the test 6 times with $10\,\upmu\mathrm{L}$ of the standard solution according to the above conditions; the relative standard deviation of the peak area of fluorouracil is NMT $2.0\%$ .  

Packaging and storage Preserve in light-resistant hermetic containers in a dark place, avoiding freezing.  

# Fluoxetine Hydrochloride 플루옥세틴염산염  

![](images/98525e92e0f51f4cf084b7e6f00f92fedd94ceecbff6b899918b80b48e0878b7.jpg)  

(trifluoromethyl)phenoxy]propan-1-aminehydrochloride [56296-78-7 ]  

Fluoxetine Hydrochloride contains NLT $98.0\%$ and NMT $102.0\%$ of fluoxetine hydrochloride $\protect(\mathrm{C}_{17}\mathrm{H}_{18}\,\mathrm{~F~}_{3}$ NO·HCl), calculated on the anhydrous basis.  

Description Fluoxetine Hydrochloride occurs as a white crystalline powder.  

It is freely soluble in ethanol(95) or methanol, sparingly soluble in water or dichloromethane, and practically insoluble in ether.  

Identification (1) Determine the infrared spectra of Fluoxetine Hydrochloride and fluoxetine hydrochloride RS as directed in the potassium bromide disk method under the Mid-infrared Spectroscopy; both spectra exhibit similar intensities of absorption at the same wavenumbers.  

(2) An aqueous solution of Fluoxetine Hydrochloride (1 in 50) responds to the Qualitative Analysis for chloride.  

Purity (1) Heavy metals —Proceed with $1.0\;\mathrm{g}$ of Fluoxetine Hydrochloride as directed under Method 2 and perform the test. Prepare the control solution with $3.0\;\mathrm{mL}$ of lead standard solution (NMT 30 ppm).  

(2) Related substances —Weigh accurately about 56 mg of Fluoxetine Hydrochloride, dissolve in the mobile phase to make exactly $10\;\mathrm{mL}$ , and use this solution as the test solution (1). To $2.0~\mathrm{mL}$ of the test solution (1), add the mobile phase to make exactly $10\,\mathrm{\mL}$ , and use this solution as the test solution (2). Perform the test with exactly $10~\upmu\mathrm{L}$ each of the test solutions (1) and (2) as directed under the Liquid Chromatography according to the following operating conditions, and determine the peak area of fluoxetine related substance I, i.e. $[(\alpha,\alpha,\alpha-$ (trifluoro$\cdot m$ -tolyl)oxy]propylamine hydrochloride}, $A_{\mathrm{{T}}}{}.$ ,and the peak area of fluoxetine, $A_{\mathrm{U}}$ , obtained from the test solution (2). Determine the peak area of individual related substance, $A_{\mathrm{i}}$ , and the total area of related substance peaks other than the major peak, $A_{S}$ , obtained from the test solution (1). The amount of related substance I is NMT $0.15\%$ ,the amount of $\mathfrak{a}$ -[2- (methylamino)ethyl]benzene methanol is NMT $0.25\%$ ,the amount of fluoxetine related substance II ( $N_{\mathbf{\Psi}}$ -methyl3-phenylpropylamine) is NMT $0.25\%$ , the amount of each related substance is NMT $0.1\%$ , and the total amount of related substances is NMT $0.5\%$ .  

Content $(\%)$ of fluoxetine related substance I  

$$
=\,100\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{T}}+A_{\mathrm{U}}}}
$$  

Content $(\%)$ of individual related substances  

$$
=\ 100\times{\frac{A_{\mathrm{T}}}{A_{\mathrm{T}}+5A_{\mathrm{U}}}}
$$  

Operating conditions  

Detector: An ultraviolet absorption photometer  

(wavelength: $215\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with base-deactivated octylsilyl silica gel for liquid chromatography ( $5\;\upmu\mathrm{m}$ in particle diameter).  

Mobile phase: A mixture of triethylamine buffer solution, stabilizer-free tetrahydrofuran, and methanol $(6:3:1)$ .  

Flow rate: 1 mL/min System suitability  

System performance: Dissolve about $22\,\textrm{m g}$ of fluoxetine hydrochloride in $10\,\mathrm{\mL}$ of $1\,\mathrm{\mol/L}$ sulfuric acid TS, heat at $80~^{\circ}\mathrm{C}$ for 3 hours, cool it, put $0.4~\mathrm{mL}$ of this solution into the $25~\mathrm{mL}$ volumetric flask, weigh and add $28~\mathrm{~mg}$ of fluoxetine hydrochloride RS, $1~\mathrm{\mg}$ of fluoxetine related substance I RS and $1~\mathrm{mg}$ of fluoxetine related substance II RS, then add the mobile phase to make exactly $25~\mathrm{mL}$ . Proceed with $10~\upmu\mathrm{L}$ of this solution according to the above operation conditions; the relative retention times of peaks of $\mathbf{\Delta}_{\mathbf{{G}}}$ -[2- (methylamino)ethyl]benzene methanol, related substance II, related substance I, fluoxetine and 4- trifluoromethylphenyl are about 0.24, 0.27, 0.94, 1.0 and 2.17, respectively, while the peak height ratio of the related substance I to the valley depth between the fluoxetine peak and the related substance I peak, measured from the related substance I peak, is NMT 1.1.  

Time span of measurement: At least 2 times the retention time of fluoxetine.  

Triethylamine buffer solution —Add $980~\mathrm{mL}$ of water to $10\;\mathrm{mL}$ of triethylamine, then add phosphoric acid to adjust the $\mathrm{pH}$ to 6.0.  

Water NMT $0.5\%$ ($\mathrm{~\textit~{~1~g~}~}$ , volumetric titration, direct titration).  

Assay Weigh accurately about $10~\mathrm{mg}$ each of Fluoxetine Hydrochloride and fluoxetine hydrochloride RS, dissolve in the mobile phase to make exactly $100~\mathrm{mL}$ each, and use these solutions as the test solution and standard solution, respectively. Perform the test with $10~\upmu\mathrm{L}$ each of the test solution and standard solution as directed under the Liquid Chromatography according to the following conditions, and determine the major peak areas from each solution, $A_{\mathrm{T}}$ and $A_{\mathrm{{S}}}$ , respectively.  

# Amount (mg) of fluoxetine hydrochloride  

$=$ amount (mg) of fluoxetine hydrochloride $\mathrm{RS}\!\times\!\frac{A_{\mathrm{T}}}{A_{\mathrm{S}}}$  

Operating conditions  

Detector: An ultraviolet absorption photometer (wavelength: $215\;\mathrm{nm}$ ).  

Column: A stainless steel column about $4.6~\mathrm{mm}$ in internal diameter and about $25~\mathrm{cm}$ in length, packed with base-deactivated octylsilyl silica gel for liquid chromatography ( $5\;{\upmu\mathrm{m}}$ in particle diameter).  